Wikipedysta:Karol007/do zrobienia

Z Wikipedii

Dziś jest niedziela, 22 czerwca 2008 roku.				Udział w projektach Wikimedia
Polska Wikipedia aktualnie posiada: 13 671 516 edycji. 883 322 wszystkich podstron. 513 364 artykułów. 200 940 użytkowników. 147 administratorów. 16 516 plików.		Różne		Wikipedie
			Statystyki wejść		pl	admin	Karol007	talk	edycje	co un t
			Bluzgi w opisach zmian		pl	bot	KamikazeBot	talk	edycje	count
			Mail do użytkownika		de		Karol007	talk	edycje	count
					en		Karol007	talk	edycje	count
					fr		Karol007	talk	edycje	count
WikiWiki		Narzędzia		Siostrzane projekty
	Ściągawka		Ostatnie zmiany (OZ)		Wikicytaty		Karol007	talk	edycje	count
	Brudnopisy: 1 2 3 4 5		Cat Scan		Wikinews		Karol007	talk	edycje	count
	Inne podstrony		CheckUsage	Projekty Meta
	Do zrobienia^[e]		Generator Holka		meta		Karol007	talk	edycje	count
	Komu zawracam głowę		Generator Holka		commons		Karol007	talk	edycje	count
	Galeria		Strażnik IP	Inne
	Linki		Detektyw - histCK		Wikimedia Polska		Karol007	talk	edycje	-
	Technikalia				Wikimedia Polska		Karol007	talk	edycje	-

[edytuj] Przeprowadzane rekategoryzacje

Rekategoryzowana kategoria	Lista pracujących "mrówek"	Data rozpoczęcia	Stan prac
Zakończone rekategoryzacje

Grafiki do narysowania:

~~Cykl glioksalanowy - praca trwa, odłożone na lipiec~~

	0%					100%
Postęp

	0%					100%
Postęp

[edytuj] .png (.gif) -> .svg (kolor)

[edytuj] Inne

Uzupełnienie szablonu Związek chemiczny aktywny:

Dla glicyny

Występowanie w białkach 7.2 %
Objętość van der Waalsa 48 Å³
Kodony GGU, GGC, GGA, GGG

dla białek, hormonów i dorobnocząsteczkowych związków np. glukozy:

stężenie w taknach

[edytuj] Rozwijane artykuły

[edytuj] Tłumaczenia fragmentów lub całych artykułów

**Czynniki krzepnięcia krwi i inne zaangażowane związki**
Numer lub nazwa	Funkcja
I (fibrynogen)	Tworzenie skrzepu fibrynowego
II (protrombina)	Pod wpływem protrombinazy przekształcana jest w nierozpuszczalną trombinę (IIa). Uczynniany na powierzchni płytek krwi przez kompleks protrombinowy (Ca²⁺, czynnik Va i Xa) (czynniki II, VII, IX, X są zymogenami zawierającymi reszty karboksyglutaminowe)
III tromboplastyna (czynnik tkankowy)	Na powierzchni pobudzonych komórek śródbłonka w obecności fosfolipidu staje sie kofaktorem dla czynnika VIII
Ca²⁺	Niezbędny do aktywacji zymogenów, reszty Gla na N-końcach cząsteczek (czynniki II, VII, IX i X) są miejscami o dużym powinowactwie do jonów Ca²⁺
V (proakceleryna)	Aktywowany jest przez trombinę, uaktywniony czynnik V (Va) jest kofaktorem w reakcji aktywacji protrombiny przez czynnik Xa
VI	niesklasyfikowany - dawna nazwa czynnika Va
VII	Aktywowany przez trombinę w obecności jonów wapnia, wraz z czynnikiem tkankowym (TF) inicjuje proces krzepnięcia
VIII (czynnik antyhemofilowy)	Aktywowany przez trombinę, czynnik VIIIa jest kofaktorem w reakcji aktywacji czynnika X przez czynnik IXa
IX (czynnik Christmasa)	Aktywowany przez czynnik XIa w obecności jonów wapnia, jest zymogenem posiadającym zależne od witaminy K reszty γ-karboksyglutaminianowe. Aktuwuje czynnik IX do proteazy serynowej - czynnika IXa, rozkładającego wiązanie między argininą i izoleucyną w cząsteczce czynnika X
X (czynnik Stuart-Prower)	Activates II: froms prothrombinase complex with factor V
XI (plasma thromboplastin antecedent)	Activates XII, IX and prekallikrein
XII (Hageman factor)	Activates prekallikrein and fibrinolysis
XIII (fibrin-stabilizing factor)	Crosslinks fibrin
Czynnik von Willebranda	Binds to VIII, mediates platelet adhesion
Prekalikreina	Activates XII and prekallikrein; cleaves HMWK
Wielkocząsteczkowy kininogen (HMWK)	Supports reciprocal activation of XII, XI, and prekallikrein
fibronectin	Mediates cell adhesion
antithrombin III	Inhibits IIa, Xa, and other proteases;
heparin cofactor II	Inhibits IIa, cofactor for heparin and dermatan sulfate ("minor antithrombin")
Białko C	Deaktywuje
protein S	Cofactor for activated protein C (APC, inactive when bound to C4b-binding protein)
protein Z	Mediates thrombin adhesion to phospholipids and stimulates degradation of factor X by ZPI
Protein Z-related protease inhibitor (ZPI)	Degrades factors X (in presence of protein Z) and XI (independently)
plasminogen	Converts to plasmin, lyses fibrin and other proteins
alpha 2-antiplasmin	Inhibits plasmin
tissue plasminogen activator (tPA)	Activates plasminogen
urokinase	Activates plasminogen
plasminogen activator inhibitor-1 (PAI1)	Inactivates tPA & urokinase (endothelial PAI)
plasminogen activator inhibitor-2 (PAI2)	Inactivates tPA & urokinase (placental PAI)
cancer procoagulant	Pathological factor X activator linked to thrombosis in cancer

[edytuj] l.poj. -> l.mnoga

~~sól amonowa - sole amonowe~~

~~prostaglandyna - prostaglandyny~~

oligomer - oligomery

[edytuj] Arty

[edytuj] Brakujące niezbędne dane w infoboxach lub zupełny brak danych

[edytuj] Numery cas różnych związków

EINECS-nr.; CAS-nr.; Name; Summenformel

[edytuj] < 100

200-694-7; 68-89-3; [[Natrium-[(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino] methansulfonat]]; C13H17N3O4S.Na
200-719-1; 69-91-0; a-Phenylglycin; C8H9NO2
200-831-0; 75-01-4; Chlorethylen; C2H3Cl
200-915-7; 75-91-2; tert-Butylhydroperoxid; C4H10O2
200-936-1; 76-13-1; 1,1,2-Trichlortrifluorethan; C2Cl3F3
200-945-0; 76-22-2; Bornan-2-on; C10H16O
201-052-9; 77-73-6; 3a,4,7,7a-Tetrahydro-4,7-methanoinden; C10H12
201-074-9; 77-99-6; Propylidintrimethanol; C6H14O3
201-114-5; 78-40-0; Triethylphosphat; C6H15O4P
201-116-6; 78-42-2; Tris(2-ethylhexyl)phosphat; C24H51O4P
201-126-0; 78-59-1; 3,5,5-Trimethylcyclohex-2-enon; C9H14O
201-148-0; 78-83-1; 2-Methylpropan-1-ol; C4H10O
201-155-9; 78-90-0; Propylendiamin; C3H10N2
201-158-5; 78-92-2; Butan-2-ol; C4H10O
201-162-7; 78-96-6; 1-Aminopropan-2-ol; C3H9NO
201-166-9; 79-00-5; 1,1,2-Trichlorethan; C2H3Cl3
201-196-2; 79-33-4; 1-(+)-Milchsäure; C3H6O3
201-199-9; 79-36-7; Dichloracetylchlorid; C2HCl3O
201-202-3; 79-39-0; Methacrylamid; C4H7NO
201-204-4; 79-41-4; Methacrylsäure; C4H6O2
201-210-7; 79-50-5; (±)-Dihydro-3-hydroxy-4,4-dimethylfuran-2(3H)-on; C6H10O3
201-245-8; 80-05-7; 4,4'-Isopropylidendiphenol; C15H16O2
201-254-7; 80-15-9; a,a-Dimethylbenzylhydroperoxid; C9H12O2
201-279-3; 80-43-3; Bis(a,a-dimethylbenzyl)peroxid; C18H22O2
201-281-4; 80-47-7; 1-Methyl-1-(4-methylcyclohexyl)ethylhydroperoxid; C10H20O2
201-291-9; 80-56-8; Pin-2(3)-en; C10H16
201-325-2; 81-11-8; 4,4'-Diaminostilben-2,2'-disulfonsäure; C14H14N2O6S2
201-331-5; 81-16-3; 2-Aminonaphthalin-1-sulfonsäure; C10H9NO3S
201-380-2; 81-84-5; Naphthalin-1,8-dicarbonsäureanhydrid; C12H6O3
201-423-5; 82-45-1; 1-Aminoanthrachinon; C14H9NO2
201-427-7; 82-49-5; 9,10-Dioxoanthracen-1-sulfonsäure; C14H8O5S
201-487-4; 83-56-7; Naphthalin-1,5-diol; C10H8O2
201-545-9; 84-61-7; Dicyclohexylphthalat; C20H26O4
201-550-6; 84-66-2; Diethylphthalat; C12H14O4
201-553-2; 84-69-5; Diisobutylphthalat; C16H22O4
201-579-4; 85-00-7; Diquatdibromid; C12H12N2.2Br
201-604-9; 85-42-7; Cyclohexan-1,2-dicarbonsäureanhydrid; C8H10O3
201-605-4; 85-43-8; 1,2,3,6-Tetrahydrophthalsäureanhydrid; C8H8O3
201-615-9; 85-56-3; 2-(4-Chlorbenzoyl)benzoesäure; C14H9ClO3
201-622-7; 85-68-7; Benzylbutylphthalat; C19H20O4
201-684-5; 86-57-7; 1-Nitronaphthalin; C10H7NO2
201-718-9; 87-02-5; 7-Amino-4-hydroxynaphthalin-2-sulfonsäure; C10H9NO4S
201-752-4; 87-56-9; Mucochlorsäure; C4H2Cl2O3
201-757-1; 87-61-6; 1,2,3-Trichlorbenzol; C6H3Cl3
201-758-7; 87-62-7; 2,6-Xylidin; C8H11N
201-761-3; 87-65-0; 2,6-Dichlorphenol; C6H4Cl2O
201-765-5; 87-68-3; Hexachlorbuta-1,3-dien; C4Cl6
201-782-8; 87-90-1; Symclosen; C3Cl3N3O3
201-800-4; 88-12-0; 1-Vinyl-2-pyrrolidon; C6H9NO
201-831-3; 88-44-8; 4-Aminotoluol-3-sulfonsäure; C7H9NO3S
201-854-9; 88-73-3; 1-Chlor-2-nitrobenzol; C6H4ClNO2
201-855-4; 88-74-4; 2-Nitroanilin; C6H6N2O2
201-857-5; 88-75-5; 2-Nitrophenol; C6H5NO3
201-861-7; 88-85-7; Dinoseb; C10H12N2O5
201-923-3; 89-61-2; 1,4-Dichlor-2-nitrobenzol; C6H3Cl2NO2
201-933-8; 89-72-5; 2-sec-Butylphenol; C10H14O
201-956-3; 89-98-5; 2-Chlorbenzaldehyd; C7H5ClO
201-963-1; 90-04-0; o-Anisidin; C7H9NO
201-983-0; 90-30-2; N-1-Naphthylanilin; C16H13N
202-000-8; 90-51-7; 6-Amino-4-hydroxynaphthalin-2-sulfonsäure; C10H9NO4S
202-039-0; 91-08-7; 2-Methyl-m-phenylendiisocyanat; C9H6N2O2
202-044-8; 91-15-6; Phthalonitril; C8H4N2
202-052-1; 91-23-6; 2-Nitroanisol; C7H7NO3
202-088-8; 91-66-7; N,N-Diethylanilin; C10H15N
202-090-9; 91-68-9; 3-Diethylaminophenol; C10H15NO
202-095-6; 91-76-9; 6-Phenyl-1,3,5-triazin-2,4-diyldiamin; C9H9N5
202-109-0; 91-94-1; 3,3'-Dichlorbenzidin; C12H10Cl2N2
202-180-8; 92-70-6; 3-Hydroxy-2-naphthoesäure; C11H8O3
202-200-5; 92-88-6; Biphenyl-4,4'-diol; C12H10O2
202-264-4; 93-65-2; 2-(4-Chlor-2-methylphenoxy)propionsäure; C10H11ClO3
202-354-3; 94-68-8; N-Ethyl-o-toluidin; C9H13N
202-360-6; 94-74-6; (4-Chlor-2-methylphenoxy)essigsäure; C9H9ClO3
202-411-2; 95-33-0; N-Cyclohexylbenzothiazol-2-sulfenamid; C13H16N2S2
202-422-2; 95-47-6; o-Xylol; C8H10
202-424-3; 95-49-8; 2-Chlortoluol; C7H7Cl
202-426-4; 95-51-2; 2-Chloranilin; C6H6ClN
202-429-0; 95-53-4; o-Toluidin; C7H9N
202-430-6; 95-54-5; o-Phenylendiamin; C6H8N2
202-431-1; 95-55-6; 2-Aminophenol; C6H7NO
202-445-8; 95-73-8; 2,4-Dichlortoluol; C7H6Cl2
202-446-3; 95-74-9; 3-Chlor-p-toluidin; C7H8ClN
202-448-4; 95-76-1; 3,4-Dichloranilin; C6H5Cl2N
202-453-1; 95-80-7; 4-Methyl-m-phenylendiamin; C7H10N2
202-455-2; 95-82-9; 2,5-Dichloranilin; C6H5Cl2N
202-466-2; 95-94-3; 1,2,4,5-Tetrachlorbenzol; C6H2Cl4
202-486-1; 96-18-4; 1,2,3-Trichlorpropan; C3H5Cl3
202-490-3; 96-22-0; Pentan-3-on; C5H10O
202-496-6; 96-29-7; Butanonoxim; C4H9NO
202-498-7; 96-31-1; 1,3-Dimethylharnstoff; C3H8N2O
202-500-6; 96-33-3; Methylacrylat; C4H6O2
202-501-1; 96-34-4; Methylchloracetat; C3H5ClO2
202-509-5; 96-48-0; ?-Butyrolacton; C4H6O2
202-551-4; 97-00-7; 1-Chlor-2,4-dinitrobenzol; C6H3ClN2O4
202-576-0; 97-36-9; 2',4'-Dimethylacetoacetanilid; C12H15NO2
202-597-5; 97-63-2; Ethylmethacrylat; C6H10O2
202-599-6; 97-65-4; Itaconsäure; C5H6O4
202-613-0; 97-86-9; Isobutylmethacrylat; C8H14O2
202-615-1; 97-88-1; Butylmethacrylat; C8H14O2
202-626-1; 98-00-0; Furfurylalkohol; C5H6O2
202-627-7; 98-01-1; 2-Furaldehyd; C5H4O2
202-634-5; 98-07-7; a,a,a-Trichlortoluol; C7H5Cl3
202-635-0; 98-08-8; a,a,a-Trifluortoluol; C7H5F3
202-636-6; 98-09-9; Benzolsulfonylchlorid; C6H5ClO2S
202-640-8; 98-13-5; Trichlor(phenyl)silan; C6H5Cl3Si
202-643-4; 98-16-8; a,a,a-Trifluor-m-toluidin; C7H6F3N
202-664-9; 98-40-8; 2-(Ethylamino)toluol-4-sulfonsäure; C9H13NO3S
202-670-1; 98-46-4; a,a,a-Trifluor-3-nitrotoluol; C7H4F3NO2
202-675-9; 98-51-1; 4-tert-Butyltoluol; C11H16
202-676-4; 98-52-2; 4-tert-Butylcyclohexanol; C10H20O
202-679-0; 98-54-4; 4-tert-Butylphenol; C10H14O
202-681-1; 98-56-6; 4-Chlor-a,a,a-trifluortoluol; C7H4ClF3
202-696-3; 98-73-7; 4-tert-Butylbenzoesäure; C11H14O2
202-705-0; 98-83-9; 2-Phenylpropen; C9H10
202-709-2; 98-87-3; a,a-Dichlortoluol; C7H6Cl2
202-715-5; 98-94-2; Cyclohexyldimethylamin; C8H17N
202-728-6; 99-08-1; 3-Nitrotoluol; C7H7NO2
202-764-2; 99-54-7; 1,2-Dichlor-4-nitrobenzol; C6H3Cl2NO2
202-776-8; 99-65-0; 1,3-Dinitrobenzol; C6H4N2O4
202-790-4; 99-82-1; 1-Isopropyl-4-methylcyclohexan; C10H20
202-797-2; 99-88-7; 4-Isopropylanilin; C9H13N
202-804-9; 99-96-7; 4-Hydroxybenzoesäure; C7H6O3
202-808-0; 99-99-0; 4-Nitrotoluol; C7H7NO2

[edytuj] 100 .. 200

202-809-6; 100-00-5; 1-Chlor-4-nitrobenzol; C6H4ClNO2
202-810-1; 100-01-6; 4-Nitroanilin; C6H6N2O2
202-811-7; 100-02-7; 4-Nitrophenol; C6H5NO3
202-825-3; 100-17-4; 4-Nitroanisol; C7H7NO3
202-837-9; 100-29-8; 4-Nitrophenetol; C8H9NO3
202-845-2; 100-37-8; 2-Diethylaminoethanol; C6H15NO
202-853-6; 100-44-7; a-Chlortoluol; C7H7Cl
202-873-5; 100-63-0; Phenylhydrazin; C6H8N2
202-908-4; 101-02-0; Triphenylphosphit; C18H15O3P
202-910-5; 101-05-3; Anilazin; C9H5Cl3N4
202-951-9; 101-54-2; N-(4-Aminophenyl)anilin; C12H12N2
202-966-0; 101-68-8; 4,4'-Methylendiphenyldiisocyanat; C15H10N2O2
202-969-7; 101-72-4; N-Isopropyl-N'-phenyl-p-phenylendiamin; C15H18N2
202-974-4; 101-77-9; 4,4'-Methylendianilin; C13H14N2
202-980-7; 101-83-7; Dicyclohexylamin; C12H23N
202-981-2; 101-84-8; Diphenylether; C12H10O
202-996-4; 102-01-2; Acetoacetanilid; C10H11NO2
203-002-1; 102-06-7; 1,3-Diphenylguanidin; C13H13N3
203-005-8; 102-09-0; Diphenylcarbonat; C13H10O3
203-026-2; 102-36-3; 3,4-Dichlorphenylisocyanat; C7H3Cl2NO
203-049-8; 102-71-6; 2,2',2”-Nitrilotriethanol; C6H15NO3
203-052-4; 102-77-2; 2-(Morpholinothio)benzothiazol; C11H12N2OS2
203-070-2; 103-01-5; N-Phenylglycin; C8H9NO2
203-079-1; 103-09-3; 2-Ethylhexylacetat; C10H20O2
203-080-7; 103-11-7; 2-Ethylhexylacrylat; C11H20O2
203-090-1; 103-23-1; Bis(2-ethylhexyl)adipat; C22H42O4
203-118-2; 103-50-4; Dibenzylether; C14H14O
203-135-5; 103-69-5; N-Ethylanilin; C8H11N
203-136-0; 103-70-8; Formanilid; C7H7NO
203-137-6; 103-71-9; Phenylisocyanat; C7H5NO
203-180-0; 104-15-4; Toluol-4-sulfonsäure; C7H8O3S
203-234-3; 104-76-7; 2-Ethylhexan-1-ol; C8H18O
203-253-7; 104-93-8; 4-Methylanisol; C8H10O
203-254-2; 104-94-9; p-Anisidin; C7H9NO
203-265-2; 105-05-5; 1,4-Diethylbenzol; C10H14
203-293-5; 105-38-4; Vinylpropionat; C5H8O2
203-294-0; 105-39-5; Ethylchloracetat; C4H7ClO2
203-299-8; 105-45-3; Methylacetoacetat; C5H8O3
203-305-9; 105-53-3; Diethylmalonat; C7H12O4
203-313-2; 105-60-2; e-Caprolactam; C6H11NO
203-328-4; 105-76-0; Dibutylmaleat; C12H20O4
203-383-4; 106-31-0; Buttersäureanhydrid; C8H14O3
203-396-5; 106-42-3; p-Xylol; C8H10
203-397-0; 106-43-4; 4-Chlortoluol; C7H7Cl
203-398-6; 106-44-5; p-Kresol; C7H8O
203-402-6; 106-48-9; 4-Chlorphenol; C6H5ClO
203-403-1; 106-49-0; p-Toluidin; C7H9N
203-419-9; 106-65-0; Dimethylsuccinat; C6H10O4
203-430-9; 106-75-2; Oxydiethylenbis(chlorformiat); C6H8Cl2O5
203-438-2; 106-88-7; 1,2-Epoxybutan; C4H8O
203-439-8; 106-89-8; 1-Chlor-2,3-epoxypropan; C3H5ClO
203-449-2; 106-98-9; But-1-en; C4H8
203-450-8; 106-99-0; Buta-1,3-dien; C4H6
203-462-3; 107-10-8; Propylamin; C3H9N
203-464-4; 107-12-0; Propiononitril; C3H5N
203-466-5; 107-13-1; Acrylonitril; C3H3N
203-475-4; 107-25-5; Methylvinylether; C3H6O
203-489-0; 107-41-5; 2-Methylpentan-2,4-diol; C6H14O2
203-508-2; 107-64-2; Dimethyldioctadecylammoniumchlorid; C38H80N.Cl
203-509-8; 107-66-4; Dibutylhydrogenphosphat; C8H19O4P
203-527-6; 107-86-8; 3-Methyl-2-butenal; C5H8O
203-539-1; 107-98-2; 1-Methoxypropan-2-ol; C4H10O2
203-542-8; 108-01-0; 2-Dimethylaminoethanol; C4H11NO
203-545-4; 108-05-4; Vinylacetat; C4H6O2
203-551-7; 108-11-2; 4-Methylpentan-2-ol; C6H14O
203-561-1; 108-21-4; Isopropylacetat; C5H10O2
203-562-7; 108-22-5; Isopropenylacetat; C5H8O2
203-576-3; 108-38-3; m-Xylol; C8H10
203-577-9; 108-39-4; m-Kresol; C7H8O
203-581-0; 108-42-9; 3-Chloranilin; C6H6ClN
203-583-1; 108-44-1; m-Toluidin; C7H9N
203-584-7; 108-45-2; m-Phenylendiamin; C6H8N2
203-603-9; 108-65-6; 2-Methoxy-1-methylethylacetat; C6H12O3
203-608-6; 108-70-3; 1,3,5-Trichlorbenzol; C6H3Cl3
203-614-9; 108-77-0; 2,4,6-Trichlor-1,3,5-triazin; C3Cl3N3
203-619-6; 108-82-7; 2,6-Dimethylheptan-4-ol; C9H20O
203-620-1; 108-83-8; 2,6-Dimethylheptan-4-on; C9H18O
203-626-4; 108-89-4; 4-Methylpyridin; C6H7N
203-636-9; 108-99-6; 3-Methylpyridin; C6H7N
203-643-7; 109-06-8; 2-Methylpyridin; C6H7N
203-678-8; 109-53-5; Isobutylvinylether; C6H12O
203-680-9; 109-55-7; 3-Aminopropyldimethylamin; C5H14N2
203-686-1; 109-60-4; Propylacetat; C5H10O2
203-696-6; 109-69-3; 1-Chlorbutan; C4H9Cl
203-697-1; 109-70-6; 1-Brom-3-chlorpropan; C3H6BrCl
203-713-7; 109-86-4; 2-Methoxyethanol; C3H8O2
203-716-3; 109-89-7; Diethylamin; C4H11N
203-733-6; 110-05-4; Di-tert-butylperoxid; C8H18O2
203-737-8; 110-12-3; 5-Methylhexan-2-on; C7H14O
203-747-2; 110-21-4; 1,1-Hydrazoformamid; C2H6N4O2
203-751-4; 110-27-0; Isopropylmyristat; C17H34O2
203-755-6; 110-30-5; N,N'-Ethylendi(stearamid); C38H76N2O2
203-766-6; 110-42-9; Methyldecanoat; C11H22O2
203-768-7; 110-44-1; Hexa-2,4-diensäure; C6H8O2
203-772-9; 110-49-6; 2-Methoxyethylacetat; C5H10O3
203-786-5; 110-63-4; Butan-1,4-diol; C4H10O2
203-787-0; 110-64-5; But-2-en-1,4-diol; C4H8O2
203-788-6; 110-65-6; But-2-in-1,4-diol; C4H6O2
203-794-9; 110-71-4; 1,2-Dimethoxyethan; C4H10O2
203-802-0; 110-77-0; 2-(Ethylthio)ethanol; C4H10OS
203-812-5; 110-88-3; 1,3,5-Trioxan; C3H6O3
203-820-9; 110-97-4; 1,1'-Iminodipropan-2-ol; C6H15NO2
203-821-4; 110-98-5; 1,1'-Oxydipropan-2-ol; C6H14O3
203-835-0; 111-11-5; Methyloctanoat; C9H18O2
203-839-2; 111-15-9; 2-Ethoxyethylacetat; C6H12O3
203-851-8; 111-26-2; Hexylamin; C6H15N
203-856-5; 111-30-8; Glutaral; C5H8O2
203-865-4; 111-40-0; 2,2'-Iminodi(ethylamin); C4H13N3
203-867-5; 111-41-1; 2-(2-Aminoethylamino)ethanol; C4H12N2O
203-868-0; 111-42-2; 2,2'-Iminodiethanol; C4H11NO2
203-870-1; 111-44-4; Bis(2-chlorethyl)ether; C4H8Cl2O
203-872-2; 111-46-6; 2,2'-Oxydiethanol; C4H10O3
203-893-7; 111-66-0; Oct-1-en; C8H16
203-905-0; 111-76-2; 2-Butoxyethanol; C6H14O2
203-906-6; 111-77-3; 2-(2-Methoxyethoxy)ethanol; C5H12O3
203-907-1; 111-78-4; Cycloocta-1,5-dien; C8H12
203-911-3; 111-82-0; Methyllaurat; C13H26O2
203-915-5; 111-85-3; 1-Chloroctan; C8H17Cl
203-918-1; 111-88-6; Octan-1-thiol; C8H18S
203-919-7; 111-90-0; 2-(2-Ethoxyethoxy)ethanol; C6H14O3
203-924-4; 111-96-6; Bis(2-methoxyethyl)ether; C6H14O3
203-933-3; 112-07-2; 2-Butoxyethylacetat; C8H16O3
203-943-8; 112-18-5; Dodecyldimethylamin; C14H31N
203-950-6; 112-24-3; Trientin; C6H18N4
203-953-2; 112-27-6; 2,2'-(Ethylendioxy)diethanol; C6H14O4
203-956-9; 112-30-1; Decan-1-ol; C10H22O
203-962-1; 112-35-6; 2-(2-(2-Methoxyethoxy)ethoxy)ethanol; C7H16O4
203-978-9; 112-50-5; 2-(2-(2-Ethoxyethoxy)ethoxy)ethanolv; C8H18O4
203-984-1; 112-55-0; Dodecan-1-thiol; C12H26S
203-986-2; 112-57-2; 3,6,9-Triazaundecamethylendiamin; C8H23N5
203-998-8; 112-70-9; Tridecan-1-ol; C13H28O
204-000-3; 112-72-1; Tetradecanol; C14H30O
204-004-5; 112-76-5; Stearoylchlorid; C18H35ClO
204-017-6; 112-92-5; Octadecan-1-ol; C18H38O
204-038-0; 113-98-4; [[Kalium-[2S-(2a,5a,6ß)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat]]; C16H18N2O4S.K
204-066-3; 115-11-7; 2-Methylpropen; C4H8
204-068-4; 115-18-4; 2-Methylbut-3-en-2-ol; C5H10O
204-070-5; 115-19-5; 2-Methylbut-3-in-2-ol; C5H8O
204-118-5; 115-96-8; Tris(2-chlorethyl)phosphat; C6H12Cl3O4P
204-122-7; 116-02-9; 3,3,5-Trimethylcyclohexanol; C9H18O
204-137-9; 116-37-0; 1,1'-Isopropylidenbis(p-phenylenoxy)dipropan-2-ol; C21H28O4
204-159-9; 116-81-4; 1-Amino-4-brom-9,10-dioxoanthracen-2-sulfonsäure; C14H8BrNO5S
204-188-7; 117-42-0; 8-Aminonaphthalin-1,3,6-trisulfonsäure; C10H9NO9S3
204-211-0; 117-81-7; Bis(2-ethylhexyl)phthalat; C24H38O4
204-214-7; 117-84-0; Dioctylphthalat; C24H38O4
204-246-1; 118-33-2; 6-Aminonaphthalin-1,3-disulfonsäure; C10H9NO6S2
204-255-0; 118-48-9; 4H-3,1-Benzoxazin-2,4(1H)-dion; C8H5NO3
204-269-7; 118-69-4; 2,6-Dichlortoluol; C7H6Cl2
204-289-6; 118-96-7; 2,4,6-Trinitrotoluol; C7H5N3O6
204-327-1; 119-47-1; 6,6'-Di-tert-butyl-2,2'-methylendi-p-kresol; C23H32O2
204-424-9; 120-78-5; Di(benzothiazol-2-yl)disulfid; C14H8N2S4
204-429-6; 120-83-2; 2,4-Dichlorphenol; C6H4Cl2O
204-445-3; 121-03-9; 4-Nitrotoluol-2-sulfonsäure; C7H7NO5S
204-496-1; 121-73-3; 1-Chlor-3-nitrobenzol; C6H4ClNO2
204-501-7; 121-86-8; 2-Chlor-4-nitrotoluol; C7H6ClNO2
204-502-2; 121-87-9; 2-Chlor-4-nitroanilin; C6H5ClN2O2
204-528-4; 122-20-3; 1,1',1”-Nitrilotripropan-2-ol; C9H21NO3
204-550-4; 122-51-0; Triethylorthoformiat; C7H16O3
204-552-5; 122-52-1; Triethylphosphit; C6H15O3P
204-591-8; 123-01-3; Dodecylbenzol; C18H30
204-596-5; 123-05-7; 2-Ethylhexanal; C8H16O
204-616-2; 123-30-8; 4-Aminophenol; C6H7NO
204-622-5; 123-35-3; 7-Methyl-3-methylenocta-1,6-dien; C10H16
204-626-7; 123-42-2; 4-Hydroxy-4-methylpentan-2-on; C6H12O2
204-634-0; 123-54-6; Pentan-2,4-dion; C5H8O2
204-638-2; 123-62-6; Propionsäureanhydrid; C6H10O3
204-650-8; 123-77-3; C,C'-Azodi(formamid); C2H4N4O2
204-685-9; 124-17-4; 2-(2-Butoxyethoxy)ethylacetat; C10H20O4
204-695-3; 124-30-1; Octadecylamin; C18H39N
204-697-4; 124-40-3; Dimethylamin,in wässriger Lösung; C2H7N
204-699-5; 124-41-4; Natriummethanolat; CH4O.Na
204-709-8; 124-68-5; 2-Amino-2-methylpropanol; C4H11NO
204-727-6; 125-12-2; [[exo-1,7,7-Trimethylbicyclo[2.2.1]hept-2-ylacetat]]; C12H20O2
204-781-0; 126-30-7; 2,2-Dimethylpropan-1,3-diol; C5H12O2
204-794-1; 126-58-9; 2,2,2',2'-Tetrakis(hydroxymethyl)-3,3'-oxydipropan-1-ol; C10H22O7
204-818-0; 126-99-8; 2-Chlorbuta-1,3-dien; C4H5Cl
204-825-9; 127-18-4; Tetrachlorethylen; C2Cl4
204-854-7; 127-65-1; Tosylchloramidnatrium; C7H8ClNO2S.Na
204-857-3; 127-68-4; Natrium-3-nitrobenzolsulfonat; C6H5NO5S.Na
204-872-5; 127-91-3; Pin-2(10)-en; C10H16
204-875-1; 128-03-0; Kaliumdimethyldithiocarbamat; C3H7NS2.K
204-876-7; 128-04-1; Natriumdimethyldithiocarbamat; C3H7NS2.Na
204-881-4; 128-37-0; 2,6-Di-tert-butyl-p-kresol; C15H24O
204-886-1; 128-44-9; 1,2-Benzisothiazol-3(2H)-on-1,1-dioxid, Natriumsalz; C7H5NO3S.Na
205-010-0; 131-09-9; 2-Chloranthrachinon; C14H7ClO2
205-025-2; 131-52-2; Natriumpentachlorphenolat; C6HCl5O.Na
205-107-8; 133-49-3; Pentachlorbenzolthiol; C6HCl5S
205-182-7; 135-19-3; 2-Naphthol; C10H8O
205-286-2; 137-26-8; Thiram; C6H12N2S4
205-288-3; 137-30-4; Ziram; C6H12N2S4Zn
205-293-0; 137-42-8; Metam-natrium; C2H5NS2.Na
205-341-0; 138-86-3; Dipenten, roh; C10H16
205-347-3; 139-02-6; Natriumphenoxid; C6H6O.Na
205-381-9; 139-89-9; Trinatrium-2-(carboxylatomethyl(2-hydroxyethyl)amino)ethyliminodi(acetat); C10H18N2O7.3Na
205-388-7; 139-96-8; Tris(2-hydroxyethyl)ammoniumdecylsulfat; C12H26O4S.C6H15NO3
205-391-3; 140-01-2; Pentanatrium(carboxylatomethyl)iminobis(ethylennitrilo)tetraacetat; C14H23-N3O10.5Na
205-399-7; 140-11-4; Benzylacetat; C9H10O2
205-411-0; 140-31-8; 2-Piperazin-1-ylethylamin; C6H15N3
205-426-2; 140-66-9; 4-(1,1,3,3-Tetramethylbutyl)phenol; C14H22O
205-438-8; 140-88-5; Ethylacrylat; C5H8O2
205-443-5; 140-93-2; Proxan-natrium; C4H8OS2.Na
205-480-7; 141-32-2; Butylacrylat; C7H12O2
205-502-5; 141-79-7; 4-Methylpent-3-en-2-on; C6H10O
205-547-0; 142-59-6; Nabam; C4H8N2S4.2Na
205-554-9; 142-72-3; Magnesiumdi(acetat); C2H4O2.½Mg
205-565-9; 142-84-7; Dipropylamin; C6H15N
205-570-6; 142-90-5; Dodecylmethacrylat; C16H30O2
205-592-6; 143-22-6; 2-(2-(2-Butoxyethoxy)ethoxy)ethanol; C10H22O4
205-685-1; 147-14-8; Tetrabenzo-5,10,15,20-diazaporphyrinphthalocyanin; C32H16CuN8
205-736-8; 149-30-4; Benzothiazol-2-thiol; C7H5NS2
205-743-6; 149-57-5; 2-Ethylhexansäure; C8H16O2
205-745-7; 149-73-5; Trimethylorthoformiat; C4H10O3
205-771-9; 150-78-7; 1,4-Dimethoxybenzol; C8H10O2
205-855-5; 156-43-4; p-Phenetidin; C8H11NO

[edytuj] 200 .. 1000

206-022-9; 288-88-0; 1,2,4-Triazol; C2H3N3
206-033-9; 294-62-2; Cyclododecan; C12H24
206-050-1; 298-00-0; Parathion-methyl; C8H10NO5PS
206-056-4; 298-07-7; Bis(2-ethylhexyl)hydrogenphosphat; C16H35O4P
206-059-0; 298-14-6; Kaliumhydrogencarbonat; CH2O3.K
207-312-8; 461-58-5; Cyanguanidin; C2H4N4
207-586-9; 482-89-3; 2-(1,3-Dihydro-3-oxo-2H-indazol-2-yliden)-1,2-dihydro-3H-indol-3-on; C16H10N2O2
207-826-2; 496-72-0; 4-Methyl-o-phenylendiamin; C7H10N2
207-938-1; 502-44-3; Hexan-6-olid; C6H10O2
207-950-7; 502-69-2; 6,10,14-Trimethylpentadecan-2-on; C18H36O
208-008-8; 505-32-8; 3,7,11,15-Tetramethylhexadec-1-en-3-ol; C20H40O
208-052-8; 506-77-4; Cyanogenchlorid; CClN
208-058-0; 506-87-6; Diammoniumcarbonat; CH2O3.2H3N
208-419-2; 527-60-6; 2,4,6-Trimethylphenol; C9H12O
208-576-7; 533-74-4; Dazomet; C5H10N2S2
208-580-9; 533-96-0; Trinatriumhydrogendicarbonat; CH2O3.3/2Na
208-778-5; 541-41-3; Ethylchlorformiat; C3H5ClO2
208-792-1; 541-73-1; 1,3-Dichlorbenzol; C6H4Cl2
208-826-5; 542-75-6; 1,3-Dichlorpropen; C3H4Cl2
208-863-7; 544-17-2; Calciumdiformiat; CH2O2.½Ca
208-993-4; 551-16-6; 6-Aminopenicillansäure; C8H12N2O3S
209-008-0; 552-30-7; Benzol-1,2,4-tricarbonsäure-1,2-anhydrid; C9H4O5
209-136-7; 556-67-2; Octamethylcyclotetrasiloxan; C8H24O4Si4
209-141-4; 556-82-1; 3-Methylbut-2-en-1-ol; C5H10O
209-151-9; 557-05-1; Zinkdistearat; C18H36O2.½Zn
209-251-2; 563-47-3; 3-Chlor-2-methylpropen; C4H7Cl
209-514-1; 583-61-9; 2,3-Dimethylpyridin; C7H9N
209-527-2; 584-03-2; Butan-1,2-diol; C4H10O2
209-544-5; 584-84-9; 4-Methyl-m-phenylendiisocyanat; C9H6N2O2
209-691-5; 590-86-3; Isovaleraldehyd; C5H10O
209-751-0; 592-35-8; Butylcarbamat; C5H11NO2
209-753-1; 592-41-6; Hex-1-en; C6H12
209-803-2; 593-70-4; Chlorfluormethan; CH2ClF
209-810-0; 593-81-7; Trimethylammoniumchlorid; C3H9N.ClH
209-840-4; 594-42-3; Trichlormethansulfenylchlorid; CCl4S
209-940-8; 598-56-1; Ethyldimethylamin; C4H11N
209-952-3; 598-78-7; 2-Chlorpropionsäure; C3H5ClO2
210-095-2; 605-71-0; 1,5-Dinitronaphthalin; C10H6N2O4
210-248-3; 611-06-3; 1,3-Dichlor-4-nitrobenzol; C6H3Cl2NO2
210-359-7; 613-90-1; Benzoylcyanid; C8H5NO
210-483-1; 616-45-5; 2-Pyrrolidon; C4H7NO
210-557-3; 618-62-2; 3,5-Dichlornitrobenzol; C6H3Cl2NO2
210-620-5; 619-93-2; cis-4,4'-Dinitrostilben; C14H10N2O4
210-848-5; 624-48-6; Dimethylmaleat; C6H8O4
210-855-3; 624-64-6; (E)-But-2-en; C4H8
210-871-0; 624-92-0; Dimethyldisulfid; C2H6S2
211-020-6; 627-93-0; Dimethyladipat; C8H14O4
211-074-0; 629-11-8; Hexan-1,6-diol; C6H14O2
211-448-3; 645-62-5; 2-Ethylhex-2-enal; C8H14O
211-617-1; 674-82-8; But-3-en-3-olid; C4H4O2
211-661-1; 682-09-7; 2,2-Bis(allyloxymethyl)butan-1-ol; C12H22O3
211-694-1; 687-47-8; Ethyl-(S)-2-hydroxypropionat; C5H10O3
211-746-3; 693-23-2; Dodecandisäure; C12H22O4
211-838-3; 700-13-0; 2,3,5-Trimethylhydrochinon; C9H12O2
211-914-6; 709-98-8; Propanil; C9H9Cl2NO
212-058-6; 757-86-8; [[Methyl-[(dimethoxyphosphinothioyl)thio]acetat]]; C5H11O4PS2
212-079-0; 760-23-6; 3,4-Dichlorbut-1-en; C4H6Cl2
212-081-1; 760-67-8; 2-Ethylhexanoylchlorid; C8H15ClO
212-091-6; 762-04-9; Diethylphosphonat; C4H11O3P
212-110-8; 763-32-6; 3-Methylbut-3-en-1-ol; C5H10O
212-121-8; 764-41-0; 1,4-Dichlorbut-2-en; C4H6Cl2
212-344-0; 793-24-8; N-1,3-Dimethylbutyl-N'-phenyl-p-phenylendiamin; C18H24N2
212-369-7; 810-16-2; [[4,4'-[Methylenbis(methylimino)]bis[1,2-dihydro-1,5-dimethyl-2-phenyl-3Hpyrazol-3-on]]]; C25H30N6O2
212-546-9; 825-52-5; (Hydroxyimino)phenylacetonitril; C8H6N2O
212-595-6; 830-13-7; Cyclododecanon; C12H22O
212-646-2; 836-30-6; 4-Nitro-N-phenylanilin; C12H10N2O2
212-658-8; 838-88-0; 4,4'-Methylendi-o-toluidin; C15H18N2
212-660-9; 839-90-7; Tris(2-hydroxyethyl)-1,3,5-triazintrion; C9H15N3O6
212-672-4; 842-18-2; Dikalium-7-hydroxynaphthalin-1,3-disulfonat; C10H8O7S2.2K
212-762-3; 867-56-1; Natrium-(S)-lactat; C3H6O3.Na
212-782-2; 868-77-9; 2-Hydroxyethylmethacrylat; C6H10O3
212-783-8; 868-85-9; Dimethylphosphonat; C2H7O3P
212-800-9; 870-72-4; Natriumhydroxymethansulfonat; CH4O4S.Na
212-828-1; 872-50-4; 1-Methyl-2-pyrrolidon; C5H9NO
212-958-9; 887-76-3; 4,4'-azo-3-hydroxynaphthalin-1-sulfonat; C10H6N2O4S
213-030-6; 917-61-3; Natriumcyanat; CHNO.Na
213-086-1; 923-02-4; N-(Hydroxymethyl)methacrylamid; C5H9NO2
213-090-3; 923-26-2; 2-Hydroxypropylmethacrylat; C7H12O3
213-179-7; 928-68-7; 6-Methylheptan-2-on; C8H16O
213-309-2; 935-92-2; 2,3,6-Trimethyl-p-benzochinon; C9H10O2
213-424-8; 947-04-6; Dodecan-12-lactam; C12H23NO
213-497-6; 959-26-2; Bis(hydroxyethyl)terephthalat; C12H14O6
213-554-5; 976-71-6; Canrenon; C22H28O3
213-666-4; 999-81-5; Chlormequatchlorid; C5H13ClN.Cl
213-668-5; 999-97-3; 1,1,1,3,3,3-Hexamethyldisilazan; C6H19NSi2

[edytuj] 1000 .. 2000

213-912-0; 1066-35-9; Chlordimethylsilan; C2H7ClSi
214-222-2; 1115-20-4; 3-Hydroxy-2,2-dimethylpropyl-3-hydroxy-2,2-dimethylpropionat; C10H20O4
214-277-2; 1119-40-0; Dimethylglutarat; C7H12O4
214-419-3; 1126-34-7; Natrium-3-aminobenzolsulfonat; C6H7NO3S.Na
214-566-3; 1151-14-0; 2-(4-Ethylbenzoyl)benzoesäure; C16H14O3
214-604-9; 1163-19-5; Bis(pentabromphenyl)ether; C12Br10O
214-987-2; 1241-94-7; 2-Ethylhexyldiphenylphosphat; C20H27O4P
215-100-1; 1302-42-7; Aluminiumnatriumdioxid; AlO2.Na
215-199-1; 1312-76-1; Kieselsäure, Kaliumsalz;
215-204-7; 1313-27-5; Molybdaentrioxid; MoO3
215-235-6; 1314-41-6; Orangemennige; O4Pb3
215-242-4; 1314-80-3; Diphosphorpentasulfid; P2S5
215-263-9; 1317-33-5; Molybdaendisulfid; MoS2
215-306-1; 1320-67-8; Methoxypropanol; C4H10O2
215-475-1; 1327-36-2; Aluminatsilicat;
215-477-2; 1327-41-9; Aluminiumchlorid, basisch;
215-524-7; 1328-53-6; Polychlorkupferphthalocyanin Diese Substanz wird im Colour Index durch Colour Index Constitution Number, C.I. 74260, identifiziert.;
215-540-4; 1330-43-4; Dinatriumtetraborat, wasserfreiv; B4Na2O7
215-548-8; 1330-78-5; Tris(methylphenyl)phosphat; C21H21O4P
215-565-0; 1331-92-6; Cinnamaldehyd, Monopentylderivat; C14H18O
215-587-0; 1333-39-7; Hydroxybenzolsulfonsäure; C6H6O4S
215-609-9; 1333-86-4; Kohlenstoffschwarz;
215-657-0; 1338-02-9; Naphthensäuren, Kupfersalze;
215-681-1; 1343-88-0; Kieselsäure, Magnesiumsalz;
215-684-8; 1344-00-9; Kieselsäure, Aluminiumnatriumsalz;
215-687-4; 1344-09-8; Kieselsäure, Natriumsalz;
215-693-7; 1344-37-2; Bleisulfochromatgelb Diese Substanz wird im Colour Index durch Colour Index Constitution Number, C.I. 77603, identifiziert.;
215-960-8; 1461-25-2; Tetrabutylzinn; C16H36Sn
216-074-4; 1490-04-6; DL-Menthol; C10H20O
216-099-0; 1498-51-7; Ethyldichlorophosphat; C2H5Cl2O2P
216-207-6; 1528-48-9; Triheptylbenzol-1,2,4-tricarboxylat; C30H48O6
216-341-5; 1561-92-8; Natrium-2-methylprop-2-en-1-sulfonat; C4H8O3S.Na
216-381-3; 1570-64-5; 4-Chlor-o-kresol; C7H7ClO
216-653-1; 1634-04-4; (tert-Butyl)methylether; C5H12O
216-732-0; 1655-29-4; Dinatriumnaphthalin-1,5-disulfonat; C10H8O6S2.2Na
216-734-1; 1655-43-2; Dinatriumnaphthalin-1,6-disulfonat; C10H8O6S2.2Na
216-768-7; 1663-39-4; tert-Butylacrylat; C7H12O2
216-917-6; 1698-53-9; 4,5-Dichlor-2,3-dihydro-2-phenylpyridazin-3-on; C10H6Cl2N2O
216-920-2; 1698-60-8; Chloridazon; C10H8ClN3O
217-031-2; 1724-39-6; Cyclododecanol; C12H24O
217-090-4; 1738-25-6; 3-Dimethylaminopropiononitril; C5H10N2
217-326-6; 1817-47-6; p-Nitrocumol; C9H11NO2
217-451-6; 1854-26-8; 4,5-Dihydroxy-1,3-bis(hydroxymethyl)imidazolidin-2-on; C5H10N2O5
217-565-6; 1888-91-1; N-Acetylhexanlactam; C8H13NO2
217-615-7; 1910-42-5; Paraquat-dichlorid; C12H14N2.2Cl

[edytuj] 2000 .. 10000

218-577-4; 2186-92-7; p-(Dimethoxymethyl)anisol; C10H14O3
218-717-4; 2217-82-5; [[Natrium-[1,1'-biphenyl]-4-sulfonat]]; C12H10O3S.Na
218-791-8; 2235-43-0; Pentanatriumhydrogen-C,C',C”-nitrilotris(methylphosphonat); C3H12- NO9P3.5Na
218-817-8; 2243-62-1; 1,5-Naphthylendiamin; C10H10N2
218-962-7; 2303-17-5; Triallat; C10H16Cl3NOS
218-986-8; 2307-55-3; Ammonium-2,4-dichlorphenoxyacetat; C8H6Cl2O3.H3N
219-283-9; 2402-79-1; 2,3,5,6-Tetrachlorpyridin; C5HCl4N
219-330-3; 2416-94-6; 2,3,6-Trimethylphenol; C9H12O
219-397-9; 2431-50-7; 2,3,4-Trichlorbut-1-en; C4H5Cl3
219-460-0; 2439-35-2; 2-(Dimethylamino)ethylacrylat; C7H13NO2
219-463-7; 2439-55-6; N-Methyloctadecylamin; C19H41N
219-488-3; 2444-90-8; Dinatrium-4,4'-isopropylidendiphenolat; C15H16O2.2Na
219-660-8; 2492-26-4; Natriumbenzothiazol-2-ylsulfid; C7H5NS2.Na
219-669-7; 2494-89-5; [[2-[(p-Aminophenyl)sulfonyl]ethylhydrogensulfat]]; C8H11NO6S2
219-754-9; 2524-03-0; O,O-Dimethyl(chlor)thiophosphat; C2H6ClO2PS
219-755-4; 2524-04-1; O,O-Diethylchlorthiophosphat; C4H10ClO2PS
219-799-4; 2536-05-2; 2,2'-Methylendiphenyldiisocyanat; C15H10N2O2
219-835-9; 2549-53-3; Tetradecylmethacrylat; C18H34O2
219-952-5; 2581-34-2; 4-Nitro-m-kresol; C7H7NO3
219-956-7; 2582-30-1; Aminoguanidiniumhydrogencarbonat; CH6N4.CH2O3
220-120-9; 2634-33-5; 1,2-Benzisothiazol-3(2H)-on; C7H5NOS
220-329-5; 2720-73-2; Kalium-O-pentyldithiocarbonat; C6H12OS2.K
220-433-0; 2764-72-9; [[6,7-Dihydrodipyrido[1,2-a:2',1'-c]pyrazindiylium]]; C12H12N2
220-548-6; 2807-30-9; 2-(Propyloxy)ethanol; C5H12O2
220-608-1; 2835-06-5; DL-a-Phenylglycin; C8H9NO2
220-666-8; 2855-13-2; 3-Aminomethyl-3,5,5-trimethylcyclohexylamin; C10H22N2
220-688-8; 2867-47-2; 2-Dimethylaminoethylmethacrylat; C8H15NO2
220-694-0; 2869-34-3; Tridecylamin; C13H29N
220-767-7; 2893-78-9; Troclosennatrium; C3HCl2N3O3.Na
221-221-0; 3033-77-0; 2,3-Epoxypropyltrimethylammoniumchlorid; C6H14NO.Cl
221-242-5; 3039-83-6; Natriumethylensulfonat; C2H4O3S.Na
221-496-7; 3120-74-9; 4-(Methylthio)-m-kresol; C8H10OS
221-508-0; 3126-80-5; Tetrakis(2-ethylhexyl)benzol-1,2,4,5-tetracarboxylat; C42H70O8
221-641-4; 3173-72-6; 1,5-Naphthylendiisocyanat; C12H6N2O2
221-717-7; 3209-22-1; 1,2-Dichlor-3-nitrobenzol; C6H3Cl2NO2
221-838-5; 3251-23-8; Kupferdinitrat; Cu.2HNO3
221-882-5; 3268-49-3; 3-(Methylthio)propionaldehyd; C4H8OS
221-975-0; 3302-10-1; 3,5,5-Trimethylhexansäure; C9H18O2
222-048-3; 3327-22-8; (3-Chlor-2-hydroxypropyl)trimethylammoniumchlorid; C6H15ClNO.Cl
222-376-7; 3452-97-9; 3,5,5-Trimethylhexan-1-ol; C9H20O
222-823-6; 3622-84-2; N-Butylbenzolsulfonamid; C10H15NO2S
222-884-9; 3648-20-2; Diundecylphthalat; C30H50O4
222-885-4; 3648-21-3; Diheptylphthalat; C22H34O4
222-981-6; 3687-46-5; Decyloleat; C28H54O2
223-051-2; 3709-43-1; Dinatrium-4,4'-dinitrostilben-2,2'-disulfonat; C14H10N2O10S2.2Na
223-622-6; 3982-91-0; Thiophosphoryltrichlorid; Cl3PS
223-795-8; 4075-81-4; Calciumdipropionat; C3H6O2.½Ca
223-819-7; 4088-22-6; N-Methyldioctadecylamin; C37H77N
223-861-6; 4098-71-9; 3-Isocyanatomethyl-3,5,5-trimethylcyclohexylisocyanat; C12H18N2O2
223-907-5; 4116-10-3; 2-Chlor-N-methyl-3-oxobutyramid; C5H8ClNO2
224-644-9; 4435-53-4; 3-Methoxybutylacetat; C7H14O3
224-698-3; 4454-05-1; 3,4-Dihydro-2-methoxy-2H-pyran; C6H10O2
224-791-9; 4497-58-9; 1,2,3,4-Tetrahydro-2,2,4-trimethylchinolin; C12H17N
224-923-5; 4553-62-2; 2-Methylglutaronitril; C6H8N2
225-379-1; 4812-20-8; o-Isopropoxyphenol; C9H12O2
225-533-8; 4904-61-4; Cyclododeca-1,5,9-trien; C12H18
225-625-8; 4979-32-2; N,N-Dicyclohexylbenzothiazol-2-sulfenamid; C19H26N2S2
225-768-6; 5064-31-3; Trinatriumnitrilotriacetat; C6H9NO6.3Na
225-861-1; 5123-63-7; Natrium-m-(diethylamino)benzolsulfonat; C10H15NO3S.Na
225-935-3; 5160-02-1; [[Bariumbis[2-chlor-5-[(2-hydroxy-1-naphthyl)azo]toluol-4-sulfonat]]]; C17H13ClN2O4S.½Ba
226-009-1; 5216-25-1; a,a,a,4-Tetrachlortoluol; C7H4Cl4
226-242-9; 5333-42-6; 2-Octyldodecan-1-ol; C20H42O
226-736-4; 5460-09-3; Natriumhydrogen-4-amino-5-hydroxynaphthalin-2,7-disulfonat; C10H9- NO7S2.Na
226-939-8; 5567-15-7; [[2,2'-[(3,3'-Dichlor[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chlor-2,5-dimethoxyphenyl)-3-oxobutyramid]]]; C36H32Cl4N6O8
227-505-0; 5860-35-5; 2-Buten-1,1-diyldiacetat; C8H12O4
227-813-5; 5989-27-5; (R)-p-Mentha-1,8-dien; C10H16
227-977-8; 6055-52-3; Hexamethylendiammoniumdichlorid; C6H16N2.2ClH
228-055-8; 6104-30-9; N,N”-(Isobutyliden)diharnstoff; C6H14N4O2
228-126-3; 6140-74-5; Pentadecylmethacrylat; C19H36O2
228-391-5; 6258-06-6; Natrium-1-amino-4-brom-9,10-dioxoanthracen-2-sulfonat; C14H8BrNO5S.Na
228-782-0; 6358-64-1; 4-Chlor-2,5-dimethoxyanilin; C8H10ClNO2
228-787-8; 6358-85-6; [[2,2'-[(3,3'-Dichlor[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-N-phenylbutyramid]]]; C32H26Cl2N6O4
229-146-5; 6419-19-8; Nitrilotrimethylentris(phosphonsäure); C3H12NO9P3
229-353-0; 6485-55-8; cis-2,6-Dimethylmorpholin; C6H13NO
229-912-9; 6834-92-0; Dinatriummetasilicat; H2O3Si.2Na
229-962-1; 6864-37-5; 2,2'-Dimethyl-4,4'-methylenbis(cyclohexylamin); C15H30N2
230-042-7; 6923-22-4; Monocrotophos; C7H14NO5P
230-086-7; 6940-53-0; 1-Chlor-2,5-dimethoxy-4-nitrobenzol; C8H8ClNO4
230-785-7; 7320-34-5; Tetrakaliumpyrophosphat; H4O7P2.4K
230-847-3; 7336-20-1; Dinatrium-4,4'-diaminostilben-2,2'-disulfonat; C14H14N2O6S2.2Na
230-898-1; 7360-53-4; Aluminiumtriformiat; CH2O2.?Al
230-991-7; 7397-62-8; Butylglykolat; C6H12O3
231-068-1; 7428-48-0; Stearinsäure, Bleisalz; C18H36O2.xPb
231-081-2; 7434-40-4; Ethan-1,2-diylbis(oxyethan-2,1-diyl)bisheptanoat; C20H38O6
231-448-7; 7558-79-4; Dinatriumhydrogenorthophosphat; H3O4P.2Na
231-449-2; 7558-80-7; Natriumdihydrogenorthophosphat; H3O4P.Na
231-509-8; 7601-54-9; Trinatriumorthophosphat; H3O4P.3Na
231-556-4; 7632-04-4; Natriumperoxometaborat; BHO3.Na
231-626-4; 7659-86-1; 2-Ethylhexylmercaptoacetat; C10H20O2S
231-673-0; 7681-57-4; Dinatriumdisulfit; H2O5S2.2Na
231-748-8; 7719-09-7; Thionyldichlorid; Cl2OS
231-767-1; 7722-88-5; Tetranatriumpyrophosphat; H4O7P2.4Na
231-786-5; 7727-54-0; Diammoniumperoxodisulfat; H3N.½H2O8S2
231-834-5; 7758-11-4; Dikaliumhydrogenorthophosphat; H3O4P.2K
231-835-0; 7758-16-9; Dinatriumdihydrogenpyrophosphat; H4O7P2.2Na
231-837-1; 7758-23-8; Calciumbis(dihydrogenorthophosphat), mit einem Gehalt an Fluor von weniger als 0,005 GHT, bezogen auf den wasserfreien Stoff; Ca.2H3O4P
231-843-4; 7758-94-3; Eisendichlorid; Cl2Fe
231-845-5; 7758-95-4; Bleidichlorid; Cl2Pb
231-892-1; 7775-27-1; Dinatriumperoxodisulfat; H2O8S2.2Na
231-907-1; 7778-53-2; Trikaliumorthophosphat; H3O4P.3K
231-913-4; 7778-77-0; Kaliumdihydrogenorthophosphat; H3O4P.K
231-944-3; 7779-90-0; Trizinkbis(orthophosphat); H3O4P.3/2Zn
231-964-2; 7782-78-7; Nitrosylschwefelsäure; HNO5S
231-982-0; 7783-18-8; Ammoniumthiosulfat; H3N.½H2O3S2
231-987-8; 7783-28-0; Diammoniumhydrogenorthophosphat; H3N.½H3O4P
232-087-8; 7785-70-8; (+)-Pin-2(3)-en; C10H16
232-234-6; 7790-94-5; Chlorschwefelsäure; ClHO3S
232-245-6; 7791-25-5; Sulfuryldichlorid; Cl2O2S
232-313-5; 8002-53-7; Montanwachs Wachs aus der Extraktion von Lignit.;
232-391-0; 8013-07-8; Sojabohnenöl, epoxidiert;
232-394-7; 8013-74-9; o-(oder p)-Toluolsulfonamid; C7H9NO2S
232-476-2; 8050-15-5; Kolophoniumsäuren, hydriert, Methylester;
232-482-5; 8050-31-5; Kolophoniumsäuren, Ester mit Glycerin;

[edytuj] 10000 .. 50000

233-046-7; 10025-87-3; Phosphoryltrichlorid; Cl3OP
233-118-8; 10039-54-0; Bis(hydroxylammonium)sulfat; H3NO.½H2O4S
233-187-4; 10058-23-8; Kaliumhydrogenperoxomonosulfat; H2O5S.K
233-250-6; 10101-39-0; Calciumsilicat; Ca.H2O3Si
233-253-2; 10101-53-8; Dichromtris(sulfat); Cr.3/2H2O4S
233-267-9; 10102-18-8; Natriumselenit; H2O3Se.2Na
233-330-0; 10124-31-9; Phosphorsäure, Ammoniumsalz; H3N.xH3O4P
233-606-0; 10265-92-6; Methamidophos; C2H8NO2PS
234-123-8; 10543-57-4; [[N,N'-Ethylenbis[N-acetylacetamid]]]; C10H16N2O4
234-186-1; 10584-98-2; 2-Ethylhexyl-4,4-dibutyl-10-ethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat; C28H56O4S2Sn
234-190-3; 10588-01-9; Natriumdichromat; Cr2H2O7.2Na
234-294-9; 11071-47-9; Isoocten; C8H16
234-304-1; 11081-15-5; Isooctylphenol; C14H22O
234-324-0; 11099-06-2; Kieselsäure, Ethylester;
234-390-0; 11138-47-9; Perborsäure, Natriumsalz;
234-409-2; 12001-85-3; Naphthensäuren, Zinksalze;
234-448-5; 12004-14-7; [[Hexacalciumhexaoxotris[sulfato(2-)]dialuminat(12-)]]; Al2O18S3.6Ca
234-588-7; 12013-56-8; Calciumdisilicid; CaSi2
234-933-1; 12042-91-0; Dialuminiumchloridpentahydroxid; Al2ClH5O5
235-067-7; 12065-90-6; Pentableitetraoxidsulfat; O8Pb5S
235-105-2; 12068-77-8; Dichromeisentetraoxid; Cr2FeO4
235-137-7; 12075-68-2; Triethyldialuminiumtrichlorid; C6H15Al2Cl3
235-184-3; 12124-99-1; Ammoniumhydrogensulfid; H5NS
235-252-2; 12141-20-7; Tribleidioxidphosphonat; HO5PPb3
235-380-9; 12202-17-4; Tetrableitrioxidsulfat; O7Pb4S
235-416-3; 12222-60-5; [[Hexanatrium-2,2'-[azobis[(2-sulfonato-4,1-phenylen)vinylen(3-sulfonato-4,1-phenylen)]]bis[2H-naphtho[1,2-d]triazol-5-sulfonat]]]; C48H32N8O18S6.6Na
235-490-7; 12252-33-4; [[Calcium-[orthosilicato(4-)]dioxodialuminat(2-)]]; Al2O6Si.Ca
235-595-8; 12336-95-7; Chromhydroxidsulfat; CrHO5S
235-649-0; 12410-14-9; Eisenchloridsulfat; ClFeO4S
235-759-9; 12656-85-8; Bleichromatmolybdatsulfatrot; Diese Substanz wird im Colour Index durch Colour Index Constitution Number, C.I. 77605, identifiziert.
235-837-2; 13001-46-2; Kalium-O-isobutyldithiocarbonat; C5H10OS2.K
235-845-6; 13005-36-2; Kaliumphenylacetat; C8H8O2.K
235-921-9; 13048-33-4; Hexamethylendiacrylat; C12H18O4
236-670-8; 13463-40-6; Pentacarbonyleisen; C5FeO5
236-688-6; 13464-80-7; Dihydraziniumsulfat; H4N2.½H2O4S
237-004-9; 13573-18-7; Triphosphorsäure, Natriumsalz; H5O10P3.xNa
237-081-9; 13601-19-9; Tetranatriumhexacyanoferrat; C6FeN6.4Na
237-158-7; 13674-84-5; Tris(2-chlor-1-methylethyl)phosphat; C9H18Cl3O4P
237-199-0; 13684-63-4; Phenmedipham; C16H16N2O4
237-215-6; 13693-11-3; Titanbis(sulfat); H2O4S.½Ti
237-239-7; 13705-05-0; 2,4-Dichlor-6-(methylthio)-1,3,5-triazin; C4H3Cl2N3S
237-410-6; 13775-53-6; Trinatriumhexafluoraluminat; AlF6.3Na
237-574-9; 13845-36-8; Pentakaliumtriphosphat; H5O10P3.5K
237-722-2; 13943-58-3; Tetrakaliumhexacyanoferrat; C6FeN6.4K
237-732-7; 13952-84-6; sec-Butylamin; C4H11N
238-688-1; 14639-98-6; Triammoniumpentachlorozincat(3-); Cl5Zn.3H4N
238-887-3; 14816-18-3; Phoxim; C12H15N2O3PS
238-932-7; 14861-17-7; 4-(2,4-Dichlorphenoxy)anilin; C12H9Cl2NO
239-106-9; 15022-08-9; Diallylcarbonat; C7H10O3
239-148-8; 15096-52-3; Trinatriumhexafluoroaluminat; AlF6.3Na
239-263-3; 15206-55-0; Methylbenzoylformiat; C9H8O3
239-289-5; 15245-12-2; Salpetersäure, Ammoniumcalciumsalz; Ca.xH3N.xHNO3
239-592-2; 15545-48-9; Chlorotoluron; C10H13ClN2O
239-622-4; 15571-58-1; 2-Ethylhexyl-10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat; C36H72O4S2Sn
239-670-6; 15593-75-6; Trinatriumantimonat(3-); Na.?O4Sb
239-701-3; 15625-89-5; [[2-Ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propandiyldiacrylat]]; C15H20O6
239-707-6; 15630-89-4; Dinatriumcarbonat, Verbindung mit Hydrogenperoxid(2:3); CH2O3.3/ 2H2O2.2Na
239-931-4; 15827-60-8; [[[[(Phosphonomethyl)imino]bis[ethan-2,1-diylnitrilobis(methylen)]]tetrakisphosphonsäure]]; C9H28N3O15P5
240-032-4; 15894-70-9; [[N,N'-1,6-Hexandiylbis[N'-cyanguanidin]]]; C10H18N8
240-286-6; 16118-49-3; Carbetamid; C12H16N2O3
240-347-7; 16219-75-3; 5-Ethyliden-8,9,10-trinorborn-2-en; C9H12
240-596-1; 16529-56-9; 2-Methyl-3-butennitril; C5H7N
240-795-3; 16731-55-8; Dikaliumdisulfit; H2O5S2.2K
240-896-2; 16871-90-2; Dikaliumhexafluorsilicat; F6Si.2K
240-898-3; 16872-11-0; Tetrafluoroborsäure; BF4.H
240-934-8; 16893-85-9; Dinatriumhexafluorsilicat; F6Si.2Na
240-969-9; 16919-27-0; Dikaliumhexafluortitanat; F6Ti.2K
241-034-8; 16961-83-4; Hexafluorkieselsäure; F6Si.2H
241-164-5; 17095-24-8; [[Tetranatrium-4-amino-5-hydroxy-3,6-bis[[4-[[2-(sulfonatooxy)ethyl]sulfonyl] phenyl]azo]naphthalin-2,7-disulfonat]]; C26H25N5O19S6.4Na
241-342-2; 17321-47-0; O,O-Dimethylthiophosphoramidat; C2H8NO2PS
241-624-5; 17639-93-9; Methyl-2-chlorpropionat; C4H7ClO2
242-348-8; 18467-77-1; Diprogulinsäure; C12H18O7
242-358-2; 18479-49-7; 3,7-Dimethyloct-1-en-3-ol; C10H20O
242-505-0; 18691-97-9; Methabenzthiazuron; C10H11N3OS
243-215-7; 19666-30-9; [[3-[2,4-Dichlor-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-on]]; C15H18Cl2N2O3
243-473-0; 20030-30-2; 2,5,6-Trimethylcyclohex-2-en-1-on; C9H14O
243-723-9; 20306-75-6; N-Methyl-3-oxobutyramid; C5H9NO2
243-746-4; 20344-49-4; Eisenhydroxidoxid; FeHO2
244-499-5; 21651-19-4; Zinn(II)-oxid; SnO
244-742-5; 22036-77-7; [[[Ethylenbis[nitrilobis(methylen)]]tetrakisphosphonsäure]], Natriumsalz; C6H20- N2O12P4.xNa
244-848-1; 22224-92-6; Fenamiphos; C13H22NO3PS
245-883-5; 23783-42-8; 3,6,9,12-Tetraoxotridecanol; C9H20O5
246-307-5; 24544-08-9; 2,6-diethyl-p-toluidin; C11H17N
246-309-6; 24549-06-2; 6-Ethyl-2-toluidin; C9H13N
246-376-1; 24634-61-5; Kalium-(E,E)-hexa-2,4-dienoat; C6H8O2.K
246-466-0; 24800-44-0; [[[(Methylethylen)bis(oxy)]dipropanol]]; C9H20O4
246-562-2; 25013-15-4; Vinyltoluol; C9H10
246-613-9; 25103-09-7; Isooctylmercaptoacetat; C10H20O2S
246-617-0; 25103-52-0; Isooctansäure; C8H16O2
246-619-1; 25103-58-6; tert-Dodecanthiol; C12H26S
246-673-6; 25154-54-5; Dinitrobenzol; C6H4N2O4
246-690-9; 25167-70-8; 2,4,4-Trimethylpenten; C8H16
246-770-3; 25265-71-8; Oxydipropanol; C6H14O3
246-771-9; 25265-77-4; Isobuttersäure, Monoester mit 2,2,4-Trimethylpentan-1,3-diol; C12H24O3
246-814-1; 25311-71-1; Isofenphos; C15H24NO4PS
246-835-6; 25321-09-9; Diisopropylbenzol; C12H18
246-837-7; 25321-22-6; Dichlorbenzol; C6H4Cl2
246-869-1; 25339-17-7; Isodecylalkohol; C10H22O
247-134-8; 25620-58-0; Trimethylhexan-1,6-diamin; C9H22N2
247-323-5; 25899-50-7; (Z)-Pent-2-ennitril; C5H7N
247-477-3; 26140-60-3; Terphenyl; C18H14
247-571-4; 26266-68-2; 2-Ethylhexenal; C8H14O
247-693-8; 26444-49-5; Diphenyltolylphosphat; C19H17O4P
247-714-0; 26447-40-5; Methylendiphenyldiisocyanat; C15H10N2O2
247-722-4; 26471-62-5; m-Tolylidendiisocyanat; C9H6N2O2
247-977-1; 26761-40-0; Diisodecylphthalat; C28H46O4
247-979-2; 26761-45-5; 2,3-Epoxypropylneodecanoat; C13H24O3
248-092-3; 26896-18-4; Isononansäure; C9H18O2
248-097-0; 26898-17-9; Dibenzyltoluol; C21H20
248-133-5; 26952-21-6; Isooctan-1-ol; C8H18O
248-206-1; 27070-59-3; Cyclododecatrien; C12H18
248-289-4; 27176-87-0; Dodecylbenzolsulfonsäure; C18H30O3S
248-310-7; 27193-28-8; (1,1,3,3-Tetramethylbutyl)phenol; C14H22O
248-363-6; 27247-96-7; 2-Ethylhexylnitrat; C8H17NO3
248-368-3; 27253-26-5; Diisotridecylphthalat; C34H58O4
248-405-3; 27323-18-8; Chlor-1,1'-biphenyl; C12H9Cl
248-433-6; 27375-52-6; [[N-[4-[(2-Hydroxyethyl)sulfonyl]phenyl]acetamid]]; C10H13NO4S
248-469-2; 27458-92-0; Isotridecan-1-ol; C13H28O
248-471-3; 27458-94-2; Isononylalkohol; C9H20O
248-523-5; 27554-26-3; Diisooctylphthalat; C24H38O4
248-654-8; 27776-01-8; Benzyltoluol; C14H14
248-704-9; 27871-49-4; Methyl-(S)-(-)-lactat; C4H8O3
248-948-6; 28299-41-4; Ditolylether; C14H14O
248-953-3; 28305-25-1; Calcium-(S)-2-hydroxypropionat; C3H6O3.½Ca
248-983-7; 28348-53-0; Natriumcumolsulfonat; C9H12O3S.Na
249-048-6; 28473-21-4; Nonan-1-ol; C9H20O
249-050-7; 28479-22-3; 3-Chlor-p-tolylisocyanat; C8H6ClNO
249-079-5; 28553-12-0; Di-isononylphthalat; C26H42O4
249-482-6; 29171-20-8; 3,7-Dimethyloct-6-en-1-in-3-ol; C10H16O
249-828-6; 29761-21-5; Isodecyldiphenylphosphat; C22H31O4P
249-894-6; 29857-13-4; Natrium-1,4-diisodecylsulfonatosuccinat; C24H46O7S.Na
250-178-0; 30399-84-9; Isooctadecansäure; C18H36O2
250-247-5; 30574-97-1; (E)-2-Methyl-2-butennitril; C5H7N
250-354-7; 30845-78-4; Kalium-9,10-dihydro-9,10-dioxoanthracen-1-sulfonat; C14H8O5S.K
250-439-9; 31027-31-3; p-Isopropylphenylisocyanat; C10H11NO
250-702-8; 31565-23-8; Di(tert-dodecyl)pentasulfid; C24H50S5
250-709-6; 31570-04-4; Tris(2,4-ditert-butylphenyl)phosphit; C42H63O3P
251-013-5; 32360-05-7; Octadecylmethacrylat; C22H42O2
251-087-9; 32536-52-0; Diphenylether, Octabromderivat; C12H2Br8O
251-835-4; 34123-59-6; 3-(4-Isopropylphenyl)-1,1-dimethylharnstoff; C12H18N2O
252-104-2; 34590-94-8; (2-Methoxymethylethoxy)propanol; C7H16O3
252-276-9; 34893-92-0; 1,3-Dichlor-5-isocyanatobenzol; C7H3Cl2NO
253-149-0; 36653-82-4; Hexadecan-1-ol; C16H34O
253-178-9; 36734-19-7; 3-(3,5-Dichlorphenyl)-2,4-dioxo-N-isopropylimidazolidin-1-carboxamid; C13H13Cl2N3O3
253-407-2; 37220-82-9; 9-Octadecensäure (Z)-, Ester mit 1,2,3-Propantriol;
253-733-5; 37971-36-1; 2-Phosphonobutan-1,2,4-tricarbonsäure; C7H11O9P
254-159-8; 38861-78-8; [[1-[4-(2-Methylpropyl)phenyl]ethan-1-on]]; C12H16O
254-320-2; 39148-24-8; Aluminiumtriethyltriphosphonat; C2H7O3P.?Al
254-400-7; 39290-78-3; Aluminiumchloridhydroxidsulfat;
255-349-3; 41394-05-2; 4-Amino-3-methyl-6-phenyl-1,2,4-triazin-5-on; C10H10N4O
255-894-7; 42576-02-3; Methyl-5-(2,4-dichlorphenoxy)-2-nitrobenzoat; C14H9Cl2NO5
256-103-8; 43121-43-3; 1-(4-Chlorphenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanon; C14H16ClN3O2
256-176-6; 44992-01-0; [[[2-(Acryloyloxy)ethyl]trimethylammoniumchlorid]]; C8H16NO2.Cl

[edytuj] 50000 ..

256-735-4; 50723-80-3; 3-Isopropyl-1H-2,1,3-benzothiadiazin-4(3H)-on-2,2-dioxid, Natriumsalz; C10H12N2O3S.Na
256-759-5; 50780-99-9; Diisobutylmalonat; C11H20O4
257-098-5; 51274-00-1; Eisenhydroxidoxidgelb Diese Substanz wird im Colour Index durch Colour Index Constitution Number, C.I. 77492, identifiziert.;
257-180-0; 51407-46-6; 2-(4-Isobutylphenyl)propionaldehyd; C13H18O
257-413-6; 51774-11-9; Isoheptan-1-ol; C7H16O
258-290-1; 53003-10-4; Salinomycin; C42H70O11
258-556-7; 53445-37-7; 2,2,4(oder 2,4,4)-Trimethyladipinsäure; C9H16O4
258-587-6; 53500-83-7; Isopropyl-3-methyl-3-(p-isobutylphenyl)oxiran-2-carboxylat; C17H24O3
258-649-2; 53585-53-8; Dibenzylbenzol, ar-Methylderivat; C21H20
259-537-6; 55219-65-3; a-tert-Butyl-ß-(4-chlorphenoxy)-1H-1,2,4-triazol-1-ethanol; C14H18ClN3O2
261-204-5; 58302-43-5; [[Natriumbis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]benzolsulfonamidato(2-)]cobaltat(1-)]]; C32H22CoN6O8S2.Na
261-233-3; 58391-97-2; [[Borsäure (H3BO3), Ester mit 2-[2-(2-Methoxyethoxy)ethoxy]ethanol und 2,2'-Oxybis[ethanol]]];
262-967-7; 61788-32-7; Terphenyl, hydriert;
263-058-8; 61789-40-0; 1-Propanaminium, 3-Amino-N-(carboxymethyl)-N,N-dimethyl-, N-Kokosacylderivate, Hydroxide, Innere Salze;
264-347-1; 63589-25-3; 4-Diazo-3,4-dihydro-7-nitro-3-oxonaphthalin-1-sulfonsäure; C10H5N3O6S
264-459-0; 63785-12-6; Ammoniumhydrogendipropionat; C3H6O2.½H3N
266-030-3; 65996-95-4; Superphosphate, konzentriert Substanz, erhalten durch Säuern von Phosphatgestein mit Phosphorsäure. Gewöhnlich gekennzeichnet durch 40% oder mehr Gehalt an verfügbarem Phosphoroxid (P2O5). Besteht in erster Linie aus Calciumphosphat.]];
266-639-4; 67306-03-0; [[4-[3-[4-(1,1-Dimethylethyl)phenyl]-2-methylpropyl]-2,6-dimethylmorpholin]]; C20H33NO
268-860-1; 68153-01-5; Naphthalensulfonsäuren;
269-587-0; 68298-96-4; [[2-[(2-Hydroxyethyl)amino]ethyldihydrogenorthoborat]]; C4H12BNO4
271-363-2; 68551-11-1; 1-Propen; Hydroformylierungsprodukte, hochsiedend Komplexe Kombination von Produkten hergestellt durch Destillation von Produkten aus der Hydrierung von Butanal aus der Hydroformylierung von Propen. Besteht vorherrschend aus organischen Verbindungen wie Aldehyden, Alkoholen, Estern, Ethern und Carbonsäuren mit Kohlenstoffzahlen im Bereich von C4-C32 und siedet im Bereich von ungefähr 143º C bis 282º C.
271-528-9; 68584-22-5; Benzolsulfonsäure; C10-16-Alkylderivate Diese Substanz wird identifiziert durch SDA Substance Name: C10-C16 alkyl benzene sulfonic acid und SDA Reporting Number: 15-080-00.
272-647-9; 68901-05-3; Propan-1,3-diylbis(oxypropan-1,3-diyl)diacrylat; C14H28Cl4Cr2F9NO9S
274-367-2; 70179-79-2; Ammoniumtetraformiat; CH2O2.¼3N
276-451-4; 72187-40-7; [[4,4'-Bis[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]stilben-2,2'-disulfonsäure, Kaliumnatriumsalz]]; C40H44- N12O16S4.xK.xNa
277-704-1; 74070-46-5; 2-Chlor-6-nitro-3-phenoxyanilin; C12H9ClN2O3
278-404-3; 76253-60-6; [[Dichlor[(dichlorphenyl)methyl]methylbenzol]]; C14H10Cl4
280-895-4; 83803-77-4; Di-tert-dodecyltrisulfid; C24H50S3
283-810-9; 84713-17-7; 2,2,4(oder 2,4,4)-Trimethylhexandinitril; C9H14N2
284-090-9; 84777-61-7; Calcium(II)isooctanoat; C8H16O2.½Ca
284-315-0; 84852-06-2; 1,2-Benzoldicarbonsäure; Di-C7-10-isoalkylester
287-735-2; 85567-22-2; [[2,5,8,10,13,16,17,20,23-Nonaoxa-1,9-diborabicyclo[7.7.7]tricosan]]; C12H24B2O9
300-949-3; 93965-02-7; [[4,4'-Bis[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]stilben-2,2'-disulfonsäure, Natriumsalz, Verbindung mit 2,2'-Iminodiethanol]]; C40H44N12O16S4.xC4H11NO2.xNa
304-180-4; 94247-05-9; Isotridecylmethacrylat; C17H32O2

[edytuj] other 50 ..

200-061-5; 50-70-4; D-Glucitol; C6H14O6
200-294-2; 56-87-1; L-Lysin; C6H14N2O2
200-405-4; 58-95-7; a-Tocopherylacetat; C31H52O3
200-432-1; 59-51-8; DL-Methionin; C5H11NO2S
200-711-8; 69-65-8; D-Mannitol; C6H14O6
201-771-8; 87-79-6; L-Sorbose; C6H12O6
204-664-4; 123-94-4; Glycerinstearat; C21H42O4
205-278-9; 137-08-6; Calciumpantothenat, D-Form; C9H17NO5.½Ca
205-590-5; 143-18-0; Kaliumoleat; C18H34O2.K
205-756-7; 150-30-1; DL-Phenylalanin; C9H11NO2
208-407-7; 527-07-1; Natriumgluconat; C6H12O7.Na
215-665-4; 1338-43-8; Sorbitanoleat; C24H44O6
216-472-8; 1592-23-0; Calciumdistearat; C18H36O2.½Ca
232-274-4; 8001-22-7; Sojabohnenöl; Extrakte und ihre physikalisch modifizierten Derivate. Besteht in erster Linie aus den Glyceriden der Linol-, Olein-, Palmitin- und Stearin-fettsäuren. (Soja hispida, Leguminosae).
232-278-6; 8001-26-1; Leinsamenöl; Extrakte und ihre physikalisch modifizierten Derivate. Besteht in erster Linie aus den Glyceriden der Linol-, Linolen- und Olein-fettsäuren. (Linum usitatissimum, Linaceae).
232-281-2; 8001-30-7; Getreideöl; Extrakte und ihre physikalisch modifizierten Derivate. Besteht in erster Linie aus den Glyceriden der Linol-, Olein-, Palmitin- und Stearin-fettsäuren. (Zea mays, Gramineae).
238-976-7; 14906-97-9; Natrium-D-gluconat; C6H12O7.xNa
248-027-9; 26836-47-5; D-Glucitolmonostearat; C24H48O7

[edytuj] new block

[edytuj] 1 .. 100

Name Summenformel Mol. Masse CAS Nutzung

Aztreonam C₁₃H₁₇N₅O₈S₂ 435.435 g/mol 1-05-7 Anti-Inflammatory Agents; ATC:D07AC10 For relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.s
Ertapenem C₂₂H₂₅N₃O₇S 475.516 g/mol 1-09-1 Anti-Bacterial Agents; ATC:J01DD05 Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria.s
Diflorason C₂₆H₃₂F₂O₇ 494.525 g/mol 1-13-8 Anti-Bacterial Agents; ATC:J01DF01 For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections.s
Cefmenoxim C₁₆H₁₇N₉O₅S₃ 511.562 g/mol 1-24-1 Antibacterials for Systemic Use; ATC:J01DH03 For the treatment the following moderate to severe infections caused by susceptible isolates of the designated microorganisms: (1) complicated intra-abdominal infections due to Escherichia coli, Clostridium clostridioforme, Eubacterium lentum, Peptostreptococcus species, Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides thetaiotaomicron, or Bacteroides uniformis, (2) complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis due to Staphylococcus aureus (methicillin susceptible isolates only), Streptococcus agalactiae, Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Bacteroides fragilis, Peptostreptococcus species, Porphyromonas asaccharolytica, or Prevotella bivia, (3) community acquired pneumonia due to Streptococcus pneumoniae (penicillin susceptible isolates only) including cases with concurrent bacteremia, Haemophilus influenzae (beta-lactamase negative isolates only), or Moraxella catarrhalis, (4) complicated urinary tract infections including pyelonephritis due to Escherichia coli, including cases with concurrent bacteremia, or Klebsiella pneumoniae, (5) acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections due to Streptococcus agalactiae, Escherichia coli, Bacteroides fragilis, Porphyromonas asaccharolytica, Peptostreptococcus species, or Prevotella bivia.s
Anagrelid C₁₀H₇Cl₂N₃O 256.088 g/mol 11-06-1 Alpha-Amylase, Pancreatic inhibitor Not Availables
Clemastin C₂₁H₂₆ClNO 343.89 g/mol 17-07-4 Phospholipase A2 inhibitor Not Availables
Diphenidol C₂₁H₂₇NO 309.445 g/mol 19-011-4 Trypanocidal Agents; Antiprotozoal Agents; Antifungal Agents; ATC:P01CX01 For the treatment of pneumonia due to Pneumocystis carinii.s
Phenobarbiton C₁₂H₁₂N₂O₃ 232.235 g/mol 50-006-6 Anti-allergic Agents; Ophthalmics; Antipruritics; Histamine Antagonists For the prevention of itching of the eyes caused by allergies such as hay fever, and allergic conjunctivitiss
Oxyphenonium C₂₁H₃₄NO₃ 348.5 g/mol 50-010-2 Antihistamines; ATC:R06AX27 For the relief of symptoms of seasonal allergic rhinitis, pruritus, reduction in the number of hives in patients with chronic idiopathic urticaria.s
Metharbital C₉H₁₄N₂O₃ 198.219 g/mol 50-011-3 Anti-bacterial Agents; Anti-Infectives; Quinolones; ATC:J01MA12; ATC:S01AX19 For the treatment of Bacterial infection of; Respiratory tract, Urinary tract, GI, CNS and Immuno compromised patients caused by: S.pneumoniae, H.influenzae, M.catarrhalis, S.aureus, H.parainfluenzae, P.aeruginosa, S.marcescens, E.coli, K.pneumoniae, C.pns
Mephenytoin C₁₂H₁₄N₂O₂ 218.252 g/mol 50-012-4 Mydriatics; Bronchodilator Agents; Antiarrhythmic Agents; Adjuvants; Antimuscarinics; Antispasmodics; ATC:A03BA03 For treatment of bladder spasms, peptic ulcer disease, diverticulitis, colic, irritable bowel syndrome, cystitis, and pancreatitis. Also used to treat certain heart conditions, to control the symptoms of Parkinson's disease and rhinitis.s
Vitamin D2 (Ergocalciferol) C₂₈H₄₄O 396.648 g/mol 50-014-6 Bronchodilator Agents; Endothelium-Dependent Relaxing Factors; Free Radical Scavengers; ATC:R07AX01 For the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failures
lactic säure C₃H₆O₃ 90.079 g/mol 50-021-5 Alpha-D-Glucose 1,6-Bisphosphate Phosphotran inhibitor Not Availables
1,3,5(10)-estratriene-3,16,17-triol C₁₈H₂₄O₃ 288.386 g/mol 50-027-1 Hypoglycemic Agents; Antiarrhythmic Agents; Sulfonylureas; ATC:A10BB Indicated as an adjunct to diet to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (Type II) whose hyperglycemia cannot be satisfactorily controlled by diet alone.s
Phentolamin C₁₇H₁₉N₃O 281.352 g/mol 50-060-2 Vasoconstrictor Agents; Selective Serotonin Agonists; ATC:N02CC01 For the treatment of migraine attacks with or without aura in adultss
d-sorbitol C₆H₁₄O₆ 182.173 g/mol 50-070-4 Muscle Relaxants, Central; ATC:D01AE07 Used, along with rest and physical therapy, to treat injuries and other painful muscular conditions.s
deoxythymidine; 2-deoxythymidine C₁₀H₁₄N₂O₅ 242.231 g/mol 50-089-5 Prodrugs; Antivirals; Nucleosides and Nucleotides; ATC:J05AB09; ATC:S01AD07 For the treatment of acute herpes zoster (shingles). Also for the treatment or suppression of recurrent genital herpes in immunocompetent patients and treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients.s
Floxuridin C₉H₁₁FN₂O₅ 246.193 g/mol 50-091-9 Free Radical Scavengers; Antiparkinson Agents; Antidyskinetics; Antioxidants; ATC:N04BC05 For the treatment of signs and symptoms of idiopathic Parkinson's diseases
beta-d-glucose C₆H₁₂O₆ 180.157 g/mol 50-099-7 Gastrointestinal Agents; Histamine Agonists; ATC:V04CG02 For use clinically to test gastric secretory function.s
alpha-d-glucose C₆H₁₂O₆ 180.157 g/mol 50-099-7 Anti-allergic Agents; Anti-inflammatory Agents; ATC:D07AC13; ATC:D07XC03; ATC:R01AD09; ATC:R03BA07 The inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy. The nasal spray is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis.s
benzimidazol C₇H₆N₂ 118.138 g/mol 51-017-2 Antiresorptives; Bisphosphonates; Antihypocalcemic Agents; ATC:M05BA07 For the treatment of Paget's disease of the bone (osteitis deformans), postmenopausal and glucocorticoid-induced osteoporosiss
2,4-dinitrophenol C₆H₄N₂O₅ 184.108 g/mol 51-028-5 Thrombolytic Agents; ATC:B01AD11 For treatment of myocardial infarction and lysis of intracoronary embolis
Dextrothyroxin C₁₅H₁₁I₄NO₄ 776.87 g/mol 51-049-0 Antineoplastic Agents; ATC:G04CA02 Used in the treatment of signs and symptoms of benign prostatic hyperplasia.s
Propylthiouracil C₇H₁₀N₂OS 170.233 g/mol 51-052-5 Antipsychotics; Antipsychotics; ATC:N05AX08 For the treatment of schizophrenia.s
Phenelzin C₈H₁₂N₂ 136.194 g/mol 51-071-8 Neuromuscular Nondepolarizing Agents; ATC:M03AC10 For inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.s
Histaminephosphat C₅H₁₅N₃O₈P₂ 307.14 g/mol 51-074-1 Neuromuscular Nondepolarizing Agents; ATC:M03AC07 Used to provide skeletal muscle relaxation as an adjunct to general anesthesia, for endotracheal intubation or to facilitate mechanical ventilation.s
Pentolinium C₁₅H₃₂N₂ 240.428 g/mol 52-062-0 L-2-Halosäure Dehalogenase inhibitor Not Availables
nicotinamide-adenine-dinucleotide C₂₁H₂₇N₇O₁₄P₂ 663.430 g/mol 53-084-9 Antineoplastic Agents; ATC:L02BG06 For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.s
Indomethacin C₁₉H₁₆ClNO₄ 357.787 g/mol 53-086-1 Insulin inhibitor Not Availables
(s)-(-)-nicotine]], [[3-((2s)-1-methyl-2-pyrrolidinyl)pyridine C₁₀H₁₄N₂ 162.234 g/mol 54-011-5 Pentaerythritol Tetranitrate Reductase inhibitor Not Availables
metyrapon C₁₄H₁₄N₂O₁ 226.277 g/mol 54-036-4 Biliverdin Ix Beta Reductase inhibitor Not Availables
metyrapon C₁₄H₁₄N₂O 226.274 g/mol 54-036-4 000002-Hydroxy-6-Oxo-7-Methylocta-2,4-Dienoate Hy inhibitor Not Availables
Metaraminol C₉H₁₃NO₂ 167.205 g/mol 54-049-9 Fibrinolytic Agents; Platelet Aggregation Inhibitors; ATC:L01XX35 For the treatment of patients with thrombocythemia, secondary to myeloproliferative disorders, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.s
Pipobroman C₁₀H₁₆Br₂N₂O₂ 356.054 g/mol 54-091-1 Malate Dehydrogenase inhibitor Not Availables
Betanidin C₁₀H₁₅N₃ 177.25 g/mol 55-073-2 S-Adenosylmethionine Decarboxylase Proenzyme inhibitor Not Availables
Isoflurophat C₆H₁₄FO₃P 184.146 g/mol 55-091-4 Beta-Trypsin inhibitor Not Availables
Quinidin C₂₀H₂₄N₂O₂ 324.417 g/mol 56-054-2 Alpha-Amylase, Pancreatic inhibitor Not Availables
Felypressin C₄₆H₆₅N₁₃O₁₁S₂ 1040.22 g/mol 56-059-7 Antianemic Agents; ATC:B03XA02 For the treatment of anemia (from renal transplants or certain HIV treatment)s
glucose-6-phosphat C₆H₁₃O₉P₁ 260.137 g/mol 56-073-5 2,3,4,5-Tetrahydropyridine-2-Carboxylate N- inhibitor Not Availables
L-Aspartinsäure C₄H₇N₁O₄ 133.104 g/mol 56-084-8 N-Acetylneuraminate Lyase Subunit inhibitor Not Availables
Demecariumbromid C₃₂H₅₂Br₂N₄O₄ 716.588 g/mol 56-094-0 Bacteriorhodopsin inhibitor Not Availables
Creatine C₄H₉N₃O₂ 131.134 g/mol 57-000-1 Serum Albumin inhibitor Not Availables
Meperidin C₁₅H₂₁NO₂ 247.333 g/mol 57-042-1 Parasympathomimetics; ATC:A07AB03 For the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis.s
1,2-propanediol C₃H₈O₂ 76.095 g/mol 57-055-6 Adrenergic Agents; Dopamine Agents; Central Nervous System Agents; Anorexigenic Agents; Stimulants; ATC:N06BA04 Children with attention deficit disorderss
Sulfinpyrazon C₂₃H₂₀N₂O₃S 404.483 g/mol 57-096-5 Anti-allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihistamines; Histamine H1 Antagonists; ATC:S01GX09 For the treatment of the signs and symptoms of allergic conjunctivitis.s
000005-formyl-5,6,7,8-tetrahydrofolate C₂₀H₂₃N₇O₇ 473.444 g/mol 58-005-9 Anti-HIV Agents; Radiation-Sensitizing Agents; Antivirals; Antineoplastic Agents; ATC:J05AB12 For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)s
Caffein C₈H₁₀N₄O₂ 194.191 g/mol 58-008-2 Anti-bacterial Agents; ATC:D10AF02; ATC:J01FA01; ATC:S01AA17 For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to Corynebacterium diphtheriae, in the treatment of infections due to Corynebacterium minutissimum, intestinal amebiasis caused by Entamoeba histolytica, acute pelvic inflammatory disease caused by Neisseria gonorrhoeae, skin and soft tissue infections of mild to moderate severity caused by Streptococcus pyogenes and Staphylococcus aureus, primary syphilis caused by Treponema pallidum, infections caused by Chlamydia trachomatis, nongonococcal urethritis caused by Ureaplasma urealyticum, and Legionnaires' disease caused by Legionella pneumophila.s
Chlordiazepoxid C₁₆H₁₄ClN₃O 299.755 g/mol 58-025-3 Antihypertensive Agents; Antiarrhythmic Agents; Angiotensin II Receptor Antagonists; ATC:C09CA01 For the treatment of hypertension.s
Vitamin K3 C₁₁H₈O₂ 172.183 g/mol 58-027-5 Anticoagulants; Antithrombotics; ATC:B01AX05 For the treatment of prophylaxis of deep vein thrombosis.s
Prochlorperazin C₂₀H₂₄ClN₃S 373.943 g/mol 58-038-8 Hypnotics and Sedatives; Anticonvulsants; ATC:N03AA;ATC:N05CA For the relief of anxiety, tension, and apprehension, also used as an anticonvulsant for the treatment of epilepsy.s
Perphenazin C₂₁H₂₆ClN₃OS 403.969 g/mol 58-039-9 Anticonvulsants; ATC:N03AC01 Used for the control of absence (petit mal) seizures that are refractory to treatment with other medications.s
Promazin C₁₇H₂₀N₂S 284.42 g/mol 58-040-2 Neuroprotective Agents; Anticonvulsants; ATC:N03AG06 For the treatment of partial seizuress
Ethacryninsäure C₁₃H₁₂Cl₂O₄ 303.137 g/mol 58-054-8 Antiarrhythmic Agents; Potassium Channel Blockers; ATC:C01BD04 For the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythms
Chlorthiazid C₇H₆ClN₃O₄S₂ 295.725 g/mol 58-094-6 5'-Methylthioadenosine Phosphorylase inhibitor Not Availables
uridin-5-monophosphat C₉H₁₃N₂O₉P₁ 324.183 g/mol 58-097-9 Anti-bacterial Agents; ATC:J01AA11 For the treatment and management of Brucellosis, mycoplasma infection, acne vulgaris, chlamydial infection;Chronic bronchitiss
uridin-5-diphosphat C₉H₁₄N₂O₁₂P₂ 404.163 g/mol 58-098-0 Dermatologic Agents; Keratolytic Agents; Prodrugs; Teratogens; ATC:D05AX05 Used to treat psoriasis, acne and sun damaged skin (photodamage).s
alpha-d-glucose-1-phosphat C₆H₁₃O₉P₁ 260.137 g/mol 59-056-3 Antibacterials for Systemic Use; ATC:J01DH02 For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.s
Isocarboxazid C₁₂H₁₃N₃O₂ 231.251 g/mol 59-063-2 Antifibrinolytic Agents; ATC:B02AA02 For use in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.s
Nitrofurazon C₆H₆N₄O₄ 198.136 g/mol 59-087-0 Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
Phenoxybenzamin C₁₈H₂₂ClNO 303.826 g/mol 59-096-1 Antiglaucomic Agents; Ophthalmics; ATC:S01EC02 For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressures
000002-sulfhydryl-ethanol C₂H₆O₁S₁ 78.129 g/mol 60-024-2 Antihypertensive Agents; Carbonic Anhydrase Inhibitors; ATC:S01EC03 For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucomas
aminocaproinsäure C₆H₁₃N₁O₂ 131.174 g/mol 60-032-2 Infertility Agents; ATC:H01CC02 For the inhibition of premature LH surges in women undergoing controlled ovarian stimulations
aminocaproinsäure C₆H₁₃NO₂ 131.173 g/mol 60-032-2 Infertility Agents; Hormone Antagonists; ATC:H01CC02 For the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.s
Mecamylamin C₁₁H₂₁N 167.291 g/mol 60-040-2 Anticoagulants; Antithrombotic Agents; ATC:B01AE02 For the treatment of heparin-induced thrombocytopenias
Tridihexethyl C₂₁H₃₆NO+ 318.517 g/mol 60-049-1 Chorismate--Pyruvate Lyase inhibitor Not Availables
Adenosin monophosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol 61-019-8 Copper Amine Oxidase inhibitor Not Availables
Cloxacillin C₁₉H₁₈ClN₃O₅S 435.882 g/mol 61-072-3 Contrast Agents: ATC:V08CA03 For intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions), spine, and associated tissues.s
(3-(o-chlorophenyl)-5-methyl-4-isoxazolyl)penicillin C₁₉H₁₈N₃O₅Cl₁S₁ 435.881 g/mol 61-072-3 Old Yellow Enzyme inhibitor Not Availables
Chlormerodrin C₅H₁₁ClHgN₂O₂ 367.196 g/mol 62-037-3 Diaminopimelate Decarboxylase inhibitor Not Availables
Lipoinsäure C₈H₁₄O₂S₂ 206.317 g/mol 62-046-4 Antineoplastic agents; Antimetabolites; Purine analogues; ATC:L01BB06 For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.s
nalorphin C₁₉H₂₁NO₃ 311.375 g/mol 62-067-9 Anti-barbituates; Stimulants; GABA receptor antagonists Used internally for relieving respiratory distress. Also for use as an antidote in poisoning by CNS depressants, especially barbiturates.s
Nandrolonephenpropionat C₂₇H₃₄O₃ 406.557 g/mol 62-090-8 Glucocorticoids; Anti-inflammatory Agents; Adrenergic Agents; ATC:A01AC01; ATC:D07AB09; ATC:D07XB02; ATC:H02AB08; ATC:R01AD11; ATC:R03BA06; ATC:S01BA05 For the treatment of perennial and seasonal allergic rhinitis.s
Diphemanilmethylsulfat C₂₁H₂₇NO₄S 389.509 g/mol 62-097-5 Prodrugs; Antivirals; ATC:J05AB For the treatment or suppression of cold sores (herpes labialis), herpes zoster (shingles), genital herpes in immunocompetent individuals, and recurrent genital herpes in HIV-infected individuals.s
000004-androstene-3-17-dion C₁₉H₂₆O₂ 286.413 g/mol 63-005-8 Antispasmodics; Anti-Incontinence Agents; Genitourinary Smooth Muscle Relaxants; ATC:G04BD07 For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).s
Benzquinamid C₂₂H₃₂N₂O₅ 404.5 g/mol 63-012-7 Analgesics; Antitussives; Narcotics; ATC:R05DA03 For relief of moderate to moderately severe pain.s
cytidine-5-diphosphat C₉H₁₅N₃O₁₁P₂ 403.179 g/mol 63-038-7 Anticonvulsants; Barbiturates; ATC:N03AA03 For the treatment of epilepsys
uridine 5-triphosphat C₉H₁₁N₂O₁₅P₃ 480.112 g/mol 63-039-8 Anti-anxiety Agents; Hypnotics and Sedatives; Barbiturates; ATC:N05CA For short-term treatment of insomnia and anxiety disorderss
Phenacemid C₉H₁₀N₂O₂ 178.188 g/mol 63-098-9 Hypnotics and Sedatives Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.s
forminsäure C₁H₂O₂ 46.026 g/mol 64-018-6 Anti-Bacterial Agents; ATC:J01XB01 For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.s
acetinsäure C₂H₄O₂ 60.052 g/mol 64-019-7 Anti-bacterial Agents; Antibiotics; ATC:D06AX09; ATC:R01AX06 For the treatment of Staphylococci nasal carriers.s
Gallamintriethiodid C₂₄H₄₅N₃O₃ 423.633 g/mol 65-029-2 Anti-inflammatory Agents; Adrenergic Agents; ATC:H02AA02 For partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.s
cytidin-5-triphosphat C₉H₁₆N₃O₁₄P₃ 483.158 g/mol 65-047-4 Anti-bacterial Agents; Tetracyclines; ATC:D06AA01; ATC:J01AA01 Used primarily to treat Lyme disease, acne, and bronchitis. Also indicated (but rarely used) to treat urinary tract infections, gum disease, malaria, and other bacterial infections such as gonorrhea and chlamydia. One of its other registered uses is the treatment of hyponatremia (low blood sodium concentration) due to the syndrome of inappropriate antidiuretic hormone (SIADH) where fluid restriction alone has been ineffective.s
n-acetylmethionin C₇H₁₃N₁O₃S₁ 191.245 g/mol 65-082-7 Anti-Infectives; Sulfonamides Treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections.s
benzoic säure C₇H₆O₂ 122.123 g/mol 65-085-0 Contrast Media; ATC:V08CA08 For magnetic resonance imaging (MRI) of the central nervous system in adults to visualize lesions with abnormal blood brain barrier or abnormal vascularity of the brain, spine, and associated tissues.s
orotic säure C₅H₄N₂O₄ 156.098 g/mol 65-086-1 Anti-HIV Agents; ATC:J05AE01 For the treatment of HIV-1 with advanced immunodeficiency together with antiretroviral nucleoside analogues.s
1,10-phenanthroline C₁₂H₈N₂ 180.209 g/mol 66-071-7 Antidepressive Agents, Second-Generation; Serotonin Uptake Inhibitors; ATC:N06AB10 For the treatment of major depressive disorder and Generalized Anxiety Disorder (GAD).s
Uracil Mustard C₈H₁₁Cl₂N₃O₂ 252.097 g/mol 66-075-1 Anticoagulants; Antithrombotic Agents; ATC:B01AE06 For treatment of heparin-induced thrombocytopenias
Dicumarol C₁₉H₁₂O₆ 336.295 g/mol 66-076-2 Antiarrhythmic Agents; ATC:R03DC For Protection against second- phase inflamation in exercise-induced bronchoconstriction and Asthma.s
Furazolidon C₈H₇N₃O₅ 225.158 g/mol 67-045-8 Anti-allergic Agents; Gastrointestinal Agents; Antipruritics; Antihistamine derivatives; ATC:R06AX02 For treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, cold urticaria, dermatographism, and as therapy for anaphylactic reactions adjunctive to epinephrine.s
Fluocinolonacetonid C₂₄H₃₀F₂O₆ 452.488 g/mol 67-073-2 Antineoplastic Agents; Photosensitizing Agents; ATC:L01XD02 For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.s
Vitamin D4 (Dihydrotachysterol) C₂₈H₄₆O 398.664 g/mol 67-096-9 Anti-HIV Agents; Nonnucleoside Reverse Transcriptase Inhibitors; ATC:J05AG01 For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.s
Norethindron C₂₀H₂₆O₂ 298.419 g/mol 68-022-4 Antihypertensive Agents; Neuroprotective Agents; ATC:S01EE01 For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.s
Sulfadiazin C₁₀H₁₀N₄O₂S 250.278 g/mol 68-035-9 Sex Comb On Midleg-Like Protein 2 inhibitor Not Availables
Fluphenazin C₂₂H₂₆F₃N₃OS 437.523 g/mol 69-023-8 Anti-allergic Agents; Antipruritics; Antihistamines; ATC:R06AB02 For the treatment of rhinitis, urticaria, allergy, common cold, asthma and hay fever.s
7,9-dihydro-1h-purine-2,6,8(3h)-trione C₅H₄N₄O₃ 168.112 g/mol 69-093-2 Anesthetics; Local Anesthetics; ATC:N01BA04 For the production of local anesthesia by infiltration and peripheral nerve block. They are not to be used for lumbar or caudal epidural anesthesia.s
Trifluridin C₁₀H₁₁F₃N₂O₅ 296.2 g/mol 70-000-8 Diuretics; Antihypertensive Agents; ATC:C03AA06 Used in the treatment of oedema (including that associated with heart failure) and hypertension.s
Hexachlorophen C₁₃H₆Cl₆O₂ 406.902 g/mol 70-030-4 Hypoglycemic Agents For treatment of diabetes (type I and II)s
Deferoxamin C₂₅H₄₈N₆O₈ 560.684 g/mol 70-051-9 Adrenergic alpha-Agonists; Sympathomimetics; Vasoconstrictor Agents; ATC:C01CA17 For the treatment of symptomatic orthostatic hypotension (OH).s
000001-proponol C₃H₈O₁ 60.096 g/mol 71-023-8 Antiviral Agents; Nucleic säure Synthesis Inhibitors; ATC:J05AC02 For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults.s
L-Threonine C₄H₉N₁O₃ 119.120 g/mol 72-019-5 Skin protectant, barrier (topical) Used to prevent or reduce the severity of allergic contact dermatitis due to urushiol, the allergenic resin of poison ivy, poison oak, and poison sumac.s
Nortriptylin C₁₉H₂₁N 263.377 g/mol 72-069-5 Anti-anemic Agents; Nutritional Supplement; ATC:B03BA03; ATC:V03AB33 For treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also used as a cyanide poisoning antidotes
L-Isoleucin C₆H₁₃N₁O₂ 131.174 g/mol 73-032-5 Diuretics, Thiazide; ATC:C03AA08 For use in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Also used as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.s
Bendroflumethiazid C₁₅H₁₄F₃N₃O₄S₂ 421.417 g/mol 73-048-3 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalance.s
000004-amino-5-hydroxymethyl-2-methylpyrimidine C₆H₉N₃O₁ 139.157 g/mol 73-067-6 Tropinone Reductase-II inhibitor Not Availables
000004-chlorobenzoic säure C₇H₅ClO₂ 156.568 g/mol 74-011-3 Hypoglycemic Agents; Meglitinides; ATC:A10BX02 For the treatment of Type II diabetes mellitus.s
acetoncyanohydrin C₄H₇N₁O₁ 85.105 g/mol 75-086-5 Antiadrenal; Anticorticosteroids; ATC:H02CA01 Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.s
Perflutren C₃F₈ 188.019 g/mol 76-019-7 Anti-HIV Agents; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors; ATC:J05AF06 For the treatment of HIV-1 infection, in combination with other antiretroviral agents.s
Oxymorphon C₁₇H₁₉NO₄ 301.337 g/mol 76-041-5 Anti-constipation Agents For the treatment of chronic idiopathic constipation in the adult population.s
Fluoxymesteron C₂₀H₂₉FO₃ 336.441 g/mol 76-043-7 Antiarrhythmic Agents; Anesthetics; ATC:C01BB01; ATC:C05AD01; ATC:D04AB01; ATC:N01BB02; ATC:R02AD02; ATC:S01HA07; ATC:S02DA01 For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.s
Hydrocortamat C₂₇H₄₁NO₆ 475.618 g/mol 76-047-1 Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Enzyme Inhibitors; Immunosuppressive Agents; ATC:D11AX15 For treatment of mild to moderate atopic dermatitis.s
Levorphanol C₁₇H₂₃NO 257.371 g/mol 77-007-6 Antihypertensive Agents; Angiotensin II Receptor Antagonists; ATC:C09CA04 For the treatment of hypertension.s
Dicyclomin C₁₉H₃₅NO₂ 309.487 g/mol 77-019-0 Antiglaucomic Agents; Ophthalmics; Carbonic Anhydrase Inhibitors; ATC:S01EC04 For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.s
Butalbital C₁₁H₁₆N₂O₃ 224.256 g/mol 77-026-9 Imaging Agent For diagnosis of extrahepatic malignant cancerss
Chlorthalidon C₁₄H₁₁ClN₂O₄S 338.767 g/mol 77-036-1 Anti-migraine Agents; Vasoconstrictor Agents; Anti-inflammatory Agents; Selective Serotonin Agonists; ATC:N02CC03 For the acute treatment of adult migraine (with or without auras)s
Procyclidin C₁₉H₂₉NO 287.44 g/mol 77-037-2 Antihypertensive Agents; Angiotensin II Receptor Antagonists; ATC:C09CA06 For the treatment of hypertension.s
Cycrimin C₁₉H₂₉NO 287.44 g/mol 77-039-4 Amebicides; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; ATC:A01AB04; ATC:A07AA07; ATC:G01AA03; ATC:J02AA01 Used to treat potentially life threatening fungal infections.s
Carisoprodol C₁₂H₂₄N₂O₄ 260.33 g/mol 78-044-4 Antidepressants; Norepinephrine-Reuptake Inhibitors; ATC:N06AA17 For the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions. Also for depression accompanied by anxiety or agitation.s
propanoic säure C₃H₆O₂ 74.079 g/mol 79-009-4 Anti-Bacterial Agents; Antifungal Agents; ATC:G01AA04 Used in the topical treatment of vulvovaginal candidiasis.s
hydroxyacetylsäure; hydroxyethanolsäure C₂H₄O₃ 76.052 g/mol 79-014-1 Anti-Bacterial Agents; Glycopeptide antibacterials; ATC:A07AA09; ATC:J01XA01 For the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci.s
isobutylsäure C₄H₈O₂ 88.106 g/mol 79-031-2 Glycosyltransferase Gtfa inhibitor Not Availables
lanosterol C₃₀H₅₀O₁ 426.724 g/mol 79-063-0 Anti-Bacterial Agents; ATC:A07AA05; ATC:J01XB02; ATC:S01AA18; ATC:S02AA11; ATC:S03AA03 For treatment of infections of the urinary tract, meninges, and blood stream, caused by susceptible strains of Pseudomonas aeruginosa.s
Dapson C₁₂H₁₂N₂O₂S 248.302 g/mol 80-008-0 Anti-Bacterial Agents; Anti-Infective Agents, Local; ATC:D06AX05; ATC:R02AB04 For the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. Also used in ointment form for topical treatment of a variety of localized skin and eye infections, as well as for the prevention of wound infections.s
Homatropinmethylbromid C₁₇H₂₄BrNO₃ 370.28 g/mol 80-049-9 Anti-Infectives; Antibiotic Agents; Ophthalmic Antibiotic; Topical Antibiotic For treatment of skin lesions, surface wounds and eye infectionss
Anisotropinmethylbromid C₁₇H₃₂BrNO₂ 362.346 g/mol 80-050-2 Non-Specific Lipid Transfer Protein inhibitor Not Availables
Chlormezanon C₁₁H₁₂ClNO₃S 273.737 g/mol 80-077-3 Synthetic Designed Peptide "Alpha-1" inhibitor Not Availables
taurocholic säure C₂₆H₄₅N₁O₇S₁ 515.704 g/mol 81-024-3 Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
cholic säure C₂₄H₄₀O₅ 408.577 g/mol 81-025-4 Anti-Arrhythmia Agents; Cardiotonic Agents; Phosphodiesterase Inhibitors; Vasodilator Agents; ATC:C01CX08 For short term treatment of acutely decompensated severe chronic heart failure (CHF).s
Cyclizin C₁₈H₂₂N₂ 266.381 g/mol 82-092-8 L-3-Hydroxyacyl-Coa Dehydrogenase inhibitor Not Availables
Buclizin C₂₈H₃₃ClN₂ 433.028 g/mol 82-095-1 Anti-emetics; ATC:R06AD03 For the treatment or relief of nausea and vomiting.s
Phenindion C₁₅H₁₀O₂ 222.239 g/mol 83-012-5 Antiviral Agents; Reverse Transcriptase Inhibitors; ATC:J05AF08 For the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.s
deoxycholic säure C₂₄H₄₀O₄ 392.578 g/mol 83-044-3 Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
Quinacrin C₂₃H₃₀ClN₃O 399.957 g/mol 83-089-6 Anti-migraine Agents; Vasoconstrictor Agents; Anti-inflammatory Agents; Selective Serotonin Agonists; ATC:N02CC06 For the acute treatment of migraine with or without aura in adults.s
Orphenadrin C₁₈H₂₃NO 269.381 g/mol 83-098-7 Anti-HIV Agents; ATC:J05AF09 Indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults.s
Dienestrol C₁₈H₁₈O₂ 266.334 g/mol 84-017-3 Anticoagulants; Antiplatelet Agents For treatment of myocardial infarction, adjunct to percutaneous coronory intervention, unstable anginas
cytidin-5-monophosphat C₉H₁₄N₃O₈P₁ 323.199 g/mol 84-052-6 Antiparkinson Agents; Antidyskinetics; ATC:N04AA01 Indicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs.s
Phytonadion C₃₁H₄₆O₂ 450.696 g/mol 84-080-0 Analgesics; Narcotics; Opiate Agonists; ATC:N01AH05 For treatment and management of pain (systemic) and for use as an anesthesia adjunct.s
Trimeprazin C₁₈H₂₂N₂S 298.447 g/mol 84-096-8 Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
guanosin-5-monophosphat C₁₀H₁₄N₅O₈P₁ 363.223 g/mol 85-032-5 Anti-Infectives; Anti-bacterial Agents For the treatment of leprosy and dermatitis herpetiformiss
coenzyme a C₂₁H₃₆N₇O₁₆P₃S₁ 767.534 g/mol 85-061-0 Anti-Infectives Agents, Local; Anti-Infectives Agents, Urinary; Anti-bacterial Agents; ATC:S01AB04 For the treatment of bacterial vaginitis, keratitis, acute conjunctivitis, and blepharitis.s
cytidin-2-monophosphat C₉H₁₄N₃O₈P₁ 323.199 g/mol 85-094-9 Dermatitis herpetiformis suppressant; Dermatologic Agents; Anti-Infectives; Sulfonamides; ATC:J01EB04 For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosums
guanosin-5-triphosphat C₁₀H₁₆N₅O₁₄P₃ 523.183 g/mol 86-001-1 Antiviral Agents; Oligonucleotides, Antisense; ATC:S01AD08 Vitravene is indicated for the local treatment of CMV retinitis. It is recommended for use by patients with acquired immune deficiency syndrome who are intolerant or have contraindications to other treatments.s
Benztropin C₂₁H₂₅NO 307.429 g/mol 86-013-5 Anti-Infective Agents, Local For the treatment of bacterial and fungal infections inside the mouth (thrush) and skin, also for the prevention of transmission of Chagas' disease (as a blood additive).s
Brompheniramin C₁₆H₁₉BrN₂ 319.24 g/mol 86-022-6 Fibrinolytic Agents; Platelet Aggregation Inhibitors; ATC:B01AC17 For treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy.s
Phensuximid C₁₁H₁₁NO₂ 189.211 g/mol 86-034-0 Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; ATC:C09CA08 For the treatment of hypertensions
Ethotoin C₁₁H₁₂N₂O₂ 204.225 g/mol 86-035-1 Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; ATC:C09CA07 For the treatment of hypertension.s
Amodiaquin C₂₀H₂₂ClN₃O 355.861 g/mol 86-042-0 Anti-migraine Agents; Vasoconstrictor Agents; Anti-inflammatory Agents; Selective Serotonin Agonists; ATC:N02CC04 For treatment of acute migraine attacks.s
Penicillin V C₁₆H₁₈N₂O₅S 350.391 g/mol 87-008-1 Antiviral Agents; Immunomodulatory Agents For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatums
glucarat C₆H₈O₈₂- 1392.080 g/mol 87-073-0 Anticholesteremic Agents; Antilipemic Agents; ATC:C10AA06 Used as an adjunct to diet for the reduction of elevated total and LDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Types IIa and IIb) when the response to dietary restriction of saturated fat and cholesterol and other non-pharmacological measures alone has been inadequate.s
phthalic säure C₈H₆O₄ 166.133 g/mol 88-099-3 Coagulants; Thrombotics; ATC:L03AC02 Increases reduced platelet levels due to chemotherapys
quinolinic säure C₇H₅N₁O₄ 167.121 g/mol 89-000-9 Udp-Galactopyranose Mutase inhibitor Not Availables
Mesalamin C₇H₇NO₃ 153.135 g/mol 89-057-6 Nitroreductase Family Protein inhibitor Not Availables
salicylhydroxamic säure C₇H₇N₁O₃ 153.137 g/mol 89-073-6 Antipsychotics; Antiemetics; ATC:N05AA05 Used mainly in the management of psychoses. Also used to control nausea and vomiting.s
(s)-mandelic säure C₈H₈O₃ 152.149 g/mol 90-064-2 Dopaminergics; Neuroprotective Agents; Antiparkinson Agents; Antidyskinetics; Central Nervous System Agents; ATC:N04BD01 For the adjunct treatment for Parkinson's disease.s
Diethylcarbamazin C₁₀H₂₁N₃O 199.293 g/mol 90-089-1 Fertility Agents For treatment of female infertilitys
Benzthiazid C₁₅H₁₄ClN₃O₄S₃ 431.94 g/mol 91-033-8 Fertility Agents For treatment of female infertilitys
Proflavin C₁₃H₁₁N₃ 209.247 g/mol 92-062-6 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:V06DD L-Proline is extremely important for the proper functioning of joints and tendons and also helps maintain and strengthen heart muscles.s
quinaldic säure C₁₀H₇N₁O₂ 173.171 g/mol 93-010-7 Immunosuppressive Agents; Antivirals; Antimetabolites; Antineoplastic Agents; ATC:L01BC01 For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.s
Aminohippurat C₉H₁₀N₂O₃ 194.187 g/mol 94-016-6 ATC:L03AX13 For reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.s
Chlorpropamid C₁₀H₁₃ClN₂O₃S 276.741 g/mol 94-020-2 Antihypertensive Agents; ATC:C02KX01 Used in the treatment of pulmonary arterial hypertension (PAH), to improve exercise ability and to decrease the rate of clinical worsening (in patients with WHO Class III or IV symptoms).s
Chlorzoxazon C₇H₄ClNO₂ 169.565 g/mol 95-025-0 Adjuvants, Immunologic; Antinematodal Agents; Antirheumatic Agents; ATC:P02CE01 For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.s
000002-aminophenol C₆H₇N₁O₁ 109.127 g/mol 95-055-6 Narcotics; Analgesics, Opioid LAAM is indicated for the treatment and management of opiate dependence. It is sometimes used to treat severe pain in terminal patients.s
pyroglutamic säure C₅H₇N₁O₃ 129.115 g/mol 98-079-3 Anticonvulsants; ATC:N03AX16 For management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia.s
nicotinamid C₆H₆N₂O₁ 122.126 g/mol 98-092-0 Adrenergic alpha-Agonists; Nasal Decongestants; Sympathomimetics; ATC:R01AA05; ATC:R01AB07; ATC:S01GA04 For treatment of nasal congestion and redness associated with minor irritations of the eyes
3,4-dihydroxybenzoic säure C₇H₆O₄ 154.122 g/mol 99-050-3 P-Hydroxybenzoate Hydroxylase inhibitor Not Availables
Valproic säure C₈H₁₆O₂ 144.211 g/mol 99-066-1 000003-Hydroxy-3-Methylglutaryl-Coenzyme A Reduct inhibitor Not Availables

[edytuj] 100 .. 1000

p-nitrophenol C₆H₅N₁O₃ 139.110 g/mol 100-02-7 Anti-HIV Agents; ATC:J05AE02 For the treatment of HIV infection.s
p-anisic säure C₈H₈O₃ 152.149 g/mol 100-09-4 Antineoplastic Agents; Antimetabolites; Enzyme Inhibitors; Folic säure Antagonists; ATC:L01BA04 For the treatment of malignant pleural mesothelioma and locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapys
Pentamidin C₁₉H₂₄N₄O₂ 340.42 g/mol 100-33-4 Antihypertensive Agents; Vasodilator Agents; ATC:C02DD01 For immediate reduction of blood pressure of patients in hypertensive crises, reduce bleeding during surgery, and for the treatment of acute congestive heart failures
Monobenzon C₁₃H₁₂O₂ 200.233 g/mol 103-16-2 Anesthetics; Barbiturates; ATC:N01AF01; ATC:N05CA15 Indicated for use as an intravenous anaesthetic.s
Chlorphenesin C₉H₁₁ClO₃ 202.635 g/mol 104-29-0 Analgesic Antagonists; Morphine Antidotes; Antinarcotic Agents; Narcotic Antagonists For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids.s
Benzonatat C₃₀H₅₃NO₁₁ 603.742 g/mol 104-31-4 Antimalarials; Anti-Infectives; Anti-Infective Agents, Urinary For the treatment of urinary tract infection and chronic bronchitis.s
Betazol C₅H₉N₃ 111.145 g/mol 105-20-4 Pregnadien derivatives; Progesterones; ATC:G03DB01 Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.s
p-cresol C₇H₈O₁ 108.140 g/mol 106-44-5 Anti-Inflammatory Agents; Glucocorticoids For relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesionss
Aminolevulinic säure C₅H₉NO₃ 131.13 g/mol 106-60-5 Antineoplastic Agents; Protein Kinase Inhibitors; ATC:L01XX28 For the treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia (CML). Also indicated for the treatment of pediatric patients with Ph+ chronic phase CML whose disease has recurred after stem cell transplant or who are resistant to interferon-alpha therapy. Also indicated with unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST).s
000002-aminoethanesulfonic säure C₂H₇N₁O₃S₁ 125.142 g/mol 107-35-7 Fertility Agents For treatment of female infertilitys
phosphocholin C₅H₁₅N₁O₄P₁₁+ 493.889 g/mol 107-73-3 Aldo-Keto Reductase Family 1 Member C3 inhibitor Not Availables
butanoic säure C₄H₈O₂ 88.106 g/mol 107-92-6 Beta-Lactamase inhibitor Not Availables
m-cresol C₇H₈O₁ 108.140 g/mol 108-39-4 Sst1-Selective Somatosatin Analog inhibitor Not Availables
n-valeric säure C₅H₁₀O₂ 102.133 g/mol 109-52-4 Antimetabolites; Antineoplastic Agents; ATC:L01BB03 For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias.s
Succinic säure C₄H₆O₄ 118.089 g/mol 110-15-6 Benzoylformate Decarboxylase inhibitor Not Availables
maleic säure C₄H₄O₄ 116.073 g/mol 110-16-7 Pyruvate Oxidase inhibitor Not Availables
fumaric säure C₄H₄O₄ 116.073 g/mol 110-17-8 Antineoplastic Agents; ATC:L01AD01 For the treatment of brain tumors, multiple myeloma, Hodgkin's disease and Non-Hodgkin's lymphomas.s
glutaric säure C₅H₈O₄ 132.116 g/mol 110-94-1 Antispasmodics; Anticholinergic Agents; ATC:A03BB03; ATC:S01FA03 Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.s
pimelic säure C₇H₁₂O₄ 160.169 g/mol 111-16-0 Antimyasthenics; Anticholinergic Agents; Cholinesterase Inhibitors; Parasympathomimetics; ATC:N07AA02 For the treatment of myasthenia gravis.s
n-octan C₈H₁₈ 114.230 g/mol 111-65-9 ATC:S01EE03 For the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication.s
oleic säure C₁₈H₃₄O₂ 282.465 g/mol 112-80-1 Adrenergic Agents; Dopamine Agents; Central Nervous System Agents; ATC:A08AA For the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restrictions
Ethchlorvynol C₇H₉ClO 144.598 g/mol 113-18-8 Antidepressants; Antipsychotics; ATC:N05AL01; ATC:N05AL07 Sulpiride is indicated for the treatment of schizophrenia.s
Methylergonovin C₂₀H₂₅N₃O₂ 339.432 g/mol 113-42-8 Anti-bacterial Agents; Cephalosporins; ATC:J01DB01 For the treatment of respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes; otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis; skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes; bone infections caused by Staphylococcus aureus and/or Proteus mirabilis; genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.s
Phenformin C₁₀H₁₅N₅ 205.26 g/mol 114-86-3 Hyaluronate Lyase inhibitor Not Availables
R-mephobarbital C₁₃H₁₄N₂O₃ 246.262 g/mol 115-38-8 Anti-migraine Agents; Vasoconstrictor Agents; Anti-inflammatory Agents; ATC:N02CC07 For the acute treatment of migraine attacks with or without aura in adults.s
Paramethadion C₇H₁₁NO₃ 157.167 g/mol 115-67-3 Antiarrhythmic Agents; ATC:R03DC03 For the treatment of asthmas
Edrophonium C₁₀H₁₆NO+ 166.24 g/mol 116-38-1 Anti-HIV Agents For treatment of HIV AIDSs
Anisindion C₁₆H₁₂O₃ 252.265 g/mol 117-37-3 Anti-HIV Agents; HIV Protease Inhibitors; ATC:J05AE04 Used in combination with other antiviral drugs in the treatment of HIV in both adults and children.s
3,5,7,3',4'-pentahydroxyflavon C₁₅H₁₀O₇ 302.240 g/mol 117-39-5 Hypoglycemic Agents For treatment of diabetes (type I and II)s
Trifluoperazin C₂₁H₂₄F₃N₃S 407.497 g/mol 117-89-5 Vasodilator Agents; Nitrates and Nitrites; Nitric Oxide Donors; ATC:C01DA14 For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.s
Diatrizoat C₁₁H₉I₃N₂O₄ 613.914 g/mol 117-96-4 Anti-Asthmatic Agents For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.s
pteroic säure C₁₄H₁₂N₆O₃ 312.287 g/mol 119-24-4 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AH02 For the treatment of osteoarthritis, acute pain in adults and menstrual pain.s
isoquinolin C₉H₇N₁ 129.161 g/mol 119-65-3 Anticonvulsants; Benzodiazepines; ATC:N03AE01 Used as an anticonvulsant in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures.s
Benzylbenzoat C₁₄H₁₂O₂ 212.244 g/mol 120-51-4 Antimucositis Agents; ATC:V03AF08 For treatment of mucositis (mouth sores)s
1,2-dihydroxybenzen C₆H₆O₂ 110.112 g/mol 120-80-9 Anti-baldness Agents; Antihyperplasia Agents; ATC:G04CB02 For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland.s
Dichlorphenamid C₆H₆Cl₂N₂O₄S₂ 305.16 g/mol 120-97-8 Anti-Ulcer Agents; Topical For topical treatment of skin ulcers (from diabetes)s
000004-hydroxy-3-methoxybenzoat C₈H₇O₄ 167.141 g/mol 121-34-6 Anti-Infective Agents; Antibacterial Agents; Protein Synthesis Inhibitors; ATC:J01XX08 For the treatment of bacterial infections caused by susceptible strains of vancomycin resistant Enterococcus faecium, Staphylococcal aureus (methicillin resistant and susceptible strains), Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae.s
phenylacetaldehyd C₈H₈O₁ 120.151 g/mol 122-78-1 Renal Agents; ATC:H01BA02 For the management of primary nocturnal enuresis and indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitarys
p-hydroxybenzaldehyd C₇H₆O₂ 122.123 g/mol 123-08-0 Antidiuretic Agents For treatment of diabetes insipidus, prevention of polydipsia, polyuria and dehydrations
Azelaic säure C₉H₁₆O₄ 188.221 g/mol 123-99-9 Cardiovascular Agents; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Vasopeptidase inhibitor; Protease Inhibitors For the treatment of hypertensions
azelaic säure C₉H₁₆O₄ 188.223 g/mol 123-99-9 Anti-Bacterial Agents; ATC:J01XX04 For use in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae.s
n-(2-amino-propyl)-1,4-diaminobutane C₇H₁₉N₃ 145.247 g/mol 124-20-9 Cyclooxygenase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; ATC:L01XX33; ATC:M01AH01 For relief and management of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, acute pain, primary dysmenorrhea and oral adjunct to usual care for patients with familial adenomatous polyposiss
Triamcinolon C₂₁H₂₇FO₆ 394.434 g/mol 124-94-7 Antiemetics; ATC:A04AD12 For the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including high-dose cisplatin (in combination with other antiemetic agents).s
Butabarbital C₁₀H₁₆N₂O₃ 212.246 g/mol 125-40-6 Neuroprotective Agents; Anticonvulsants; Anesthetics; Central Nervous System Agents; ATC:N07XX02 For the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease)s
Oxyphencyclimin C₂₀H₂₈N₂O₃ 344.448 g/mol 125-53-1 Antineoplastic Agents; ATC:V10XX02 For treatment of non-Hodgkin's lymphomas
Methyprylon C₁₀H₁₇NO₂ 183.248 g/mol 125-64-4 Antineoplastic Agents; ATC:L01XC02 For treatment of B-cell non-Hodgkins lymphoma (CD20 positive)s
Aminoglutethimide C₁₃H₁₆N₂O₂ 232.278 g/mol 125-84-8 Dietary supplement; Cofactor For the treatment of tetrahydrobiopterin (BH4) deficiency.s
Ethinamat C₉H₁₃NO₂ 167.205 g/mol 126-52-3 Antihypertensive Agents; Diuretics, Sulfamyl; ATC:C03BA08 For the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class.s
Hydroxyurea CH₄N₂O₂ 76.0547 g/mol 127-07-1 Anti-Arrhythmia Agents; Cardiotonic Agents; Enzyme Inhibitors; ATC:C01AA07 For the treatment and management of Congestive cardiac insufficiency, arrhythmias and heart failure.s
Pyruvic säure C₃H₄O₃ 88.063 g/mol 127-17-3 Anti-Anxiety Agents; GABA Modulators; Hypnotics and Sedatives; ATC:N05CD01 For short-term and intermittent use in patients with recurring insomnia and poor sleeping habitss
Demeclocyclin C₂₁H₂₁ClN₂O₈ 464.853 g/mol 127-33-3 Fertility Agents; gonadotropins (68:18.00); ATC: G03GA08 For the treatment of female infertilitys
Xanthophyll C₄₀H₅₆O₂ 568.881 g/mol 127-40-2 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalances
Trimethadion C₆H₉NO₃ 143.141 g/mol 127-48-0 Thermolysin inhibitor Not Availables
Sulfisoxazol C₁₁H₁₃N₃O₃S 267.305 g/mol 127-69-5 Antineoplastic Agents; Protease Inhibitors; ATC:L01XX32 For treatment of multiple myeloma in patients who have not been successfully treated with at least two previous therapies.s
n-ethylmaleimid C₆H₇N₁O₂ 125.127 g/mol 128-53-0 Antifungals; ATC:J02AX04 For the treatment of esophageal candidiasis and invasive aspergillosis in patients who are refractory to or intolerant of other therapies.s
Cyproheptadin C₂₁H₂₁N 287.398 g/mol 129-03-3 Antiparkinson Agents; Antidyskinetics; ATC:G02CB02; ATC:N02CA07 For the management of Parkinson's Diseases
Quinin C₂₀H₂₄N₂O₂ 324.417 g/mol 130-95-0 Antineoplastic Agents For treatment of HER2-positive metatsatic breast cancers
Deserpidin C₃₂H₃₈N₂O₈ 578.653 g/mol 131-01-1 Antihistamines; ATC:D04AA32; ATC:D04AA33; ATC:R06AA02 For management of symptoms related to hay fever and other types of allergy and used to help bring up phlegm, thin secretions, and make a cough productive.s
inosinic säure C₁₀H₁₃N₄O₈P₁ 348.208 g/mol 131-99-7 Anti-migraine Agents; Anti-inflammatory Agents; Vasoconstrictor Agents; Selective Serotonin Agonists; ATC:N02CC05 For the treatment of acute migraine headache in adultss
Dexbrompheniramin C₁₆H₁₉BrN₂ 319.24 g/mol 132-21-8 Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AH03 For the treatment of osteoarthritis and dysmenorrhoeas
Chlorpheniramin C₁₆H₁₉ClN₂ 274.788 g/mol 132-22-9 Multidrug-Efflux Transporter 1 Regulator Bmr inhibitor Not Availables
Chloroprocain C₁₃H₁₉ClN₂O₂ 270.755 g/mol 133-16-4 Bile säure sequestrants; ATC:C10AC04 For use, alone or in combination with an HMG-CoA reductase inhibitor, as adjunctive therapy to diet and exercise for the reduction of elevated LDL cholesterol in patients with primary hypercholesterolemia (Fredrickson Type IIa).s
Trichlormethiazid C₈H₈Cl₃N₃O₄S₂ 380.657 g/mol 133-67-5 Anti-bacterial Agents; Lincomycins; ATC:D10AF01; ATC:G01AA10; ATC:J01FF01 For the treatment of serious infections caused by susceptible anaerobic bacteria (anaerobes, streptococci, pneumococci, and staphylococci)s
Phenmetrazin C₁₁H₁₅NO 177.243 g/mol 134-49-6 Protein Kinase Inhibitors; ATC:L01XX34 For the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Also for use, in combination with gemcitabine, as the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.s
Diethylpropion C₁₃H₁₉NO 205.296 g/mol 134-80-5 Anti-Testosterone Agents; Antineoplastic Agents For palliative treatment of advanced prostate cancers
Methyclothiazid C₉H₁₁Cl₂N₃O₄S₂ 360.239 g/mol 135-07-9 Antineoplastic Agents; Protein Kinase Inhibitors; ATC:L01XX31 For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.s
Hydroflumethiazid C₈H₈F₃N₃O₄S₂ 331.294 g/mol 135-09-1 Antirheumatic Agents; Immunomodulatory Agents For treatment of severe adult and juvenille rheumatoid arthritiss
Tetrahydrofolic säure C₁₉H₂₃N₇O₆ 445.434 g/mol 135-16-0 Adrenergic beta-Agonists; Tocolytic Agents; Bronchodilator Agents; ATC:R03AC For relief and prevention of bronchospasm due to asthma; Emphysema; Chronic bronchitiss
pseudotropin C₈H₁₅N₁O₁ 141.213 g/mol 135-97-7 Anticoagulants; Antiplatelet Agents For treatment of myocardial infarction, acute coronary syndromes
Trimethobenzamid C₂₁H₂₈N₂O₅ 388.458 g/mol 138-56-7 Cytochrome P450Epok inhibitor Not Availables
ricinoleic säure C₁₈H₃₄O₃ 298.465 g/mol 141-22-0 Antiemetics; Antivertigo Agents For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.s
dicarboxylic säure c3; propanediolic säure;metahnedicarboxylic säure C₃H₄O₄ 104.062 g/mol 141-82-2 Antihypertensive Agents; Alpha-adrenergic Blocking Agents; ATC:C02CA01 For treatment of hypertension and chronic heart failure.s
glyceraldehyd-3-phosphat C₃H₇O₆P₁ 170.058 g/mol 142-10-9 Antineoplastic Agents For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular)s
dodecanoic säure C₁₂H₂₄O₂ 200.320 g/mol 143-07-7 DNA Primase/Helicase inhibitor Not Availables
lauric säure C₁₂H₂₄O₂ 200.320 g/mol 143-07-7 Antihypocalcemic Agents; Antihypoparathyroid Agents; Vitamins (Vitamin D); ATC:A11CC06 Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.s
Trihexyphenidyl C₂₀H₃₁NO 301.466 g/mol 144-11-6 Antihypocalcemic Agents; Antihypoparathyroid Agents; Vitamins (Vitamin D); ATC:A11CC06 Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.s
Anileridin C₂₂H₂₈N₂O₂ 352.47 g/mol 144-14-9 Antitrichomonal Agents; Anti-Infectives; Antiprotozoals; ATC:J01XD02; ATC:P01AB02 For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients older than three years of age.s
oxalic säure C₂H₂O₄ 90.035 g/mol 144-62-7 Vasodilator Agents; Enzyme Inhibitors; Anti-Arrhythmia Agents; ATC:C01BD01 Intravenously, for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. Orally, for the treatment of life-threatening recurrent ventricular arrhythmias such as recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia.s
Sulfoxon C₁₄H₁₆N₂O₆S₃ 404.485 g/mol 144-75-2 In process For the treatment of insomnia characterized by difficulty with sleep onset.s
Sulfacetamid C₈H₁₀N₂O₃S 214.243 g/mol 144-80-9 Analgesics; Psychotropic Drugs; Hallucinogens; Antiemetics; ATC:A04AD10 For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatmentss
Sulfamethizol C₉H₁₀N₄O₂S₂ 270.333 g/mol 144-82-1 Antipsychotics; Dopamine Antagonists; ATC:N05AH01 For the management of the manifestations of psychotic disorderss
Sulfapyridin C₁₁H₁₁N₃O₂S 249.29 g/mol 144-83-2 Antidepressants, Second-Generation; Anti-anxiety Agents; Serotonin Uptake Inhibitors; ATC:N06AX05 For the treatment of depression.s
flavin-adenin dinucleotid C₂₇H₃₃N₉O₁₅P₂ 785.557 g/mol 146-14-5 Antineoplastic Agents; Antiviral Agents; Immunomodulatory Agents For treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcomas
riboflavin monophosphat C₁₇H₂₁N₄O₉P₁ 456.348 g/mol 146-17-8 Antihistamines; ATC:R06AD04 Used for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorderss
Triflupromazin C₁₈H₁₉F₃N₂S 352.418 g/mol 146-54-3 Algq2 inhibitor Not Availables
guanosin-5-diphosphat C₁₀H₁₅N₅O₁₁P₂ 443.203 g/mol 146-91-8 Anti-HIV Agents; Protease Inhibitors; ATC:J05AE08 For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection.s
Diphenylpyralin C₁₉H₂₃NO 281.392 g/mol 147-20-6 Dopamine Agents; Antiparkinson Agents; Antidyskinetics; Excitatory Amino säure Antagonists; Central Nervous System Agents; ATC:N06DX01 For the treatment of moderate to severe dementia of the Alzheimer's type.s
L-Prolin C₅H₁₀N₁O₂ 116.139 g/mol 147-85-3 Anti-inflammatory Agents; Glucocorticoids; Antipruritics; ATC:C05AA10; ATC:D07AC04 For the treatment of contact dermatitis, atopic dermatitis, exczema, psoriasis, diaper rash and other skin conditionss
Melphalan C₁₃H₁₈Cl₂N₂O₂ 305.2 g/mol 148-82-3 Antimetabolites; Antifungals; ATC:D01AE21; ATC:J02AX01 For the treatment (in combination with amphotericin B) of serious infections caused by susceptible strains of Candida (septicemia, endocarditis and urinary system infections) and/or Cryptococcus (meningitis and pulmonary infections).s
000004-aminobenzoic säure C₇H₇N₁O₂ 137.138 g/mol 150-13-0 Antimycobacterials; Leprostatic Agents; Dyes; Anti-Inflammatory Agents, Non-Steroidal; ATC:J04BA01 For the treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.s
(r)-mevalonat C₆H₁₁O₄₁- 739.128 g/mol 150-97-0 Kinesin Heavy Chain inhibitor Not Availables
Methohexital C₁₄H₁₈N₂O₃ 262.304 g/mol 151-83-7 Radiation-Protective Agents; ATC:V03AF05 For reduction in the cumulative renal toxicity in patients with ovarian cancer (using cisplatin) and moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.s
Levallorphan C₁₉H₂₅NO 283.408 g/mol 152-02-3 Bifunctional Deaminase/Diphosphatase inhibitor Not Availables
Sulfametopyrazin C₁₁H₁₂N₄O₃S 280.304 g/mol 152-47-6 Daptomycin inhibitor Not Availables
Dydrogesteron C₂₁H₂₈O₂ 312.446 g/mol 152-62-5 Antineoplastic Agents For treatment of metastatic colorectal cancers
000002-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside C₂₇H₃₀O₁₆ 610.524 g/mol 153-18-4 Analgesics, Opioid; Narcotic Antagonists; Narcotics; ATC:N02AF02 For the relief of moderate to severe pain.s
Cephalothin C₁₆H₁₆N₂O₆S₂ 396.44 g/mol 153-61-7 Anti-Dyskinesia Agents; Antipsychotic Agents; Dopamine Antagonists; ATC:N05AG02 Used for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatment.s
000003-[[acetoxymethyl-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic säure]] C₁₆H₁₆N₂O₆S₂ 396.432 g/mol 153-61-7 Chondroitinase Ac inhibitor Not Availables
d-tryptophan C₁₁H₁₂N₂O₂ 204.228 g/mol 153-94-6 Anesthetics, Intravenous; Anticonvulsants; Antiemetics; Free Radical Scavengers; Hypnotics and Sedatives; ATC:N01AX10 Used for both induction and/or maintenance of anesthesia.s
Tranylcypromin C₉H₁₁N 133.19 g/mol 155-09-9 Hypoglycemic Agents; Sulfonylureas; ATC:A10BB09 For the treatment of Diabetes mellituss
Methscopolamin C₁₈H₂₄NO₄ 318.387 g/mol 155-41-9 Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AE12 Used to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis.s
Pyridostigmin C₉H₁₃N₂O₂ 181.212 g/mol 155-97-5 Streptogramin A Acetyltransferase inhibitor Not Availables
Benzphetamin C₁₇H₂₁N 239.355 g/mol 156-08-1 Immunomodulatory Agents; Immunosupressants For treatment of psoriasiss
Decamethonium C₁₆H₃₈N₂ 258.486 g/mol 156-74-1 Central Nervous System Stimulants; ATC:N06BA05 For treatment of Attention Deficit Hyperactivity Disorder (ADHD)s
d-arginin C₆H₁₅N₄O₂₁+ 479.199 g/mol 157-06-2 Anti-Bacterial Agents For treatment of infections caused by susceptible bacteria.s
Ethynodiol Diacetat C₂₄H₃₂O₄ 384.508 g/mol 297-76-7 Anesthetics, Local; ATC:N01BB01; ATC:N01BB10 For the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures.s
glyoxalat, glyoxylat C₂H₂O₃ 74.036 g/mol 298-12-4 Tocolytic Agents; Vasodilator Agents; Calcium Channel Blockers; Dihydropyridines; ATC:C08CA05 For the management of vasospastic angina, chronic stable angina and hypertension.s
Propanthelin C₂₃H₃₀NO₃ 368.489 g/mol 298-50-0 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AE03; ATC:M01AE17; ATC:M02AA10 For the treatment of pain (muscular and rheumatic), sprains, strains, backache and neuralgia and for the management of the signs and symptoms of rheumatoid arthritis and osteoarthritis.s
Cinnarizin C₂₆H₂₈N₂ 368.514 g/mol 298-57-7 Antihypertensive Agents Used to treat and control hypertension.s
3,5-diiodotyrosin C₉H₉N₁O₃I₂ 432.984 g/mol 300-39-0 Antithyroid Agents; ATC:H03BB01 For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy.s
Amphetamine C₉H₁₃N 135.206 g/mol 300-62-9 Adrenergic Uptake Inhibitors; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; ATC:A08AA05 Used in short-term (a few weeks) treatment of exogenous obesity in conjunction with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m²) or in patients with a body mass index of 27 kg/m² in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.s
Retinoic säure C₂₀H₂₈O₂ 300.440 g/mol 302-79-4 Immunomodulatory Agents; Immunosuppresants For treatment of moderate to severe chronic plaque psoriasiss
Cyclobenzaprine C₂₀H₂₁N 275.387 g/mol 303-53-7 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:N02BA11 For acute or long-term use for symptomatic treatment of mild to moderate pain, osteoarthritis, and rheumatoid arthritis.s
Novobiocin C₃₁H₃₆N₂O₁₁ 612.624 g/mol 303-81-1 Glutamine Receptor 2 inhibitor Not Availables
Succimer C₄H₆O₄S₂ 182.22 g/mol 304-55-2 Antihypertensive Agents; Diuretics; ATC:C03AA09; ATC:C03AB09 Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.s
Doxapram C₂₄H₃₀N₂O₂ 378.507 g/mol 309-29-5 Dietary supplement; Micronutrient Used as a diet supplement and sugar substitute.s
d-serin C₃H₇N₁O₃ 105.093 g/mol 312-84-5 Antifungal Agents; ATC:A01AB09; ATC:A07AC01; ATC:D01AC02; ATC:G01AF04; ATC:J02AB01; ATC:S02AA13 For topical application in the treatment of tinea pedis (athlete’s foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.s
Aminophyllin C₁₆H₂₄N₁₀O₄ 420.427 g/mol 317-34-0 Anti-anxiety Agents; Sedative; Muscle Relaxants; Benzodiazepines; ATC:N05BA13 Used to relieve anxiety, nervousness, and tension associated with anxiety disorders.s
Hexafluoreniumbromid C₃₆H₄₂N₂+₂ 502.732 g/mol 317-52-2 Methionine Aminopeptidase inhibitor Not Availables
propionyl coenzym a C₂₄H₄₁N₇O₁₇P₃S₁ 824.606 g/mol 317-66-8 Anti-Bacterial Agents; ATC:J01XX01 For the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of Escherichia coli and Enterococcus faecalis.s
isocitric säure C₆H₈O₇ 192.125 g/mol 320-77-4 Antibiotics; Antineoplastic Agents; ATC:L01DB01 For the treatment of Koposi's sarcome connected to AIDS.s
Tacrin C₁₃H₁₄N₂ 198.264 g/mol 321-64-2 Antifungals; ATC:J02AX05 For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.s
d-leucin C₆H₁₃N₁O₂ 131.174 g/mol 328-38-1 Anti-Infective Agents, Local; Antifungal Agents; Growth Inhibitors; ATC:A01AB18; ATC:D01AC01; ATC:G01AF02 For the local treatment of oropharyngeal candidiasis and vaginal yeast infections, also used in fungal infections of the skin such as ringworm, athlete's foot, and jock itch.s
000004-nitrophenylphosphat C₆H₆N₁O₆P₁ 219.090 g/mol 330-13-2 Anti-Anxiety Agents; Anticonvulsants; GABA Modulators; ATC:N05BA05 For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Also used as adjunctive therapy in the management of partial seizures and for the symptomatic relief of acute alcohol withdrawal.s
3,4-dihydroxycinnamic säure C₉H₈O₄ 180.160 g/mol 331-39-5 Anti-Asthmatic Agents; Immunomodulatory Agents For treatment of asthma caused by allergiess
decanoic säure C₁₀H₂₀O₂ 172.267 g/mol 334-48-5 Antispasmodics; Anti-Incontinence Agents; ATC:G04BD08 For the treatment of micturition frequency/polyuria.s
d-alanin C₃H₇N₁O₂ 89.094 g/mol 338-69-2 Ubiquitin-Conjugating Enzyme E2 2 inhibitor Not Availables
d-prolin C₅H₉N₁O₂ 115.132 g/mol 344-25-2 Antivirals; Antimetabolites; ATC:J05AB03; ATC:S01AD06 For treatment of chickenpox - varicella, herpes zoster and herpes simplexs
000002-fluoroanilin C₆H₆N₁F₁ 111.119 g/mol 348-54-9 Immunosuppressive Agents; Chelating Agents; Cardiovascular Agents; Antineoplastic Agents; ATC:V03AF02 For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer.s
d-methionin C₅H₁₁N₁O₂S₁ 149.207 g/mol 348-67-4 Nh inhibitor Not Availables
Fluocinonid C₂₆H₃₂F₂O₇ 494.525 g/mol 356-12-7 Antihypertensive Agents; ATC:C02AA01 For the treatment of hypertensions
Methysergid C₂₁H₂₇N₃O₂ 353.458 g/mol 361-37-5 Nucleoside Diphosphate Kinase II inhibitor Not Availables
Propiomazin C₂₀H₂₄N₂OS 340.483 g/mol 362-29-8 Antilipemic Agents; Fribic säure Derivatives; ATC:C10AB04 For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.s
Dinoproston C₂₀H₃₂O₅ 352.465 g/mol 363-24-6 Antiparkinson Agents; Antidepressive Agents; Central Nervous System Agents; Monoamine Oxidase Inhibitors; ATC:N06AX07 For the treatment of depressions
Diazoxid C₈H₇ClN₂O₂S 230.672 g/mol 364-98-7 Antipsychotics Used in the treatment of acute or chronic schizophrenic reactions in hospitalized patients.s
thymidin-5-phosphat C₁₀H₁₅N₂O₈P₁ 322.211 g/mol 365-07-1 In process For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G).s
(2r)-2,3-dihydroxypropanal C₃H₆O₃ 90.079 g/mol 367-47-5 Adrenergic beta-Agonists; Tocolytic Agents; Sympathomimetic; ATC:G02CA01 For the treatment and prophylaxis of premature labours
palmitoleic säure C₁₆H₃₀O₂ 254.412 g/mol 373-49-9 Topical anti-inflammatory Agent; ATC:S01BA08 For the treatment of allergic conjunctivitis, vernal conjunctivitis, episcleritis, and epinephrine sensitivity.s
Desoximetason C₂₂H₂₉FO₄ 376.462 g/mol 382-67-2 Antihypertensive Agents; Diuretics, Sulfamyl; ATC:C03BA11 For the treatment of hypertension, alone or in combination with other antihypertensive drugs as well as for the treatment of salt and fluid retention associated with congestive heart failure or edema from pregnancy.s
Nalidixic säure C₁₂H₁₂N₂O₃ 232.235 g/mol 389-08-2 Antihypertensive Agents; Anti-Arrhythmia Agents; Adrenergic beta-Antagonists; ATC:C07AA06; ATC:S01ED01 In its oral form it is used to treat high blood pressure and prevent heart attacks, and occasionally to prevent migraine headaches. In its opthalmic form it is used to treat open-angle and occasionally secondary glaucoma.s
Methoxamin C₁₁H₁₇NO₃ 211.258 g/mol 390-28-3 Antipsychotics; Thioxanthenes; Dopamine Antagonists For use in schizophrenia and depressions
Fluormetholon C₂₂H₂₉FO₄ 376.462 g/mol 426-13-1 Anesthetics; ATC:N01BB10 For the production of local or regional anesthesia for surgery and obstetrics, and for post-operative pain managements
Protriptylin C₁₉H₂₁N 263.377 g/mol 438-60-8 Diuretics, Sulfamyl; ATC:C03CA02 For the treatment of edema associated with congestive heart failure, hepatic and renal disease including the nephrotic syndrome.s
Conjugated Estrogens C₁₈H₂₁NaO₅S 372.412 g/mol 438-67-5 Anesthetics, Inhalation; Platelet Aggregation Inhibitors; ATC:N01AB08 Used for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.s
5,7-dihydroxy-3-(4-hydroxyphenyl)-4h-1-benzopyran-4-one; 4',5,7-trihydroxyisoflavon; prunetol; genisteol C₁₅H₁₀O₅ 270.241 g/mol 446-72-0 Anti-ulcer Agents; Antimuscarinics; Antispasmodics; ATC:A02BX03 For the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.s
pyridoxin-5-phosphat C₈H₁₂N₁O₆P₁ 249.160 g/mol 447-05-2 Cytochrome C Peroxidase inhibitor Not Availables
Ethoxzolamid C₉H₁₀N₂O₃S₂ 258.319 g/mol 452-35-7 Dopamine Agents; Antiparkinson Agents; Antidyskinetics; ATC:N04BA For treatment of the symptoms of idiopathic Parkinson's disease (paralysis agitans), post-encephalitic parkinsonisms
000004-methyl-1,2-benzenediol C₇H₈O₂ 124.139 g/mol 452-86-8 Anti-Anxiety Agents; Adjuvants, Anesthesia; GABA Modulators; Benzodiazepines; ATC:N05CD05 For the short-term treatment of insomnia.s
(3-carboxy-2-(r)-hydroxy-propyl)-trimethyl-ammonium C₇H₁₆N₁O₃₁+ 610.192 g/mol 461-06-3 Antihypermagnesemic; Antihypocalcemic; Electrolyte replenisher; Nutritional supplement, mineral For treatment of mild hypocalcemia due to neonatal tetany, tetany due to parathyroid deficiency or vitamin D deficiency, and alkalosis, as prophylaxis of hypocalcemia during exchange transfusions, in the treatment of intestinal malabsorption, and to replenish electrolytes.s
dihydrolipoic säure C₈H₁₆O₂S₂ 208.333 g/mol 462-20-4 Hypoglycemic Agents; ATC:A10BB07 For use as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with non-insulin-dependent diabetes mellitus (NIDDM; type II), formerly known as maturity-onset diabetes, after an adequate trial of dietary therapy has proved unsatisfactory.s
a-Linolenic säure C₁₈H₃₀O₂ 278.434 g/mol 463-40-1 Sympatholytics; Antihypertensive Agents; ATC:C02AC02 For management of High blood pressures
carbamic säure C₁H₃N₁O₂ 61.040 g/mol 463-77-4 Sympatholytics; Antihypertensive Agents; Antiarrhythmic Agents; Adrenergic Agents; ATC:C07AB03; ATC:C07AB11 For the management of hypertention and long-term management of patients with angina pectoriss
Propoxyphen C₂₂H₂₉NO₂ 339.471 g/mol 469-62-5 Antineoplastic Agents; ATC:L01CB02 Treatment of refractory acute lymphoblastic leukaemias
2,4-dihydroxy-3,3-dimethyl-butyrat C₆H₁₁O₄₁- 739.128 g/mol 470-29-1 Isocitrate Lyase inhibitor Not Availables
oxamic säure C₂H₃N₁O₃ 89.051 g/mol 471-47-6 Analgesics; Antimanic Agents; Anticonvulsants; ATC:N03AF01 For the treatment of epilepsy and pain associated with true trigeminal neuralgia.s
n-cholylglycin C₂₆H₄₃N₁O₆ 465.629 g/mol 475-31-0 Anti-ulcer Agents; Antimuscarinics; Antispasmodics; ATC:A03AB05 For the treatment of enuresis.s
Podofilox C₂₂H₂₂O₈ 414.405 g/mol 477-47-4 anti-emetics; antivertigo ATC:N07CA02 For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.s
Dyphyllin C₁₀H₁₄N₄O₄ 254.243 g/mol 479-18-5 Antineoplastic Agents; Pigmenting Agents; ATC:D05AD02; ATC:D05BA02 For the treatment of psoriasis and vitiligos
chlorophyll a C₅₅H₇₂N₄O₅Mg₁ 893.503 g/mol 479-61-8 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalances
Crotamiton C₁₃H₁₇NO 203.28 g/mol 483-63-6 Antineoplastic Agents; Radiation-Protective Agents; ATC:L01XX11 For the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostates
Triprolidin C₁₉H₂₂N₂ 278.391 g/mol 486-12-4 Thermal Hysteresis Protein inhibitor Not Availables
Carbinoxamin C₁₆H₁₉ClN₂O 290.788 g/mol 486-16-8 Adrenergic Agents; Dopamine Agents; Dopamine Uptake Inhibitors; Adrenergic Uptake Inhibitors; Central Nervous System Stimulants; Amphetamines; Sympathomimetics; ATC:N06BA01 For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.s
000003-methyl-benzene-1,2-diol C₇H₈O₂ 124.139 g/mol 488-17-5 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalance.s
canalin C₄H₁₀N₂O₃ 134.135 g/mol 496-93-5 Keratolytic Agents; Antineoplastic Agents; Cell Stimulants and Proliferants (84:16.00); ATC:D10AD01; ATC:D10AD04; ATC:D10BA01; ATC:L01XX14; ATC:L01XX22 For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.s
Proparacain C₁₆H₂₆N₂O₃ 294.389 g/mol 499-67-2 Antidepressive Agents, Tricyclic; Serotonin Uptake Inhibitors; ATC:N06AA04 For the treatment of depression, obsessive compulsive disorder (OCD), panic attacks with or without agoraphobia, narcolepsy, chronic pain, and enuresis.s
Masoprocol C₁₈H₂₂O₄ 302.365 g/mol 500-38-9 Tranquilizing Agents; Muscle Relaxants; Antidepressive Agents, Tricyclic; Skeletal Muscle Relaxants; ATC:M03BX08 For use as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.s
Mimosin C₈H₁₀N₂O₄ 198.176 g/mol 500-44-7 Anti-bacterial Agents; Enzyme Inhibitors; ATC:J01GB For the treatment of infections due to staphylococci and other susceptible organismss
isovaleric säure C₅H₁₀O₂ 102.133 g/mol 503-74-2 Antidotes; Chelating Agents; ATC:V09CA02; ATC:V09IA03 For the treatment of lead poisoning in pediatric patients with blood lead levels above 45 µg/dL. May also be used to treat mercury or arsenic poisoning.s
12-hydroxydodecanoic säure C₁₂H₂₄O₃ 216.320 g/mol 505-95-3 Antineoplastic Agents; ATC:L01AA02 For treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin's diseases
arachidonic säure C₂₀H₃₂O₂ 304.472 g/mol 506-32-1 Anti-HIV Agents; Antimetabolites; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors; ATC:J05AF01 For the treatment of Human immunovirus (HIV) infections.s
Cyclopentolat C₁₇H₂₅NO₃ 291.385 g/mol 512-15-2 Anti-HIV Agents; Antimetabolites; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors; ATC:J05AF04 For the treatment of human immunovirus (HIV) infections.s
methylmalonic säure C₄H₆O₄ 118.089 g/mol 516-05-2 Neuromuscular Depolarizing Agents; Skeletal Muscle Relaxants; ATC:M03BX Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT)s
chlorophyll b C₅₅H₇₀N₄O₆Mg₁ 907.486 g/mol 519-62-0 Central Nervous System Stimulants; Respiratory System Agents; ATC:R07AB01 For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.s
Hesperetin C₁₆H₁₄O₆ 302.279 g/mol 520-33-2 Anti-Bacterial Agents; ATC:J01CF01 Used to treat infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.s
Medroxyprogesteron C₂₂H₃₂O₃ 344.488 g/mol 520-85-4 Head Decoration Protein inhibitor Not Availables
Dromostanolon C₂₃H₃₆O₃ 360.53 g/mol 521-12-0 Antinematodal Agents; ATC:P02CA01 For the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.s
malonyl-coenzyme a C₂₄H₃₈N₇O₁₉P₃S₁ 853.581 g/mol 524-14-1 Cardiotonic Agents; Bronchodilator Agents; Respiratory Smooth Muscle Relaxants; ATC:R03DA05 For the treatment of bronchospasm due to asthma, emphysema and chronic bronchitis.s
Isoetharin C₁₃H₂₁NO₃ 239.311 g/mol 530-08-5 Propionyl-Coa Carboxylase Complex B Subunit inhibitor Not Availables
Methocarbamol C₁₁H₁₅NO₅ 241.241 g/mol 532-03-6 Anti-Arrhythmia Agents; ATC:C01BB02 For the treatment of ventricular tachycardia and symptomatic premature ventricular beats, and prevention of ventricular fibrillation.s
thiaminphosphat C₁₂H₁₇N₄O₄P₁S₁ 344.324 g/mol 532-40-1 Anti-Arrhythmia Agents Used to treat irregular heartbeats (arrhythmias) and maintain a normal heart rate.s
Hexylcain C₁₆H₂₃NO₂ 261.359 g/mol 532-77-4 Antimetabolites, Antineoplastic; Enzyme Inhibitors For treatment of patients with the following myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia.s
Hydroxystilbamidineisethionat C₁₈H₂₂N₄O₅S 406.457 g/mol 533-22-2 Probable Methylisocitrate Lyase inhibitor Not Availables
Ethionamid C₈H₁₀N₂S 166.244 g/mol 536-33-4 Cholinesterase Inhibitors; Nootropic Agents; Parasympathomimetics; ATC:N06AA18; ATC:N06DA01 For the treatment of mild to moderate dementia of the Alzheimer's type.s
Levocarnitin C₇H₁₅NO₃ 161.199 g/mol 541-15-1 ATC:A11CC04; ATC:D05AX03; Antihypocalcemic Agents; Antihypoparathyroid Agents; Essential Vitamin; Vitamins (Vitamin D) Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.s
acetoacetic säure C₄H₆O₃ 102.090 g/mol 541-50-4 ATC:A11CC04; ATC:D05AX03; Antihypocalcemic Agents; Antihypoparathyroid Agents; Essential Vitamin; Vitamins (Vitamin D) Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.s
Acetohydroxamic säure C₂H₅NO₂ 75.0666 g/mol 546-88-3 Serotonin reuptake inhibitor; Antiobesity Agents; Appetite Depressants; ATC:A08AA04 For the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diets
acetohydroxamic säure C₂H₅N₁O₂ 75.067 g/mol 546-88-3 Chondroitinase Ac inhibitor; Chondroitinase B inhibitor Not Availables
crystal violet C₂₅H₃₀N₃₁+ 764.720 g/mol 548-62-9 Gramicidin A inhibitor Not Availables
000002-amino-3-hydroxybenzoic säure C₇H₇N₁O₃ 153.137 g/mol 548-93-6 Anti-bacterial Agents; Aminoglycosides; ATC:J01GB01; ATC:S01AA12 For the treatment of pseudomonas aeruginosa lung infectionss
purine riboside C₁₀H₁₃N₄O₄₁+ 845.215 g/mol 550-33-4 Acylamino-säure-Releasing Enzyme inhibitor Not Availables
d-xylulose C₅H₁₀O₅ 150.131 g/mol 551-84-8 Antineoplastic Agents; ATC:L01CD01 Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast.s
4,7-dihydroxyisoflavone; 7-o-b-d-glucopyranosid C₂₁H₂₀O₉ 416.384 g/mol 552-66-9 Photoactive Yellow Protein inhibitor Not Availables
protoporphyrin ix C₃₄H₃₄N₄O₄ 562.667 g/mol 553-12-8 Anesthetics, Intravenous; Hypnotics and Sedatives; ATC:N01AX07 Used in the induction of general anesthesia.s
Methazolamid C₅H₈N₄O₃S₂ 236.274 g/mol 554-57-4 Lipoxygenase-3 inhibitor Not Availables
d-tyrosin C₉H₁₁N₁O₃ 181.191 g/mol 556-02-5 Immunomodulatory Agents; Immunosuppresants; ATC:L04AA12 For treatment of Crohn's disease, psoriasis, rheumatoid arthitis and ankylosing spondylitiss
Chlorotrianisen C₂₃H₂₁ClO₃ 380.864 g/mol 569-57-3 Daptomycin inhibitor Not Availables
Meclizin C₂₅H₂₇ClN₂ 390.948 g/mol 569-65-3 Antineoplastic Agents, Phytogenic; Nucleic säure Synthesis Inhibitors; ATC:L01CB01 For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.s
artigenin congener; dibenzylbutyrolactonlignanolid C₂₀H₂₃O₆ 359.398 g/mol 580-72-3 Osmotic Agents Used for continuous ambulatory peritoneal dialysis (CAPD) of diabetic patients or automated peritoneal dialysis (APD) for the management of end-stage renal disease.s
5,6-dimethylbenzimidazol C₉H₁₀N₂ 146.191 g/mol 582-60-5 Peptide inhibitor Not Availables
Metaproterenol C₁₁H₁₇NO₃ 211.258 g/mol 586-06-1 Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh inhibitor Not Availables
Dyclonin C₁₈H₂₇NO₂ 289.413 g/mol 586-60-7 Anti-Asthmatic Agents; Anti-Inflammatory Agents; ATC:R01AD04; ATC:R03BA03 For the maintenance treatment of asthma as a prophylactic therapy.s
Glycopyrrolat C₁₉H₂₈NO₃ 318.4351 g/mol 596-51-0 Antirheumatic Agents, Gold; ATC:M01CB03 Used in the treatment of active, progressive or destructive forms of inflammatory arthritis, such as adult rheumatoid arthritis.s
000002-oxobutanoic säure C₄H₆O₃ 102.090 g/mol 600-18-0 Ferric Hydroxamate Receptor inhibitor Not Availables
succinyl-coenzyme a C₂₅H₄₀N₇O₁₉P₃S₁ 867.608 g/mol 604-98-8 Tetrameric Beta-Beta-Alpha Mini-Protein inhibitor Not Availables
NADH C₂₁H₂₉N₇O₁₄P₂ 665.446 g/mol 606-68-8 Cation-Independent Mannose 6-Phosphate Recep inhibitor Not Availables
benzoylformic säure C₈H₆O₃ 150.134 g/mol 611-73-4 Anti-Allergic Agents; Antipruritics; Histamine H1 Antagonists; ATC:R06AX17; ATC:S01GX08 Indicated as an add-on or prophylactic oral medication in the chronic treatment of mild atopic asthmatic children. Also for the temporary prevention of itching of the eye due to allergic conjunctivitis (ophthalmic).s
benzamidin C₇H₈N₂ 120.154 g/mol 618-39-3 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Propionic säure derivatives; ATC:M01AE04 For relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain.s
d-threonin C₄H₉N₁O₃ 119.120 g/mol 632-20-2 Methionine Aminopeptidase 2 inhibitor Not Availables
Clofibrat C₁₂H₁₅ClO₃ 242.698 g/mol 637-07-0 Antidepressants; ATC:N07BA02 For the treatment of depression and as aid to smoking cessation.s
Meclofenamat C₁₄H₁₁Cl₂NO₂ 295.02 g/mol 644-62-2 Anti-Bacterial Agents Not Availables
Altretamin C₉H₁₈N₆ 210.28 g/mol 645-05-6 Anti-bacterial Agents; Penicillins; ATC:J01CA18 Not Availables
Procarbazin C₁₂H₁₉N₃O 221.299 g/mol 671-16-9 Anti-bacterial Agents; Quinolones; ATC:J01MA14 For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).s
l-homoserin C₄H₉N₁O₃ 119.120 g/mol 672-15-1 Anti-Allergic Agents; Anti-Inflammatory Agents; Glucocorticoids; ATC:C05AA11; ATC:D07AC08 A topical anti-inflammatory product for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.s
Metyrosine C₁₀H₁₃NO₃ 195.215 g/mol 672-87-7 Beta-Lactamase Ctx-M-9 inhibitor Not Availables
d-phenylalanin C₉H₁₁N₁O₂ 165.191 g/mol 673-06-3 Antineoplastic Agents, Hormonal; Contraceptives, Oral, Synthetic; ATC:G03AC05; ATC:G03DB02; ATC:L02AB01 For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used to treat breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.s
Bethanechol C₇H₁₇N₂O₂ 161.222 g/mol 674-38-4 Nootropic Agents; Parasympathomimetics; ATC:N06DA04 For the treatment of mild to moderate dementia of the Alzheimer's type.s
gamma-glutamylcystein C₈H₁₄N₂O₅S₁ 250.269 g/mol 686-58-8 Anti-Bacterial Agents For treatment of severe infections caused by susceptible bacteria.s
Alprostadil C₂₀H₃₄O₅ 354.481 g/mol 745-65-3 Sedatives and Hypnotics; ATC:N05CM06 Used to produce sleepiness or drowsiness and to relieve anxiety before or during surgery or certain procedures. Also used with analgesics during labor to produce drowsiness and relieve anxiety.s
Chloroxin C₉H₅Cl₂NO 214.048 g/mol 773-76-2 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AC01; ATC:M02AA07; ATC:S01BC06 For treatment of osteoarthritis and rheumatoid arthritis.s
Haloprogin C₉H₄Cl₃IO 361.39 g/mol 777-11-7 Antiemetics; Prokinetic Agents; Dopamine Antagonists; ATC:A03FA01 For the treatment of gastroesophageal reflux disease (GERD)s
Desoxycorticosteronpivalat C₂₆H₃₈O₄ 414.578 g/mol 808-48-0 Antihypertensive Agents; Diuretics, Thiazide; Vasodilator Agents; ATC:C02DA01; ATC:V03AH01 Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma.s
2-deoxyguanosin-5-monophosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol 902-04-5 Antiviral Agents; ATC:J05AB04 For the treatment of chronic hepatitis C and for respiratory syncytial virus (RSV).s
Methacyclin C₂₂H₂₂N₂O₈ 442.419 g/mol 914-00-1 Anti-Bacterial Agents; Penicillins; ATC:J01CA09 For the treatment of infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae.s
Diphenoxylat C₃₀H₃₂N₂O₂ 452.587 g/mol 915-30-0 Diagnostic Aids; ATC:V04CK03 Used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy.s
d-cystein C₃H₇N₁O₂S₁ 121.154 g/mol 921-01-7 Antidepressants; ATC:N05BA07 For treatment of panic disorders
d-lysin C₆H₁₄N₂O₂ 146.189 g/mol 923-27-3 Dietary supplement; Micronutrient; Non-essential Amino säure; ATC:V06DD Used for nutritional supplementation, also for treating dietary shortage or imbalance.s
2-deoxycytidin C₉H₁₃N₃O₄ 227.219 g/mol 951-77-9 Enzyme replacement; ATC: A16AB01 For the treatment of Gaucher's disease (deficiency in glucocerebrosidase)s
2'-deoxyuridin C₉H₁₂N₂O₅ 228.204 g/mol 951-78-0 Bifunctional P-450: Nadph-P450 Reductase inhibitor Not Availables
Acetohexamid C₁₅H₂₀N₂O₄S 324.396 g/mol 968-81-0 Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Enzyme Inhibitors; ATC:C05BA04 For the relief of bladder pain or discomfort associated with interstitial cystitis.s
Testolacton C₁₉H₂₄O₃ 300.392 g/mol 968-93-4 Sympatholytics; Antihypertensive Agents; Antiarrhythmic Agents; Adrenergic Agents; ATC:C07AB02; ATC:C07AB52 For the treatment of hypertension and angina pectoris.s
s-adenosyl-l-homocystein C₁₄H₂₀N₆O₅S₁ 384.409 g/mol 979-92-0 Antiarrhythmic Agents; ATC:C01BA03 For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias.s
Nafcillin C₂₁H₂₂N₂O₅S 414.476 g/mol 985-16-0 Anti-bacterial Agents; Aminoglycosides; ATC:D06AX12; ATC:J01GB06; ATC:S01AA21 For short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, and Acinetobacter (Mima-Herellea) species.s
Lymecyclin C₂₂H₂₃ClN₂O₈ 478.879 g/mol 992-21-2 Antineoplastic Agents; Immunosuppressive Agents; ATC:L01AA06 For third line chemotherapy of germ cell testicular cancer. It should ordinarily be used in combination with a prophylactic agent for hemorrhagic cystitis, such as mesna.s

[edytuj] 1000 .. 10000

2-deoxycytidin-5-monophosphat C₉H₁₄N₃O₇P₁ 307.199 g/mol 1032-65-1 Corticosteroid; Glucocorticoids; Anti-inflammatory, steroidal; Immunosuppressants; ATC:A07EA04; ATC:C05AA05; ATC:D07AC01; ATC:D07XC01; ATC:H02AB01; ATC:R01AD06; ATC:R03BA04; ATC:S01BA06; ATC:S01CB04; ATC:S02BA07; ATC:S03BA03 Topical use (cream, lotion and ointment): for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Topical use (foam): relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp
Systemic use: for the treatment of edocrine disorders, rheumatic disorders, collagen diseases, dermatological diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, tuberculous meningitis and trichinosis.s
o-phosphoethanolamin C₃H₁₀N₁O₅P₁ 171.089 g/mol 1071-23-4 Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cyclooxygenase Inhibitors; ATC:M01AB02 For acute or long-term use in the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis. ankylosing spondylitis, acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis), and acute gouty arthritis.s
7,8-dimethylalloxazin; 6,7-dimethylalloxazin C₁₂H₁₀N₄O₂ 242.237 g/mol 1086-80-2 Vasodilator Agents; Antihypertensive Agents; ATC:C02DC01; ATC:D11AX01 For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.s
Ethopropazin C₁₉H₂₄N₂S 312.473 g/mol 1094-08-2 Abortifacient Agents, Nonsteroidal; Oxytocics; Diagnostic aid (angiography); Uterine stimulants; ATC:G02AD01 Used for aborting second-trimester pregnancy (between the twelfth to eighteenth week of gestation) and in incomplete abortion or for therapeutic abortion in cases of intrauterine fetal death and congenital abnormalities incompatible with life. Also used at low-doses for medically indicated induction of labor at term. Also injected intra-arterially for use as a vasodilator to assist in angiography.s
amylotrios C₁₈H₃₂O₁₆ 504.441 g/mol 1109-28-0 Cellobiohydrolase II inhibitor Not Availables
000003-hydroxypyruvic säure C₃H₄O₄ 104.062 g/mol 1113-60-6 Anti-Infective Agents; Enzyme Inhibitors; ATC:J01MB02 For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of E. Coli, Enterobacter species, Klebsiella species, and Proteus species.s
000003-sulfinoalanin C₃H₇N₁O₄S₁ 153.153 g/mol 1115-65-7 Adrenergic alpha-Agonists; Sympathomimetics; Vasoconstrictor Agents; ATC:C01CA10 Indicated for the treatment and management of hypotension.s
biphenyl-2,3-diol C₁₂H₁₀O₂ 186.210 g/mol 1133-63-7 Vasodilator Agents; Antihypertensive Agents; ATC:C08CA08; Calcium Channel Blockers; For the treatment of mild to moderate hypertensions
Tolazamid C₁₄H₂₁N₃O₃S 311.401 g/mol 1156-19-0 Histamine H1 Antagonists; ATC:R06AX09 For the relief of the symptoms of upper respiratory mucosal congestion in perennial and allergic rhinitis, and for the relief of nasal congestion and eustachian t.b. congestion.s
Clomocyclin C₂₃H₂₅ClN₂O₉ 508.905 g/mol 1181-54-0 Antivirals; ATC:D06BB06; ATC:J05AB13 Used to treat recurrent cold sores on the lips and face.s
n-acetyl-l-glutamat C₇H₁₁N₁O₅ 189.168 g/mol 1188-37-0 DNA Gyrase Subunit B inhibitor Not Availables
Sotradecol C₁₄H₃₀O₄S 294.452 g/mol 1191-50-0 Anti-Infective Agents For the treatment of Bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patientss
Tranexamic säure C₈H₁₅NO₂ 157.21 g/mol 1197-18-8 Dihydrofolate Reductase inhibitor Not Availables
Bentoquatam Not Available Not Available 1340-69-8 Anti-Asthmatic Agents; Antiarrhythmic Agents; Bronchodilator Agents; Anti-Inflammatory Agents, Non-Steroidal Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.s
Cryptenamin C₂₈H₄₆₀₁₀N Not Available 1356-18-9 Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AB08 For acute and long-term use in the management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.s
Candicidin C₅₉H₈₄N₂O₁₈ 1108.5715 g/mol 1403-17-4 Antineoplastic Agents; ATC:L01XA02 For the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of PARAPLATIN and cyclophosphamide.s
Polymyxin B Sulfat C₅₅H₉₅N₁₆O₁₃R.(H₂O₄S)x Not Available 1405-20-5 Sympatholytics; Antihypertensive Agents; Anti-Arrhythmia Agents; Adrenergic beta-Antagonists; ATC:C07AA12 Used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension.s
acetoacetyl-coenzyme a C₂₅H₄₀N₇O₁₈P₃S₁ 851.608 g/mol 1420-36-6 Immunosuppressive Agents; Antineoplastic Agents; ATC:L01BB04 For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms.s
Thiethylperazin C₂₂H₂₉N₃S₂ 399.618 g/mol 1420-55-9 Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; ATC:M01AX01 For acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.s
Levomethadylacetat C₂₃H₃₁NO₂ 353.498 g/mol 1477-40-3 Hypnotics and Sedatives; Anxiolytics sedatives and hypnotics; ATC:N05CF01 For the short-term treatment of insomnia.s
Oxymetazolin C₁₆H₂₄N₂O 260.375 g/mol 1491-59-4 Antineoplastic Agents; ATC:L01AX04 For the treatment of metastatic malignant melanoma. In addition, DTIC-Dome is also indicated for Hodgkin's disease as a secondary-line therapy when used in combination with other effective agentss
Tropicamid C₁₇H₂₀N₂O₂ 284.353 g/mol 1508-75-4 Tryptophanyl-tRNA Synthetase inhibitor Not Availables
Flurandrenolid C₂₄H₃₃FO₆ 436.514 g/mol 1524-88-5 Anesthetics; Narcotics; Adjuvants; Analgesics; Opiate Agonists; ATC:N01AH01; ATC:N02AB03 For the treatment of cancer patients with severe pain that breaks through their regular narcotic therapy.s
Metaxalon C₁₂H₁₅NO₃ 221.252 g/mol 1665-48-1 Estrogens; ATC:G03CA57 For the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)s
Spectinomycin C₁₄H₂₄N₂O₇ 332.35 g/mol 1695-77-8 Alkaline Phosphatase inhibitor Not Availables
Riluzol C₈H₅F₃N₂OS 234.199 g/mol 1744-22-5 Antiarrhythmic Agents; Glucocorticoids; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA07; ATC:D07AC15; ATC:R01AD01; ATC:R03BA01 For the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and olders
g-Homolinolenic säure C₂₀H₃₄O₂ 306.487 g/mol 1783-84-2 Radiation-Sensitizing Agents; Anti-Infectives; Antiprotozoals; ATC:A01AB17; ATC:D06BX01; ATC:G01AF01; ATC:J01XD01; ATC:P01AB01 Treatment of acute acne rosaceas
d-aspartic säure C₄H₇N₁O₄ 133.104 g/mol 1783-96-6 Estrogen Receptor Beta inhibitor Not Availables
Bromodiphenhydramin C₁₇H₂₀BrNO 334.251 g/mol 1808-12-4 Antimetabolites; Antimetabolites, Antineoplastic; Antirheumatic Agents; Immunosuppressive Agents; ATC:L04AX01 For use as an adjunct in the prevention of rejection in renal homotransplantation. Also for the management of severe, active rheumatoid arthritis unresponsive to rest, aspirin or other nonsteroidal anti-inflammatory drugs, or to agents in the class of which gold is an example.s
2-deoxyadenosin 5-triphosphat C₁₀H₁₆N₅O₁₂P₃ 491.184 g/mol 1927-31-7 Ornithine Decarboxylase inhibitor Not Availables
Loxapin C₁₈H₁₈ClN₃O 327.808 g/mol 1977-10-2 Catechol 1,2-Dioxygenase inhibitor Not Availables
Methdilazin C₁₈H₂₀N₂S 296.431 g/mol 1982-37-2 Serotonin reuptake inhibitor; Anorexigenic Agents; Stimulants; ATC:A08AA02; ATC:A08AA04 For the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction.s
d-mannuronic säure C₆H₁₀O₇ 194.141 g/mol 1986-14-7 Amine Oxidase [Flavin-Containing] B inhibitor Not Availables
Flumethasonpivalat C₂₇H₃₆F₂O₆ 494.568 g/mol 2002-29-1 Carnitine Acetyltransferase Isoform 2 inhibitor Not Availables
Amilorid C₆H₈ClN₇O 229.627 g/mol 2016-88-8 Aminomethyltransferase inhibitor Not Availables
Clofazimin C₂₇H₂₂Cl₂N₄ 473.396 g/mol 2030-63-9 Beta-Lactamase inhibitor Not Availables
2-deoxycytidin-5-triphosphat C₉H₁₆N₃O₁₃P₃ 467.159 g/mol 2056-98-6 Antinarcotic Agents; Depressants; Opiate Antagonists; ATC:V03AB15 For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol.s
d-asparagin C₄H₈N₂O₃ 132.119 g/mol 2058-58-4 Analgesics, Opioid; Narcotics; ATC:N02AA03 For the relief of moderate to severe pain such as that due to surgery, cancer, trauma/injury, burns, myocardial infarction and colic.s
l-iduronic säure C₆H₁₀O₇ 194.141 g/mol 2073-35-0 Narcotics; Antitussives; Analgesics; ATC:N02AC04; ATC:N02AC54; ATC:N02AC74 For the relief of mild to moderate pains
000003-[[bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4- dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1 dioxide]] C₁₄H₁₆N₃O₄Cl₁S₂ 389.871 g/mol 2259-96-3 Sympatholytics; EENT Drugs; ATC:S01ED03 For lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertensions
Cyclothiazid C₁₄H₁₆ClN₃O₄S₂ 389.879 g/mol 2259-96-3 Ileal Lipid Binding Protein inhibitor Not Availables
diphosphat O₇P₂₄- 855.366 g/mol 2466-09-3 Antimitotic agent; Antineoplastic Agents, Phytogenic; Keratolytic Agents For treatment of external genital warts (Condyloma acuminatum).s
2'-deoxyguanosine-5'-triphosphat C₁₀H₁₆N₅O₁₃P₃ 507.183 g/mol 2564-35-4 Vasodilator Agents; Bronchodilator Agents; Respiratory Smooth Muscle Relaxants; Phosphodiesterase Inhibitors; ATC:R03DA01 For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema.s
Carphenazin C₂₄H₃₁N₃O₂S 425.59 g/mol 2622-30-2 Chlorophyll A-B Binding Protein Ab80 inhibitor Not Availables
Benzylpenicilloyl Polylysin C₂₂H₃₁N₃O₆S Not Available 2642-55-9 Chalcone-Flavonone Isomerase 1 inhibitor Not Availables
Medryson C₂₂H₃₂O₃ 344.488 g/mol 2668-66-8 Antiparasitics; Scabicides; Antipruritics; Scabicides; ATC:D04A; ATC:P03AX For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.s
Flupenthixol C₂₃H₂₅F₃N₂OS 434.519 g/mol 2709-56-0 Anti-allergic Agents; ATC:R06AX07 For the treatment of hay fever, urticaria (hives), and other allergic systems.s
Acetophenazin C₂₃H₂₉N₃O₂S 411.561 g/mol 2751-68-0 Antihistamines; ATC:R06AA08 For symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis.s
Stavudin C₁₀H₁₂N₂O₄ 224.213 g/mol 3056-17-5 Anesthetic Adjuvants; Permeabilizing Agents; ATC:B06AA03 For increase of absorption and distribution of other injected drugs and for rehydrations
Dicloxacillin C₁₉H₁₇Cl₂N₃O₅S 470.327 g/mol 3116-76-5 Antilipemic Agents; Fribic säure Derivatives; ATC:C10AB05 For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)s
Dexfenfluramin C₁₂H₁₆F₃N 231.257 g/mol 3239-44-9 Ornithine Aminotransferase inhibitor Not Availables
000004-nitrocatechol C₆H₅N₁O₄ 155.110 g/mol 3316-09-4 Antiparkinson Agents; Muscarinic antagonists; ATC:N04AA03 Used for the symptomatic treatment of parkinsonism.s
Flunisolid C₂₄H₃₁FO₆ 434.498 g/mol 3385-03-3 Local Anesthetics; ATC:N01BA04 For local (ophthalmic) anesthetic.s
000002-amino-2-deoxy-d-glucose C₆H₁₃N₁O₅ 179.172 g/mol 3416-24-8 D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
alpha-d-mannos C₆H₁₂O₆ 180.157 g/mol 3458-28-4 Antineoplastic Agents, Hormonal; Glucocorticoids; Antiemetics; Anti-inflammatory Agents; Adrenergic Agents; ATC:A01AC02; ATC:C05AA09; ATC:D07AB19; ATC:D07XB05; ATC:D10AA03; ATC:H02AB02; ATC:R01AD03; ATC:S01BA01; ATC:S01CB01; ATC:S02BA06; ATC:S03BA01 Injection: for the treatment of endocrine disorders, rheumatic D=disorders, collagen diseases, dermatologic diseases, allergic statesc, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, cerebral edema.s
Cyclacillin C₁₅H₂₃N₃O₄S 341.427 g/mol 3485-14-1 Hypnotics and Sedatives; Anticonvulsants; For the treatment of Epilepsys
Hetacillin C₁₉H₂₃N₃O₄S 389.47 g/mol 3511-16-8 Antibiotics, Antineoplastic; Alkylating Agents; Cross-Linking Reagents; Nucleic säure Synthesis Inhibitors; ATC:L01DC03 For treatment of malignant neoplasm of lip, oral cavity, pharynx, digestive organs, peritoneum, female breast, and urinary bladder.s
Megestrol C₂₂H₃₀O₃ 342.472 g/mol 3562-63-8 Mydriatics; ATC:A03AB03 For the treatment of visceral spasmss
Cephaloglycin C₁₈H₁₉N₃O₆S 405.426 g/mol 3577-01-3 Anticonvulsants; ATC:N03AA30 For the treatment of epilepsys
l-rhamnose C₆H₁₂O₅ 164.158 g/mol 3615-41-6 Anticonvulsants; ATC:N03AB04 For the treatment of refractory partial epilepsy.s
Sotalol C₁₂H₂₀N₂O₃S 272.365 g/mol 3930-20-9 Nima-Related Protein inhibitor Not Availables
Azatadin C₂₀H₂₂N₂ 290.402 g/mol 3964-81-6 Anti-Inflammatory Agents; ATC:A01AC03; ATC:A07EA02; ATC:C05AA01; ATC:D07AA02; ATC:D07AB02; ATC:D07AB11; ATC:D07AC16; ATC:D07XA01; ATC:H02AB09; ATC:S01BA02; ATC:S01CB03; ATC:S02BA01 For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.s
dihydrofolic säure C₁₉H₂₁N₇O₆ 443.418 g/mol 4033-27-6 Antineoplastic Agents; Glucocorticoids; Anti-inflammatory Agents; Adrenergic Agents; ATC:A07EA01; ATC:C05AA04; ATC:D07AA01; ATC:D07AA03; ATC:D07AC14; ATC:D07XA02; ATC:D10AA02; ATC:H02AB04; ATC:H02AB06; ATC:R01AD02; ATC:S01BA04; ATC:S01CB02; ATC:S02BA03; ATC:S03BA02 For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders.s
ribose-5-phosphat C₅H₁₃O₈P₁ 232.127 g/mol 4151-19-3 Cytochrome P450 51 inhibitor Not Availables
Cladribin C₁₀H₁₂ClN₅O₃ 285.687 g/mol 4291-63-8 Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AA01; ATC:M02AA01 For the treatment of backache and ankylosing spondylitiss
Dacarbazin C₆H₁₀N₆O 182.183 g/mol 4342-03-4 Angiogenesis Inhibitors; Immunosuppressive Agents; Leprostatic Agents; Teratogens; ATC:L04AX02 For the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Also for use as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.s
000005-hydroxy-l-tryptophan C₁₁H₁₁N₂O₃ 219.219 g/mol 4350-09-8 Vasoconstrictor Agents; Anesthetics; Local Anesthetics; ATC:N01BC01; ATC:R02AD03; ATC:S01HA01; ATC:S02DA02 For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.s
phosphonoacetic säure C₂H₅O₅P₁ 140.032 g/mol 4408-78-0 Antineoplastic Agents; Antimetabolites; Purine analogues; ATC:L01BB02 For remission induction and maintenance therapy of acute lymphatic leukemia.s
trehalose-6-phosphat C₁₂H₂₃O₁₄P₁ 422.279 g/mol 4484-88-2 Analgesics, Non-Narcotic; Antidepressive Agents, Tricyclic; Adrenergic Uptake Inhibitors; ATC:N06AA09 For the treatment of anxiety, bipolar disorders, and depression.s
Carbenicillin C₁₇H₁₈N₂O₆S 378.401 g/mol 4697-36-3 Antipsychotics; Antiemetics; Dopamine Antagonists; Phenothiazines; ATC:N05AA01 For the treatment of schizophrenia, control nausea and vomiting, For relief of restlessness and apprehension before surgery, adjunct in the treatment of tetanus, control the manifestations of the manic type of manic-depressive illness.s
Metixen C₂₀H₂₃NS 309.469 g/mol 4969-02-2 Anti-tocolytic Agents; Labor Induction Agents; ATC:Oxytocin To assist in labor, elective labor induction, uterine contraction inductions
Guanabenz C₈H₈Cl₂N₄ 231.081 g/mol 5051-62-7 Antihypertensive Agents; Sympatholytics; ATC:C04AB01; ATC:G04BE05 For the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. Also for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision.s
Flurbiprofen C₁₅H₁₃FO₂ 244.261 g/mol 5104-49-4 Ribokinase inhibitor Not Availables
Flucloxacillin C₁₉H₁₇ClFN₃O₅S 453.873 g/mol 5250-39-5 D-Xylose Isomerase inhibitor Not Availables
Alitretinoin C₂₀H₂₈O₂ 300.435 g/mol 5300-03-8 Antibiotics; Anti-bacterial Agents; Antineoplastic Agents; ATC:L01DA01 For the treatment of Wilms' tumor, childhood rhabdomyosarcoma, Ewing's sarcoma and metastatic, nonseminomatous testicular cancer as part of a combination chemotherapy and/or multi-modality treatment regimens
beta-l-arabinose C₅H₁₀O₅ 150.131 g/mol 5328-37-0 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Fibrinolytic Agents; Anticoagulants; Salicylates; ATC:A01AD05; ATC:B01AC06; ATC:N02BA01 For use in the temporary relief of various forms of pain, inflammation associated with various conditions (including rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and ankylosing spondylitis), and is also used to reduce the risk of death and/or nonfatal myocardial infarction in patients with a previous infarction or unstable angina pectoris.s
Pentagastrin C₃₇H₄₉N₇O₉S 767.893 g/mol 5534-95-2 Hyaluronate Lyase inhibitor Not Availables
Mesoridazin C₂₁H₂₆N₂OS₂ 386.576 g/mol 5588-33-0 Antioxidants; Essential Vitamins; Free Radical Scavengers; Vitamins (Vitamin C); ATC:A11GA01 Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine säureification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.s
Oxybutynin C₂₂H₃₁NO₃ 357.486 g/mol 5633-20-5 Antioxidants; Essential Vitamins; Free Radical Scavengers; Vitamins (Vitamin C); ATC:A11GA01 Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine säureification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.s
Methanthelin C₂₁H₂₆NO₃ 340.436 g/mol 5818-17-7 Antineoplastics; antimetabolites; Antimetabolites For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means.s
d-glutamin C₅H₁₀N₂O₃ 146.146 g/mol 5959-95-5 Bacteriorhodopsin inhibitor Not Availables
Norgestrel C₂₁H₂₈O₂ 312.446 g/mol 6533-00-2 Antineoplastic Agents Not Availables
Perhexilin C₁₉H₃₅N 277.488 g/mol 6621-47-2 Nrh Dehydrogenase [Quinone] 2 inhibitor Not Availables
Pralidoxim C₇H₉N₂O+ 137.159 g/mol 6735-59-7 Aspartate Aminotransferase inhibitor Not Availables
Echothiophate Iodid C₉H₂₃INO₃PS 383.228 g/mol 6736-03-4 Enzyme replacement For the treatment of mucopolysaccharidosiss
Liothyronin C₁₅H₁₂I₃NO₄ 650.974 g/mol 6893-02-3 Sympatholytics; Antihypertensive Agents For management of High blood pressures
d-glutamic säure C₅H₉N₁O₄ 147.130 g/mol 6893-26-1 Prostaglandin H2 Synthase-1 inhibitor Not Availables
Gonadorelin C₅₅H₇₅N₁₇O₁₃ 1182.29 g/mol 6918-09-8 Antiarrhythmic Agents; Anti-allergic Agents; Antihistamines; ATC:R06AX12 For the treatment of allergic rhinitis, hay fever, and allergic skin disorders.s
Tubocurarin C₃₇H₄₁N₂O₆ 609.731 g/mol 6989-98-6 Anion Exchange Resins; Antilipemic Agents; ATC:C10AC02 For use, as adjunctive therapy to diet, for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet.s
Clidinium C₂₂H₂₆NO₃ 352.447 g/mol 7020-55-5 Antiarrhythmic Agents; ATC:C01BA02 For the treatment of life-threatening ventricular arrhythmias.s
Trimethaphan C₂₂H₂₅N₂OS 365.513 g/mol 7187-66-8 Cytochrome C Peroxidase inhibitor Not Availables
Etidronat C₂H₈O₇P₂ 206.028 g/mol 7414-83-7 Immunosuppressive Agents; Antimetabolites; Antineoplastic Agents; ATC:L01BC02 For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, rectum, breast, stomach and pancrease.s
Zalcitabin C₉H₁₃N₃O₃ 211.218 g/mol 7481-89-2 Pentaerythritol Tetranitrate Reductase inhibitor Not Availables
N-Acetyl-D-glucosamin C₈H₁₅N₁O₆ 221.210 g/mol 7512-17-6 Histamine N-Methyltransferase inhibitor Not Availables
Fomepizol C₄H₆N₂ 82.1039 g/mol 7554-65-6 Antithyroid Agents; Anticoagulants; ATC:H03AA01 For use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor.s
Ambenonium C₂₈H₄₂Cl₂N₄O₂ 537.564 g/mol 7648-98-8 Antihyperlipidemics; ATC:C10AX01 Used to lower high cholesterol levels in the blood.s
Alseroxylon Not Available Not Available 8001-95-4 Cardiotonic Agents; Sympathomimetic; ATC:C01CA04 For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failures
Phosphatidylserin C₈H₁₂NO₁₀PR₂ 455.441 g/mol 8002-43-5 Antidepressants; ATC:N06AF03 For the treatment of depression.s
Ethiodol Not Available Not Available 8008-53-5 Diagnostic Aid; ATC:V04CG03 Histamine phosphate is indicated as a diagnostic aid for evaluation of gastric säure secretory function.s
Ergoloidmesylat C₃₃H₄₅N₅O₅ 591.741 g/mol 8067-24-1 Analgesics, Non-Narcotic; Cardiotonic Agents; Cholinergic Agonists; Miotics; ATC:N07AB01; ATC:S01EB02 Primarily used in the treatment of glaucoma, but is also used during ophthalmic surgery.s
Colistimethat C₅₈H₁₀₅N₁₆Na₅O₂₈S₅ 1749.82 g/mol 8068-28-8 Acetylcholinesterase inhibitor Not Availables
Collagenase C₅₀₂₈H₇₆₆₆N₁₃₀₀O₁₅₆₄S₂₁ 112023.2 9001-12-1 Corticosteroids, topical; ATC:D07AC11 For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.s
Coagulation factor VIIa C₁₉₇₂H₃₀₇₆N₅₆₀O₅₉₇S₂₈ 45079.1 9001-25-6 Anti-Anxiety Agents; Antiemetics; ATC:A04AD11 Used for the control of nausea and vomiting, caused by chemotherapeutic agents used in the treatment of cancer, in patients who have failed to respond adequately to conventional antiemetic treatments.s
Factor IX C₂₀₄₁H₃₁₃₆N₅₅₈O₆₄₁S₂₅ 46548.2 9001-28-9 Anti-inflammatory Agents; Analgesics; Nonsteroidal Antiinflammatory Agents (NSAIDs); Carbonic Anhydrase Inhibitors; Cyclooxygenase Inhibitors; ATC:M01AE09; ATC:M02AA19; ATC:S01BC04 Flurbiprofen tablets are indicated for the acute or long-term treatment of the signs and symptoms of rheumatoid arthritis and osteorarthritis.s
Streptokinase C₂₁₀₀H₃₂₇₈N₅₆₆O₆₆₉S₄ 47286.7 9002-01-1 Antimuscarinic eye preparations; Muscarinic Antagonists; Mydriatics; Parasympatholytics; ATC:S01FA04 Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.s
Follitropin beta C₉₇₅H₁₅₁₃N₂₆₇O₃₀₄S₂₆ 22672.9 9002-68-0 Antineoplastic Agents; ATC:L01XX01 For treatment of acute myeloid leukaemia.s
Follitropin alfa/beta C₉₇₅H₁₅₁₃N₂₆₇O₃₀₄S₂₆ 22672.9 9002-68-0 Glutamine Synthetase inhibitor Not Availables
Thyrotropin Alfa C₉₇₅H₁₅₁₃N₂₆₇O₃₀₄S₂₆ 22672.9 9002-71-5 Muscle Relaxants; Anticonvulsants; Analgesics; Skeletal Muscle Relaxants; ATC:M03BX02 For the management of increased muscle tone associated with spasticitys
Dornase alfa (Dnase) C₁₃₂₁H₁₉₉₉N₃₃₉O₃₉₆S₉ 29253.9 9003-98-9 Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02 For the treatment of mild to moderate active Crohn's disease.s
Insulin recombinant C₂₅₇H₃₈₇N₆₅O₇₆S₆ 5795.6 9004-10-8 Antiparkinson Agents; Antidyskinetics; Muscarinic Antagonists; Parasympatholytics; ATC:N04AA02 For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.s
Insulin, porcin C₂₅₇H₃₈₇N₆₅O₇₆S₆ 5795.6 9004-14-2 Analgesics; Anti-ulcer Agents; Adjuvants; Histamine Antagonists; ATC:A02BA01 For the treatment and the management of säure-reflux disorders (GERD), peptic ulcer disease, heartburn, and säure indigestions
Hydroxypropylcellulose (C₃₆H₄₄O₁₈)n ~100,000 g/mol 9004-64-2 Anti-bacterial Agents; Penicillins; ATC:J01CA10 Used to treat serious gram–negative infections of the lungs, urinary tract, and skin.s
Iron Dextran (FeO.OH.₂H₂O)₄₇₈ (Dx.COOH)₉ ~105,000 g/mol 9004-66-4 Methylmalonyl-Coa Carboxyltransferase 12S Su inhibitor Not Availables
Enoxaparin (C₂₆H₄₀N₂O₃₆S₅)n 003500-5500 g/mol (average 4500 g/mol) 9005-49-6 Sympatholytics; Antihypertensive Agents; Antiarrhythmic Agents; ATC:C07AA15; ATC:S01ED05 For the treatment of intraocular hypertension and chronic open-angle glaucomas
Ardeparin (C₂₆H₄₀N₂O₃₆S₅)n 1134.93 g/mol 9005-49-6 Chlorophyll A-B Binding Protein, Chloroplast inhibitor Not Availables
Inulin (C₆H₁₀O₅)n ~1700 g/mol 9005-80-5 Vasodilator Agents; Antiarrhythmic Agents; Calcium-channel blocking agents; ATC:C08DA01 For the treatment of hypertension and angina.s
Calcitonin, salmon C₁₄₅H₂₄₁N₄₃O₄₉S₂ 3434.8 9007-12-9 Antihypertensive Agents Used to produce controlled hypotension during surgical procedures and in hypertensive crises.s
Glucagon recombinant C₁₆₅H₂₄₉N₄₉O₅₁S₁ 3767.1 9007-92-5 Antidotes; Antirheumatic Agents; Chelating Agents; ATC:M01CC01 For treatment of Wilson's disease, cystinuria and active rheumatoid arthritiss
Interferon alfa-n3 C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19241.1 9008-11-1 Antidyskinetics; Antipsychotics; Antiemetics; Butyrophenones; Dopamine Antagonists; ATC:N05AD01 For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.s
Oral interferon alfa C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19241.1 9008-11-1 Dietary supplement; Nutritional Supplement; ATC:R05CB01; ATC:S01XA08; ATC:V03AB23 For the prevention of liver damage and kidney damage associated with overdoses of acetaminophens
Interferon alfa-2a C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19241.1 9008-11-1 Anticholesteremic Agents For lowering cholesterol and, possibly, otherwise favorably affecting lipids. In vitro research also suggests the possibility that hesperetin might have some anticancer effects and that it might have some anti-aromatase activity, as well as activity agains
Pegademase bovine C₁₈₂₁H₂₈₃₄N₄₈₄O₅₅₂S₁₄ 40788.2 9026-93-1 Anabolic Agents; Antineoplastic Agents, Hormonal For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.s
Alpha-1-proteinase inhibitor C₂₀₀₁H₃₁₃₀N₅₁₄O₆₀₁S₁₀ 44324.5 9041-92-3 Antiemetics; Histamine H1 Antagonists Used for treating vertigo, motion sickness, and nausea associated with pregnancy.s
Serum albumin C₂₉₃₆H₄₆₂₄N₇₈₆O₈₈₉S₄₁ 66472.2 9048-49-1 Ophthalmologicals; Sympathomimetics; ATC:S01EA02 Used as initial therapy for the control of intraocular pressure in chronic open-angle glaucoma.s
Human Serum Albumin C₂₉₃₆H₄₆₂₄N₇₈₆O₈₈₉S₄₁ 66472.2 9048-49-1 Chalcone Synthase inhibitor Not Availables
Serum albumin iodonated C₂₉₃₆H₄₆₂₄N₇₈₆O₈₈₉S₄₁ 66472.2 9048-49-1 Narcotics; Analgesics, Opioid; Narcotic Antagonists; ATC:N02AE01; ATC:N07BC01 For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.s
chymostatin C₃₁H₄₂N₇O₆₁+ 1488.683 g/mol 9076-44-2 Vasodilator Agents; Anti-anxiety Agents; Antihypertensive Agents; Antiarrhythmic Agents; Adrenergic Agents; ATC:C07AA05 For the prophylaxis of migraine.s

[edytuj] 10000 .. 100000

alpha-d-glucose 1,6-bisphosphat C₆H₁₃O₁₂P₂₁- 927.610 g/mol 10139-18-1 Antineoplastic Agents; Osteoporosis Prophylactic; Anti-menopausal Agents; Estrogens; ATC:G03CA07; ATC:G03CC04 For management of Menopausal and postmenopausal disorderss
Glyburid C₂₃H₂₈ClN₃O₅S 494.004 g/mol 10238-21-8 Antineoplastic Agents; ATC:L01XX23 For treatment of inoperable adrenocortical tumours; Cushing's syndromes
d-lactic säure C₃H₆O₃ 90.079 g/mol 10326-41-7 Alpha-Glucosidase inhibitor Not Availables
Trospium C₂₅H₃₀NO₃ 392.511 g/mol 10405-02-4 Tocolytic Agents; Cardiovascular Agents; Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:S01BC; ATC:M01AB For moderate to severe rheumatoid arthritis including acute flares of chronic disease, ankylosing spondylitis, osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.s
Icosapent C₂₀H₃₀O₂ 302.456 g/mol 10417-94-4 Bronchodilator Agents; Adrenergic beta-Agonists For the treatment of asthma, wheezing, and chronic asthmatic bronchitis.s
Clodronat CH₄Cl₂O₆P₂ 244.892 g/mol 10596-23-3 Immunosuppressive Agents; Antifungals; ATC:L04AA10 For the prophylaxis of organ rejection in patients receiving renal transplants.s
Capreomycin C₂₅H₄₄N₁₄O₈ 668.706 g/mol 11003-38-6 Muscle Relaxants, Central; ATC:M03BA03 For use as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions.s
Gadobenatdimeglumin Not Available Not Available 12700-20-8 Antitubercular Agents; Leprostatic Agents; ATC:J04AD03 For use in the treatment of pulmonary and extrapulmonary tuberculosis when other antitubercular drugs have failed.s
Flutamid C₁₁H₁₁F₃N₂O₃ 276.212 g/mol 13311-84-7 Immunosuppressive Agents; Antibiotics; Antineoplastic Agents; ATC:L01XX08 For the treatment of hairy cell leukaemia refractory to alpha interferon.s
Rimantadin C₁₂H₂₁N 179.302 g/mol 13392-28-4 Anti-bacterial Agents; Cephalosporins; ATC:J01DC04 Fro the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.s
Hydroxocobalamin C₆₂H₈₉CoN₁₃O₁₅P 1345.5663 g/mol 13422-51-0 Antirheumatic Agents; Antimalarials; Amebicides; ATC:P01BA01; ATC:P01BA02 For the suppressive treatment and for acute attacks of malaria due to P. vivax, P.malariae, P. ovale, and susceptible strains of P. falciparum, Second-line agent in treatment of Rheumatoid Arthritiss
000002-((formyl-hydroxy-amino)-methyl)-heptanoic säure (1-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl)-amide C₁₉H₃₅N₃O₅ 385.503 g/mol 13434-13-4 Acetylcholine-Binding Protein inhibitor Not Availables
Pindolol C₁₄H₂₀N₂O₂ 248.321 g/mol 13523-86-9 Anti-craving Agents; Central Nervous System Agents; Autonomic drugs; Nicotinic Agonists; ATC:N07BA01 For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.s
Alprenolol C₁₅H₂₃NO₂ 249.349 g/mol 13655-52-2 Cytochrome P450 3A4 inhibitor Not Availables
Amoxapin C₁₇H₁₆ClN₃O 313.781 g/mol 14028-44-5 Antivirals; Nucleic säure Synthesis Inhibitors; ATC:D06BB01; ATC:J05AB02; ATC:S01AD01 For use in keratoconjunctivitis and keratitis caused by herpes simplex virus.s
Gentian Violet C₂₅H₃₀N₃+ 372.526 g/mol 14426-25-6 Dietary supplement; Micronutrient; ATC:A11HA02 For nutritional supplementation and for treating dietary shortage or imbalances
Levamisol C₁₁H₁₂N₂S 204.292 g/mol 14769-73-4 Antitubercular Agents; ATC:J04AC01 For the treatment of all forms of tuberculosis in which organisms are susceptible.s
Phenylpropanolamin C₉H₁₃NO 151.206 g/mol 14838-15-4 Antineoplastic Agents; ATC:L01AX02 For the treatment of polycythaemia vera and refractory chronic myeloid leukaemia.s
galacturonic säure C₆H₁₀O₇ 194.141 g/mol 14982-50-4 Contraceptives, Oral, Synthetic; ATC:G03AC09 For the prevention of pregnancy in women who elect to use this product as a method of contraception.s
Flavoxat C₂₄H₂₅NO₄ 391.46 g/mol 15301-69-6 Anti-Arrhythmia Agents; ATC:C01BC03 Used to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms in patients without structural heart disease. Also used for the treatment of life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia.s
Cephalexin C₁₆H₁₇N₃O₄S 347.39 g/mol 15686-71-2 Anti-Ulcer Agents; ATC:A02BX02 For the short-term treatment (up to 8 weeks) of active duodenal ulcer. Also used as maintenance therapy for duodenal ulcer patients at reduced dosage (1 gram twice a day) after healing of acute ulcers.s
Isosorbide Mononitrat C₆H₉NO₆ 191.139 g/mol 16051-77-7 Enzyme Inhibitors; ATC:G04BX03 Used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections.s
Cromolyn C₂₃H₁₆O₁₁ 468.367 g/mol 16110-51-3 Macrophage Metalloelastase inhibitor Not Availables
Desmopressinacetat C₆₈H₁₀₂N₂₂O₂₀S₂ 1611.8 16679-58-6 Adjuvants, Anesthesia; Antiemetics; Antipsychotic Agents; Dopamine Antagonists; ATC:N01AX01; ATC:N05AD08 Used to produce tranquilization and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures.s
Cerulenin C₁₂H₁₇NO₃ 223.268 g/mol 17397-89-6 Phenazine Biosynthesis Protein Phzf inhibitor Not Availables
L-Norgestrel C₂₁H₂₈O₂ 312.446 g/mol 17489-40-6 Antidepressants, Second-Generation; Selective Serotonin Reuptake Inhibitors (SSRIs); ATC:N06AB03 For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.s
Metolazon C₁₆H₁₆ClN₃O₃S 365.835 g/mol 17560-51-9 Anti-bacterial Agents; Anti-Infectives; ATC:A01AB03; ATC:B05CA02; ATC:D08AC02; ATC:D09AA12; ATC:R02AA05; ATC:S01AX09; ATC:S02AA09; ATC:S03AA04 For reduction of pocket depth in patients with adult periodontitis, used as an adjunct to scaling and root planing procedures. Also for prevention of dental caries, oropharyngeal decontamination in critically ill patients, hand hygiene in health-care personnel, general skin cleanser, and catheter site preparation and care.s
Deslanosid C₄₇H₇₄O₁₉ 943.079 g/mol 17598-65-1 Tocolytic Agents; Vasodilator Agents; Nitrates and Nitrites; ATC:C01DA02 For the prevention of anginas
Ceruletid C₄₅H₅₇N₉O₁₄S 980.052 g/mol 17650-98-5 Antiglaucomic Agents; Ophthalmics; Cholinesterase Inhibitors; Miotics; Protease Inhibitors; ATC:S01EB For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.s
tetraphenylphosphonium C₂₄H₂₀P₁₁+ 649.133 g/mol 18198-39-5 Adenosine Deaminase inhibitor Not Availables
Streptozocin C₈H₁₅N₃O₇ 265.221 g/mol 18883-66-4 Fibrinolytic Agents; Platelet Aggregation Inhibitors; ATC:B01AC05 Used to reduce the risk of thrombotic stroke (fatal or nonfatal) in patients who have experienced stroke precursors, and in patients who have had a completed thrombotic stroke.s
Calcidiol C₂₇H₄₄O₂ 400.637 g/mol 19356-17-3 Anthelmintics; ATC:P02BA01 For the treatment of infections due to all species of schistosoma.s
Tinidazol C₈H₁₃N₃O₄S 247.273 g/mol 19387-91-8 Anti-bacterial Agents; Cephalosporins; ATC:J01DC02 For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.s
adenosin-5-diphosphat C₁₀H₁₅N₅O₁₀P₂ 427.204 g/mol 20398-34-9 Diagnostic aid; gastric function; ATC:V04CG04 Used as a diagnostic aid for evaluation of gastric säure secretory functions
Amifostin C₅H₁₅N₂O₃PS 214.224 g/mol 20537-88-6 Diuretics; Carbonic Anhydrase Inhibitors; ATC:S01EC05 For treatment of chronic open-angle glaucoma and acute angle-closure glaucomas
Gliclazid C₁₅H₂₁N₃O₃S 323.412 g/mol 21187-98-4 Antipsychotics; Phenothiazines; ATC:N05AC03 Used in the treatment of schizophrenia, organic brain disorders, alcoholism and psychoneuroses.s
Oxaprozin C₁₈H₁₅NO₃ 293.317 g/mol 21256-18-8 Antiparasitics For the treatment of diarrhea in adults and children caused by the protozoa Giardia lamblia; For the treatment of diarrhea in children caused by the protozoa Cryptosporidium parvums
virginiamycin m1 C₂₈H₃₅N₃O₇ 525.600 g/mol 21411-53-0 Antiarrhythmic Agents; Vasodilator Agents; Antihypertensive Agents; Dihydropyridines; ATC:C08CA04 Used for the management of patients with chronic stable angina and for the treatment of hypertension.s
Cephapirin C₁₇H₁₇N₃O₆S₂ 423.466 g/mol 21593-23-7 Hypnotics and Sedatives Insomnias
Oxamniquin C₁₄H₂₁N₃O₃ 279.335 g/mol 21738-42-1 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:B03AA01; ATC:B05CX03 Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.s
Nifedipine C₁₇H₁₈N₂O₆ 346.335 g/mol 21829-25-4 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:V06DD Used for protein synthesis.s
Guanadrelsulfat C₁₀H₁₉N₃O₂ 213.277 g/mol 22195-34-2 Transthyretin inhibitor Not Availables
Carbimazol C₇H₁₀N₂O₂S 186.233 g/mol 22232-54-8 Antimalarials; Antiarrhythmic Agents; Antiarrhythmic Agents; ATC:C01BA01 For the treatment of ventricular pre-excitation and cardiac dysrhythmiass
Mazindol C₁₆H₁₃ClN₂O 284.74 g/mol 22232-71-9 Renal Agents; Vasoconstrictor Agents Local anaesthetics
Clobazam C₁₆H₁₃ClN₂O₂ 300.739 g/mol 22316-47-8 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalances
Diflunisal C₁₃H₈F₂O₃ 250.198 g/mol 22494-42-4 Glucose-6-Phosphate Isomerase inhibitor Not Availables
Metipranolol C₁₇H₂₇NO₄ 309.401 g/mol 22664-55-7 Anti-Bacterial Agents; Protein Synthesis Inhibitors; ATC:D06AX02; ATC:D10AF03; ATC:G01AA05; ATC:J01BA01; ATC:S01AA01; ATC:S02AA01; ATC:S03AA08 Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.s
Miconazol C₁₈H₁₄Cl₄N₂O 416.127 g/mol 22916-47-8 Dietary supplement; Micronutrient; Non-essential Amino säure; ATC:B03AA09; ATC:V06DD There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.s
Halazepam C₁₇H₁₂ClF₃N₂O 352.738 g/mol 23092-17-3 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:A09AB01; ATC:V06DD In addition to being one of the building blocks in protein synthesis, it is the most widespread neurotransmitter in brain function, as an excitatory neurotransmitter and as a precursor for the synthesis of GABA in GABAergic neurons.s
fumagillin C₂₆H₃₆O₇ 460.566 g/mol 23110-15-8 Dietary supplement; Essential Amino säure; Micronutrient; ATC:B05XB03; ATC:V06DD Supplemental L-lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.s
Vidarabin C₁₀H₁₅N₅O₅ 285.257 g/mol 24356-66-9 Diuretics; Antihypertensive Agents; ATC:C03CA04 For the treatment of hypertension, edema induced by congestive heart failure or renal disease, and ascites associated with hepatic disease.s
Dexrazoxan C₁₁H₁₆N₄O₄ 268.269 g/mol 24584-09-6 Diuretics; Antihypertensive Agents; ATC:C03CA01 For the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease. Also for the treatment of hypertension alone or in combination with other antihypertensive agents.s
Gemfibrozil C₁₅H₂₂O₃ 250.333 g/mol 25812-30-0 Anti-Bacterial Agents; ATC:J01DC09 For the treatment of infections caused by susceptible organisms.s
Minaprin C₁₇H₂₂N₄O 298.383 g/mol 25905-77-5 Tailspike Protein inhibitor Not Availables
Tolmetin C₁₅H₁₅NO₃ 257.285 g/mol 26171-23-3 Antineoplastic Agents; Estrogens, Non-Steroidal; ATC:G03CA06 Used to treat symptoms of menopause, deficiencies in ovary function (including underdevelopment of female sexual characteristics and some types of infertility), and in rare cases, prostate cancer. Chlorotrianisene may also be used to prevent breast engorgement following childbirth.s
Ritodrin C₁₇H₂₁NO₃ 287.354 g/mol 26652-09-5 Anti-allergic Agents; Antiemetics; Antihistamines For the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness.s
Timolol C₁₃H₂₄N₄O₃S 316.421 g/mol 26839-75-8 Antineoplastic Agents; ATC:L01CA02 For treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, acute panmyelosiss
Econazol C₁₈H₁₅Cl₃N₂O 381.683 g/mol 27220-47-9 Anticonvulsants; ATC:N03AB02; ATC:N03AB04; ATC:N03AB05 For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.s
Levobupivacain C₁₈H₂₈N₂O 288.428 g/mol 27262-47-1 Narcotics; Adjuvants; Analgesics; Opiate Agonists; ATC:N02AB Used to control moderate to severe pain.s
Nicergolin C₂₄H₂₆BrN₃O₃ 484.386 g/mol 27848-84-6 Cholinesterase Inhibitors; Miotics; ATC:S01EB05; ATC:V03AB19 For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.s
Bumetanid C₁₇H₂₀N₂O₅S 364.417 g/mol 28395-03-1 Lysozyme inhibitor Not Availables
Cinoxacin C₁₂H₁₀N₂O₅ 262.218 g/mol 28657-80-9 Glycerol Dehydratase inhibitor Not Availables
Pirenzepin C₁₉H₂₁N₅O₂ 351.403 g/mol 28797-61-7 Estrogens; ATC:G03CA01 For treatment of moderate to severe vasomotor symptoms associated with the menopause, female hypogonadism, prostatic carcinoma-palliative therapy of advanced disease, breast cancer, as an oral contraceptive, and as emergency contraceptive.s
Calcium Gluceptate C₁₄H₂₆CaO₁₆ 490.0848 g/mol 29039-00-7 Nuclear Receptor Ror-Alpha inhibitor Not Availables
Glipizide C₂₁H₂₇N₅O₄S 444.548 g/mol 29094-61-9 Anti-bacterial Agents; Aminoglycosides; ATC:A07AA04; ATC:J01GA01; ATC:S01AA15 For the treatment of Tuberculosiss
Guanfacin C₉H₉Cl₂N₃O 246.093 g/mol 29110-47-2 Uricosuric Agents; ATC:M04AB02 For the treatment of gout and gouty arthritis.s
Atenolol C₁₄H₂₂N₂O₃ 266.336 g/mol 29122-68-7 Anesthetics, Inhalation; Neuroprotective Agents; ATC:N01AB07 For use as an inhalation agent for induction and/or maintenance of anesthesia for inpatient and outpatient surgery in adults.s
Mequitazin C₂₀H₂₂N₂S 322.468 g/mol 29216-28-2 Antiemetics; Miscellaneous GI drugs; ATC:A03FA03; Dopamine Antagonists For management of Dyspepsia, Heartburn, Epigastric pain, Nausea, Vomitings
Ciclopirox C₁₂H₁₇NO₂ 207.269 g/mol 29342-05-0 Antipsychotics; ATC:N05AH02 For the management of severely ill schizophrenic patients who fail to respond adequately to standard drug treatment for schizophrenias
Teniposide C₃₂H₃₂O₁₃S 656.655 g/mol 29767-20-2 Aminomethyltransferase inhibitor Not Availables
Estazolam C₁₆H₁₁ClN₄ 294.738 g/mol 29975-16-4 Antiprotozoals; Antimalarials; Folic säure Antagonists; ATC:P01BD01 For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamines
Docosanol C₂₃H₄₆O₂ 354.61 g/mol 30303-65-2 Antineoplastic Agents; Anabolic Agents; Androgens; ATC:G03BA02; ATC:G03BA03; ATC:G03EK01 For topical testosterone replacement therapy in males with deficiency or absence of testosterones
Bitolterol Mesylate C₂₈H₃₁NO₅ 461.549 g/mol 30392-41-7 Anti-anxiety Agents; Hypnotics and Sedatives; Adjuvants, Anesthesia; Benzodiazepines; GABA Modulators; ATC:N05BA02 For the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.s
Mebendazole C₁₆H₁₃N₃O₃ 295.293 g/mol 31431-39-7 Antipsychotics; Antiemetics; Phenothiazines; ATC:N05AB04 For control of severe nausea and vomiting, also used in management of the manifestations of psychotic disorders.s
d-glucuronic säure C₆H₈O 176.124 g/mol 32449-92-6 Anti-inflammatory Agents; Essential Vitamin; Vitamins (Vitamin B For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy.s
Amdinocillin C₂₁H₃₃N₃O₅S 439.57 g/mol 32887-01-7 Anti-inflammatory Agents; Essential Vitamin; Vitamins (Vitamin B For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy.s
Tobramycin C₁₈H₃₇N₅O₉ 467.515 g/mol 32986-56-4 Vasodilator Agents; Antiarrhythmic Agents; Analgesics; Cardiac drugs; ATC:C01EB10 For controlling paroxysmal supraventricular tachycardia (PSVT). This drug can also be used diagnostically for stable, wide complex tachyardias of unknown type.s
Methyl aminolevulinate C₆H₁₁NO₃ 145.156 g/mol 33320-16-0 Dietary supplement; Micronutrient; ATC:A11HA05 For nutritional supplementation, also for treating dietary shortage or imbalance.s
Etoposide C₂₉H₃₂O₁₃ 588.557 g/mol 33419-42-0 Antiscabies Agent; Scabicide; ATC:P03AB02 For the treatment of patients infested with Sarcoptes scabiei (scabies or lice) who have either failed to respond to adequate doses, or are intolerant of other approved therapies.s
Clocortolon C₂₇H₃₆ClFO₅ 495.023 g/mol 34097-16-0 Diuretics, Thiazide; Antihypertensive Agents; ATC:C03AA03; ATC:C03AA04 Chlorothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.s
Ketotifen Fumarate C₁₉H₁₉NOS 309.426 g/mol 34580-14-8 Ribonuclease Mc inhibitor Not Availables
Fenoprofen C₁₅H₁₄O₃ 242.27 g/mol 34597-40-5 N-Acetyllactosaminide Alpha-1,3- Galactosylt inhibitor Not Availables
maltotetraose C₂₄H₄₂O₂₁ 666.583 g/mol 34612-38-9 Rhizome Secoisolariciresinol Dehydrogenase inhibitor Not Availables
Epoprostenol C₂₀H₃₂O₅ 352.465 g/mol 35121-78-9 Anticholinergic Agents; Antispasmodics; ATC:A03AB07 For the treatment of peptic ulcer disease, irritable bowel syndrome, pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, and reflex neurogenic bladder in children.s
Norgestimate C₂₃H₃₁NO₃ 369.497 g/mol 35189-28-7 Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
cefoxitin C₁₆H₁₇N₃O₇S₂ 427.446 g/mol 35607-66-0 Abortifacient Agents, Nonsteroidal; Oxytocics; ATC:G02AD04 For aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in the following conditions related to second trimester abortion: 1. Failure of expulsion of the fetus during the course of treatment by another method; 2. Premature rupture of membranes in intrauterine methods with loss of drug and insufficient or absent uterine activity; 3. Requirement of a repeat intrauterine instillation of drug for expulsion of the fetus; 4. Inadvertent or spontaneous rupture of membranes in the presence of a previable fetus and absence of adequate activity for expulsion. Also for the treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management.s
Labetalol C₁₉H₂₄N₂O₃ 328.406 g/mol 36894-69-6 Analgesics, Opioid; Antitussive Agents; Narcotic Antagonists; Narcotics; ATC:N02AF01 For the management of pain when the use of an opioid analgesic is appropriate. Also indicated as a preoperative or preanesthetic medication, as a supplement to balanced anesthesia, and for the relief of pain during labor.s
Azlocillin C₂₀H₂₃N₅O₆S 461.493 g/mol 37091-66-0 Antibiotics; Antineoplastic Agents; ATC:L01DB06 For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.s
Bentiromide C₂₃H₂₀N₂O₅ 404.415 g/mol 37106-97-1 Aminoglycoside 3'-Phosphotransferase inhibitor Not Availables
Adinazolam C₁₉H₁₈ClN₅ 351.833 g/mol 37115-32-5 Dietary supplement; Micronutrient; ATC:A11 Vitamin E, known for its antioxidant activities, is protective against cardiovascular disease and some forms of cancer and has also demonstrated immune-enhancing effects. It may be of limited benefit in some with asthma and rheumatoid arthritis. It may be helpful in some neurological diseases including Alzheimer's, some eye disorders including cataracts, and diabetes and premenstrual syndrome. It may also help protect skin from ultraviolet irradiation although claims that it reverses skin aging, enhances male fertility and exercise performance are poorly supported. It may help relieve some muscle cramps.s
Alglucerase C₂₅₃₂H₃₈₅₄N₆₇₂O₇₁₁S₁₆ 55597.4 37228-64-1;143003-46-7 Antirheumatic Agents; Immunosuppressive Agents; Dermatologic Agents; Antimetabolites; Abortifacient Agents; Antineoplastic Agents; ATC:L01BA01; ATC:L04AX03 For the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Also for the treatment of severe psoriasis and severe, active, classical or definite rheumatoid arthritis.s
Pentosan Polysulfate C₁₀H₁₈O₂₁S₄ 602.501 g/mol 37300-21-3 Dietary supplement; Micronutrient; ATC:B03BB01 For treatment of folic säure deficiency, megaloblastic anemia and in anemias of nutritional supplements, pregnancy, infancy, or childhood.s
Amikacin C₂₂H₄₃N₅O₁₃ 585.603 g/mol 37517-28-5 Adrenergic alpha-Agonists; Cardiotonic Agents; Nasal Decongestants; Sympathomimetics; Vasoconstrictor Agents; Mydriatics; ATC:C01CA06; ATC:R01AA04; ATC:R01AB01; ATC:R01BA03; ATC:S01FB01; ATC:S01GA05 For the treatment of ophthalmic disorders (hyperaemia of conjunctiva, posterior synechiae, acute atopic), nasal congestion, hemorrhoids, hypotension, shock, hypotension during spinal anesthesia, paroxysmal supraventricular tachycardia. It is also used as an aid in the diagnosis of heart murmurs and for prolongation of spinal anesthesias
Sulindac C₂₀H₁₇FO₃S 356.412 g/mol 38194-50-2 Anti-inflammatory Agents; Essential Vitamin; Vitamins (Vitamin B Complex); ATC:A11DA01 For the treatment of thiamine and niacin deficiency states, Korsakov's alcoholic psychosis, Wernicke-Korsakov syndrome, delirium, and peripheral neuritis.s
Dinoprost Tromethamin C₂₄H₄₅NO₈ 475.616 g/mol 38562-01-5 Glucose-1-Phosphate Thymidylyltransferase inhibitor Not Availables
cellotetraose C₂₄H₄₂O₂₂ 682.583 g/mol 38819-01-1 Antidepressants; ATC:N06AF01 Isocarboxazid is used to treat depression, especially when the patient is excitable or suffering from phobias (fears).s
clorobiocin C₃₅H₃₇N₂O₁₁Cl₁ 697.137 g/mol 39868-96-7 Vasodilator Agents; Antilipemic Agents; Vitamins (Vitamin B Complex); ATC:C04AC01; ATC:C10AD02 For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy.s
Acrosoxacin C₁₇H₁₄N₂O₃ 294.305 g/mol 40034-42-2 Trypanocidal Agents; Anti-Infectives For the treatement of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.s
Pamidronate C₃H₁₁NO₇P₂ 235.07 g/mol 40391-99-9 Dopamine Agents; Antiparkinson Agents; Antidyskinetics; ATC:N04BA01; ATC:N04BA04 For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication.s
Suprofen C₁₄H₁₂O₃S 260.309 g/mol 40828-46-4 Vasodilator Agents; Antihypertensive Agents; ATC:C04AX02 For the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension.s
Enprofyllin C₈H₁₀N₄O₂ 194.191 g/mol 41078-02-8 Vasodilator Agents; Antihypertensive Agents; ATC:C04AB02; ATC:M02AX02 For the treatment of pulmonary artery anomaliess
Etodolac C₁₇H₂₁NO₃ 287.354 g/mol 41340-25-4 Oxytocics; Anti-ulcer Agents; Abortifacient Agents; Prostaglandins; ATC:A02BB01 Indicated for the treatment of ulceration (duodenal, gastric and NSAID induced) and prophylaxis for NSAID induced ulceration.s
Tocainide C₁₁H₁₆N₂O 192.258 g/mol 41708-72-9 Adjuvants, Anesthesia; Muscarinic Antagonists; Anti-cholinergic Agents For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free säureity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.s
d-myo-inositol-1,4-bisphosphat C₆H₁₄O₁₂P₂ 340.117 g/mol 47055-78-7 Antirheumatic Agents; Gastrointestinal Agents; Anti-inflammatory Agents; Anti-Infectives; Sulfonamides; ATC:A07EC01 For the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent.s
Levobunolol C₁₇H₂₅NO₃ 291.385 g/mol 47141-42-4 Antineoplastic Agents; ATC:L01CA03 For the treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia and acute panmyelosiss
Fenofibrate C₂₀H₂₁ClO₄ 360.831 g/mol 49562-28-9 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:V06DD Tyrosine is claimed to act as an effective antidepressant, however results are mixed. Tyrosine has also been claimed to reduce stress and combat narcolepsy and chronic fatigue, however these claims have been refuted by some studies.s
Rimexolon C₂₄H₃₄O₃ 370.525 g/mol 49697-38-3 Lysozyme inhibitor Not Availables
Laronidase C₃₁₆₀H₄₈₄₈N₈₉₈O₈₈₁S₁₂ 69899.4 50378-38-2;210589-09-6 Antifibrinolytic Agents; ATC:B02AA01 For use in the treatment of excessive postoperative bleeding.s
Terfenadin C₃₂H₄₁NO₂ 471.673 g/mol 50679-08-8 Apolipoprotein inhibitor Not Availables
Colestipol C₁₁H₂₈ClN₅O 281.826 g/mol 50925-79-6 Amidase Operon inhibitor Not Availables
Amcinonide C₂₈H₃₅FO₇ 502.572 g/mol 51022-69-6 Antihypertensive Agents; Nicotinic Receptor Antagonist ATC:C02BB01 For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertensions
Amsacrin C₂₁H₁₉N₃O₃S 393.46 g/mol 51264-14-3 Anti-bacterial Agents; Antiprotozoal; Tetracyclines; ATC:A01AB13; ATC:A01AB21; ATC:D06AA02; ATC:D06AA03; ATC:D06AA04; ATC:G01AA07; ATC:J01AA03; ATC:J01AA06; ATC:J01AA07; ATC:J01AA09; ATC:S01AA02; ATC:S01AA04; ATC:S01AA09; ATC:S02AA08; ATC:S03AA02 For the treatment of infections caused by Mycoplasma pneumoniae, chlamydiae, and rickettsiae, syphilis gonorrhea; For the treatment of respiratory infections, bacterial enteritis, meningcoccal carrier state, Lyme disease, cholera, brucellosis, leptospirosis, plague, and acne.s
000002-amino-4-(hydroxymethyl-phosphinyl)butanoic säure C₅H₁₂N₁O₄P₁ 181.128 g/mol 51276-47-2 Antithyroid Agents; ATC:H03B For the treatment of hyperthyroidism, goiter, Graves disease and psoriasis.s
Budesonide C₂₅H₃₄O₆ 430.534 g/mol 51333-22-3 000001-Aminocyclopropane-1-Carboxylate Deaminase inhibitor Not Availables
Mezlocillin C₂₁H₂₅N₅O₈S₂ 539.584 g/mol 51481-65-3 Antisepsis Agents For treatment of severe sepsiss
Carteolol C₁₆H₂₄N₂O₃ 292.373 g/mol 51781-06-7 Bronchodilator Agents; Cholinergic Antagonists; Antimuscarinics; Antispasmodics; ATC:R01AX03; ATC:R03BB01 For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.s
Trimetrexate C₁₉H₂₃N₅O₃ 369.418 g/mol 52128-35-5 Anti-Anxiety Agents; GABA Modulators; Hypnotics and Sedatives; ATC:N05BA04 For treatment of anxiety disorderss
Dipivefrin C₁₉H₂₉NO₅ 351.437 g/mol 52365-63-6 2,3,4,5-Tetrahydropyridine-2-Carboxylate N- inhibitor Not Availables
Pancrelipase C₅₈₅₀H₈₉₀₂N₁₆₀₆O₁₇₃₉S₄₉ 131125.6 53608-75-6 Anti-Bacterial Agents; ATC:J01DC11 For the treatment of infections caused by susceptible organisms.s
Dezocin C₁₆H₂₃NO 245.36 g/mol 53648-55-8 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalances
Pentostatin C₁₁H₁₆N₄O₄ 268.269 g/mol 53910-25-1 Anti-bacterial Agents; Penicillins; ATC:J01CE01; ATC:S01AA14 For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required.s
Cefaclor C₁₅H₁₄ClN₃O₄S 367.808 g/mol 53994-73-3 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AG01 For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.s
Desogestrel C₂₂H₃₀O 310.473 g/mol 54024-22-5 Beta-Lactamase inhibitor Not Availables
Etonogestrel C₂₂H₂₈O₂ 324.457 g/mol 54048-10-1 Anti-Bacterial Agents; ATC:J01CF02 Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci.s
Propafenon C₂₁H₂₇NO₃ 341.444 g/mol 54063-53-5 Anti-Bacterial Agents; Penicillins; ATC:J01CF01; ATC:J01CF02; ATC:J01CF04; ATC:J01CF05 Used in resistant staphylococci infectionss
Etretinat C₂₃H₃₀O₃ 354.483 g/mol 54350-48-0 Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Histamine H1 Antagonists; ATC:N06AX11 For the treatment of major depressive disorder.s
Fluvoxamin C₁₅H₂₁F₃N₂O₂ 318.335 g/mol 54739-18-3 Antimycobacterials; Antibiotics, Antitubercular; Leprostatic Agents; ATC:J04AB05 For the treatment of pulmonary tuberculosis.s
Acitretin C₂₁H₂₆O₃ 326.429 g/mol 55079-83-9 Trypsin II, Anionic inhibitor Not Availables
Cefuroxime C₁₆H₁₆N₄O₈S 424.386 g/mol 55268-75-2 Mercurial Diuretics; Diagnostic aids Previously used as a diuretic. The radiolabeled form has been used as a diagnostic and research tool.s
piretanide C₁₇H₁₈N₂O₅S 362.401 g/mol 55837-27-9 Analgesics Used to treat rheumatoid arthritis (subacute type);Intercostal neuralgia;Some forms of ataxias
Nitazoxanide C₁₂H₉N₃O₅S 307.283 g/mol 55981-09-4 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalance.s
Nicardipin C₂₆H₂₉N₃O₆ 479.525 g/mol 55985-32-5 Dietary supplement; Micronutrient; ATC:N02BA03; ATC:N07AX02 For nutritional supplementation, also for treating dietary shortage or imbalances
Valrubicin C₃₄H₃₆F₃NO₁₃ 723.644 g/mol 56124-62-0 Antinarcotic Agents; Depressants Opioid-induced respiratory depressions
Torsemid C₁₆H₂₀N₄O₃S 348.421 g/mol 56211-40-6 Bronchodilator Agents; Muscarinic Antagonists; Parasympatholytics; ATC:A03AB15 Used in the treatment of peptic ulcer, gastric hypersäureity, and hypermotility in gastritis and pylorospasm, and in the treatment of hyperhidrosis (excessive perspiration).s
Netilmicin C₂₁H₄₁N₅O₇ 475.58 g/mol 56391-56-1 Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA01 For the treatment of hypertension. It may be used alone or in combination with thiazide diuretics.s
Cefmetazole C₁₅H₁₇N₇O₅S₃ 471.538 g/mol 56796-20-4 Putative Clc Family, Chlorine Transport Prot inhibitor Not Availables
abequose C₆H₁₂O₄ 148.158 g/mol 56816-60-5 Lck Tyrosine Kinase inhibitor Not Availables
Clavulanat C₈H₉NO₅ 199.161 g/mol 58001-44-8 Antiemetics; Antipsychotics Used to prevent and treat nausea and vomiting associated with anesthesia and surgery, administered intramuscularly or intravenously.s
Carboprost Tromethamin C₂₁H₃₆O₅ 368.508 g/mol 58551-69-2 Cytidine Monophosphate Kinase inhibitor Not Availables
Azelastin C₂₂H₂₄ClN₃O 381.898 g/mol 58581-89-8 tRNA Nucleotidyltransferase inhibitor Not Availables
Butorphanol Tartrate C₂₁H₂₉NO₂ 327.461 g/mol 58786-99-5 N-Acetyllactosaminide Alpha-1,3-Galactosyltr inhibitor Not Availables
Idarubicin C₂₆H₂₇NO₉ 497.494 g/mol 58957-92-9 Dietary supplement; Essential Amino säure; Micronutrient; ATC:V03AB26; ATC:V06DD Used for protein synthesis including the formation of SAMe, L-homocysteine, L-cysteine, taurine, and sulfate.s
Acyclovir C₈H₁₁N₅O₃ 225.205 g/mol 59277-89-3 Cholinergic Agonists; Nootropics For use in possible or probable dementia of the Alzheimer type .Used in the treatment of tapeworm infections
Brimonidin C₁₁H₁₀BrN₅ 292.135 g/mol 59803-98-4 Cardiotonic Agents For the treatment of atrial fibrillation and flutter and heart failures
Tenoxicam C₁₃H₁₁N₃O₄S₂ 337.376 g/mol 59804-37-4 Thermolysin inhibitor Not Availables
Drotrecogin alfa C₁₇₈₆H₂₇₇₉N₅₀₉O₅₁₉S₂₉ 55000 60202-16-6 Antineoplastic Agents; ATC:L02BB02 Used as an add-on therapy following surgical or chemical castration due to prostate cancers
Ipratropium C₂₀H₃₀NO₃ 332.457 g/mol 60205-81-4 Sympatholytics; Antihypertensive Agents; Adrenergic beta-Antagonists; EENT Drugs; ATC:C07AB05; ATC:S01ED02 For the management of hypertension.s
Palivizumab Not Available Not Available 60574-4111-01 Vasodilator Agents; Antihypertensive Agents; ATC:C08CA07 Hypertensions
Ceforanid C₂₀H₂₁N₇O₆S₂ 519.556 g/mol 60925-61-3 Trypsinogen inhibitor Not Availables
Rifapentin C₄₇H₆₄N₄O₁₂ 877.031 g/mol 61379-65-5 Guanylate Kinase inhibitor Not Availables
000004-[[[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinon]] C₁₆H₂₁N₁O₃ 275.347 g/mol 61413-54-5 Cytosine Deaminase inhibitor Not Availables
Cefotiam C₁₈H₂₃N₉O₄S₃ 525.631 g/mol 61622-34-2 Hypoglycemic Agents; Sulfonylureas; ATC:A10BB03; ATC:V04CA01 Used as an oral hypoglycemic agent in non-insulin-dependent (type 2) Diabetes Miletus with adult onset.s
Dirithromycin C₄₂H₇₈N₂O₁₄ 835.074 g/mol 62013-04-1 Antineoplastic Agents For treatment of cutaneous T-cell lymphomas
Progabid C₁₇H₁₆ClFN₂O₂ 334.772 g/mol 62666-20-0 Antineoplastic Agents; ATC:L01XX03 For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.s
staurosporin C₂₈H₂₆N₄O₃ 466.538 g/mol 62996-74-1 Adrenergic Agents; Antihypertensive Agents; Sympatholytics; ATC:C02CC02; ATC:S01EX01 For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.s
staurosporin C₂₈H₂₆N₄O₃ 466.538 g/mol 62996-74-1 Vasodilator Agents; Antihypertensive Agents; Antiarrhythmic Agents; Calcium Channel Blockers; ATC:C08EA02 For the treatment of chronic stable angina (classic effort-associated angina).s
Cefotaxime C₁₆H₁₇N₅O₇S₂ 455.468 g/mol 63527-52-6 Antifungal Agents; ATC:G01AF15 For the local treatment of vulvovaginal candidiasis (infections caused by Candida)s
Terazosin C₁₉H₂₅N₅O₄ 387.433 g/mol 63590-64-7 Free Radical Scavengers; Vasodilator Agents; Radiation-Protective Agents; Hematologic Agents; Hemorrheologic Agents; ATC:C04AD03 For the treatment of patients with intermittent lameness or immobility arising from chronic occlusive arterial disease of the limbs.s
Nilutamid C₁₂H₁₀F₃N₃O₄ 317.221 g/mol 63612-50-0 Dietary supplement; Micronutrient; ATC:A11HA06; ATC:C10AX07 For nutritional supplementation, also for treating dietary shortage or imbalances
Betaxolol C₁₈H₂₉NO₃ 307.428 g/mol 63659-18-7 Neuromuscular Nondepolarizing Agents; Nicotinic Antagonists; Skeletal Muscle Relaxants; ATC:M03AC02 For use as adjuncts to anesthesia to induce skeletal muscle relaxation and to facilitate the management of patients undergoing mechanical ventilations
Nisoldipin C₂₀H₂₄N₂O₆ 388.414 g/mol 63675-72-9 000004-Diphosphocytidyl-2-C-Methylerythritol Synt inhibitor Not Availables
Oxiconazole Nitrate C₁₈H₁₃Cl₄N₃O 429.126 g/mol 64211-46-7 Antituberculosis Agents; ATC:J04AA01 For the treatment of tuberculosiss
Denileukin diftitox C₂₅₆₀H₄₀₄₂N₆₇₈O₇₉₉S₁₇ 57647.3 64365-503-01 N-Acylamino säure Racemase inhibitor Not Availables
Bepridil C₂₄H₃₄N₂O 366.54 g/mol 64706-54-3 Peroxiredoxin 5 inhibitor; Ras-Related Protein Rab-9A inhibitor Not Availables
Butoconazol C₁₉H₁₇Cl₃N₂S 411.776 g/mol 64872-77-1 Dihydroorotate Dehydrogenase A inhibitor Not Availables
coenzyme f420 C₂₉H₃₅N₅O₁₈P₁ 772.592 g/mol 64885-97-8 Antineoplastic Agents; Analgesics; ATC:L01DB07 For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosiss
Naftifin C₂₁H₂₁N 287.398 g/mol 65472-88-0 Mydriatics; Adjuvants; Antimuscarinics; Antispasmodics; ATC:A04AD01; ATC:N05CM05; ATC:S01FA02 For the treatment of excessive salivation, colicky abdominal pain, bradycardia, sialorrhoea, diverticulitis, irritable bowel syndrome and motion sickness.s
Goserelin C₅₉H₈₄N₁₈O₁₄ 1268.6403 65807-02-5 Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; ATC:D01AE22 For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.s
Tioconazol C₁₆H₁₃Cl₃N₂OS 387.711 g/mol 65899-73-2 Hypoglycemic Agents; ATC:A10BA02 For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.s
Piperacillin C₂₃H₂₆N₅O₇S 516.548 g/mol 66258-76-2 Uracil-DNA Glycosylase inhibitor Not Availables
Cefadroxil C₁₆H₁₇N₃O₅S 363.389 g/mol 66592-87-8 Uncoupling Agents; Anticoagulants; Enzyme Inhibitors; ATC:B02 For decreasing blood clottings
Ketorolac C₁₅H₁₃NO₃ 255.269 g/mol 66635-83-4 Vasodilator Agents; Antihypertensive Agents; Vasodilator Agents; ATC:C08CA06 For the treatment of subarachnoid bleeding.s
Apraclonidin C₉H₁₀Cl₂N₄ 245.108 g/mol 66711-21-5 Neuroprotective Agents; Antiparkinson Agents; Antidyskinetics; Dopamine Agonists; Central Nervous System Agents; ATC:N04BC02 Indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of Parkinson’s disease.s
Alclometason C₂₈H₃₇ClO₇ 521.042 g/mol 66734-13-2 Anti-bacterial Agents; Penicillins; ATC:J01CA12 For the treatment of polymicrobial infections.s
Encainid C₂₂H₂₈N₂O₂ 352.47 g/mol 66778-36-7 Anti-Ulcer Agents; Histamine H2 Antagonists; ATC:A02BA02; ATC:A02BA07 Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).s
Halobetasol Propionat C₂₅H₃₁ClF₂O₅ 484.96 g/mol 66852-54-8 Antiresorptives; Bisphosphonates; Antihypocalcemic Agents; ATC:M05BA04 For the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women.s
Fenoldopam C₁₆H₁₆ClNO₃ 305.756 g/mol 67227-57-0 Anti-bacterial Agents; Cephalosporins; ATC:J01DB05 For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogeness
Terconazol C₂₆H₃₁Cl₂N₅O₃ 532.462 g/mol 67915-31-5 Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AB15; ATC:S01BC05 For the short-term (~5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.s
Zonisamid C₈H₈N₂O₃S 212.227 g/mol 68291-97-4 Antiglaucomic Agents; Ophthalmics; EENT Drugs; ATC:S01EA03 For short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional Intra Ocular Pressure (IOP) reduction.s
Amlexanox C₁₆H₁₄N₂O₄ 298.293 g/mol 68302-57-8 Sympatholytics; Antihypertensive Agents; Adrenergic Agents; ATC:C07AB07 For the management of hypertension and prophylaxis treatment of angina pectoris and heart failure.s
Didanosin C₁₀H₁₂N₄O₃ 236.227 g/mol 69655-05-6 Anti-Infectives; Anti-Infectives; ATC:J01XE01 For the treatment of infection (urinary tract)s
Halofantrin C₂₆H₃₀Cl₂F₃NO 500.423 g/mol 69756-53-2 Anti-Infective Agents, Local; Anti-Infective Agents, Urinary; Antitrichomonal Agents; Monoamine Oxidase Inhibitors; ATC:G01AX06 For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.s
Pefloxacin C₁₇H₂₀FN₃O₃ 333.358 g/mol 70458-92-3 Analgesics, Non-Narcotic; Cryoprotective Agents; Free Radical Scavengers; Solvents; ATC:G04BX13; ATC:M02AX03 For the symptomatic relief of patients with interstitial cystitis.s
Cefpiramid C₂₅H₂₄N₈O₇S₂ 612.64 g/mol 70797-11-4 Antihypocalcemic Agents; Antihypoparathyroid Agents; Vitamins (Vitamin D); ATC:A11CC02 Used for the treatment of acute, chronic, and latent forms of postoperative tetany, idiopathic tetany, and hypoparathyroidisms
Miglitol C₈H₁₇NO₅ 207.224 g/mol 72432-03-2 Enzyme Inhibitors For use in the treatment of patients with pheochromocytoma for preoperative preparation of patients for surgery, management of patients when surgery is contraindicated, and chronic treatment of patients with malignant pheochromocytoma.s
Rifabutin C₄₆H₆₂N₄O₁₁ 847.005 g/mol 72559-06-9 Sandostatin inhibitor Not Availables
Miglustat C₁₀H₂₁NO₄ 219.278 g/mol 72599-27-0 Antidotes; Cholinesterase Reactivators; ATC:V03AB04 For the treatment of poisoning due to those pesticides and chemicals of the organophosphate class which have anticholinesterase activity and in the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis.s
Dapiprazol C₁₉H₂₇N₅ 325.451 g/mol 72822-12-9 Cholinesterase Inhibitors; Miotics; Parasympathomimetics For use in the treatment of subacute or chronic angle-closure glaucoma after iridectomy or where surgery is refused or contraindicated.s
pyrroloquinoline quinon C₁₄H₆N₂O₈ 330.210 g/mol 72909-34-3 Parasympathomimetics; ATC:N07AB02 For the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.s
Prednicarbat C₂₇H₃₆O₈ 488.57 g/mol 73771-04-7 Contraceptives, Oral, Synthetic; Progestins; ATC:G03CA For use as an oral contraceptive in the prevention of pregnancy.s
Cilostazol C₂₀H₂₇N₅O₂ 369.461 g/mol 73963-72-1 Anti-acne Agents; Essential Vitamin; Vitamins (Vitamin A); ATC:V04CB01 For the treatment of vitamin A deficiency.s
Enoxacin C₁₅H₁₇FN₄O₃ 320.319 g/mol 74011-58-8 Anti-acne Agents; Essential Vitamin; Vitamins (Vitamin A); ATC:V04CB01 For the treatment of vitamin A deficiency.s
Doxazosin C₂₃H₂₅N₅O₅ 451.475 g/mol 74191-85-8 Antiprotozoals; Anti-Infectives; ATC:D06BA01; ATC:J01EC02 For the treatment of rheumatic fever and meningococcal meningitiss
Leuprolide C₅₉H₈₄N₁₆O₁₂ 1209.4 74381-53-6 Antibiotics; ATC:J04AB01 Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).s
Indecainid C₂₀H₂₄N₂O 308.417 g/mol 74517-78-5 Antipruritics; Histamine H1 Antagonists; Anxiolytics sedatives and hypnotics; ATC:N05BB01 For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria.s
Interferon alfa-n1 C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19241.1 74899-72-2;9008-11-1 Antioxidants; Anticonvulsants; ATC:N03AX15 For use as adjunctive treatment of partial seizures in adults with epilepsy.s
Lovastatin C₂₄H₃₆O₅ 404.54 g/mol 75330-75-5 Anti-Allergic Agents; Antiulcer agent (topical); Anti-inflammatory, Locally Applied; ATC:A01AD07; ATC:R03DX01 Used as a paste in the mouth to treat aphthous ulcers (canker sores).s
Fludarabin C₁₀H₁₃FN₅O₇P 365.212 g/mol 75607-67-9 Glutathine Synthetase inhibitor Not Availables
Isradipin C₁₉H₂₁N₃O₅ 371.387 g/mol 75695-93-1 Neuroprotective Agents; Central Nervous System Agents; Anorexigenic Agents; Stimulants; ATC:N06BA07 To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.s
Loracarbef C₁₆H₁₆ClN₃O₄ 349.769 g/mol 76470-66-1 Thermolysin inhibitor Not Availables
Divalproex C₁₆H₃₁NaO₄ 310.405 g/mol 76584-70-8 Antipsychotics; Phenothiazines; ATC:N05AB02 For management of manifestations of psychotic disorders.s
thiorphan C₁₂H₁₅NO₃S 253.318 g/mol 76721-89-6 Anti-bacterial Agents; Penicillins; ATC:J01CA01; ATC:J01CA02; ATC:J01CA06; ATC:J01CA14; ATC:J01CA15; ATC:S01AA19 For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptocs
Famotidin C₈H₁₅N₇O₂S₃ 337.449 g/mol 76824-35-6 Mannitol Dehydrogenase inhibitor Not Availables
Nafarelin C₆₆H₈₃N₁₇O₁₃ 1321.6344 g/mol 76932-56-4 Diuretics, Osmotic; Sweetening Agents; ATC:A06AD16; ATC:B05BC01; ATC:B05CX04 Used for the promotion of diuresis before irreversible renal failure becomes established; The reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.s
Nizatidin C₁₂H₂₁N₅O₂S₂ 331.46 g/mol 76963-41-2 Cyclodextrin Glycosyltransferase inhibitor Not Availables
aztreonam C₁₃H₁₇N₅O₈S₂ 435.426 g/mol 78110-38-0 Glycogen Phosphorylase, Liver Form inhibitor Not Availables
9,10-deepithio-9,10-didehydroacanthifolicin C₄₄H₆₈O₁₃ 805.013 g/mol 78111-17-8 Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents; ATC:R01AC07; ATC:R03BC03; ATC:S01GX04 For the treatment of mild to moderate asthmas
Milrinon C₁₂H₉N₃O 211.219 g/mol 78415-72-2 Fertility Agents, Female; ATC:H01CA01; ATC:V04CM01 For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.s
Ceftazidim C₂₂H₂₂N₆O₇S₂ 546.578 g/mol 78439-06-2 Anti-HIV Agents; Antimetabolites; Reverse Transcriptase Inhibitors; ATC:J05AF02 For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection in adults.s
Iloprost C₃₀H₃₈O₅ 478.62 g/mol 78919-13-8 Neuromuscular Nondepolarizing Agents; Skeletal Muscle Relaxants; ATC:M03AA02; ATC:M03AA04 Used as a diagnosis agent for myasthenia gravis; Used to facilitate the intubation after induction of anesthesia in surgical procedures
Cefixim C₁₆H₁₅N₅O₇S₂ 453.452 g/mol 79350-37-1 Antimetabolites; Antiviral Agents; ATC:S01AD02 Ophthalmic solution for the treatment of primay keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.s
Levocabastin C₂₆H₂₉FN₂O₂ 420.519 g/mol 79516-68-0 Dietary supplement; Micronutrient; ATC:V03AB32 For nutritional supplementation, also for treating dietary shortage or imbalances
(1s,6s,7r,8r,8ar)-1,6,7,8-tetrahydroxyindolizidin C₈H₁₅N₁O₄ 189.211 g/mol 79831-76-8 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:V06DD Used for nutritional supplementation, also for treating dietary shortage or imbalance.s
Simvastatin C₂₅H₃₈O₅ 418.566 g/mol 79902-63-9 Iron Chelating Agents; Chelating agent; ATC:V03AC01 Used to treat acute iron or aluminum toxicity (an excess of aluminum in the body) in certain patients. Also used in certain patients with anemia who must receive many blood transfusions.s
Fluticason-propionat C₂₅H₃₁F₃O₅S 500.572 g/mol 80474-14-2 Anti-Infectives; ATC:J01MA03 Uncomplicated gonococcal urethritis in males; gram-negative-bacterial infections in the gastrointestinal system and the genitourinary tract.s
Balsalazid C₁₇H₁₅N₃O₆ 357.318 g/mol 80573-04-2 Anti-Infectives; Enzyme Inhibitors; Quinolones; ATC:J01MA06; ATC:S01AX12 For the treatment of urinary tract infections
Rifaximin C₄₃H₅₁N₃O₁₁ 785.879 g/mol 80621-81-4 Anti-Bacterial Agents; ATC:J01DD11 For treatment of severe infections caused by susceptible bacteria.s
Cisaprid C₂₃H₂₉ClFN₃O₄ 465.945 g/mol 81098-60-4 Odorant Binding Protein Lush inhibitor Not Availables
Alfuzosin C₁₉H₂₇N₅O₄ 389.449 g/mol 81403-80-7 Analgesics; Antineoplastic Agents; Antiemetics; Nonsteroidal Antiinflammatory Agents (NSAIDs); Cyclooxygenase Inhibitors; Growth Inhibitors; ATC:M01AC06 For the treatment of arthritis and osteoarthritis.s
ncs-chromophore C₃₅H₃₃N₁O₁₂ 659.645 g/mol 81604-85-5 Antidepressants; ATC:N06AG02 For the treatment of depression.s
Anistreplas C₂₅₆₉H₃₉₂₈N₇₄₆O₇₈₁S₄₀ 59042.3 81669-57-0 Radiation-Sensitizing Agents; Antineoplastic Agents; ATC:L01CA04 For the treatment of non-small-cell lung carcinomas
Treprostinil C₂₃H₃₄O₅ 390.513 g/mol 81846-19-7 Antihypertensive Agents; Vasodilator Agents; ATC:C02BA01 For the controlled reduction of blood pressure during surgery and in the treatment of hypertensive emergencies.s
Loteprednol Etabonat C₂₄H₃₁ClO₇ 466.951 g/mol 82034-46-6 Dietary supplements; Essential Amino säures; Micronutrients; ATC:V06DD Promotes mental vigor, muscle coordination, and calm emotions. May also be of use in a minority of patients with hepatic encephalopathy and in some with phenylketonuria.s
000004-hydroxy-3,5-dimethyl-5-(2-methyl-buta-1,3-dienyl)-5h-thiophen-2-on C₁₁H₁₄O₂S₁ 210.290 g/mol 82079-32-1 Dietary supplement; Essential Amino säure; Micronutrient; ATC:V06DD L-Threonine makes up collagen, elastin, and enamel protein. It aids proper fat metabolism in the liver, helps the digestive and intestinal tracts function more smoothly, and assists in metabolism and assimilation.s
Interferon gamma-1b C₇₆₁H₁₂₀₆N₂₁₄O₂₂₅S₆ 17145.6 82115-62-6;98059-61-1 Antidepressants; Norepinephrine-Reuptake Inhibitors; ATC:N06AA10 For the treatment of depression.s
Ofloxacin C₁₈H₂₀FN₃O₄ 361.368 g/mol 82419-36-1 Anti-Bacterial Agents; Enzyme Inhibitors; Hypoglycemic Agents; ATC:A10BF02 For use as an adjunct to diet to improve glycemic control in patients with non-insulin-dependent diabetes mellitus (NIDDM) whose hyperglycemia cannot be managed with diet alone.s
Tolrestat C₁₆H₁₄N₁O₃F₃S₁ 357.347 g/mol 82964-04-3 Anti-bacterial Agents; Antituberculosis Agents; ATC:J04AB04 For the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.s
Octreotid acetat C₄₉H₆₆N₁₀O₁₀S₂.₂C₂H₄O₂ 1138.4822 83150-76-9 Anti-HIV Agents; Enzyme Inhibitors; ATC:A16AX06 For the treatment of adult patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access).s
Fexofenadin C₃₂H₃₉NO₄ 501.656 g/mol 83799-24-0 Adrenergic alpha-Antagonists; Antimydriatics; Ophthalmologicals; ATC:S01EX02 Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.s
Sargramostim C₆₃₉H₁₀₀₆N₁₆₈O₁₉₆S₈ 14434.5 83869-56-1 Coenzyme Pqq Synthesis Protein C inhibitor Not Availables
Mometason furoat C₂₇H₃₀O₆Cl₂ 521.436 g/mol 83919-23-7 Dietary supplement; Micronutrient For nutritional supplementation, also for treating dietary shortage or imbalances
Raloxifen C₂₈H₂₇NO₄S 473.584 g/mol 84449-90-1 Pokeweed Antiviral Protein inhibitor Not Availables
Quinapril C₂₅H₃₀N₂O₅ 438.516 g/mol 85441-61-8 Phosphomethylpyrimidine Kinase inhibitor Not Availables
Temozolomid C₆H₆N₆O₂ 194.151 g/mol 85622-93-1 Anti-bacterial Agents; Cephalosporins; ATC:J01DD04 For the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphs
Aldesleukin C₆₉₀H₁₁₁₅N₁₇₇O₂₀₂S₆ 15314.8 85898-30-2 Anti-ulcer Agents; Proton-pump Inhibitors; ATC:A02BC01; ATC:A02BC05 For the treatment of gastroesophageal reflux disease.s
Gadopentetat dimeglumin C₁₄H₂₀N₃O₁₀.₂C₇H₁₇NO₅.Gd 938.2604 g/mol 86050-77-3 Corticosteroid; Anti Inflammatory; Steroidal; ATC:D07AC18 For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.s
Sermorelin C₁₅₄H₂₅₃N₄₅O₄₅S₁ 3487.0 86168-78-7 Antimalarials; Anti-Infectives; ATC:J01EA01 For the treatment of initial episodes of uncomplicated urinary tract infectionss
Benazepril C₂₄H₂₈N₂O₅ 424.49 g/mol 86541-75-5 Neuroprotective Agents; Vasodilator Agents; Fibrinolytic Agents; Bronchodilator Agents; ATC:C04AD For the reduction of symptoms of intermittent claudication (pain in the legs that occurs with walking and disappears with rest)s
Emedastin C₁₇H₂₆N₄O 302.415 g/mol 87233-61-2 000004-Chlorobenzoyl Coa Ligase inhibitor Not Availables
Trandolapril C₂₄H₃₄N₂O₅ 430.537 g/mol 87679-37-6 Dietary supplement; Micronutrient; Non-Essential Amino säure; ATC:B05XB01; ATC:V06DD Used for nutritional supplementation, also for treating dietary shortage or imbalance.s
Porfimer C₆₈H₇₄N₈O₁₁ 1179.36 g/mol 87806-31-3 Probable Ammonium Transporter inhibitor Not Availables
gabaculin C₇H₁₁N₁O₂ 141.169 g/mol 87980-11-8 Anti-Infective Agents; ATC:J01MA04 For the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria gonorrhoeae, (2) uncomplicated urinary tract infections (cystitis) due to Escherichia coli, Staphylococcus epidermidis, or Staphylococcus saprophyticus, and (3) complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis, or Enterobacter cloacae.s
Amlodipin C₂₀H₂₅ClN₂O₅ 408.876 g/mol 88150-42-9 Antihypocalcemic Agents; Antineoplastic Agents; Bisphosphonates; Osteoporosis Prophylactic; ATC:M05BA01; ATC:M05BB01 For the treatment of symptomatic Paget's disease of bone and in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury.s
Toremifen C₂₆H₂₈ClNO 405.959 g/mol 89778-26-7 Anti-Estrogen Agents; Antineoplastic Agents For treatment of prostate cancer, endometriosis, uterine fibroids and premature pubertys
Tazobactam C₁₀H₁₂N₄O₅S₁ 300.289 g/mol 89786-04-9 Fibrinolytic Agents; Platelet Aggregation Inhibitors; Vasodilator Agents; ATC:C01EA01; ATC:G04BE01 For palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. Also for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology.s
Tiludronat C₇H₉ClO₆P₂S 318.609 g/mol 89987-06-4 Antidysrhythmic Agents; Sodium channel blockers For the treatment of life-threatening dysrhythmias and sustained ventricular tachycardia.s
Bicalutamid C₁₈H₁₄F₄N₂O₄S 430.374 g/mol 90357-06-5 Anti-HIV Agents; Antimetabolites; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors; ATC:J05AF03 For the treatment of Human immunovirus (HIV) infections.s
Terbinafin C₂₁H₂₅N 291.43 g/mol 91161-71-6 Anticoagulants; Anticoagulants; ATC:B01AE03 For prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenias
Cefdinir C₁₄H₁₃N₅O₅S₂ 395.416 g/mol 91832-40-5 Antiviral Agents; Immunomodulatory Agents For treatment of venereal or genital warts caused by the Human Papiloma Viruss
Cefprozil C₁₈H₁₉N₃O₅S 389.427 g/mol 92665-29-7 Hydroxynitrile Lyase inhibitor Not Availables
Glimpirid C₂₄H₃₄N₄O₅S 490.617 g/mol 93479-97-1 Antineoplastic Agents; Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA02 For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart diseases
Fluvastatin C₂₄H₂₆FNO₄ 411.466 g/mol 93957-54-1 Antidotes; ATC:V03AB34 Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysiss
Interferon beta-1b C₉₀₈H₁₄₀₈N₂₄₆O₂₅₃S₆ 20011.0 96778-78-8;145155-23-3 Immunosuppressive Agents; Antivirals; Antiparasitics; Antineoplastic Agents; Anti-inflammatory Agents; Adjuvants; ATC:L04AA13 For the treatment of active rheumatoid arthritis (RA).s
Cisatracurium Besylat C₆₅H₈₂N₂O₁₈S₂ 1243.48 g/mol 96946-42-8 Contrast Media; Ultrasound contrast agent Use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.s
Troglitazon C₂₄H₂₇NO₅S 441.541 g/mol 97322-87-7 Narcotics; Adjuvants; Analgesics; Opiate Agonists; ATC:N02A For the treatment of moderate-to-severe pains
Lomefloxacin C₁₇H₁₉F₂N₃O₃ 351.348 g/mol 98079-51-7 Anabolic Agents; Antineoplastic Agents, Hormonal; ATC:G03BA01 In males, used as replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone. In females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.s
Finasteride C₂₃H₃₆N₂O₂ 372.544 g/mol 98319-26-7 Corticosteroid; Glucocorticoids; Anti-inflammatory, steroidal; Immunosuppressant; ATC:A07EA04; ATC:C05AA05; ATC:D07AC01 Used topically as an antiinflammatory in the treatment of steroid-responsive dermatosess
Interferon alfa-2b C₈₆₀H₁₃₅₃N₂₂₉O₂₅₅S₉ 19269.1 98530-12-2 Narcotics; Antitussives; Analgesics; Opiate Agonists; ATC:N02AA08; ATC:R05DA04 For treatment and management of pain (Systemic), also used as an Antidiarrheal and as a cough suppressant.s
Reboxetin C₁₉H₂₃NO₃ 313.391 g/mol 98769-81-4 Hypnotics and Sedatives; Adjuvants; Barbiturates; ATC:N05CA06 For the Short-term treatment of intractable insomnia for patients habituated to barbituratess
Peginterferon alfa-2b C₈₆₀H₁₃₅₃N₂₂₉O₂₅₅S₉ 19269.1 99210-65-8 Anesthetics, Intravenous; Anticonvulsants; GABA Modulators; Hypnotics and Sedatives; ATC:N01AF03; ATC:N05CA19 For use as the sole anesthetic agent for brief (15 minute) procedures, for induction of anesthesia prior to administration of other anesthetic agents, to supplement regional anesthesia, to provide hypnosis during balanced anesthesia with other agents for analgesia or muscle relaxation, for the control of convulsive states during or following inhalation anesthesia or local anesthesia, in neurosurgical patients with increased intracranial pressure, and for narcoanalysis and narcosynthesis in psychiatric disorders.s
Sertaconazol C₂₀H₁₅Cl₃N₂OS 437.77 g/mol 99592-32-2 Narcotics; Antitussives; Analgesics; Opiate Agonists; ATC:N02AC52; ATC:N07BC02; ATC:R05DA06 For the treatment of dry cough, drug withdrawal syndrome, opioid type drug dependence, and pains

[edytuj] 100000 .. 200000

Pemirolast C₁₀H₈N₆O 228.21 g/mol 100299-08-9 Antimanic Agents; GABA Agents; Anticonvulsants; ATC:N03AG For treatment and management of seizure disorders, mania, and prophylactic treatment of migraine headache.s
Lercanidipin C₃₆H₄₁N₃O₆ 611.727 g/mol 100427-26-7 Anti-Arrhythmic Agents; Vasodilator Agents; Antihypertensive Agents Not Availables
Butenafin C₂₃H₂₇N 317.467 g/mol 101828-21-1 Anti-Ulcer Agents; Histamine H2 Antagonists; ATC:A02BA03 For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).s
calyculin a C₅₀H₈₁N₄O₁₅P₁ 1009.181 g/mol 101932-71-2 Cardiotonic Agents; Bronchodilator Agents; Sympathomimetic; ATC:R03AC For the treatment of mild or transient episodes of heart block that do not require electric shock or pacemaker therapy also used in management of asthma and chronic bronchitiss
adma C₈H₁₈N₄O₂ 202.256 g/mol 102783-24-4 Narcotics; Analgesics, Opioid For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriates
Daptomycin C₇₂H₁₀₁N₁₇O₂₆ 1619.7086 g/mol 103060-53-3 Hallucinogens Intravenous anesthetic s
huperzine b C₁₆H₂₀N₂O₁ 256.347 g/mol 103548-82-9 Anticholinergic Agents; Antispasmodics; Antimuscarinics; Antispasmodics; ATC:A03BA For the treatment of functional bowel/irritable bowel syndromes
Lansoprazol C₁₆H₁₄F₃N₃O₂S 369.363 g/mol 103577-45-3 Analgesics; ATC:N05CA Used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches, migraines, and pain.s
Moexipril C₂₇H₃₄N₂O₇ 498.568 g/mol 103775-10-6 Antiparkinson Agents; Antidyskinetics; Antiparkinson Agents; Muscarinic Antagonists; ATC:N04AA04 For the treatment of Parkinson's Disease (especially drug induced)s
Agalsidase beta C₂₀₂₉H₃₀₈₀N₅₄₄O₅₈₇S₂₇ 45351.6 104138-64-9 Antiparkinson Agents; Antidyskinetics; ATC:N04AA For treatment and management of Parkinson's disease.s
Nitisinon C₁₄H₁₀F₃NO₅ 329.228 g/mol 104206-65-7 Anticonvulsants; Succinimides; ATC:N03AD01 For the treatment of petit mal epilepsy.s
Mometason C₂₂H₂₈Cl₂O₄ 427.361 g/mol 105102-22-5 Anti-fungal Agents; ATC:D01AE11 Used to treat fungal (Tinea) skin infections such as athlete's foot, jock itch, ringworm, and tinea versicolor.s
Risedronate C₇H₁₁NO₇P₂ 283.112 g/mol 105462-24-6 Muscle Relaxants; Skeletal Muscle Relaxants; ATC:M03BA02 For the relief of discomfort associated with acute, painful, musculoskeletal conditions.s
Nateglinide C₁₉H₂₇NO₃ 317.423 g/mol 105816-04-4 Beta-Lactamase inhibitor Not Availables
Tenecteplase C₂₅₆₁H₃₉₁₉N₇₄₇O₇₈₁S₄₀ 58951.2 105857-23-6 Serine/Threonine Protein Phosphatase Pp1-Gam inhibitor Not Availables
Alteplase C₂₅₆₉H₃₉₂₈N₇₄₆O₇₈₁S₄₀ 59042.3 105857-23-6 Vasodilator Agents; Cardiotonic Agents; ATC:C01CE02 Indicated for the treatment of congestive heart failure.s
Mivacurium C₅₈H₈₀N₂O₁₄+₂ 1029.26 g/mol 106791-40-6 Beta-Lactamase Shv-1 inhibitor Not Availables
Doxacurium Chloride C₅₆H₇₈Cl₂N₂O₁₆ 1106.13 g/mol 106819-53-8 Glucose-6-Phosphate 1-Dehydrogenase inhibitor Not Availables
Perindopril Erbumin C₁₉H₃₂N₂O₅ 368.468 g/mol 107133-36-8 Meta-Cleavage Product Hydrolase inhibitor Not Availables
Cevimelin C₁₀H₁₇NOS 489.565 g/mol 107233-08-9 Anti-bacterial Agents; Tetracyclines; ATC:D06AA03; ATC:G01AA07; ATC:J01AA06; ATC:S01AA04 Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.s
Zafirlukast C₃₁H₃₃N₃O₆S 575.676 g/mol 107753-78-6 Anti-bacterial Agents; Cephalosporins; ATC:J01DD08 For use in the treatment of the following infections when caused by susceptible strains of the designated microorganisms:s
Exemestan C₂₀H₂₄O₂ 296.403 g/mol 107868-30-4 Histamine H1 Antagonists; ATC:R01AC02; ATC:S01GX02 As an ophthalmic for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. Also used as a nasal spray for allergic rhinitis.s
Granisetron C₁₈H₂₄N₄O 312.41 g/mol 109889-09-0 Antidepressants; Selective Serotonin Reuptake Inhibitors (SSRIs); ATC:N06AB06 For the treatment of posttraumatic stress disorder, depression, obsessive-compulsive disorder and panic disorders
Ridogrel C₁₈H₁₇F₃N₂O₃ 366.334 g/mol 110140-89-1 Anti-allergic Agents; Antipruritics; Antihistamines; Histamine H1 Antagonists, Non-Sedating; ATC:R06AX13; ATC:R06AX27 For the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and for the treatment of chronic idiopathic urticaria in patients 2 years of age or olders
Sparfloxacin C₁₉H₂₂F₂N₄O₃ 392.4 g/mol 110871-86-8 Exo- inhibitor Not Availables
Letrozol C₁₇H₁₁N₅ 285.303 g/mol 112809-51-5 Anticholinergics; Parasympatholytics For use in conjunction with antsäures or histamine H₂-receptor antagonists in the treatment of peptic ulcer, to reduce further gastric säure secretion and delay gastric emptying.s
Gatifloxacin C₁₉H₂₂FN₃O₄ 375.394 g/mol 112811-59-3 Antipsychotics; Anti-Anxiety Agents; Benzodiazepines; Muscle Relaxants, Central; ATC:M03BB02 Used in the management of anxiety and in the treatment of muscle spasm.s
zd1694 C₂₁H₂₂N₄O₆S₁ 458.488 g/mol 112887-68-0 Adrenergic Uptake Inhibitors For the treatment of hypertension and as an adjunct in the management of angina pectoris.s
Raltitrexed C₂₁H₂₂N₄O₆S 458.489 g/mol 112887-68-0 Antihistamines; Ophthalmics; ATC:R06AX24; ATC:S01GX10 For the prevention of itching associated with allergic conjunctivitis.s
(1s,5z,7z,17alpha,22e)-24-cyclopropyl-9,10-secochola-5,7,10,22-tetraene-1,3,24-triol; 1-alpha,24s-(oh)2-22-ene-26,27-dehydrovitamin d3 C₂₇H₄₀O₃ 412.611 g/mol 112965-21-6 Dietary supplement; Micronutrient Phosphatidylserine has demonstrated some usefulness in treating cognitive impairment, including Alzheimer's disease, age-associated memory impairment and some non-Alzheimer's dementias. More research is needed before phosphatidylserine can be indicated for immune enhancement or for reduction of exercise stress.s
enalkiren C₃₅H₅₆N₆O₆ 656.856 g/mol 113082-98-7 Antineoplastic Agents; Contrast Media For use as a radio-opaque medium for hysterosalpingography and lymphography, and as an antineoplastic agent when part of the iodine is 131-I.s
Dexmedetomidin C₁₃H₁₆N₂ 200.28 g/mol 113775-47-6 Anti-allergic Agents; Dermatologic Agents; Bronchodilator Agents; Anti-inflammatory Agents; Adrenergic Agents; ATC:D07AC17; ATC:R01AD08; ATC:R03BA05 For the maintenance treatment of asthma as prophylactic therapy and for patients requiring oral corticosteroid therapy for asthma.s
Olopatadin C₂₁H₂₃NO₃ 337.412 g/mol 113806-05-6 Anti-ulcer Agents; ATC:A07EC04 For the treatment of mildly to moderately active ulcerative colitis.s
Cidofovir C₈H₁₄N₃O₆P 279.187 g/mol 113852-37-2 Anti-Infective Agents; Gastrointestinal Agents; ATC:A07AA11; ATC:D06AX11 For the treatment of patients (>=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli.s
Ibandronate C₉H₂₃NO₇P₂ 319.229 g/mol 114084-78-5 Anti-bacterial Agents; ATC:A07AA08; ATC:J01GB04; ATC:S01AA24 For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.s
Losartan C₂₂H₂₃ClN₆O 422.911 g/mol 114798-26-4 Adrenergic alpha-Antagonists; Nootropic Agents; Vasodilator Agents; Sympatholytics; ATC:C04AE01 For use as an adjunct therapy for patients with dementias
Fondaparinux C₃₁H₄₃N₃Na₁₀O₄₉S₈ 1726.77 g/mol 114870-03-0 Antibacterial agents For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.s
Docetaxel C₄₃H₅₃NO₁₄ 807.879 g/mol 114977-28-5 Diuretics; Anti-Addison Agents; ATC:H02A For treatment of adrenocortical insufficiency especially in multiple sclerosis, congenital cerebral palsy, polyarteritis nodosa, and rheumatoid arthritis.s
Dofetilide C₁₉H₂₇N₃O₅S₂ 441.567 g/mol 115256-11-6 Estrogen-Related Receptor Gamma inhibitor Not Availables
Dolasetron C₁₉H₂₀N₂O₃ 324.374 g/mol 115956-12-2 Rodenticides; Anticoagulants; Coumarin and Indandione Derivatives; ATC:B01AA03 For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.s
Cefditoren Pivoxil C₂₅H₂₈N₆O₇S₃ 620.724 g/mol 117467-28-4 Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA03 For the treatment of hypercholesterolemia to reduce the risk of myocardial infarction.s
Rabeprazol C₁₈H₂₁N₃O₃S 359.444 g/mol 117976-89-3 Gastrointestinal Agents; Anti-ulcer Agents; Prokinetic Agents; Serotonin Agonists; ATC:A03FA02 For the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease.s
Zoledronate C₅H₁₀N₂O₇P₂ 272.09 g/mol 118072-93-8 Anti-bacterial Agents; Other Macrolides; ATC:J01FA09 For the treatment of Bacterial infection of (Pharyngitis/Tonsillitis, sinusitis, bronchitis, Pneumonia, Uncomplicated skin and skin structure infections ) caused by H.influenzae, M.catarrhalis, M.pneumoniae, S.pneumoniae, C.pneumoniae (TWAR), S.aureus, S. pyogenes, Mycobacterium avium and Mycobacterium intracellulares
Tazaroten C₂₁H₂₁NO₂S 351.463 g/mol 118292-40-3 Antihypertensive Agents; ATC:G04CA01 For the treatment of the signs and symptoms of benign prostatic hyperplasia.s
Interferon alfacon-1 C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19343 118390-30-0 Antineoplastic Agents; Antiparkinson Agents; Dopamine Agonists; ATC:G02CB03; ATC:N04BC06 For the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.s
Candoxatril C₂₉H₄₁NO₇ 515.638 g/mol 118785-03-8 Neocarzinostatin inhibitor Not Availables
Meropenem C₁₇H₂₅N₃O₅S 383.464 g/mol 119478-56-7 Antiemetics; Piperazine Derivatives; ATC:R06AE03; ATC:R06AE04 For prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness, and vertigo (dizziness caused by other medical problems).s
Grepafloxacin C₁₉H₂₂FN₃O₃ 359.395 g/mol 119914-60-2 Anti-Allergic Agents; ATC:S01BA14 As an ophthalmic it is used for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal spray, used for the treatment and management of seasonal allergic rhinitis.s
Gadoteridol C₁₇H₂₉N₄O₇.Gd 559.1277 g/mol 120066-54-8 Antiviral Agents; Immunomodulatory Agents For treatment of Chronic granulomatous disease, Osteopetrosiss
Dorzolamide C₁₀H₁₆N₂O₄S₃ 324.443 g/mol 120279-96-1 Antidepressants; Central Nervous System Agents; ATC:N06BA09 For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).s
Cetrorelix Not Available 1431.06 g/mol 120287-85-6 Antiviral Agents; ATC:J05AB06; ATC:J05AB14; ATC:S01AD09 For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients.s
Cetrorelix Not Available 1431.06 g/mol 120287-85-6 Anti-bacterial Agents; Anti-Infectives; Quinolones; ATC:J01MA01; ATC:J01MA02; ATC:J01MA12; ATC:S01AX11; ATC:S01AX13; ATC:S01AX19; ATC:S03AA07 For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.s
Anastrozol C₁₇H₁₉N₅ 293.366 g/mol 120511-73-1 Hypnotics and Sedatives; ATC:N05CF02 For the short-term treatment of insomnia.s
Lepirudin C₂₈₈H₄₄₈N₈₀O₁₁₀S₆ 6983.5 120993-53-5 Aldose Reductase inhibitor Not Availables
soraphen a C₂₉H₄₄O₈ 520.662 g/mol 122547-72-2 Major Pollen Allergen Bet V 1-L inhibitor Not Availables
Ibutilide Fumarate C₂₀H₃₆N₂O₃S 384.578 g/mol 122647-32-9 Radiation-Sensitizing Agents; Vitamins (Vitamin B Complex); ATC:A11HA04 For the treatment of ariboflavinosis (vitamin B2 deficiency).s
Gadodiamide C₁₆H₂₆N₅O₈.Gd.(H₂O)x Not Available 122795-43-1 Radiation-Sensitizing Agents; Vitamins (Vitamin B Complex); ATC:A11HA04 For the treatment of ariboflavinosis (vitamin B2 deficiency).s
Alosetron C₁₇H₁₈N₄O 294.351 g/mol 122852-42-0 Antihelmintics; Antiprotozoals; Antineoplastic Agents; Antinematodal Agents; Antimalarials; Anticestodal Agents; Enzyme Inhibitors For the treatment of giardiasis and cutaneous leishmaniasis and the management of malignant effusions.s
Clofarabin C₁₀H₁₁ClFN₅O₃ 303.677 g/mol 123318-82-1 Antiparkinson Agents; Antidyskinetics; Skeletal Muscle Relaxants; ATC:M03BC01; ATC:N04AB02 Indicated for the treatment of Parkinson's disease.s
Tolterodin C₂₂H₃₁NO 325.488 g/mol 124937-51-5 Antihistamines; ATC:R06AX26 For management of Seasonal allergic rhinitiss
Remikiren C₃₃H₅₀N₄O₆S 630.839 g/mol 126222-34-2 <<<<<<< BTD00035.txt For the treatment of cancer and bone marrow transplants
Bivalirudin C₉₈H₁₃₈N₂₄O₃₃ 2180.3 128270-60-0 Cardiotonic Agents; Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA03 For the treatment of hypertension, heart failure and acute myocardial infarction. It may be used alone or in combination with thiazide diureticss
Cinalukast C₂₃H₂₈N₂O₃S 412.546 g/mol 128312-51-6 Progesterone Receptor inhibitor Not Availables
Arbutamin C₁₈H₂₃NO₄ 317.38 g/mol 128470-16-6 Estrogens, Non-Steroidal; ATC:G03CB01; ATC:G03CC02 For use in the treatment of atrophic vaginitis and kraurosis vulvae.s
Ganirelix Not Available 1570.4 g/mol 129311-55-3 2C-Methyl-D-Erythritol 2,4-Cyclodiphosphate inhibitor; Coenzyme A Biosynthesis Bifunctional Protein inhibitor Not Availables
Fulvestrant C₃₂H₄₇F₅O₃S 606.772 g/mol 129453-61-8 Antifibrinolytic Agents; Vitamins (Vitamin K) For the treatment of haemorrhagic conditions in infants, antidote for coumarin anticoagulants in hypoprothrombinaemias
Verteporfin C₄₁H₄₂N₄O₈ 718.794 g/mol 129497-78-5 Antipruritics; Phenothiazine Derivatives; ATC:D04AA10; ATC:R06AD02; ATC:R06AD05 Used to prevent and relieve allergic conditions which cause pruritus (itching) and urticaria (some allergic skin reactions).s
Nevirapin C₁₅H₁₄N₄O 266.298 g/mol 129618-40-2 Antimanic Agents; Antidepressants; Anticonvulsants; Analgesics; Calcium Channel Blockers; Excitatory Amino säure Antagonists; ATC:N03AX09 For the adjunctive treatment of partial seizures in epilepsy and generalized seizures of Lennox-Gastaut syndrome; For the maintenance treatment of Bipolar I Disorders
Pegaspargase C₁₃₇₇H₂₂₀₈N₃₈₂O₄₄₂S₁₇ 31731.9 130167-69-0 Menstruation-Inducing Agents; Luteolytic Agents; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Hormone Antagonists; Abortifacient Agents, Steroidal; ATC:G03XB01 For the medical termination of intrauterine pregnancy through 49 days' pregnancy.s
Latanoprost C₂₆H₄₀O₅ 432.593 g/mol 130209-82-4 Antihypocalcemic Agents; Osteoporosis Prophylactic; Selective Estrogen Receptor Modulators; Estrogen Antagonists; ATC:G03XC01 For the prevention of osteoporosis in post-menopausal womens
Gadoversetamide C₂₀H₃₄N₅O₁₀-₃ 504.512 g/mol 131069-91-5 Anti-anxiety Agents; Adjuvants, Anesthesia; Benzodiazepines; GABA Modulators; ATC:N05CD07 For the short-term treatment of insomnia (generally 7-10 days).s
Paricalcitol C₂₇H₄₄O₃ 416.636 g/mol 131918-61-1 Antiprotozoals; Antifungals; ATC:J02AC02 For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.s
Eprosartan C₂₃H₂₄N₂O₄S 424.514 g/mol 133040-01-4 Anesthetics, Local For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.s
Darifenacin C₂₈H₃₀N₂O₂ 426.55 g/mol 133099-04-4 Ribonuclease A inhibitor Not Availables
Insulin Lyspro recombinant C₂₅₇H₃₈₇N₆₅O₇₆S₆ 5808 133107-64-9 Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA06 For the treatment of hypertension and chronic heart failure.s
Midodrin C₁₂H₁₈N₂O₄ 254.282 g/mol 133163-28-7 Antineoplastic Agents; ATC:L01AX03 For the treatment of adult patients diagnosed with anaplastic astrocytoma who have relapsed following chemotherapys
Reteplase C₁₇₃₆H₂₆₇₁N₄₉₉O₅₂₂S₂₂ 39589.6 133652-38-7 Anti-Infectives; Quinolones; ATC:J01MA02; ATC:S01AX13; ATC:S03AA07 For the treatment of Bacterial infection of Respiratory tract, UTI, Uncomplicated Cystitis in females, GI, Chronic Bacterial Prostatitis, CNS, Immuno compromised patients, Skin, Bone and Joint Infections, Uncomplicated cervical and urethral gonorrheas
Tolcapon C₁₄H₁₁NO₅ 273.241 g/mol 134308-13-7 Antineoplastic Agents For treatment of adults with metastatic renal cell carcinomas
Rasburicase C₁₅₂₁H₂₃₈₁N₄₁₇O₄₆₁S₇ 34109.5 134774-451 Anti-Allergic Agents; Histamine H1 Antagonists; ATC:R06AB01; ATC:R06AB06 For the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing.s
Repaglinide C₂₇H₃₆N₂O₄ 452.586 g/mol 135062-02-1 Anticonvulsants; Antiepileptic Agents; ATC:N03AD02 For the treatment of epilepsys
Abacavir C₁₄H₁₈N₆O 286.333 g/mol 136470-78-5 Amebicides; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; ATC:P01BA06 For treatment of acute malarial attacks in non-immune subjects.s
Lubiproston C₂₀H₃₂F₂O₅ 390.462 g/mol 136790-76-6 Contrast Agents; ATC:V08CA03 For use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues as well as lesions with abnormal vascularity in the head and neck. Also used to facilitate the visualization of lesions with abnormal vascularity in the body (excluding the heart).s
Delavirdin C₂₂H₂₈N₆O₃S 456.562 g/mol 136817-59-9 Anabolic Agents; Hormone replacement; ATC: V04CD03; ATC: H01AC04 For the treatment of dwarfism, prevention of HIV-induced weight losss
Valsartan C₂₄H₂₉N₅O₃ 435.519 g/mol 137862-53-4 Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA07 For the treatment of hypertension. It may be used alone or in combination with thiazide diuretics.s
Irbesartan C₂₅H₂₈N₆O 428.53 g/mol 138402-11-6 Anti-bacterial Agents; Penicillins; ATC:J01CE02 For the treatment of mild to moderately severe infections (e.g. dental infection, infections in the heart, middle ear infections, rheumatic fever, scarlet fever, skin infections, upper and lower respiratory tract infections) due to microorganismss
Eszopiclon C₁₇H₁₇ClN₆O₃ 388.808 g/mol 138729-47-2 Vasodilator Agents; Nitrates and Nitrites; ATC:C01DA08; ATC:D03AX08 For the prevention of angina pectoris due to coronary artery disease.s
Brinzolamide C₁₂H₂₁N₃O₅S₃ 383.51 g/mol 138890-62-7 Glucarate Dehydratase inhibitor Not Availables
Satumomab Pendetide C₆₂₆₈H₉₇₀₈N₁₆₆₆O₁₉₇₁S₄₈ 141478.9 138955-26-7 Anti-Allergic Agents; Histamine H1 Antagonists; ATC:S01GX06 For the temporary relief of the signs and symptoms of allergic conjunctivitis.s
Candesartan C₂₄H₂₀N₆O₃ 440.454 g/mol 139481-59-7 Dermatologic Agents; Antivirals; Antineoplastic Agents; ATC:L01XD01 Indicated in the treatment of esophageal cancer.s
Levosimendan C₁₄H₁₂N₆O 280.285 g/mol 141505-33-1 Quinolinic säure Phosphoribosyltransferase inhibitor Not Availables
Adefovir Dipivoxil C₂₀H₃₂N₅O₈P 501.471 g/mol 142340-99-6 Vasodilator Agents; Antianginals; Antihypertensive Agents; Calcium Channel Blockers; ATC:C08CA01 For the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.s
Imiglucerase C₂₅₃₂H₃₈₅₄N₆₇₂O₇₁₁S₁₆ 55597.4 143003-46-7 Quinolinate Phosphoribosyltransferase inhibitor Not Availables
Filgrastim C₈₄₅H₁₃₄₃N₂₂₃O₂₄₃S₉ 18802.8 143011-72-7 Anti-Inflammatory Agents, Non-Steroidal For the treatment of active ulcerative proctitis.s
Emtricitabin C₈H₁₀FN₃O₃S 247.248 g/mol 143491-57-0 Bronchodilator Agents; Sympathomimetic; Adrenergic beta-Agonists; ATC:R03AC12 For the treatment of asthma and chronic obstructive pulmonary disease (COPD).s
Abciximab C₆₄₆₂H₉₉₆₄N₁₆₉₀O₂₀₄₉S₄₈ 145651.1 143653-53-6 Antineoplastic Agents; Selective Estrogen Receptor Modulators; ATC:L02BA02 For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumorss
Fomivirsen C₂₀₄H₂₄₃N₆₃O₁₁₄P₂₀S₂₀Na₂₀ 7122 144245-52-3 Beta-Lactamase Shv-1 inhibitor Not Availables
Olmesartan Medoxomil C₂₉H₃₀N₆O₆ 558.585 g/mol 144689-63-4 Antiprotozoal; Antimalarials; ATC:P01BA03 For the treatment of malaria.s
Telmisartan C₃₃H₃₀N₄O₂ 514.617 g/mol 144701-48-4 Mandelate Racemase inhibitor Not Availables
Interferon beta-1a C₉₀₈H₁₄₀₈N₂₄₆O₂₅₂S₇ 20027.0 145258-61-3 Anthelmintics; Filaricides; Lipoxygenase Inhibitors; ATC:P02CB02 Used for the treatment of individual patients with certain filarial diseases including tropical pulmonary eosinophilia, loiasis, and lymphatic filariasis caused by infection with Wuchereria bancrofti, Brugia malayi, or Brugia timori.s
Capromab Not Available Not Available 145464-28-4 Anti-Ulcer Agents; Topical For treatment of chronic dermal ulcers and severe skin burnss
Cerivastatin C₂₆H₃₄FNO₅ 459.55 g/mol 145599-86-6 Coagulants; Thrombotic Agents For treatment of hemorrhagic complications in hemophilia A and Bs
Oprelvekin C₈₅₄H₁₄₁₁N₂₅₃O₂₃₅S₂ 19047.2 145941-26-0 Coagulants; Thrombotic Agents For treatment of hemophilia (Christmas diseae)s
Urofollitropin C₉₇₅H₁₅₁₃N₂₆₇O₃₀₄S₂₆ 22672.9 146479-72-3 Thrombolytic Agents; ATC:B01AD01; ATC:B06AA55 For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or embolism and occlusion of arteriovenous cannulaes
Menotropins C₁₀₁₄H₁₆₀₉N₂₈₇O₂₉₄S₂₇ 23390.3 146479-72-3 Fertility Agents For treatment of female infertilitys
Trovafloxacin C₂₀H₁₅F₃N₄O₃ 416.353 g/mol 147059-72-1 Diagnostic Agents For detection of residueal or recurrent thyroid cancers
Tenofovir C₉H₁₄N₅O₄P 287.213 g/mol 147127-20-6 Enzyme replacement; ATC:R05CB13 For treatment of cystic fibrosiss
Glatiramer acetat Ala(₅n)-Lys(₃n)-Glu(₁.₅n)-Tyr(n) 005000-9000 g/mol 147245-92-9 Hypoglycemic Agents For treatment of diabetes (type I and II)s
Bosentan C₂₇H₂₉N₅O₆S 551.615 g/mol 147536-97-8 Hypoglycemic Agents For the treatment of diabetes (type I and II)s
Pemetrexed C₂₀H₂₁N₅O₆ 427.411 g/mol 150399-23-8 Anticoagulants; Fibrinolytic Agents For prevention of deep vein thrombosis, which may result in pulmonary embolism, following knee surgery.s
Daclizumab C₆₃₃₂H₉₈₀₈N₁₆₇₈O₁₉₈₉S₄₂ 142612.1 152923-56-3 Antihypocaclemic Agents; Antiosteporotic Agents For the treatment of post-menopausal osteoporosiss
Basiliximab C₆₃₇₈H₉₈₄₄N₁₆₉₈O₁₉₉₇S₄₈ 143801.3 152923-56-3 Antihypoglycemic Agents For treatment of severe hypoglycemia, also used in gastrointestinal imagings
Lutropin alfa C₁₀₁₄H₁₆₀₉N₂₈₇O₂₉₄S₂₇ 23390.3 152923-57-4 Antineoplastic Agents; Antiviral Agents For treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemias
[[cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylic säure]] C₂₀H₂₅N₁O₄ 343.422 g/mol 153259-65-5 Antineoplastic Agents; Antiviral Agents; Immunomodulatory Agents For the treatment of hairy cell leukemia, malignant melanoma, AIDS-related Kaposi's sarcoma, refractory or recurring external condylomata acuminata in patients 18 years of age or older, laryngeal papillomatosis in children and some types of hepatitiss
Bexaroten C₂₄H₂₈O₂ 348.478 g/mol 153559-49-0 Antiinfective; Antineoplastic For the treatment of oral warts arising from HIV infections
Marimastat C₁₅H₂₉N₃O₅ 331.408 g/mol 154039-60-8 Antineoplastic Agents; ATC:L01XX02 For treatment of acute lympocytic leukemia and non-Hodgkins lymphomas
Arcitumomab C₆₃₉₈H₉₉₀₀N₁₇₁₄O₁₉₉₅S₅₄ 144482.5 154361-48-5 Rc-Rnase6 Ribonuclease inhibitor Not Availables
Efavirenz C₁₄H₉ClF₃NO₂ 315.675 g/mol 154598-52-4 Antineoplastic Agents; ATC:L02BB03 For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.s
Bimatoprost C₂₅H₃₇NO₄ 415.566 g/mol 155206-00-1 Thrombolytic Agents; ATC:B01AD04 For the treatment of pulminary embolism, coronary artery thrombosis and IV catheter clearances
Travoprost C₂₆H₃₅F₃O₆ 500.548 g/mol 157283-68-6 Serum substitutes For treatment of severe blood loss, hypervolemia, hypoproteinemias
n-acetyl-d-galactosamine 6-sulfat C₈H₁₅N₁O₉S₁ 301.268 g/mol 157296-99-6 Serum substitutes For treatment of severe blood loss, hypervolemia, hypoproteinemias
Montelukast C₃₅H₃₆ClNO₃S 586.184 g/mol 158966-92-8 Peptide Amidase inhibitor Not Availables
Enfuvirtide C₂₀₂H₂₉₈N₅₀O₆₄ 4450.8 159519-65-0 Antihypertensive Agents; Diuretics; Stimulants; ATC:C03AA For the treatment of high blood pressure and management of edema.s
Insulin Glargine recombinant C₂₆₇H₄₀₈N₇₂O₇₇S₆ 6063 160337-95-1 Anti-allergic Agents; Ethylenediamine Derivatives; Histamine H1 Antagonists; ATC:D04AA04; ATC:R06AC04 Used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold.s
Palifermin C₇₂₁H₁₁₄₂N₂₀₂O₂₀₄S₉ 16192.7 162394-19-6 Anti-bacterial Agents For the treatment of acute bacterial exacerbations of chronic bronchitiss
Ezetimibe C₂₄H₂₁F₂NO₃ 409.425 g/mol 163222-33-1 Narcotics; Antidiarrheals; Antiperistaltic; ATC:A07DA01 For as adjunctive therapy in the management of diarrheas
Dutasteride C₂₇H₃₀F₆N₂O₂ 528.53 g/mol 164656-23-9 Anti-Infectives; ATC:J01DD15 For the treatment of the respiratory, skin, soft tissue, and ENT infections caused by H. influenzae (including b-lactamase producing strains), H. parainfluenzae (including b-lactamase producing strains), S. pneumoniae (penicillin-susceptible strains), S. pyogenes, S. aureus (including b-lactamase producing strains), and M. catarrhalis.s
Becaplermin C₅₃₂H₈₉₂N₁₆₂O₁₅₃S₉ 12294.4 165101-51-9 Anti-Infectives, local; ATC:D08AA02 Topical antiseptic used mainly in wound dressings.s
Omapatrilat C₁₉H₂₄N₂O₄S₂ 408.537 g/mol 167305-00-2 Catabolic Alanine Racemase Dadx inhibitor Not Availables
Aprepitant C₂₃H₂₁F₇N₄O₃ 534.427 g/mol 170729-80-3 Human Immunodeficiency Virus Type 2 inhibitor Not Availables
Ibritumomab C₆₃₈₂H₉₈₃₀N₁₆₇₂O₁₉₇₉S₅₄ 143375.5 174722-31-7 Immunosuppressive Agents; Hypoglycemic Agents; Antiarrhythmic Agents; Sulfonylureas; ATC:A10BB12 For concomitant use with insulin for the treatment of noninsulin-dependent (Type II) diabetes mellitus; For the treatment ofs
Gemifloxacin C₁₈H₂₀FN₅O₄ 389.381 g/mol 175463-14-6 Free Radical Scavengers; Antioxidants; Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA04 For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemias
Choriogonadotropin alfa C₁₁₀₅H₁₇₇₀N₃₁₈O₃₃₆S₂₆ 25719.7 177073-44-8 Anesthetics; Antipruritics; Local Anesthetics; ATC:C05AD03; ATC:D04AB04; ATC:N01BA05; ATC:R02AD01 For general use as a lubricant and topical anesthetic on esophagus, larynx, mouth, nasal cavity, rectum, respiratory tract or trachea, urinary tract, vagina. It is also used to suppress gag reflex.s
Valdecoxib C₁₆H₁₄N₂O₃S 314.36 g/mol 181695-72-7 Radiation-Sensitizing Agents; Immunosuppressive Agents; Antivirals; Antimetabolites; Antineoplastic Agents; ATC:L01BC05 For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas.s
Colesevelam Not Available 618.248 g/mol 182815-44-7 Class B säure Phosphatase inhibitor Not Availables
Abarelix C₇₂h₉₅O₁₄N₁₄Cl 1416.06 183552-38-7 Antifungal Agents; Antimalarials; Antiprotozoal Agents; Enzyme Inhibitors; ATC:P01AX06 For the treatment or prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX). Also indicated for the acute oral treatment of mild to moderate PCP in patients who are intolerant to TMP-SMX.s
Gefitinib C₂₂H₂₄ClFN₄O₃ 446.902 g/mol 184475-35-2 Dihydroxyacetone Kinase inhibitor Not Availables
Eptifibatide C₃₅H₄₉N₁₁O₉S₂ 831.96 188627-80-7 Antiviral Agents; Immunomodulatory Agents For treatment of relapsing/remitting multiple sclerosiss
Tegaserod C₁₆H₂₃N₅O 301.387 g/mol 189188-57-6 Hypoglycemic Agents; Sulfonylureas; ATC:A10BB31 Used in the management of diabetes mellitus type 2 (adult-onset).s
epothilone d C₂₇H₄₁N₁O₅S₁ 491.685 g/mol 189453-10-9 Antineoplastic Agents, Hormonal For palliative treatment of advanced breast cancer in postmenopausal women.s
Telithromycin C₄₃H₆₅N₅O₁₀ 812.004 g/mol 191114-48-4 Anti-Obesity Agents; Enzyme Inhibitors; ATC:A08AB01 For obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. Also used to reduce the risk for weight regain after prior weight loss.s
Tositumomab C₆₄₁₆H₉₈₇₄N₁₆₈₈O₁₉₈₇S₄₄ 143859.7 192391-48-3 Neuromuscular Blocking Agents; ATC:M03AC11 For inpatients and outpatients as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation in the ICU.s
Peginterferon alfa-2a C₈₆₀H₁₃₅₃N₂₂₇O₂₅₅S₉ 19241.1 198153-51-4 Anti-Obesity Agents; Neuroprotective Agents; Anticonvulsants; ATC:N03AX11 Used for the treatment and control of partial seizures and severe tonic-clonic (grand mal) seizures and also for the prevention of migraine headaches. In children it is also used for treatment of Lennox-Gastaut syndrome.s
Oseltamivir phosphat C₁₆H₂₈N₂O₄ (free base) 312.405 g/mol (free base) 204255-11-8 Protein Arginine N-Methyltransferase 1 inhibitor Not Availables
Cetuximab C₆₄₈₄H₁₀₀₄₂N₁₇₃₂O₂₀₂₃S₃₆ 145781.6 205923-56-4 Agglutinin Isolectin 3 inhibitor Not Availables
Pegfilgrastim C₈₄₅H₁₃₄₃N₂₂₃O₂₄₃S₉ 18802.8 208265-92-3 Bone Marrow Stromal Cell Antigen 1 inhibitor Not Availables
Efalizumab Not Available Not Available 214745-43-3 Antitubercular Agents; ATC:J04AK01 For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.s
Gemtuzumab ozogamicin Not Available Not Available 220578-59-6 Anti-Infective Agents, Urinary; Antitubercular Agents; Photosensitizing Agents; ATC:J01MA07; ATC:S01AX17 For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: S.pneumoniae, H.influenzae, S.aureus, P.aeruginosa, E. cloacae, P. mirabilis, C. civersus, S. asprphyticus, E.coli, and K.pneumoniae.s
Alefacept C₂₃₀₆H₃₅₉₄N₆₁₀O₆₉₄S₂₆ 51801.1 222535-22-0 Anti-baldness Agents; Antihyperplasia Agents; Skin and Mucous Membrane Agents (84:92.00); ATC:D11AX10; ATC:G04CB01 For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostat.s
Cinacalcet C₂₂H₂₂F₃N 357.412 g/mol 226256-56-0 Antineoplastic Agents; Antiviral Agents; Immunomodulatory Agents For treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcomas
Micafungin C₅₆H₇₁N₉O₂₃S 1270.28 g/mol 235114-32-6 Antidepressants; ATC:N06AX18 For the treatment of clinical depression.s
Omalizumab C₆₄₅₀H₉₉₁₆N₁₇₁₄O₂₀₂₃S₃₈ 145058.2 242138-07-4 Acriflavine Resistance Protein B inhibitor Not Availables
Solifenacin succinate C₂₇H₃₂N₂O₆ 480.553 g/mol 242478-38-2 Anesthetics, Local; ATC:D04AB03; ATC:S01HA02 Used to temporarily numb the front surface of the eye so that the eye pressure can be measured or a foreign body removed.s
Adalimumab C₆₄₂₈H₉₉₁₂N₁₆₉₄O₁₉₈₇S₄₆ 144190.3 331731-18-1 Antimanic Agents; GABA Agents; Enzyme Inhibitors; Anticonvulsants; ATC:N03AG01 For use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures.s
Icodextrin Not Available 13,000-19,000 g/mol 337376-15-5 Antiprotozoals; Anti-bacterial Agents; ATC:J01AA04 For the treatment of bacterial infection including: Brucellosis; Mycoplasma infection; Trachoma; Chronic bronchitis; Acne vulgaris; Chlamydial infections
Hyaluronidase C₂₄₅₅H₃₇₇₅N₆₁₇O₇₀₄S₂₁ 53870.9 488712-31-8 Antifungal Agents; ATC:D01AC14 For the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.s
Galsulfase C₂₅₂₉H₃₈₄₃N₆₈₉O₇₁₆S₁₆ 55868.4 g/mol 552858-79-4 Anti-anxiety Agents; Antipsychotics; Antipruritics; Antiemetics; Serotonin Antagonists; ATC:A04AA01 For treatment of chemotherapy-induced nausea and vomitings

[edytuj] unknown

adamantane-1-carboxylic säure-5-dimethylamino-naphthalene-1-sulfonylamino-butyl-amide C₂₇H₃₈N₃O₃S₁ 484.675 g/mol NotAvailable Catechol-O-Methyltransferase inhibitor Not Availables
d-2-keto-3-deoxygalactonate C₆H₁₂O₆ 180.157 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
d-2-keto-3-deoxygluconate C₆H₁₂O₆ 180.157 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
d-allopyranose C₆H₁₂O₆ 180.157 g/mol NotAvailable Deoxycytidylate Deaminase inhibitor Not Availables
000003-[[(4-amino-2-tert-butyl-5-methyl-phenylsulfanyl)-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxy-phenyl)-ethyl]-5,6-dihydro-pyran-2-on]] C₂₉H₃₇N₁O₄S₁ 495.676 g/mol NotAvailable Micronutrient; Dietary supplement For nutritional supplementation, also for treating dietary shortage or imbalances
d-eritadenin C₉H₁₁N₅O₄ 253.217 g/mol NotAvailable 000004-Hydroxyphenylpyruvate Dioxygenase inhibitor Not Availables
000009-n-phenylmethylamino-tacrin C₂₀H₂₀N₂ 288.391 g/mol NotAvailable Azurin inhibitor Not Availables
000004-(4-hydroxy-3-isopropylphenylthio)-2-isopropylphenol C₁₈H₂₂O₂S₁ 302.431 g/mol NotAvailable S-Adenosylhomocysteine Hydrolase inhibitor Not Availables
000009-methylguanin C₆H₇N₅O₁ 165.154 g/mol NotAvailable Glycinamide Ribonucleotide Transformylase inhibitor Not Availables
(3,4-dihydroxy-phenyl)-triphenyl-arsonium C₂₄H₂₀O₂As₁₁+ 1164.558 g/mol NotAvailable Interleukin-2 inhibitor Not Availables
a-98881 C₃₄H₃₇N₃O₆ 583.683 g/mol NotAvailable In process Not Availables
cytidine-3'-monophosphat C₉H₁₄N₃O₈P₁ 323.199 g/mol NotAvailable Apocarotenoid-Cleaving Oxygenase inhibitor Not Availables
000003-trimethylsilylsuccinic säure C₇H₁₄O₄Si₁ 190.271 g/mol NotAvailable Thiostrepton inhibitor Not Availables
abt-378, lopinavir C₃₇H₄₈N₄O₅ 628.810 g/mol NotAvailable Inositol 1,3,4-Trisphosphate 5/6-Kinase inhibitor Not Availables
allosamizolin C₉H₁₆N₂O₄ 216.236 g/mol NotAvailable Inositol 1,3,4-Trisphosphate 5/6-Kinase inhibitor Not Availables
cysteinesulfonic säure C₃H₇N₁O₅S₁ 169.152 g/mol NotAvailable Uridine Phosphorylase Putative inhibitor Not Availables
cysteine-s-sulfonic säure C₃H₇N₁O₅S₂ 201.212 g/mol NotAvailable 5'-Deoxy-5'-Methylthioadenosine Phosphorylas inhibitor Not Availables
d-(l-a-aminoadipoyl)-l-cysteinyl-d-isodehydrovalin C₁₄H₂₃N₃O₆S₁ 361.412 g/mol NotAvailable Hypoxanthine-Guanine Phosphoribosyltransfera inhibitor Not Availables
cytosine arabinose-5'-phosphat C₉H₁₄N₃O₈P₁ 323.199 g/mol NotAvailable Orf3 inhibitor Not Availables
naphthalene trisulfonate C₁₀H₅O₉S₃₃- 1327.124 g/mol NotAvailable Thermolysin inhibitor Not Availables
[[d-[(amino)carbonyl]phenylalanin]] C₁₀H₁₂N₂O₃ 208.216 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
cytidine-5'-monophosphate-5-n-acetylneuraminic säure C₂₀H₃₁N₄O₁₆P₁ 614.456 g/mol NotAvailable Urocanate Hydratase inhibitor Not Availables
cytidine-5'-diphospho-beta-d-xylose C₁₄H₂₃N₃O₁₅P₂ 535.294 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
a disubstituted succinyl caprolactam hydroxymate mmp3inhibitor C₂₀H₃₇N₃O₆ 415.529 g/mol NotAvailable Pol Protein inhibitor Not Availables
tetraethylene glycol C₈H₁₈O₅ 194.227 g/mol NotAvailable Beta-N-Acetylhexosaminidase inhibitor Not Availables
[[hydroxy-phenyl-acetic säure 8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester]] C₁₆H₂₁N₁O₃ 275.347 g/mol NotAvailable Prfa inhibitor Not Availables
d(-)-tartaric säure C₄H₆O₆ 150.088 g/mol NotAvailable Sugar Transport Protein inhibitor Not Availables
d-xylitol C₅H₁₂O₅ 152.147 g/mol NotAvailable Green-Fluorescent Protein inhibitor Not Availables
tetra(imidazole)diaquacopper (ii) C₁₂H₂₀N₈O₂Cu₁₂+ 3176.701 g/mol NotAvailable Formylmethionine Deformylase inhibitor Not Availables
dalfopristin C₃₄H₅₀N₄O₉S₁ 690.850 g/mol NotAvailable Alpha-Tocopherol Transfer Protein inhibitor Not Availables
para-mercury-benzenesulfonic säure C₆H₅O₃Hg₁S₁ 357.754 g/mol NotAvailable Feglymycin inhibitor Not Availables
d-para-chlorophenyl-1-acteamidoboronic säure alanin C₁₃H₁₉N₂O₆B₁Cl₁₁- 700.096 g/mol NotAvailable Feglymycin inhibitor Not Availables
ethylaminobenzylmethylcarbonyl group C₁₁H₁₄N₁O₁ 176.238 g/mol NotAvailable Androgen Receptor inhibitor Not Availables
d-treitol C₄H₁₀O₄ 122.121 g/mol NotAvailable Thiostrepton inhibitor Not Availables
d-pyridoxyl-n,o-cycloserylamide-5-monophosphat C₁₁H₁₆N₃O₇P₁ 333.237 g/mol NotAvailable Methionine Aminopeptidase 2 inhibitor Not Availables
000001-(3-mercapto-2-methyl-propionyl)-pyrrolidine-2-carboxylic säure C₉H₁₅N₁O₃S₁ 217.282 g/mol NotAvailable Peptidic Toxin Nodularin inhibitor Not Availables
tert-butyloxycarbonyl group C₅H₉O₂ 101.125 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
decaethylene glycol C₂₀H₄₂O₁₁ 458.545 g/mol NotAvailable Leucoanthocyanidin Dioxygenase inhibitor Not Availables
(2s,3s)-trans-dihydroquercetin C₁₅H₁₂O₇ 304.256 g/mol NotAvailable Trypsinogen inhibitor Not Availables
dazoxiben C₁₂H₁₂N₂O₃ 232.235 g/mol NotAvailable 000006-Oxocamphor Hydrolase inhibitor Not Availables
tetra(imidazole)diaquacopper (i) C₁₂H₂₀N₈O₂Cu₁₁+ 2938.672 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
000009-hydroxypropyladenine, r-isomer C₈H₁₁N₅O₁ 193.208 g/mol NotAvailable Cara inhibitor Not Availables
000002-(acetylamino)-2-deoxy-4-o-beta-d-galactopyranosyl-alpha-d-glucopyranose C₁₄H₂₅N₁O₁₁ 383.352 g/mol NotAvailable Hepatitis C Virus Ns5B RNA-Dependent RNA Pol inhibitor Not Availables
d-naphthyl-1-acetamido boronic säure alanin C₁₇H₂₂N₂O₆B₁₁- 469.281 g/mol NotAvailable Hepatitis C Virus Ns5B RNA-Dependent RNA Pol inhibitor Not Availables
d-gluconhydroximo-1,5-lactam C₆H₁₂N₂O₅ 192.171 g/mol NotAvailable Methionyl Aminopeptidase inhibitor Not Availables
000002-deoxy-2-fluoro-beta-d-mannose C₆H₁₁O₅F₁ 182.148 g/mol NotAvailable Epilancin 15X inhibitor Not Availables
tetrabutylammonium ion C₁₆H₃₆N₁₁+ 382.534 g/mol NotAvailable Sst1-Selective Somatosatin Analog inhibitor Not Availables
5,10,15,20-tetrakis(4-sulpfonatophenyl)-21h,23h-porphin C₄₄H₃₄N₄O₁₂S₄ 939.012 g/mol NotAvailable Sst1-Selective Somatosatin Analog inhibitor Not Availables
d-galactohydroximo-1,5-lactam C₆H₁₂N₂O₅ 192.171 g/mol NotAvailable Feglymycin inhibitor Not Availables
rapamycin immunosuppressant drug C₅₁H₇₉N₁O₁₃ 914.184 g/mol NotAvailable Beta-Glucosidase inhibitor Not Availables
d-galctopyranosyl-1-on C₆H₁₀O₆ Not Available NotAvailable Dipeptidyl Peptidase IV inhibitor Not Availables
d-galactose-4-sulfat group C₆H₁₁O₉S₁ 259.207 g/mol NotAvailable Hcv Ns5B Polymerase inhibitor Not Availables
uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester C₁₅H₂₃N₂O₁₆F₁P₂ 568.296 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
d-myo-inositol-1-phosphat C₆H₁₁O₉P₁₂- 598.833 g/mol NotAvailable Oxysterols Receptor Lxr-Beta inhibitor Not Availables
d-myo-inositol-hexasulphate C₆H₁₂O₂₄S₆ 660.506 g/mol NotAvailable Prostaglandin H2 Synthase-1 inhibitor Not Availables
d-myo-inositol-2,4,5-trisphosphat C₆H₁₅O₁₅P₃ 420.097 g/mol NotAvailable Glyceraldehyde 3-Phosphate Dehydrogenase, Gl inhibitor Not Availables
d-mannose 1-phosphat C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable Integrase inhibitor Not Availables
d-glycero-d-mannopyranose-7-phosphat C₇H₁₅O₁₀P₁ 290.163 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
zk-805623 C₂₀H₁₈N₅O₂F₂₁+ 759.361 g/mol NotAvailable Proto-Oncogene Serine/Threonine-Protein Kina inhibitor Not Availables
d-limonene 1,2-epoxide C₁₀H₁₆O₁ 152.236 g/mol NotAvailable Glycogen Synthase Kinase-3 Beta inhibitor Not Availables
000009-hydroxypropyladenine, s-isomer C₈H₁₁N₅O₁ 193.208 g/mol NotAvailable Putative Cellulase Cel6 inhibitor Not Availables
[[thieno[2,3-b]pyridine-2-carboxamidin]] C₈H₈N₃S₁₁+ 498.831 g/mol NotAvailable 000003-Hydroxy-3-Methylglutaryl-Coenzyme A Reduct inhibitor Not Availables
2'-monophosphoadenosine 5'-diphosphoribose C₂₁H₂₈N₇O₁₇P₃ 743.410 g/mol NotAvailable Peptidyl-Prolyl Cis-Trans Isomerase A inhibitor Not Availables
epigallocatechin C₁₅H₁₄O₇ 306.271 g/mol NotAvailable Pyrogenic Exotoxin B inhibitor Not Availables
cra_10762 C₂₀H₁₅N₄O₁Cl₁ 362.818 g/mol NotAvailable Daptomycin inhibitor Not Availables
cra_10656 C₁₈H₂₀N₄O₂ 324.382 g/mol NotAvailable Fkbp12 inhibitor Not Availables
clorocruoro hem C₃₃H₃₀N₄O₅Fe₁ 618.471 g/mol NotAvailable Fkbp12 inhibitor Not Availables
aconitate ion C₆H₃O₆₃- 1083.052 g/mol NotAvailable Peptidyl-Prolyl Cis-Trans Isomerase A inhibitor Not Availables
monothioglycerol C₃H₈O₂S₁ 108.155 g/mol NotAvailable Chitinase B inhibitor Not Availables
[[4,6-dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-d-lyxo-hexopyranosyl-(1->4)-alpha-d-threo-hexopyranosyl-(1->6)-alpha-l-threo-hexopyranose]] C₂₅H₄₃N₁O₁₈ 645.611 g/mol NotAvailable Chitinase B inhibitor Not Availables
z-ala prolinal C₁₆H₂₀N₂O₅ 320.344 g/mol NotAvailable Thiostrepton inhibitor Not Availables
thiarsahydroxy-cystein C₃H₇N₁O₃As₁S₁ 212.075 g/mol NotAvailable Methionyl Aminopeptidase inhibitor Not Availables
acetylgalactosamine-4-sulfat C₈H₁₅N₁O₉S₁ 301.268 g/mol NotAvailable Phospholipase C inhibitor Not Availables
000002-[[[3-({methyl[1-(2-naphthoyl)piperidin-4-yl]amino}carbonyl)-2-naphthyl]-1-(1-naphthyl)-2-oxoethylphosphonic säure]] C₄₀H₃₅N₂O₆P₁ 670.700 g/mol NotAvailable Pol Polyprotein inhibitor Not Availables
000003-[[(4-fluorophenyl)-2-(6-methylpyridin-2-yl)-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol]] C₁₈H₁₆N₃F₁ 293.343 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Lck inhibitor Not Availables
cra_17693 C₂₄H₁₇N₄O₅F₁₂- 669.403 g/mol NotAvailable Ramoplanin inhibitor Not Availables
000002-[[hydroxy-5-({1-[(4-methylphenoxy)methyl]-3-oxoprop-1-enyl}amino)-l-tyrosin]] C₂₀H₂₁N₂O₆ 385.396 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
000004-[[amino-n-{4-[2-(2,6-dimethyl-phenoxy)-acetylamino]-3-hydroxy-1-isobutyl-5-phenyl-pentyl}-benzamide]] C₃₂H₄₁N₃O₄ 531.694 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
(s)-rolipram C₁₆H₂₁N₁O₃ 275.347 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
cra_1144 C₁₄H₁₂N₄O₁ 252.275 g/mol NotAvailable 000004-Aminobutyrate Aminotransferase inhibitor Not Availables
cra_11092 C₂₁H₂₃N₄O₂F₁ 382.437 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
[[2,6-diamino-(s)-9-[2-(phosphonomethoxy)propyl]purin]] C₉H₁₃N₆O₄P₁₂- 640.925 g/mol NotAvailable Xylose Isomerase inhibitor Not Availables
thiocoumarin C₁₄H₁₇N₁O₂S₁ 263.354 g/mol NotAvailable Trichodiene Synthase inhibitor Not Availables
d-2-amino-3-phosphono-propionic säure C₃H₈N₁O₅P₁ 169.074 g/mol NotAvailable In process Not Availables
adamantane-1-carboxylic säure-5-dimethylamino-naphthalene-1-sulfonylamino-octyl-amide C₃₁H₄₅N₃O₃S₁ 539.775 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
[[compound 6; n-(allyloxycarbonyl)-4-[n-(carboxy-formyl)-2-(benzoic säure)-amino]-l-phenylalaninyl-amino-butyloxy-(6-hydroxy-benzoic säure methyl ester)]] C₃₄H₃₅N₃O₁₂ 677.663 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
compound 19 C₂₇H₂₉N₁O₄S₁ 463.590 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
aspartic säure-4-carboxymethyl ester C₆H₉N₁O₆ 191.140 g/mol NotAvailable Thiostrepton inhibitor Not Availables
compound 5, 2-(naphthalen-1-yl-oxalyl-amino)-benzoicsäure C₁₉H₁₃N₁O₅ 335.315 g/mol NotAvailable Aspartate-Semialdehyde Dehydrogenase inhibitor Not Availables
adamantanon C₁₀H₁₄O₁ 150.220 g/mol NotAvailable Ubiquitin inhibitor Not Availables
alpha-aminobutyric säure C₄H₉N₁O₂ 103.121 g/mol NotAvailable Trichodiene Synthase inhibitor Not Availables
cp-526423; 1,2-bis(2-(5-chloroindole-2-carbonylamino)ethoxy)ethan C₂₄H₂₄N₄O₄Cl₂ 503.384 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
cp-271485; (6r)-4-benzyl-6-(1-methyl-2,2-dioxido-1,3-dihydro-2,1-benzisothiazol-5-yl)morpholin-3-on C₁₉H₂₀N₂O₄S₁ 372.438 g/mol NotAvailable 5'-D inhibitor Not Availables
thio-maltopentaose C₃₀H₅₂O₂₃S₃ 876.907 g/mol NotAvailable Casein Kinase II, Alpha Chain inhibitor Not Availables
[[thiobutyric säure s-{2-[3-(2-hydroxy-3,3-dimethyl-4-phosphonooxy-butyrylamino)-propionylamino]-ethyl} ]] Not Available Not Available NotAvailable Beta-Galactosidase inhibitor Not Availables
cp-166572, 2-hydroxymethyl-4-(4-n,n-dimethylaminosulfonyl-1-piperazino)-pyrimidin C₁₁H₁₉N₅O₃S₁ 301.363 g/mol NotAvailable Folc Bifunctional Protein inhibitor Not Availables
coproporphyrin iii C₃₆H₄₄N₄O₈ 660.766 g/mol NotAvailable Cgmp-Inhibited 3',5'-Cyclic Phosphodiesteras inhibitor Not Availables
coproporphyrin i containing co(iii) C₃₆H₃₆N₄O₈Co₁ 680.713 g/mol NotAvailable Dihydropyrimidine Dehydrogenase inhibitor Not Availables
thiocamphor C₁₀H₁₆S₁ 168.296 g/mol NotAvailable Cyan Fluorescent Protein Cfp inhibitor Not Availables
cyclohexyl-hexyl-beta-d-maltoside C₂₄H₄₄O₁₁ 508.605 g/mol NotAvailable Scytalone Dehydratase inhibitor Not Availables
tetrahydrooxazin C₅H₁₁N₁O₄ 149.146 g/mol NotAvailable Class C Beta-Lactamase inhibitor Not Availables
cyclohexane propionic säure C₉H₁₆O₂ 156.224 g/mol NotAvailable Retinol Dehydratase inhibitor Not Availables
zebularin C₉H₁₃N₂O₇P₁ 292.185 g/mol NotAvailable Phenylalanine-4-Hydroxylase inhibitor Not Availables
[[cyclohexyl-{4-[5-(3,4-dichlorophenyl)-2-piperidin-4-yl-3-propyl-3h-imidazol-4-yl]-pyrimidin-2-yl}amin]] C₂₇H₃₄N₆Cl₂ 513.512 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
[[[2-(methyleneamine)-4-(4-hydroxy-benzylidine) -5-oxo-4,5-dihydro-imidazol-1-yl]-acetaldehyde]] C₁₃H₁₃N₃O₃ 259.264 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
cyclic amp; camp C₁₀H₁₂N₅O₆P₁ 329.208 g/mol NotAvailable Cell Division Protein Zipa inhibitor Not Availables
acetic säure salicyloyl-amino-ester C₉H₉N₁O₄ 195.174 g/mol NotAvailable Chitinase B inhibitor Not Availables
cyclo-hepta-amylose C₄₂H₇₀O₃₅ 1134.994 g/mol NotAvailable Mu Class Tetradeca- inhibitor Not Availables
cyclic guanosine monophosphat C₁₀H₁₂N₅O₇P₁ 345.208 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
cysteine-methylene-carbamoyl-1,10-phenanthrolin C₁₇H₁₆N₄O₃S₁ 356.398 g/mol NotAvailable Alanine--Glyoxylate Aminotransferase inhibitor Not Availables
n-alpha-acetyl-3,5-diiodotyrosylglycin C₁₃H₁₄N₂O₅I₂ 532.073 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
tetrahydrodeoxyuridin C₉H₁₄N₂O₅ 230.220 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
cysteine sulfenic säure C₃H₇N₁O₃S₁ 137.153 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
cystein-s-yl cacodylate C₅H₁₂N₁O₃As₁S₁ 241.136 g/mol NotAvailable Arginine Kinase inhibitor Not Availables
cyclotheonamide a C₃₆H₄₅N₉O₈ 731.807 g/mol NotAvailable S-Adenosylmethionine Synthetase inhibitor Not Availables
cyclohexylformamide C₇H₁₃N₁O₁ 127.186 g/mol NotAvailable Methionine Aminopeptidase 2 inhibitor Not Availables
000002-deoxy-2-aminogalactose C₆H₁₃N₁O₅ 179.172 g/mol NotAvailable Hypothetical Protein Ydce inhibitor Not Availables
[[cyclopropyl-{4-[5-(3,4-dichlorophenyl)-2-[(1-methyl)-piperidin]-4-yl-3-propyl-3h-imidazol-4-yl]-pyrimidin-2-yl}amin]] C₂₅H₃₀N₆Cl₂ 485.458 g/mol NotAvailable Porin inhibitor Not Availables
tetrahydrofuran-2-carboxylic säure C₅H₈O₃ 116.116 g/mol NotAvailable Sulfite Oxidase inhibitor Not Availables
000001-3 sugar ring of pentamannosyl 6-phosphat C₁₈H₃₃O₁₉P₁ 584.421 g/mol NotAvailable Nitrous-Oxide Reductase inhibitor Not Availables
ly374571 C₁₇H₁₉N₇O₇ 433.380 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
cra_9334 C₁₅H₁₃N₄O₁Br₁ 345.198 g/mol NotAvailable Halohydrin Dehalogenase inhibitor Not Availables
ethyl-carbamic säure methyl ester C₄H₉N₁O₂ 103.121 g/mol NotAvailable Probable 2-Phosphosulfolactate Phosphata inhibitor Not Availables
carboxyethyllumazin C₁₄H₁₈N₄O₉ 386.318 g/mol NotAvailable Alanine Racemase inhibitor Not Availables
filaminast C₁₅H₂₀N₂O₄ 292.334 g/mol NotAvailable Mandelate Racemase inhibitor Not Availables
z-dehydrobutyrin C₄H₇N₁O₂ 101.105 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodieste inhibitor Not Availables
thiarsa dihydroxy cystein C₃H₈N₁O₄As₁S₁ 229.082 g/mol NotAvailable Alcohol Dehydrogenase E Chain inhibitor Not Availables
cra_7806 C₂₀H₁₆N₄O₁ 328.373 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000001-[[benzyloxycarbonylamino-2-phenyl-ethyl)-{2-[1-carbamoyl-2-(1h-indol-3-yl)-ethylcarbamoyl]-5-phenyl-pentyl}-phosphinic säure]] C₃₉H₄₃N₄O₆P₁ 694.766 g/mol NotAvailable Interleukin-2 inhibitor Not Availables
cu-cyclam C₁₀H₂₄N₄Cu₁₄+ 3544.743 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodieste inhibitor Not Availables
tetramethylammonium ion C₄H₁₂N₁₁+ 214.213 g/mol NotAvailable Peptide Deformylase inhibitor Not Availables
acetate ion C₂H₃O₂₁- 363.033 g/mol NotAvailable General Control Protein Gcn4 inhibitor Not Availables
000002-hydroxymethyl-pyrrolidine-3,4-diol C₅H₁₁N₁O₃ 133.147 g/mol NotAvailable Udp-N-Acetylglucosamine 1- Carboxyvinylt inhibitor Not Availables
tyrosyladenylate C₁₉H₂₃N₇O₈S₁ 509.493 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
tetrazolyl histidin C₇H₉N₇O₁ 207.194 g/mol NotAvailable Sigf1-Gfp Fusion Protein inhibitor Not Availables
000004-[[[5-pyridin-4-yl-1h-[1,2,4]triazol-3-yl]-pyridine-2-carbonitrile]] C₁₃H₈N₆ 248.246 g/mol NotAvailable Sigf1-Gfp Fusion Protein inhibitor Not Availables
crotonaldehyde C₄H₆O₁ 70.091 g/mol NotAvailable S-Ribosylhomocysteinase inhibitor Not Availables
[[acetic säure n-[2-chloro-5-[6-ethyl-2,4-diamino-pyrimid-5-yl]-phenyl]-[benzyl-triazen-3-yl]ethyl ]] Not Available Not Available NotAvailable Mandelate Racemase inhibitor Not Availables
sri-9662 C₁₈H₁₉N₅O₂ 337.380 g/mol NotAvailable Peroxisome Proliferator Activated Receptor G inhibitor Not Availables
etheno-nad C₁₇H₂₃N₅O₁₄P₂ 583.341 g/mol NotAvailable Isopentenyl-Diphosphate Delta-Isomerase inhibitor Not Availables
ethyl dihydrogen phosphat C₂H₇O₄P₁ 126.049 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
ethyl dihydrogen diphosphat C₂H₇O₇P₂ 205.021 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
ethanesulfonic säure C₂H₆O₃S₁ 110.128 g/mol NotAvailable Myosin II Heavy Chain inhibitor Not Availables
equilin C₁₈H₂₀O₂ 268.355 g/mol NotAvailable Glutamate Receptor Subunit 2 inhibitor Not Availables
equilenin C₁₈H₁₈O₂ 266.339 g/mol NotAvailable 000003-Hydroxy-3-Methylglutaryl Coa Synthase inhibitor Not Availables
erythose-4-phosphat C₄H₉O₇P₁ 200.085 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
o-sialic säure C₁₁H₁₉N₁O₉ 309.272 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodieste inhibitor Not Availables
ethylisothiourea C₃H₈N₂S₁ 104.170 g/mol NotAvailable Wiskott-Aldrich Syndrome Protein inhibitor Not Availables
[[n-methyl-n-[3-(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)phenyl]acetamide]] C₂₀H₁₇N₅O₁ 343.387 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
factor iiim C₆₁H₈₆N₁₃O₁₅Co₁P₁ 1300.413 g/mol NotAvailable Elastase inhibitor Not Availables
f-loop of vitamin b12 C₃H₁₀N₁O₁₁+ 236.112 g/mol NotAvailable Phosphatidylinositol Transfer Protein Alpha inhibitor Not Availables
xylose-derived lactam oxime C₅H₁₀N₂O₄ 162.145 g/mol NotAvailable Trypsin, Cationic inhibitor Not Availables
5,4'-dideoxyflavanon C₁₅H₁₂O₃ 240.258 g/mol NotAvailable Amine Oxidase [Flavin-Containing] B inhibitor Not Availables
ethyl dimethyl ammonio propane sulfonate C₇N₁O₃S₁ 178.142 g/mol NotAvailable Beta-Lactamase Ctx-M-9 inhibitor Not Availables
sr12813 C₂₄H₄₂O₇P₂ 504.539 g/mol NotAvailable Leucyl-tRNA Synthetase inhibitor Not Availables
ethyl oxo(piperidin-1-yl)acetat C₉H₁₅N₁O₃ 185.222 g/mol NotAvailable ADP-Ribose Pyrophosphatase inhibitor Not Availables
su9516 C₁₃H₁₁N₃O₂ 241.249 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
duroquinon C₁₀H₁₂O₂ 164.204 g/mol NotAvailable Protein-Tyrosine Phosphatase inhibitor Not Availables
000009-deazaguanin C₆H₆N₄O₁ 150.140 g/mol NotAvailable Tem-1 Beta Lactamase inhibitor Not Availables
elaidoylamide C₁₈H₃₅N₁O₁ 281.481 g/mol NotAvailable 000001-Deoxy-D-Xylulose 5-Phosphate Reductoisomer inhibitor Not Availables
dump C₉H₁₃N₂O₈P₁ 308.184 g/mol NotAvailable Cruzipain inhibitor Not Availables
domoic säure C₁₅H₂₁N₁O₆ 311.334 g/mol NotAvailable Cruzipain inhibitor Not Availables
diethylcarbamodithioic säure C₅H₁₁N₁S₂ 149.269 g/mol NotAvailable Cruzipain inhibitor Not Availables
dpb-t C₁₇H₁₉N₂O₈P₁ 410.319 g/mol NotAvailable Cathepsin K inhibitor Not Availables
double oxidized cystein C₃H₇N₁O₄S₁ 153.153 g/mol NotAvailable Green Fluorescent Protein inhibitor Not Availables
000009-butyl-8-(4-methoxybenzyl)-9h-purin-6-amin C₁₇H₂₁N₅O₁ 311.386 g/mol NotAvailable Avermectin-Sensitive Chloride Channel Gl inhibitor Not Availables
epothilone b C₂₇H₄₁N₁O₆S₁ 507.684 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
cra_10433 C₂₀H₂₁N₃O₂ 335.405 g/mol NotAvailable Green Fluorescent Protein inhibitor Not Availables
sti-571 C₂₉H₃₁N₇O₁ 493.610 g/mol NotAvailable Ctp: Phosphocholine Cytidylytransferase inhibitor Not Availables
s,s'-(1,4-phenylene-bis(1,2-ethanediyl))bis-isothiourea C₁₂H₁₈N₄S₂ 282.421 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
000003-(4-phenylamino-phenylamino)-2-(1h-tetrazol-5-yl)-acrylonitrile C₁₆H₁₃N₇ 303.326 g/mol NotAvailable Triosephosphate Isomerase inhibitor Not Availables
eniluracil C₆H₄N₂O₂ 136.108 g/mol NotAvailable Neprilysin inhibitor Not Availables
000005-[[chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4(1h,3h)-dion]] C₉H₉N₄O₂Cl₁ 240.649 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
zn(ii)-(20-oxo-protoporphyrin ix) C₃₄H₃₂N₄O₅Zn₁ 642.031 g/mol NotAvailable Trypsin inhibitor Not Availables
2,4(1h,3h)-pyrimidinedione, [[1-[2-deoxy-5-o-[hydroxy(phosphonoamino)phosphinyl]-beta-d-erythro-pentofuranosyl]-]] C₉H₁₅N₃O₁₀P₂ 387.179 g/mol NotAvailable Cholera Toxin B Protein inhibitor Not Availables
formycin C₁₀H₁₃N₅O₄ 267.244 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
sp4160 C₃₃H₄₂N₈O₄Cl₂ 685.652 g/mol NotAvailable ADP, ATP Carrier Protein Heart Isoform T1 inhibitor Not Availables
formycin-5'-monophosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol NotAvailable Thyroid Hormone Receptor Beta-1 inhibitor Not Availables
(s)-2-hydroxy-2-phenylpropionic säure;(s)-alpha-methylmandelic säure C₉H₁₀O₃ 166.176 g/mol NotAvailable Trypsin inhibitor Not Availables
fluoro-willardiin C₇H₈N₃O₄F₁ 217.156 g/mol NotAvailable Trypsin inhibitor Not Availables
sparsomycin C₁₃H₁₉N₃O₅S₂ 361.430 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
flurbiprofen methyl ester C₁₆H₁₅O₂F₁ 258.292 g/mol NotAvailable Thyroid Hormone Receptor Beta-1 inhibitor Not Availables
hg9a-9, nonanoyl-n-hydroxyethylglucamide C₁₇H₃₅N₁O₇ 365.466 g/mol NotAvailable Green Fluorescent Protein inhibitor Not Availables
fr236913 C₂₄H₂₆N₆O₃ 446.508 g/mol NotAvailable Trypsin inhibitor Not Availables
al4623 C₁₁H₁₉N₃O₅S₃ 369.468 g/mol NotAvailable Myristoyl-Coa: Protein N-Myristoyltransferas inhibitor Not Availables
4'-deoxy-4'-acetylyamino-pyridoxal-5'-phosphat C₁₀H₁₅N₂O₈P₁ 322.211 g/mol NotAvailable Putative Betaine Aldehyde Dehydrogenase inhibitor Not Availables
sp2456 C₂₅H₃₃N₇O₂Cl₂ 534.487 g/mol NotAvailable Sarcosine Oxidase inhibitor Not Availables
fr230513 C₁₈H₁₉N₃O₂ 309.367 g/mol NotAvailable Sarcosine Oxidase inhibitor Not Availables
fotemustin C₉H₁₉ClN₃O₅P 315.691 g/mol NotAvailable Sarcosine Oxide inhibitor Not Availables
fosmidomycin C₄H₁₀N₁O₅P₁ 183.100 g/mol NotAvailable 000002-Amino-4-Hydroxy-6- Hydroxymethyldihydropte inhibitor Not Availables
geranyl diphosphat C₁₀H₂₀O₇P₂ 314.211 g/mol NotAvailable Proteinase inhibitor Not Availables
000002-ammoniobut-3-enoate, 2-amino-3-butenoate C₄H₇N₁O₂ 101.105 g/mol NotAvailable Iron-Utilization Periplasmic Protein inhibitor Not Availables
fidarestat C₁₂H₁₀N₃O₄F₁ 279.227 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
cra_23653 C₂₂H₂₂N₅O₁ 372.449 g/mol NotAvailable Inosine-5'-Monophosphate Dehydrogenase 2 inhibitor Not Availables
fidarestat(stereoisomer) C₁₂H₁₀N₃O₄F₁ 279.227 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
000009-deazainosin C₁₁H₁₃N₃O₅ 267.241 g/mol NotAvailable Alanine Racemase inhibitor Not Availables
000009-amino-2-deoxy-2,3-dehydro-n-acetyl-neuraminic säure C₁₁H₁₈N₂O₇ 290.272 g/mol NotAvailable L-Threonine-O-3-Phosphate Decarboxylase inhibitor Not Availables
ferricrocin-iron C₂₈H₄₄N₉O₁₃Fe₁ 770.555 g/mol NotAvailable Fk506 Binding Protein inhibitor Not Availables
fexaramin C₃₂H₃₂N₂O₃ 492.616 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
000003-deoxy-d-manno-oct-2-ulosonic säure C₈H₁₄O₈ 238.194 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Lck inhibitor Not Availables
spermine (fully protonated form) C₁₀H₃₀N₄₄+ 766.642 g/mol NotAvailable Fructose-1,6-Bisphosphatase inhibitor Not Availables
000007-[[(1-methyl-1,2,3-triazol-4-yl)-6-formyl-2,7-dihydro-[1,4]thiazepine-3-carboxylic säure]], brl42715, c6-(n1-methyl-1,2,3-triazolylmethylene)penem C₁₀H₁₀N₄O₃S₁ 266.274 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodieste inhibitor Not Availables
fluoresceinylthioureido C₂₃H₁₇N₂O₅S₁ 433.458 g/mol NotAvailable Pancreatic Ribonuclease A inhibitor Not Availables
flufenamic säure C₁₄H₁₀N₁O₂F₃ 281.234 g/mol NotAvailable Green Fluorescent Protein inhibitor Not Availables
[[spiro(2,4,6-trinitrobenzene[1,2a]-2o',3o'-methylene-adenine-triphosphat]] C₁₆H₁₆N₈O₁₉P₃₁- 1584.531 g/mol NotAvailable Phosphoenolpyruvate Carboxykinase, Cytosolic inhibitor Not Availables
fkb-001 C₃₅H₄₂N₂O₆F₂ 624.723 g/mol NotAvailable Profilin II inhibitor Not Availables
diethylphosphono group C₄H₁₀O₃P₁ 137.095 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
000009-butyl-8-(3,4,5-trimethoxybenzyl)-9h-purin-6-amin C₁₉H₂₅N₅O₃ 371.438 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
di-linoleoyl-3-sn-phosphatidylcholin C₄₄H₈₀N₁O₈P₁ 782.092 g/mol NotAvailable Angiotensin Converting Enzyme inhibitor Not Availables
[[(6r,7r)-3-[(acetyloxy)methyl]-7-{[(6s)-6-(glycylamino)-7-oxido-7-oxoheptanoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate]] C₁₉H₂₇N₄O₉S₁ 487.504 g/mol NotAvailable Pancreatic Ribonuclease A inhibitor Not Availables
di-stearoyl-3-sn-phosphatidylethanolamin C₄₁H₈₂N₁O₈P₁ 748.074 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
kifunensin C₈H₁₂N₂O₆ 232.193 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
s-selanyl cystein C₃H₆N₁O₂S₁Se₁ 199.106 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
desferal C₂₇H₄₉N₆O₁₁Fe₁S₁ 721.625 g/mol NotAvailable Trypsin inhibitor Not Availables
descarboxy-nor-n(omega)-hydroxy-l-arginin C₄H₁₃N₄O₁ 133.173 g/mol NotAvailable 000003-Oxoacyl-[Acyl-Carrier-Protein] Synthas inhibitor Not Availables
desvancosaminyl vancomycin C₅₉H₆₂N₈O₂₂Cl₂ 1306.085 g/mol NotAvailable Hiv-1 Integrase inhibitor Not Availables
monoisopropyl ester phosphonic säure group C₃H₈O₃P₁ 123.068 g/mol NotAvailable P38 Map Kinase inhibitor Not Availables
didecyl-dimethyl-ammonium C₂₂H₄₈N₁₁+ 466.695 g/mol NotAvailable P38 Map Kinase inhibitor Not Availables
diclosan C₁₂H₈O₂Cl₂ 255.100 g/mol NotAvailable Orotidine 5'-Monophosphate Decarboxylase inhibitor Not Availables
swainsonin C₈H₁₅N₁O₃ 173.211 g/mol NotAvailable Cellobiohydrolase I inhibitor Not Availables
000005-aminocarbonyl-3-nitrophenyl-alpha-d-galactopyranose C₁₃H₁₆N₂O₉ 344.277 g/mol NotAvailable Designed Protein Ctpr3 inhibitor Not Availables
compound 4-d C₂₇H₂₉N₁O₄S₁ 463.590 g/mol NotAvailable Cytochrome P450-Cam inhibitor Not Availables
diacetyldeuteroheme C₃₄H₃₂N₄O₆Fe₁ 648.497 g/mol NotAvailable Indole-3-Glycerol Phosphate Synthase inhibitor Not Availables
di(n-acetyl-d-glucosamine) C₁₆H₂₈N₂O₁₁ 424.404 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
dica C₁₀H₁₁N₁O₂Cl₂S₁ 280.168 g/mol NotAvailable Isopenicillin N Synthase inhibitor Not Availables
n-acetyl-d-allosamin C₈H₁₅N₁O₆ 221.210 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
delta-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-c2-adamantane ruthenium (ii) C₅₄H₄₃N₇F₈Ru₁₂+ 2154.808 g/mol NotAvailable Cathepsin K inhibitor Not Availables
delta-amino valeric säure C₅H₁₂N₁O₂₁+ 422.144 g/mol NotAvailable Baculoviral Iap Repeat-Containing Protein 4 inhibitor Not Availables
terlipressin C₅₂H₇₄N₁₆O₁₅S₂ 1227.37 g/mol NotAvailable Estrogen Receptor inhibitor Not Availables
o-(2-acetamido-2-deoxy-alpha-d-galactopyranosyl)-l-serin C₁₁H₂₀N₂O₈ 308.288 g/mol NotAvailable Neuraminidase inhibitor Not Availables
terminal dimethyl C₂H₆ 30.069 g/mol NotAvailable Flavohemoprotein inhibitor Not Availables
decyloxy-methanol C₁₁H₂₄O₂ 188.309 g/mol NotAvailable Cathepsin K inhibitor Not Availables
6,4'-dihydroxy-3-methyl-3',5'-dibromoflavon C₁₆H₁₀O₄Br₂ 426.061 g/mol NotAvailable Azurin inhibitor Not Availables
degraded cephaloridin C₁₄H₁₆N₂O₄S₂ 340.411 g/mol NotAvailable Alpha-Tocopherol Transfer Protein inhibitor Not Availables
deglucobalhimycin C₆₀H₆₅N₉O₂₀Cl₂ 1303.128 g/mol NotAvailable Cation-Dependent Mannose-6-Phosphate Recepto inhibitor Not Availables
deoxyuridine-5'-diphosphat C₉H₁₄N₂O₁₁P₂ 388.164 g/mol NotAvailable Integrin Alpha-L inhibitor Not Availables
deoxyguanidinoproclavaminic säure C₉H₁₅N₄O₃ 227.242 g/mol NotAvailable Phosphoenolpyruvate Carboxykinase, Cytosolic inhibitor Not Availables
dequadin C₃₀H₄₀N₄₂+ 988.927 g/mol NotAvailable Aspartic Proteinase inhibitor Not Availables
deoxyuridine-5'-triphosphat C₉H₁₅N₂O₁₄P₃ 468.144 g/mol NotAvailable Cyclodextrin Glycosyltransferase inhibitor Not Availables
[[(5z)-2-[(1s,2r)-1-amino-2-hydroxypropyl]-5-[(4-amino-1h-indol-3-yl)methylene]-3-(2-hydroxyethyl)-3,5-dihydro-4h-imidazol-4-on]] C₁₇H₂₁N₅O₃ 343.385 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
delta-bis(2,2'-bipyridine)imidazole ruthenium (ii) C₂₃H₂₀N₆Ru₁₂+ 1593.291 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Deaminase inhibitor Not Availables
tazobactam trans-enamine intermediate C₁₀H₁₂N₄O₅S₁ 300.289 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Deaminase inhibitor Not Availables
n-hydroxy 1n(4-methoxyphenyl)sulfonyl-4-(z,e-n-methoxyimino)pyrrolidine-2r-carboxamide C₁₃H₁₉N₃O₆S₁ 345.370 g/mol NotAvailable Pheromone Binding Protein inhibitor Not Availables
deoxy-2-fluoro-b-d-cellotrioside C₁₈H₃₁O₁₅F₁ 506.432 g/mol NotAvailable 000003-Hydroxyacyl-Coa Dehydrogenase Type II inhibitor Not Availables
o1-pentyl-mannose C₁₁H₂₂O₆ 250.291 g/mol NotAvailable Protease Retropepsin inhibitor Not Availables
disordered solvent H₂O₁ 18.015 g/mol NotAvailable Stromelysin-1 Precursor inhibitor Not Availables
000003-fluoro-2-(phosphonooxy)propanoic säure C₃H₆O₆F₁P₁ 188.049 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
diundecyl phosphatidyl cholin C₅₀H₁₀₁N₁O₈P₁₁+ 1185.061 g/mol NotAvailable Stromelysin 3 inhibitor Not Availables
dithiane diol C₄H₈O₂S₂ 152.226 g/mol NotAvailable Cytidine Deaminase inhibitor Not Availables
dipicolinic säure C₇H₅N₁O₄ 167.121 g/mol NotAvailable Haloalkane Dehalogenase inhibitor Not Availables
sucrose octasulfat C₁₂H₂₂O₃₅S₈ 982.765 g/mol NotAvailable Aminopeptidase inhibitor Not Availables
dioxothiomolybdenum(vi) ion H₁O₂Mo₁S₁ 161.007 g/mol NotAvailable Proclavaminate Amidino Hydrolase inhibitor Not Availables
diphthamide; 2-(3-carboxyamido-3-(trimethylammonio)propyl)histidin C₁₃H₂₄N₅O₃ 298.364 g/mol NotAvailable Acriflavine Resistance Protein B inhibitor Not Availables
diphenylacetic säure C₁₄H₁₂O₂ 212.248 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
zk-806711 C₂₇H₃₁N₆O₁₁+ 615.575 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
dodecane-trimethylamin C₁₅H₃₄N₁₁+ 368.507 g/mol NotAvailable Glycogen Phosphorylase B inhibitor Not Availables
ic261 C₁₈H₁₇N₁O₄ 311.337 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
dodecyl sulfat C₁₂H₂₆O₄S₁ 266.395 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
4,7-dioxosebacic säure C₁₀H₁₄O₆ 230.217 g/mol NotAvailable 000002-Dehydro-3-Deoxyphosphooctonate Aldolase inhibitor Not Availables
dmp450 C₃₃H₃₈N₄O₃ 538.688 g/mol NotAvailable Pyridoxal Phosphate Biosynthetic Protein Pdx inhibitor Not Availables
n-acetyl-2-deoxy-2-amino-galactose C₈H₁₅N₁O₆ 221.210 g/mol NotAvailable D-Xylose Isomerase inhibitor Not Availables
dnqx C₈H₂N₄O₆ 250.127 g/mol NotAvailable ADP-Ribosyl Cyclase inhibitor Not Availables
dmp450(inhibitor of dupont merck) C₃₃H₃₈N₄O₃ 538.688 g/mol NotAvailable Mannosyl-Oligosaccharide Alpha-1,2-Mannosida inhibitor Not Availables
dihydroorotic säure C₅H₆N₂O₄ 158.113 g/mol NotAvailable Beta-Glucosidase A inhibitor Not Availables
dihydrogenphosphate ion H₂O₄P₁₁- 406.725 g/mol NotAvailable Diisopropylfluorophosphatase inhibitor Not Availables
dihydrotestosteron C₁₉H₃₀O₂ 290.445 g/mol NotAvailable Hypothetical 65.0 Kda Protein In Cox14-C inhibitor Not Availables
sulfopyruvate C₃H₄O₆S₁ 168.121 g/mol NotAvailable Deoxyhypusine Synthase inhibitor Not Availables
diguanosine-5'-triphosphat C₂₀H₂₇N₁₀O₁₈P₃ 788.411 g/mol NotAvailable Carboxylesterase Est2 inhibitor Not Availables
difluoromethionin C₅H₉N₁O₂F₂S₁ 185.188 g/mol NotAvailable Outer Membrane Phospholipase A inhibitor Not Availables
flavopiridol C₂₁H₂₀N₁O₅Cl₁ 401.846 g/mol NotAvailable Palmitoyl Protein Thioesterase 1 inhibitor Not Availables
bromo-wr99210 C₁₄H₂₀N₅O₂Br₁ 370.248 g/mol NotAvailable Fatty säure Binding Protein inhibitor Not Availables
Digibind C₆₃₉₄H₉₉₀₈N₁₆₉₈O₂₀₁₁S₅₈ 144602257 NotAvailable Prolyl Oligopeptidase inhibitor Not Availables
dinor-n(omega)-hydroxy-l-arginin C₄H₁₀N₄O₃ 162.148 g/mol NotAvailable Farnesyl Pyrophosphate Synthetase inhibitor Not Availables
dinitrophenylen C₆H₄N₂O₄ 168.109 g/mol NotAvailable Aspartic Proteinase inhibitor Not Availables
000009-deazahypoxanthin C₆H₅N₃O₁ 135.125 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
sulfamic säure 2,3-o-(1-methylethylidene)-4,5-o-sulfonyl-beta-fructopyranose ester C₉H₁₅N₁O₁₀S₂ 361.338 g/mol NotAvailable Renin inhibitor Not Availables
(s)-3-(4-(2-carbazol-9-yl-ethoxy)-phenyl)-2-ethoxy-propionic säure C₂₅H₂₅N₁O₄ 403.477 g/mol NotAvailable Matrix Metallo Proteinase-8 inhibitor Not Availables
dimethyl propionate ester heme H₃₆C₃₆N₄O₄Fe₁ 644.552 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
cra_10950 C₁₈H₁₉N₄O₂F₁ 342.372 g/mol NotAvailable Endoplasmin inhibitor Not Availables
dimethylformamide C₃H₇N₁O₁ 73.094 g/mol NotAvailable Outer Membrane Lipoprotein Lolb inhibitor Not Availables
dimethylallyl s-thiolodiphosphat C₅H₁₄O₆P₂S₁ 264.170 g/mol NotAvailable Renin inhibitor Not Availables
aspartate beryllium trifluoride C₄H₇N₁O₄Be₁F₃ 199.111 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
udp-glucuronic säure C₁₅H₂₂N₂O₁₈P₂ 580.289 g/mol NotAvailable Vp39 inhibitor Not Availables
modified acarbose hexasaccharide C₃₇H₆₃N₁O₂₆ 937.896 g/mol NotAvailable Sensor Protein Fixl inhibitor Not Availables
aspartate semialdehyde C₄H₇N₁O₃ 117.104 g/mol NotAvailable Stromelysin-1 inhibitor Not Availables
arginineamide C₆H₁₆N₅O₁₁+ 334.219 g/mol NotAvailable Lipoprotein Mxim inhibitor Not Availables
argadin C₂₉H₄₀N₁₀O₉ 672.697 g/mol NotAvailable Halorhodopsin inhibitor Not Availables
4'-hydroxyflavanon C₁₅H₁₂O₃ 240.258 g/mol NotAvailable Glycogen Phosphorylase, Liver Form inhibitor Not Availables
xylose-derived imidazol C₇H₁₀N₂O₃ 170.168 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
argifin C₂₉H₄₁N₉O₁₀ 675.697 g/mol NotAvailable Galactoside O-Acetyltransferase inhibitor Not Availables
[[n-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-(2-thiophen-2-yl-acetylamino)-5-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-benzamide]] C₂₉H₄₃N₅O₈S₁ 621.747 g/mol NotAvailable Lectin inhibitor Not Availables
azo-dye hapten C₃₅H₂₅N₉O₂₂S₆ 1115.990 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
nadph dihydro-nicotinamide-adenine-dinucleotidephosphat C₂₁H₃₀N₇O₁₇P₃ 745.426 g/mol NotAvailable Phosphoglucose Isomerase inhibitor Not Availables
b-2-octylglucoside C₁₄H₂₈O₆ 292.372 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
tyvelose C₆H₁₂O₄ 148.158 g/mol NotAvailable Odorant-Binding Protein inhibitor Not Availables
atropin C₁₇H₂₃N₁O₃ 289.374 g/mol NotAvailable Cyclooxygenase-2 inhibitor Not Availables
aspartyl-adenosine-5'-monophosphat C₁₄H₁₉N₆O₁₀P₁ 462.312 g/mol NotAvailable Haematopoetic Cell Kinase inhibitor Not Availables
udp-alpha-d-xylopyranose C₁₄H₂₂N₂O₁₆P₂ 536.279 g/mol NotAvailable Lck Kinase inhibitor Not Availables
atrazine glutathione conjugate C₁₈H₃₀N₈O₆S₁ 486.545 g/mol NotAvailable Endoglucanase G inhibitor Not Availables
u-pi-a-pi C₁₉H₂₇N₇O₂₀P₄ 797.352 g/mol NotAvailable Mol_Id: 1; Molecule: Bacteriorhodopsin inhibitor Not Availables
ampa C₇H₁₀N₂O₄ 186.167 g/mol NotAvailable Mol_Id: 1; Molecule: Bacteriorhodopsin inhibitor Not Availables
aminophosphonic säure-guanylate ester C₁₀H₁₆N₆O₁₀P₂ 442.218 g/mol NotAvailable Phospholipase C inhibitor Not Availables
[[ampcpr; {[5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]-hydroxy-phosphorylmethyl}-phosphonic säure mono-(3,4,5-trihydroxy-tetrahydro-furan-2-ylmethyl) ester]] C₁₆H₂₅N₅O₁₃P₂ 557.347 g/mol NotAvailable Phosphatidylinositol Transfer Protein Al inhibitor Not Availables
undecyl-phosphinic säure butyl ester C₁₅H₃₃O₂P₁ 276.398 g/mol NotAvailable 1,3,4,6-Tetrachloro-1,4-Cyclohexadiene H inhibitor Not Availables
uridine-2',3'-vanadate C₉H₁₂N₂O₉V₁ 343.143 g/mol NotAvailable Diisopropylfluorophosphatase inhibitor Not Availables
aminoanthracen C₁₄H₁₁N₁ 193.248 g/mol NotAvailable Chlorophyll A-B Binding Protein, Chloroplast inhibitor Not Availables
000004-(1-benzyl-3-carbamoylmethyl-2-methyl-1h-indol-5-yloxy)-butyric säure C₂₂H₂₄N₂O₄ 380.443 g/mol NotAvailable Udp-N-Acetylglucosamine Enolpyruvyl Transfer inhibitor Not Availables
aminodi(ethyloxy)ethylaminocarbonylbenzenesulfonamide C₁₃H₂₁N₃O₅S₁ 331.386 g/mol NotAvailable In process Not Availables
000001-ethoxy-2-(2-methoxyethoxy)ethan C₇H₁₆O₃ 148.202 g/mol NotAvailable Phenylethanolamine N-Methyltransferase inhibitor Not Availables
dpi59 C₁₁H₁₁O₄P₁ 238.179 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
Antithymocyte globulin Not Available Not Available NotAvailable Nitric Oxide Synthase inhibitor Not Availables
000003-(benzoylamino)-l-alanin C₁₀H₁₂N₂O₃ 208.216 g/mol NotAvailable 1,3,6,8-Tetrahydroxynaphthalene Reductase inhibitor Not Availables
ara-alpha(1,3)-xyl C₁₀H₁₈O₉ 282.247 g/mol NotAvailable Transcriptional Regulator Qacr inhibitor Not Availables
apstatin C₂₃H₃₃N₅O₅ 459.544 g/mol NotAvailable Orotidine 5'-Monophosphate Decarboxylase inhibitor Not Availables
Antihemophilic Factor C₁₁₇₉₄H₁₈₃₁₄N₃₂₂₀O₃₅₅₃S₈₃ 264725.5 NotAvailable Nitrophorin 4 inhibitor Not Availables
undecanal C₁₁H₂₂O₁ 170.294 g/mol NotAvailable Succinylated Concanavalin A inhibitor Not Availables
000003-butylthiolane 1-oxide C₈H₁₆O₁S₁ 160.274 g/mol NotAvailable L-Fuculose 1-Phosphate Aldolase inhibitor Not Availables
analogue of indinavir drug C₃₉H₅₀N₄O₆ 670.847 g/mol NotAvailable ADP-Ribosylation Factor 2 inhibitor Not Availables
Anakinra C₇₅₉H₁₁₈₆N₂₀₈O₂₃₂S₁₀ 17257.6 NotAvailable Thiostrepton inhibitor Not Availables
benzylcystein C₁₀H₁₃N₁O₂S₁ 211.278 g/mol NotAvailable Trypsin inhibitor Not Availables
tetrahydropyran C₅H₁₀O₁ 86.133 g/mol NotAvailable Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh inhibitor Not Availables
trivanadate O₈V₃ 280.819 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
benzylsulfinic säure C₇H₈O₂S₁ 156.199 g/mol NotAvailable Penicillin-Insensitive Murein Endopeptidase inhibitor Not Availables
benzoyl-arginine-alanine-methyl keton C₁₈H₂₉N₅O₄ 379.458 g/mol NotAvailable Endo-1,4-Beta-Glucanase F inhibitor Not Availables
000003-phenyl-1,2-propandiol C₉H₁₂O₂ 152.193 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
cra_10655 C₁₉H₂₀N₄O₂ 336.393 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
trypanothion C₂₇H₄₉N₉O₁₀S₂ 723.858 g/mol NotAvailable Heparan Sulfate D-Glucosaminyl 3-O- Sulfotra inhibitor Not Availables
000008-hydroxy-2'-deoxyguanosin C₁₀H₁₃N₅O₅ 283.243 g/mol NotAvailable Cytotoxin 3 inhibitor Not Availables
thymidine-5'-diphospho-beta-d-xylose C₁₅H₂₄N₂O₁₅P₂ 534.307 g/mol NotAvailable Epsin inhibitor Not Availables
tris(hydroxyethyl)aminomethan C₇H₁₇N₁O₃ 163.216 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
beta-amino isobutyrate C₄H₈N₁O₂ 102.113 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
triphospate H₅O₁₀P₃ 257.955 g/mol NotAvailable Cathepsin K inhibitor Not Availables
adenosine-5'-diphosphate-2',3'-vanadate C₁₀H₁₃N₅O₁₂P₂V₁ 508.128 g/mol NotAvailable Alpha-Mannosidase II inhibitor Not Availables
beta-3-serin C₄H₉N₁O₃ 119.120 g/mol NotAvailable Fructose-Bisphosphate Aldolase Class I inhibitor Not Availables
000001-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic säure C₁₇H₁₈N₃O₃F₁ 331.346 g/mol NotAvailable Agmatinase inhibitor Not Availables
000005-fluoro-2'-deoxyuridine-5'-monophosphat C₉H₁₂N₂O₈F₁P₁ 326.175 g/mol NotAvailable 385Aa Long Conserved Hypothetical Protein inhibitor Not Availables
tris(hydroxymethyl)aminomethan C₄H₁₁N₁O₃ 121.136 g/mol NotAvailable P450Cin inhibitor Not Availables
beta-1,4-galactotrioside C₁₈H₃₀O₁₆ 502.425 g/mol NotAvailable Casein Kinase II, Alpha Chain inhibitor Not Availables
balanol analog 8 C₃₂H₃₆N₂O₇ 560.646 g/mol NotAvailable Casein Kinase II, Alpha Chain inhibitor Not Availables
tungstopterin cofactor C₂₀H₂₉N₁₀O₁₄Mg₁P₂S₄W₁ 1031.850 g/mol NotAvailable Polyamine Oxidase inhibitor Not Availables
batimastat; bb94 C₂₃H₃₁N₃O₄S₂ 477.636 g/mol NotAvailable 000003-Methyladenine DNA Glycosylase inhibitor Not Availables
balhimycin C₆₆H₇₇N₉O₂₅Cl₂ 1467.286 g/mol NotAvailable Transketolase inhibitor Not Availables
balanol analog 1 C₂₀H₂₂N₂O₅ 370.404 g/mol NotAvailable Tem-1 Beta-Lactamase inhibitor Not Availables
tyrosinal C₉H₁₁N₁O₂ 165.191 g/mol NotAvailable Aclacinomycin Methylesterase inhibitor Not Availables
b-nonylglucoside C₁₅H₃₀O₆ 306.398 g/mol NotAvailable Aclacinomycin Methylesterase inhibitor Not Availables
balanol C₂₈H₂₆N₂O₁₀ 550.521 g/mol NotAvailable Phosphoribosylglycinamide Formyltransferase inhibitor Not Availables
bacteriochlorophyll a C₅₅H₇₄N₄O₆Mg₁ 911.518 g/mol NotAvailable Glycinamide Ribonucleotide Transformylase inhibitor Not Availables
tryptophanyl-5'amp C₂₁H₂₄N₇O₈P₁ 533.436 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
benzhydroxamic säure C₇H₇N₁O₂ 137.138 g/mol NotAvailable Protein Rdmb inhibitor Not Availables
000004-carboxycinnamic säure C₁₀H₈O₄ 192.171 g/mol NotAvailable Bovine Beta-Lactoglobulin A inhibitor Not Availables
ttnpb C₂₄H₂₈O₂ 348.484 g/mol NotAvailable Heme Oxygenase 1 inhibitor Not Availables
[[benzo[b]thiophene-2-boronic säure]] C₈H₇O₂B₁S₁ 178.012 g/mol NotAvailable Molecule: Protein Kinase C Delta Type; Domain inhibitor Not Availables
benzene, benzoyl-; benzophenone (8ci); benzoylbenzene;diphenyl ketone; ketone, diphenyl; methanone, diphenyl- (9ci); phenyl ketone; wln: rvr C₁₃H₁₀O₁ 182.221 g/mol NotAvailable Constitutive Androstane Receptor inhibitor Not Availables
n-(5'-phosphopyridoxyl)-d-alanin C₁₁H₁₇N₂O₇P₁ 320.238 g/mol NotAvailable Glucosamine-Phosphate N-Acetyltransferase inhibitor Not Availables
tungstopterin C₂₁H₂₃N₁₀O₁₃Mg₁P₂S₄W₁ 1021.814 g/mol NotAvailable Heat Shock 90Kda Protein 1, Alpha inhibitor Not Availables
adenosine-3'-5'-diphosphat C₁₀H₁₅N₅O₁₀P₂ 427.204 g/mol NotAvailable Vitamin D3 Receptor inhibitor Not Availables
adenosine-5'-ditungstate C₁₀H₁₅N₅O₁₀W₂ 732.956 g/mol NotAvailable Saccharopepsin inhibitor Not Availables
allo-isoleucin C₆H₁₃N₁O₂ 131.174 g/mol NotAvailable E-Selectin inhibitor Not Availables
all-trans axerophthen C₂₀H₃₀ 270.457 g/mol NotAvailable Prostaglandin G/H Synthase 1 inhibitor Not Availables
vitamin b6 complexed with 2-amino-hexanoic säure C₁₄H₂₃N₂O₇P₁ 362.319 g/mol NotAvailable Pol Polyprotein inhibitor Not Availables
allolactose C₁₂H₂₂O₁₁ 342.299 g/mol NotAvailable Devb Protein inhibitor Not Availables
3,4-dimethylanilin C₈H₁₁N₁ 121.182 g/mol NotAvailable Cellobiose Dehydrogenase inhibitor Not Availables
al7182 C₁₃H₁₄N₂O₅S₃ 374.444 g/mol NotAvailable Complement C1S Component inhibitor Not Availables
al-6619, [[[2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide,2-(3-hydroxyphenyl)-3-(4-morpholinyl)-]], 1,1-dioxide] C₁₇H₁₉N₃O₆S₃ 457.534 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
[[n-(1-benzyl-3-{[3-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-propionyl]-[2-(hexahydro-benzo[1,3]dioxol-5-yl)-ethyl]-amino}-2-hydroxy-propyl)-4-benzyloxy-3,5-dimethoxy-benzamide]] C₄₆H₅₁N₃O₁₀ 805.923 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
way-151693 C₂₁H₂₁N₃O₅S₁ 427.474 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
alpha-methylisocitric säure C₇H₁₀O₇ 206.152 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
vanoxerin C₁₄H₁₁ClN₄O₄ 334.714 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
xylopyranose C₅H₁₀O₅ 150.131 g/mol NotAvailable Glutathione-Requiring Prostaglandin D Syntha inhibitor Not Availables
alpha-amino-2-indanacetic säure C₁₁H₁₃N₁O₂ 191.229 g/mol NotAvailable Xanthine Dehydrogenase inhibitor Not Availables
alpha-adenosine monophosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol NotAvailable Peptide Deformylase inhibitor Not Availables
000007-methyl-guanosine-5'-triphosphat C₁₁H₁₉N₅O₁₄P₃₁+ 1405.483 g/mol NotAvailable Homoprotocatechuate 2,3-Dioxygenase inhibitor Not Availables
[[allyl-{6-[3-(4-bromo-phenyl)-1-methyl-1h-indazol-6-yl]oxy}hexyl)-n-methylamin]] C₂₄H₃₀N₃O₁Br₁ 456.425 g/mol NotAvailable Phosphatidylinositol 3-Kinase Catalytic Subu inhibitor Not Availables
[[allyl-{4-[3-(4-bromo-phenyl)-benzofuran-6-yloxy]-but-2-enyl}-methyl-amin]] C₂₂H₂₂N₁O₂Br₁ 412.325 g/mol NotAvailable Poly inhibitor Not Availables
[[allyl-{6-[3-(4-bromo-phenyl)-benzofuran-6-yloxy]-hexyl-}-methyl-amin]] C₂₄H₂₈N₁O₂Br₁ 442.395 g/mol NotAvailable Poly [ADP-Ribose] Polymerase-1 inhibitor Not Availables
[[[2(formyl-hydroxy-amino)-ethyl]-phosphonic säure]] C₃H₈N₁O₅P₁ 169.074 g/mol NotAvailable Phosphatidylinositol 3-Kinase Catalytic Subu inhibitor Not Availables
aetiocholanolon C₁₉H₃₀O₂ 290.445 g/mol NotAvailable Hemolytic Lectin From Laetiporus Sulphureus inhibitor Not Availables
aeruginosin 98-b C₂₉H₄₆N₆O₉S₁ 654.777 g/mol NotAvailable Chondroitinase B inhibitor Not Availables
aicar C₉H₁₅N₄O₈P₁ 338.213 g/mol NotAvailable Chitotriosidase inhibitor Not Availables
wrr-204 C₃₄H₃₆N₂O₆S₁ 600.728 g/mol NotAvailable Angiotensin Converting Enzyme inhibitor Not Availables
000005-(2-chlorophenyl)furan-2-carboxylic säure C₁₁H₇O₃Cl₁ 222.627 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
ru85053 C₃₃H₃₅N₃O₇ 585.655 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
adenylyl-3'-5'-phospho-uridine-3'-monophosphat C₁₉H₂₅N₇O₁₅P₂ 653.392 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
adenylosuccinic säure C₁₄N₅O₁₁P₁H₁₈ 463.297 g/mol NotAvailable Neutrophil Collagenase inhibitor Not Availables
wrr-99 C₁₉H₂₈N₂O₅ 364.441 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
al7099a C₁₄H₁₇N₃O₅S₃ 403.485 g/mol NotAvailable Cellobiose Dehydrogenase inhibitor Not Availables
al5927 C₁₂H₁₄N₂O₅S₃ 362.433 g/mol NotAvailable L inhibitor Not Availables
al5424 C₁₃H₁₄N₂O₆S₃ 390.443 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
al7089a C₁₄H₁₇N₃O₅S₃ 403.485 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
decylamine-n,n-dimethyl-n-oxide C₁₂H₂₇N₁O₁ 201.351 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
penicillin g acyl-serin C₁₉H₂₄N₃O₇S₁₂- 791.135 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
fr233623 C₁₉H₂₁N₃O₂ 323.394 g/mol NotAvailable 000002-Dehydro-3-Deoxyphosphooctonate Aldolase inhibitor Not Availables
pyridoxyl-glutamic säure-5'-monophosphat C₁₃H₂₀N₂O₉P₁₁+ 689.020 g/mol NotAvailable 5'-D inhibitor Not Availables
wrr-112 C₁₉H₂₈N₂O₅ 364.441 g/mol NotAvailable Major Urinary Protein 2 inhibitor Not Availables
al5300 C₁₁H₁₂N₂O₅S₄ 380.466 g/mol NotAvailable Atrolysin C inhibitor Not Availables
uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-d-galactose C₁₅H₂₁N₂O₁₆F₁P₂ 566.281 g/mol NotAvailable Npqtn Specific Sortase B inhibitor Not Availables
[[(s)-2-amino-3-(6h-selenolo[2,3-b]-pyrrol-4-yl)-propionic säure]] C₉H₁₀N₂O₂Se₁ 257.150 g/mol NotAvailable Fatty säure-Binding Protein, Adipocyte inhibitor Not Availables
alpha-methylene adenosine monophosphat C₁₁H₁₆N₅O₆P₁ 345.251 g/mol NotAvailable Protein Ycei inhibitor Not Availables
alpha-methyl-n-acetyl-d-glucosamin C₉H₁₇N₁O₆ 235.236 g/mol NotAvailable Cystathionine Gamma-Synthase inhibitor Not Availables
alpha-l-methyl-fucose C₇H₁₄O₅ 178.185 g/mol NotAvailable Phospholipase A2 Isoform 3 inhibitor Not Availables
alpha-l-fucose C₆H₁₂O₅ 164.158 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
000001-[[[pyrrol-1-yl-2,5-dione-methoxymethyl]-pyrrole-2,5-dion]] C₁₀H₈N₂O₅ 236.184 g/mol NotAvailable Macrophage Metalloelastase inhibitor Not Availables
000005-methoxy-1,2-dimethyl-3-(4-nitrophenoxymethyl)indole-4,7-dion C₁₈H₁₆N₂O₆ 356.334 g/mol NotAvailable Interleukin-2 inhibitor Not Availables
uridine-5'-diphosphate-mannose C₁₅H₂₄N₂O₁₇P₂ 566.305 g/mol NotAvailable Phosphoserine Aminotransferase inhibitor Not Availables
000006-amino hexanoic säure C₆H₁₃N₁O₂ 131.174 g/mol NotAvailable Cathepsin G inhibitor Not Availables
alpha,beta-methyleneadenosine-5'-triphosphat C₁₁H₁₈N₅O₁₂P₃ 505.211 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
000003-iodo-benzyl alcohol C₇H₇O₁I₁ 234.036 g/mol NotAvailable Alpha1-Antitrypsin inhibitor Not Availables
phosphoaminophosphonic säure-adenylate ester C₁₀H₁₇N₆O₁₂P₃ 506.199 g/mol NotAvailable Acetyl-Coa Carboxylase inhibitor Not Availables
alrestatin C₁₄H₉N₁O₄ 255.229 g/mol NotAvailable Dihydroorotate Dehydrogenase inhibitor Not Availables
alpha-ribazole-5'-phosphate derivative C₁₂H₁₅N₂O₇P₁ 330.233 g/mol NotAvailable Thyroid Hormone Receptor Beta-1 inhibitor Not Availables
alpha-phosphoribosylpyrophosphoric säure C₅H₁₃O₁₄P₃ 390.071 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
(4r)-2-methylpentane-2,4-diol C₆H₁₄O₂ 118.175 g/mol NotAvailable Elastase 1 inhibitor Not Availables
alpha-ribazole-5'-phosphat C₁₄H₁₉N₂O₇P₁ 358.287 g/mol NotAvailable Bifunctional Purine Biosynthesis Protein Pur inhibitor Not Availables
adenosine-5'-phosphosulfat C₁₀H₁₄N₅O₁₀P₁S₁ 427.282 g/mol NotAvailable Elastase inhibitor Not Availables
alpha-d-galactose-1-phosphat C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
alpha-d-glucose-1-phosphate-6-vanadate C₆H₁₃O₁₂P₁V₁ 359.077 g/mol NotAvailable 92 Kda Type IV Collagenase inhibitor Not Availables
alpha-d-glucopyranosyl-2-carboxylic säure amide C₇H₁₃N₁O₆ 207.183 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
glycoluril C₄H₆N₄O₂ 142.117 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
alpha-aminoisobutyric säure C₄H₉N₁O₂ 103.121 g/mol NotAvailable Alpha Amylase inhibitor Not Availables
acylated ceftazidime C₁₇H₁₉N₅O₇S₂ 469.486 g/mol NotAvailable Poly [ADP-Ribose] Polymerase-1 inhibitor Not Availables
alpha-cyclodextrin (cyclohexa-amylose) C₃₆H₆₀O₃₀ 972.852 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
alpha-benzyl-aminobenzyl-phosphonic säure C₁₄H₁₆N₁O₃P₁ 277.259 g/mol NotAvailable Collagenase-3 inhibitor Not Availables
alpha-l-arabinose C₅H₁₀O₅ 150.131 g/mol NotAvailable Formylmethionine Deformylase inhibitor Not Availables
s-(2-oxo)pentadecylcoa C₃₆H₆₄N₇O₁₇P₃S₁ 991.920 g/mol NotAvailable Chitinase B inhibitor Not Availables
alpha-ketomalonic säure C₃H₂O₅ 118.046 g/mol NotAvailable Pyruvate-Ferredoxin Oxidoreductase inhibitor Not Availables
uridine-5'-diphosphate-n-acetylmuramoyl-l-alanine-d-glutamate C₂₈H₄₃N₅O₂₃P₂ 879.615 g/mol NotAvailable Cytochrome C-552 inhibitor Not Availables
alpha-l-1-methyl-fucose C₇H₁₄O₅ 178.185 g/mol NotAvailable Lysozyme inhibitor Not Availables
000001-(isopropylthio)-beta-galactopyranside C₉H₁₈O₅S₁ 238.298 g/mol NotAvailable Lysozyme inhibitor Not Availables
uridine-diphosphate-n-acetylgalactosamin C₁₇H₂₇N₃O₁₇P₂ 607.358 g/mol NotAvailable Peptaibol inhibitor Not Availables
alpha-d-mannose-6-phosphat C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable Ionotropic Glutamate Receptor 2 inhibitor Not Availables
lauryl dimethylamine-n-oxide C₁₄H₃₁N₁O₁ 229.405 g/mol NotAvailable Cyan Fluorescent Protein Cfp inhibitor Not Availables
alpha-fluoro-carboxymethyldethia coenzyme a complex C₂₃H₃₇N₇O₁₈F₁P₃ 811.501 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
carboxymycobactin t C₃₅H₄₉N₅O₁₂Fe₁ 787.645 g/mol NotAvailable Imidazole Glycerol Phosphate Synthase Hi inhibitor Not Availables
monastrol C₁₄N₂O₃S₁ 276.226 g/mol NotAvailable Thioesterase I inhibitor Not Availables
carpropamide C₁₅H₁₈N₁O₁Cl₃ 334.672 g/mol NotAvailable Copper Amine Oxidase inhibitor Not Availables
cardiolipin C₅₈H₁₂₀O₁₇P₂ 1151.523 g/mol NotAvailable Bifunctional Histidine Biosynthesis Prot inhibitor Not Availables
000002-aminoethanimidic säure C₂H₆N₂ 58.083 g/mol NotAvailable Arylsulfatase A inhibitor Not Availables
carboxymethylated cystein C₅H₉N₁O₄S₁ 179.190 g/mol NotAvailable 000002-Amino-3-Ketobutyrate Conenzyme A Ligas inhibitor Not Availables
tl-3-093 C₂₅H₃₃N₃O₅ 455.553 g/mol NotAvailable Des[Gly1]-Contryphan-R inhibitor Not Availables
carboxymethylthio-3-(3-chlorophenyl)-1,2,4-oxadiazol C₁₀H₇N₂O₃Cl₁S₁ 270.690 g/mol NotAvailable Dipeptidyl Peptidase IV Soluble Form inhibitor Not Availables
carboxymethylenecystein C₅H₉N₁O₄S₁ 179.190 g/mol NotAvailable Steryl-Sulfatase inhibitor Not Availables
thionicotinamide-adenine-dinucleotide C₂₁H₂₇N₇O₁₃P₂S₁ 679.491 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Synthase 2 inhibitor Not Availables
adenosine-2'-5'-diphosphat C₁₀H₁₅N₅O₁₀P₂ 427.204 g/mol NotAvailable 7,8-Diamino-Pelargonic säure Aminotransferase inhibitor Not Availables
cellotriose C₁₈H₃₂O₁₆ 504.441 g/mol NotAvailable Odorant Binding Protein inhibitor Not Availables
cephalothin group C₁₆H₁₆N₂O₆S₂ 396.432 g/mol NotAvailable 000005-Methyltetrahydropteroyltriglutamate-- inhibitor Not Availables
cephalosporin c C₁₆H₂₂N₃O₈S₁ 416.425 g/mol NotAvailable Salicylic säure-Binding Protein 2 inhibitor Not Availables
cephalosporin analog C₃₂H₄₂N₆O₁₃S₁ 750.776 g/mol NotAvailable Dihydroneopterin Aldolase inhibitor Not Availables
cd564 C₂₆H₂₆O₃ 386.490 g/mol NotAvailable Urokinase inhibitor Not Availables
bis-tris buffer C₈H₁₉N₁O₅ 209.242 g/mol NotAvailable Queuine tRNA-Ribosyltransferase inhibitor Not Availables
thymidine-5'-(dithio)phosphat C₁₀H₁₅N₂O₆P₁S₂ 354.332 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
cefotaxime group C₁₆H₁₇N₅O₇S₂ 455.460 g/mol NotAvailable Glutaminase-Asparaginase inhibitor Not Availables
camphan C₁₀H₁₈ 138.252 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
adenosine-5-diphosphoribose C₁₅H₂₃N₅O₁₄P₂ 559.319 g/mol NotAvailable tRNA Guanine Transglycosylase inhibitor Not Availables
lfa703 C₃₇H₄₉N₁O₆ 603.797 g/mol NotAvailable Leucyl-tRNA Synthetase inhibitor Not Availables
gpi-1046 C₂₀H₂₈N₂O₄ 360.452 g/mol NotAvailable Csdb inhibitor Not Availables
open form of 2'-deoxy-ribofuranose-5'-phosphat C₅H₁₃O₇P₁ 216.127 g/mol NotAvailable 92 Kda Type IV Collagenase inhibitor Not Availables
c16-fatty-acyl-substrate-mimic C₂₀H₃₉N₁O₂S₁ 357.594 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
biliverdine ix alpha C₃₃H₃₄N₄O₆ 582.655 g/mol NotAvailable Ornithine Carbamoyltransferase inhibitor Not Availables
adenosine-5'-(dithio)phosphat C₁₀H₁₄N₅O₅P₁S₂ 379.345 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
[[adenosine-5'-[beta]], [[gamma-methylene]tetraphosphat]] C₁₁H₁₉N₅O₁₅P₄ 585.191 g/mol NotAvailable L-Amino säure Oxidase inhibitor Not Availables
cilastatin C₁₆H₂₆N₂O₅S₁ 358.452 g/mol NotAvailable Cathepsin B inhibitor Not Availables
carbobenzoxy-pro-lys-phe-y(po2)-ala-pro-ome C₃₆H₅₂N₆O₉P₁₁+ 1053.553 g/mol NotAvailable Delta-Aminolevulinic säure Dehydratase inhibitor Not Availables
n,o6-disulfo-glucosamin C₆H₁₃N₁O₁₁S₂ 339.289 g/mol NotAvailable 2,3,4,5-Tetrahydropyridine-2-Carboxylate N- inhibitor Not Availables
thymidine-5'-triphosphat C₁₀H₁₇N₂O₁₄P₃ 482.171 g/mol NotAvailable Thiostrepton inhibitor Not Availables
carboxyatractyloside C₃₁H₄₆O₁₉S₂ 786.813 g/mol NotAvailable Arylsulfatase inhibitor Not Availables
carbamyl-cholin C₆H₁₅N₂O₂ 147.197 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
(1h-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic säure C₁₂H₁₄N₂O₃S₁ 266.314 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Deaminase inhibitor Not Availables
benzene hexacarboxylic säure C₁₂H₆O₁₂ 342.172 g/mol NotAvailable 000003-Dehydroquinate Dehydratase inhibitor Not Availables
carbaphosphonate C₈H₁₅O₈P₁ 270.175 g/mol NotAvailable Imp-1 Metallo Beta-Lactamase inhibitor Not Availables
000004-hydroxy-1-benzopyran-2-one; 4-hydroxycoumarin C₉H₆O₃ 162.145 g/mol NotAvailable Carboxypeptidase A inhibitor Not Availables
coa-s-trimethylene-acetyl-tryptamin C₃₆H₅₄N₉O₁₇P₃S₁ 1009.854 g/mol NotAvailable Serum Albumin inhibitor Not Availables
cobalt hexammine ion H₁₈N₆Co₁₃+ 322.186 g/mol NotAvailable 1,3,4,6-Tetrachloro-1,4-Cyclohexadiene Hydro inhibitor Not Availables
thiopyrophosphat H₃O₆P₂S₁ 193.028 g/mol NotAvailable Glycerol-3-Phosphate Dehydrogenase inhibitor Not Availables
coa-s-acetyl tryptamin C₃₃H₄₈N₉O₁₇P₃S₁ 967.774 g/mol NotAvailable Glycerol-3-Phosphate Dehydrogenase inhibitor Not Availables
co-methylcobalamin C₆₃H₉₁N₁₃O₁₄Co₁P₁ 1313.475 g/mol NotAvailable Prostaglandin H2 Synthase-1 inhibitor Not Availables
5alpha-androstan-3,17-dion C₁₉H₂₈O₂ 288.429 g/mol NotAvailable Alpha-1-Purothionin inhibitor Not Availables
coa-s-acetyl 5-bromotryptamin C₃₃H₄₇N₉O₁₇Br₁P₃S₁ 1046.670 g/mol NotAvailable Queuine tRNA-Ribosyltransferase inhibitor Not Availables
l-709,587 C₅₂H₇₆N₂O₁₃ 937.178 g/mol NotAvailable Triosephosphate Isomerase inhibitor Not Availables
compound 19 C₃₂H₄₀N₄O₁₀S₁ 672.749 g/mol NotAvailable Methylmalonyl Coa Decarboxylase inhibitor Not Availables
dioxyselenocystein C₃H₆N₁O₄Se₁ 199.045 g/mol NotAvailable Lysozyme inhibitor Not Availables
compound 15 C₂₈H₃₁N₁O₄S₁ 477.617 g/mol NotAvailable Endoplasmin inhibitor Not Availables
adenosine diphosphate 5-(beta-ethyl)-4-methyl-thiazole-2-carboxylic säure C₁₇H₁₉N₆O₁₂P₂S₁₃- 978.098 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
compound 18 C₂₇H₂₉N₁O₄S₁ 463.590 g/mol NotAvailable Renin Complexed With Polyhydroxymonoamide In inhibitor Not Availables
compound 15 C₂₉H₃₆N₂O₁₂ 604.610 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
thiodigalactoside C₁₂H₂₂O₁₀S₁ 358.360 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
coenzyme a persulfide C₂₁H₃₆N₇O₁₆P₃S₂ 799.594 g/mol NotAvailable Beta-Hydroxydecanoyl Thiol Ester Dehydrase inhibitor Not Availables
compound 12, [[n-acetyl-4-[(carboxycarbonyl)(2-carboxyphenyl)amino]-n-pentyl-1-napthylalaniamide]] C₂₉H₃₁N₃O₇ 533.580 g/mol NotAvailable 000003-Methyl-2-Oxobutanoate Hydroxymethyltransfe inhibitor Not Availables
zk-800270 C₇H₇N₃ 133.152 g/mol NotAvailable Glucosamine 6-Phosphate Synthase inhibitor Not Availables
chloroaceton C₃H₅O₁Cl₁ 92.525 g/mol NotAvailable Mannan Endo-1,4-Beta-Mannosidase inhibitor Not Availables
chromophore (gly-tyr-gly) C₁₅H₁₇N₃O₄ 303.317 g/mol NotAvailable Alpha-Mannosidase II inhibitor Not Availables
cholesteryl linoleate C₄₅H₇₆O₂ 649.094 g/mol NotAvailable Mannan Endo-1,4-Beta-Mannosidase inhibitor Not Availables
chloro diiron-oxo moiety O₁Cl₁Fe₂ 163.146 g/mol NotAvailable Sialidase 2 inhibitor Not Availables
thymidine-5'- diphosphat C₁₀H₁₆N₂O₁₁P₂ 402.191 g/mol NotAvailable Beta-Glucosidase A inhibitor Not Availables
adenosine phosphonoacetic säure C₁₂H₁₆N₅O₈P₁ 389.261 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
chitotriose C₂₄H₄₁N₃O₁₆ 627.598 g/mol NotAvailable Myo-Inositol-Phosphate Synthase inhibitor Not Availables
hadsäurein C₃H₅N₁O₄ 119.077 g/mol NotAvailable Myo-Inositol-1-Phosphate Synthase inhibitor Not Availables
co-cyanocobalamin C₆₃H₈₈N₁₄O₁₄Co₁P₁ 1324.458 g/mol NotAvailable Glycogen Phosphorylase B inhibitor Not Availables
y-700 C₁₆H₁₇N₃O₃ 299.329 g/mol NotAvailable Isopentenyl-Diphosphate Delta-Isomerase inhibitor Not Availables
adenosine monotungstate C₁₀H₁₄N₅O₇W₁ 500.100 g/mol NotAvailable Nad-Dependent Alcohol Dehydrogenase inhibitor Not Availables
threonine derivative C₁₅H₁₈N₂O₆I₂ 576.126 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
cmp-2-keto-3-deoxy-octulosonic säure C₁₇H₂₆N₃O₁₅P₁ 543.377 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
[[cis-[4,5-bis-(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihyd roimidazol-1-yl]-piperazin-1-yl-methanon]] C₃₀H₃₂N₄O₃Cl₂ 567.514 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
carboxylic prpp; cprpp C₆H₁₅O₁₃P₃ 388.098 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
[[[2,4,6-triisopropyl-phenylsulfonyl-l-[3-amidino-phenylalanin]]-piperazine-n'-beta-alanin]] C₃₂H₄₈N₆O₄S₁ 612.829 g/mol NotAvailable Cytochrome C-552 inhibitor Not Availables
threonine-aspartic ester C₈H₁₆N₂O₆ 236.224 g/mol NotAvailable Carboxypeptidase Gp180 Residues 503-882 inhibitor Not Availables
[[cis-[4,5-bis-(4-bromophenyl)-2-(2-ethoxy-4-methoxyphenyl)-4,5-dihydroimidazol-1-yl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanon]] C₃₁H₃₄N₄O₄Br₂ 686.442 g/mol NotAvailable Glycosyltransferase B inhibitor Not Availables
bilh 434 C₂₉H₁₉N₃O₆Cl₂S₁ 608.452 g/mol NotAvailable Histo-Blood Group Abo System Transferase inhibitor Not Availables
tricyclazol C₉H₈N₃S₁₁+ 510.842 g/mol NotAvailable Human Immunodeficiency Virus Type 2 inhibitor Not Availables
tricosanoic säure C₂₃H₄₆O₂ 354.615 g/mol NotAvailable P-Hydroxybenzoate Hydroxylase inhibitor Not Availables
biliverdin ix gamma chromophore C₃₃H₃₄N₄O₆ 582.655 g/mol NotAvailable Phenylethylamine Oxidase inhibitor Not Availables
beta(2-thienyl)alanin C₇H₉N₁O₂S₁ 171.214 g/mol NotAvailable Phenylethylamine Oxidase inhibitor Not Availables
000005-[[chloro-1h-indole-2-carboxylic säure [1-(4-fluorobenzyl)-2-(4-hydroxypiperidin-1yl)-2-oxoethyl]amide]] C₂₃H₂₃N₃O₃Cl₁F₁ 443.904 g/mol NotAvailable Matrix Metalloproteinase 8 inhibitor Not Availables
beta-d-mannose C₆H₁₂O₆ 180.157 g/mol NotAvailable Quinohemoprotein Alcohol Dehydrogenase inhibitor Not Availables
beta-sialic säure C₁₁H₁₉N₁O₉ 309.272 g/mol NotAvailable Lysozyme inhibitor Not Availables
beta-methyl-d-galactoside C₇H₁₄O₆ 194.184 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
000002-dimethylamino-ethyl-diphosphat C₄H₁₃N₁O₇P₂ 249.097 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Deaminase inhibitor Not Availables
[[7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-4,10-dihydro-1h,3h-pyrano[4,3-b]chromene-9-carboxylic säure]] C₁₅H₁₄O₈ 322.271 g/mol NotAvailable Streptavidin inhibitor Not Availables
bis(5-amidino-2-benzimidazolyl)methane ketone hydrate C₁₇H₁₈N₈O₂₂+ 686.370 g/mol NotAvailable 1,4-Beta-D-Glucan Cellobiohydrolase I inhibitor Not Availables
bis(5-amidino-benzimidazolyl)methane zinc C₁₇H₁₆N₈Zn₁ 397.747 g/mol NotAvailable Major Urinary Protein inhibitor Not Availables
butan-1-ol C₄H₁₀O₁ 74.122 g/mol NotAvailable 000002-Keto-3-Deoxygluconate Kinase inhibitor Not Availables
bis(5-amidino-2-benzimidazolyl)methane keton C₁₇H₁₆N₈O₁₂+ 524.360 g/mol NotAvailable Major Urinary Protein inhibitor Not Availables
ru79073 C₉H₁₂N₁O₄P₁ 229.172 g/mol NotAvailable Vanillyl-Alcohol Oxidase inhibitor Not Availables
tricarballylic säure C₆H₈O₆ 176.126 g/mol NotAvailable Sex Hormone-Binding Globulin inhibitor Not Availables
[[(4ar,6s,8ar)-11-[8-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4ah-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium]] C₃₂H₃₇N₂O₅₁+ 1265.627 g/mol NotAvailable Diisopropylfluorophosphatase inhibitor Not Availables
bis-napthyl beta-ketophosphonic säure C₂₂H₁₇O₄P₁ 376.348 g/mol NotAvailable Ribonuclease A inhibitor Not Availables
trifluorofurnesyl diphosphat C₁₅H₂₅O₇F₃P₂ 436.301 g/mol NotAvailable Molybdenum Cofactor Biosynthesis Protein inhibitor Not Availables
000007-hydroxy-2-oxo-chromene-3-carboxylic säure ethyl ester C₁₂H₁₀O₅ 234.208 g/mol NotAvailable Renin inhibitor Not Availables
000005-[[{[(2-amino-9h-purin-6-yl)oxy]methyl}-2-pyrrolidinon]] C₁₀H₁₂N₆O₂ 248.244 g/mol NotAvailable Hpv11 Regulatory Protein E2 inhibitor Not Availables
beta-d-glucose-6-phosphat C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable 000002-Hydroxy-6-Oxo-7-Methylocta-2,4-Dienoate Hy inhibitor Not Availables
triglu-5-formyl-tetrahydrofolate C₃₀H₃₇N₉O₁₃ 731.675 g/mol NotAvailable Branched-Chain Amino säure Aminotransferase inhibitor Not Availables
beta-d-arabinofuranose-5'-phosphat C₅H₁₁O₈P₁ 230.111 g/mol NotAvailable Xylose Isomerase inhibitor Not Availables
2,2-dimethylthiazolidine-4-carboxylic säure;(dmt)thiazolidin C₆H₁₁N₁O₂S₁ 161.218 g/mol NotAvailable Vanillyl-Alcohol Oxidase inhibitor Not Availables
beta-d-fucose C₆H₁₂O₅ 164.158 g/mol NotAvailable Chondroitinase B inhibitor Not Availables
trihydroxyarsenite(iii) H₃O₃As₁ 125.944 g/mol NotAvailable Isocitrate Dehydrogenase inhibitor Not Availables
beta-mercaptoethanol C₂H₆O₁S₁ 78.129 g/mol NotAvailable 000004-Oxalocrotonate Tautomerase inhibitor Not Availables
beta-hydroxytryptophan C₁₁H₁₂N₂O₃ 220.227 g/mol NotAvailable Deacetoxycephalosporin C Synthase inhibitor Not Availables
trifluoroacetonyl coenzyme a C₂₄H₃₇N₇O₁₇F₃P₃S₁ 877.569 g/mol NotAvailable Anthocyanidin Synthase inhibitor Not Availables
trifluoro-thiamin phosphat C₁₂H₁₃N₄O₄F₃P₁S₁₁- 717.888 g/mol NotAvailable Copper Amine Oxidase inhibitor Not Availables
beta-l-methyl-fucose C₇H₁₄O₅ 178.185 g/mol NotAvailable Factor Inhibiting Hif1 inhibitor Not Availables
beta-hydroxyaspartic säure C₄H₇N₁O₅ 149.103 g/mol NotAvailable Heat-Labile Enterotoxin B Chain inhibitor Not Availables
cyclo-tetrametavanadate O₁₂V₄₄- 2433.414 g/mol NotAvailable Estrogen Receptor inhibitor Not Availables
000005-hydroxy-n-propargyl-1(r)-aminoindan C₁₂H₁₃N₁O₁ 187.241 g/mol NotAvailable Phosphotriesterase inhibitor Not Availables
beta-hydroxyasparagin C₄H₈N₂O₄ 148.118 g/mol NotAvailable Glucose-Resistance Amylase Regulator inhibitor Not Availables
beta-hydroxy aspartic säure C₄H₇N₁O₅ 149.103 g/mol NotAvailable Heme Oxygenase 1 inhibitor Not Availables
butyl group C₄H₉ 57.115 g/mol NotAvailable Enolase inhibitor Not Availables
butenoic säure C₄H₆O₂ 86.090 g/mol NotAvailable Triosephosphate Isomerase inhibitor Not Availables
adenosine-5'-diphosphate monothiophosphat C₁₀H₁₆N₅O₁₂P₃S₁ 523.244 g/mol NotAvailable Phospho-2-Dehydro-3-Deoxyheptonate Aldolase inhibitor Not Availables
1h-benoximidazole-2-carboxylic säure C₈H₆N₂O₂ 162.148 g/mol NotAvailable Small Inducible Cytokine A20 inhibitor Not Availables
tmr C₂₈H₂₄N₃O₅ 482.515 g/mol NotAvailable Intramolecular Trans-Sialidase inhibitor Not Availables
000004-methylthio-alpha-d-mannose C₇H₁₄O₅S₁ 210.245 g/mol NotAvailable Lysozyme inhibitor Not Availables
bulgecin a C₁₆H₃₀N₃O₁₄S₂₁+ 1161.685 g/mol NotAvailable Molecule: Cathepsin B; Ec: 3.4.22.1; Mutatio inhibitor Not Availables
[[n-[2-(1h-indol-5-yl)-butyl]-4-sulfamoyl-benzamide]] C₁₉H₂₁N₃O₃S₁ 371.453 g/mol NotAvailable Adenosine Kinase inhibitor Not Availables
c-1027 aromatized chromophore C₄₃H₄₅N₃O₁₃Cl₁₁+ 1201.824 g/mol NotAvailable Lantibiotic Merssäurein inhibitor Not Availables
bvdu-mp C₁₁H₁₄N₂O₈Br₁P₁ 413.118 g/mol NotAvailable Matrix Metallo Proteinase-8 inhibitor Not Availables
bv4 C₇₉H₁₂₃N₁₅O₃₂ 1794.922 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
serine vanadate C₃H₇N₁O₇V₁₃- 831.329 g/mol NotAvailable Scytalone Dehydratase inhibitor Not Availables
c-(1-azido-alpha-d-glucopyranosyl) formamide C₇H₁₂N₄O₆ 248.195 g/mol NotAvailable Delta-Conotoxin Evia inhibitor Not Availables
000002-[[butyl-5,6-dihydro-1h-imidazo[4,5-d]pyridazine-4,7-dion]] C₉H₁₂N₄O₂ 208.219 g/mol NotAvailable Endo-1,4-B-D-Mannanase inhibitor Not Availables
ethyl-trimethyl-silan C₅H₁₄Si₁ 102.251 g/mol NotAvailable 000003-Dehydroquinate Dehydratase inhibitor Not Availables
butyramide C₄H₉N₁O₁ 87.121 g/mol NotAvailable Imp-1 Metallo Beta-Lactamase inhibitor Not Availables
000002-methoxy-4-vinyl-phenol C₉H₁₀O₂ 150.177 g/mol NotAvailable Mol_Id: 1; Molecule: Bacteriorhodopsin inhibitor Not Availables
bv2 C₅₁H₇₉N₁₁O₂₂ 1198.246 g/mol NotAvailable 47 Kda Membrane Antigen inhibitor Not Availables
[[bishydroxy[2h-1-benzopyran-2-one,1,2-benzopyron]]] C₁₉H₁₂O₆ 336.300 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
trans-6-(2-phenylcyclopropyl)-naphthalene-2-carboxamidin C₂₀H₁₈N₂ 286.376 g/mol NotAvailable Lantibiotic Merssäurein inhibitor Not Availables
bmsc-0013 C₁₄H₂₆N₂O₈ 350.368 g/mol NotAvailable 5'-D inhibitor Not Availables
bms184394 C₂₆H₂₈O₃ 388.505 g/mol NotAvailable Alcohol Dehydrogenase E Chain inhibitor Not Availables
7,10,13-tri(carboxymethyl)-5,15-dioxo-4,7,10,13,16-pentaaza-1,19-dithianonadecan C₁₈H₃₃N₅O₈S₂ 511.607 g/mol NotAvailable Glucarate Dehydratase inhibitor Not Availables
bis(adenosine)-5'-pentaphosphat C₂₀H₂₉N₁₀O₂₂P₅ 916.372 g/mol NotAvailable 2,3-Dihydroxybenzoate-Amp Ligase inhibitor Not Availables
bis(5-amidino-benzimidazolyl)methanone zinc C₁₇H₁₈N₈O₁Zn₁ 415.762 g/mol NotAvailable Acetohydroxy-säure Isomeroreductase inhibitor Not Availables
kabiramide c C₄₈H₇₁N₅O₁₄ 942.114 g/mol NotAvailable Cytochrome C Peroxidase inhibitor Not Availables
p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphat C₂₀H₃₀N₇O₂₃P₅ 891.359 g/mol NotAvailable Cell Wall Peptide In Complex With Deglucobalhi inhibitor Not Availables
tnt C₇H₅N₃O₆ 227.133 g/mol NotAvailable Neutrophil Gelatinase-Associated Lipocalin inhibitor Not Availables
bromo-dodecanol C₁₂H₂₅O₁Br₁ 265.233 g/mol NotAvailable Alcohol Dehydrogenase E Chain inhibitor Not Availables
Bromfenac C₁₅H₁₂BrNO₃ 334.165 g/mol NotAvailable Galectin-3 inhibitor Not Availables
000001-hexadecanosulfonic säure C₁₆H₃₄O₃S₁ 306.503 g/mol NotAvailable Neuraminidase N9 inhibitor Not Availables
tosyl-d-prolin C₁₂H₁₅N₁O₄S₁ 269.315 g/mol NotAvailable Ricin A Chain inhibitor Not Availables
diethyl 4-methylbenzylphosphonate C₁₂H₁₉O₃P₁ 242.254 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
Botulinum toxin type B C₆₇₆₀H₁₀₄₄₇N₁₇₄₃O₂₀₁₀S₃₂ 149322.7 NotAvailable Dihydrofolate Reductase inhibitor Not Availables
trans-4-aminomethylcyclohexane-1-carboxylic säure C₈H₁₅N₁O₂ 157.212 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
[[morpholine-4-carboxylic säure [1-(2-benzylsulfanyl-1-formyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide]] C₂₄H₂₉N₃O₄S₁ 455.571 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
trans-2-phenylcyclopropylamin C₉H₁₂N₁₁+ 274.267 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
n-butyl-n'-hydroxyguanidin C₅H₁₃N₃O₁ 131.177 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
nicotinamide adenine dinucleotide cyclohexanon C₂₇H₃₅N₇O₁₅P₂ 759.559 g/mol NotAvailable Alcohol Dehydrogenase E Chain inhibitor Not Availables
n-cyclohexyl-n'-(propyl)phenyl urea C₁₆H₂₄N₂O₁ 260.378 g/mol NotAvailable Beta-Glucosidase inhibitor Not Availables
n-butylbenzen C₁₀H₁₄ 134.221 g/mol NotAvailable Chymotrypsinogen A inhibitor Not Availables
protoporphyrin ix containing zn C₃₄H₃₂N₄O₄Zn₁ 626.031 g/mol NotAvailable P-Hydroxybenzoate Hydroxylase inhibitor Not Availables
n-benzylformamide C₈H₉N₁O₁ 135.165 g/mol NotAvailable Oxygen-Insensitive Nad inhibitor Not Availables
n-acetylprolin C₇H₁₁N₁O₃ 157.169 g/mol NotAvailable Beta-Glucosidase A inhibitor Not Availables
pseudouridine-5'-monophosphat C₉H₁₃N₂O₉P₁ 324.183 g/mol NotAvailable Pteridine Reductase inhibitor Not Availables
glutathionylspermidin C₁₇H₃₄N₆O₅S₁ 434.553 g/mol NotAvailable Transthyretin inhibitor Not Availables
n-butyl isocyanide C₅H₉N₁ 83.133 g/mol NotAvailable Pentaerythritol Tetranitrate Reductase inhibitor Not Availables
n-cyclohexyl-n'-(4-iodophenyl)urea C₁₃H₁₇N₂O₁I₁ 344.195 g/mol NotAvailable Deoxyuridine 5'-Triphosphate Nucleotide Hydr inhibitor Not Availables
n-carbamoyl-l-aspartate C₅H₈N₂O₅ 176.129 g/mol NotAvailable Fructose-1,6-Bisphosphatase inhibitor Not Availables
n-cyclohexyltaurine; ches C₈H₁₇N₁O₃S₁ 207.287 g/mol NotAvailable Nad inhibitor Not Availables
1,4-deoxy-1,4-dithio-beta-d-glucopyranose C₆H₁₂O₄S₂ 212.278 g/mol NotAvailable D-Xylose Isomerase inhibitor Not Availables
hymenialdisin C₁₁H₁₀N₅O₂Br₁ 324.136 g/mol NotAvailable Acetolactate Synthase, Mitochondrial inhibitor Not Availables
000003-[[*[[n-[4-methyl-piperazinyl]carbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonic säure benzyloxy-amide]] C₃₃H₄₃N₅O₅S₁ 621.793 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
12-bromododecanoic säure C₁₂H₂₃O₂Br₁ 279.216 g/mol NotAvailable Putative Cytochrome P450 inhibitor Not Availables
n-coeleneterazin C₃₀H₂₅N₃O₄ 491.545 g/mol NotAvailable Chondroitin Ac Lyase inhibitor Not Availables
n-carbamyl-d-valin C₆H₁₂N₂O₃ 160.172 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
n-carbamyl-d-methionin C₆H₁₂N₂O₃S₁ 192.232 g/mol NotAvailable tRNA-Guanine Transglycosylase inhibitor Not Availables
n-acetylmannosaminitol C₈H₁₉N₁O₆ 225.241 g/mol NotAvailable Queuine tRNA-Ribosyltransferase inhibitor Not Availables
n-acetyl-serin C₅H₉N₁O₄ 147.130 g/mol NotAvailable tRNA-Guanine-Transglycoylase inhibitor Not Availables
n-benzoyl-n'-beta-d-glucopyranosyl urea C₁₄H₁₈N₂O₇ 326.305 g/mol NotAvailable Pituitary Adenylate Cyclase Activating Po inhibitor Not Availables
000003-[[(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-n-(3,5-dichlorobenzyl)-benzamide]] C₁₈H₁₃N₇O₂Cl₂ 430.252 g/mol NotAvailable Diaminopimelic säure Dehydrogenase inhibitor Not Availables
l-xylitol 5-phosphat C₅H₁₃O₈P₁ 232.127 g/mol NotAvailable Queuine tRNA-Ribosyltransferase inhibitor Not Availables
n-acetyl-p-nitrophenylserinol C₁₁H₁₄N₂O₅ 254.242 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
n-acetyl-n'-beta-d-glucopyranosyl urea C₉H₁₆N₂O₇ 264.235 g/mol NotAvailable Mitogen-Activated Protein Kinase 10 inhibitor Not Availables
000006-[[[n-(1-isopropyl-3,4-dihydro-7-isoquinolinyl)carbamyl]-2-naphthalenecarboxamidin]] C₂₄H₂₄N₄O₁ 384.480 g/mol NotAvailable Serum Albumin inhibitor Not Availables
pyoverdine-chromophore C₅₅H₈₅N₁₇O₂₂ 1336.377 g/mol NotAvailable Odorant-Binding Protein inhibitor Not Availables
000002-bromo-2-chloro-1,1,1-trifluoroethan C₂H₁Br₁Cl₁F₃ 197.382 g/mol NotAvailable Motuporin inhibitor Not Availables
n-aminoethylmorpholin C₆H₁₄N₂O₁ 130.189 g/mol NotAvailable 5'-D inhibitor Not Availables
pterin-6-yl-methyl-monophosphat C₇H₈N₅O₅P₁ 273.144 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
pterin cytosine dinucleotide C₁₉H₂₂N₈O₁₃P₂S₂ 696.496 g/mol NotAvailable Biphenyl-2,3-Diol 1,2-Dioxygenase inhibitor Not Availables
000002-aminothiazolin C₃H₆N₂S₁ 102.154 g/mol NotAvailable Mre11 Nuclease inhibitor Not Availables
n-benzyl-3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-benzamide; bmsc001; 3-benzylaminocarbonylphenyl-alpha-d-galactoside; bapg C₂₀H₂₃N₁O₇ 389.404 g/mol NotAvailable Dtdp-Glucose Oxidoreductase inhibitor Not Availables
n-alpha-(2-naphthylsulfonyl)-n(3-amidino-l-phenylalaninyl)-4-acetyl-piperazin C₂₆H₂₉N₅O₄S₁ 507.606 g/mol NotAvailable Purine Trans Deoxyribosylase inhibitor Not Availables
purine riboside-5'-monophosphat C₁₀H₁₃N₄O₇P₁ 332.209 g/mol NotAvailable Ribonuclease, Seminal inhibitor Not Availables
methylethylamin C₃H₉N₁ 59.111 g/mol NotAvailable Ribonuclease A inhibitor Not Availables
Cysteamine Bitartrate Not Available Not Available NotAvailable Nucleoside Diphosphate Kinase II inhibitor Not Availables
n-alpha-(2-naphthylsulfonyl)-n(3-amidino-l-phenylalaninyl)isopipecolinic säure methyl ester C₂₇H₃₀N₄O₅S₁ 522.618 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
octanoyl-coenzyme a C₂₉H₅₀N₇O₁₇P₃S₁ 893.732 g/mol NotAvailable Beta-Amylase inhibitor Not Availables
[[n-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-n'-hydroxyimidoformamide]] C₁₀H₁₁N₅O₁S₁ 249.290 g/mol NotAvailable Ribonuclease 4 inhibitor Not Availables
platelet activating factor C₂₆H₅₄N₁O₇P₁ 523.689 g/mol NotAvailable Deoxyuridine 5'-Triphosphate Nucleotidohydro inhibitor Not Availables
inositol-(1,3,4,5)-tetrakisphosphat C₆H₁₆O₁₈P₄ 500.077 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
n-methyl-pyridoxal-5'-phosphat C₉H₁₃N₁O₆P₁₁+ 571.916 g/mol NotAvailable Shikimate 5-Dehydrogenase inhibitor Not Availables
n-methyl-n-propargyl-3-(2,4-dichlorophenoxy)propylamin C₁₃H₁₅N₁O₁Cl₂ 272.174 g/mol NotAvailable Acetohydroxy-säure Isomeroreductase inhibitor Not Availables
n-methyl-lysin C₇H₁₆N₂O₂ 160.216 g/mol NotAvailable Silent Information Regulator 2 inhibitor Not Availables
n-formylmethionin C₆H₁₁N₁O₃S₁ 177.218 g/mol NotAvailable 5'-D inhibitor Not Availables
000002-thiomethyl-3-phenylpropanoic säure C₁₀H₁₂O₂S₁ 196.264 g/mol NotAvailable Nucleoside Diphosphate Kinase inhibitor Not Availables
n-methyl-n-(methylbenzyl)formamide C₁₀H₁₃N₁O₁ 163.219 g/mol NotAvailable Nucleoside Diphosphate Kinase inhibitor Not Availables
[[n-methyl-n-(10-methylundecanoyl)-d-seryl-l-alanyl-n~1~-[(7s,10s,13s)-13-carboxy-3,18-dihydroxy-10-methyl-8,11-dioxo-9,12-diazatricyclo[13.3.1.1~2,6~]icosa-1(19),2(20),3,5,15,17-hexaen-7-yl]-n~1~-methylglycinamide]] C₄₂H₆₀N₆O₁₁ 824.970 g/mol NotAvailable Terminal Deoxynucleotidyltransferase Short I inhibitor Not Availables
[[n-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosin]] C₃₀H₃₀N₆O₆ 570.604 g/mol NotAvailable Cytidylate Kinase inhibitor Not Availables
n-methylmesoporphyrin C₃₅H₄₀N₄O₄ 580.725 g/mol NotAvailable Thymidylate Kinase inhibitor Not Availables
phosphothiophosphoric säure-adenylate ester C₁₀H₁₆N₅O₁₂P₃S₁ 523.244 g/mol NotAvailable Isoliquiritigenin 2'-O-Methyltransferase inhibitor Not Availables
n-octyl-2-hydroxyethyl sulfoxide C₁₀H₂₂O₂S₁ 206.343 g/mol NotAvailable Endoglucanase 5A inhibitor Not Availables
n-octanoyl-b-d-fructofuranosyl-a-d-glucopyranoside,sucrose monocaproylate C₂₀H₃₆O₁₂ 468.497 g/mol NotAvailable Biphenyl-2,3-Diol 1,2-Dioxygenase inhibitor Not Availables
n-methylleucin C₇H₁₅N₁O₂ 145.201 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
n'-(2s,3r)-3-amino-4-cyclohexyl-2-hydroxy-butano-n-(4-methylphenyl)hydrazide C₁₇H₂₇N₃O₂ 305.419 g/mol NotAvailable Dtdp-D-Glucose 4,6-Dehydratase inhibitor Not Availables
nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvalin C₂₆H₃₅N₈O₁₈P₂ 809.553 g/mol NotAvailable Arginase inhibitor Not Availables
n-methylmesoporphyrin containing copper C₃₅H₃₉N₄O₄Cu₁ 829.758 g/mol NotAvailable 2C-Methyl-D-Erythritol 2,4-Cyclodiphosph inhibitor Not Availables
piclamilast C₁₈H₁₈N₂O₃Cl₂ 381.258 g/mol NotAvailable Daptomycin inhibitor Not Availables
l-phospholactate C₃H₇O₆P₁ 170.058 g/mol NotAvailable 000003-Methylaspartate Ammonia-Lyase inhibitor Not Availables
propyl trihydrogen diphosphat C₃H₁₀O₇P₂ 220.055 g/mol NotAvailable Glutamate Receptor, Ionotropic Kainate 2 inhibitor Not Availables
pnu177836 C₃₁H₄₇N₃O₉ 605.727 g/mol NotAvailable Pol Polyprotein [Contains: Protease inhibitor Not Availables
n-heptylformamide C₈H₁₇N₁O₁ 143.228 g/mol NotAvailable Dethiobiotin Synthetase inhibitor Not Availables
proline betain C₇H₁₄N₁O₂₁+ 448.182 g/mol NotAvailable Bba1 inhibitor Not Availables
n-dimethyl-lysin C₈H₁₈N₂O₂ 174.242 g/mol NotAvailable Stromelysin-1 inhibitor Not Availables
n-cyclopentyl-n-cyclobutylformamide C₁₀H₁₇N₁O₁ 167.250 g/mol NotAvailable Delta-Aminolevulinic säure Dehydratase inhibitor Not Availables
n-ethyl-5'-carboxamido adenosin C₁₂H₁₆N₆O₄ 308.296 g/mol NotAvailable Triosephosphate Isomerase, Glycosomal inhibitor Not Availables
n-ethyl retinamide C₂₂H₃₃N₁O₁ 327.509 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
propyl acetat C₅H₁₀O₂ 102.133 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
pregnenolon C₂₁H₃₂O₂ 316.483 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
zk-806450 C₃₁H₃₁N₅O₁ 489.619 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
pmp-hydroxyisoxazole, pyridoxamine-5-phosphate-hydroxyisoxazol C₁₁H₁₄N₃O₇P₁ 331.221 g/mol NotAvailable Carbonyl Reductase [Nadph] 1 inhibitor Not Availables
n-isopropyl-n'-hydroxyguanidin C₄H₁₁N₃O₁ 117.150 g/mol NotAvailable Hepatitis C Virus Ns5B RNA Polymerase inhibitor Not Availables
n-hydroxyguanidin C₁H₅N₃O₁ 75.070 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
n-hexylphosphonate ethyl ester C₈H₁₉O₃P₁ 194.210 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
000005-[[[bis-2(chloro-ethyl)-amino]-2,4-dintro-benzamide]] C₁₁H₁₂N₄O₅Cl₂ 351.146 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
[[n-hydroxy-4-[(4-methoxylphenyl)sulfonyl]-2,2-dimethyl-hexahydro-1,4-thiazepine-3(s)-carboxamide]] C₁₅H₂₂N₂O₅S₂ 374.469 g/mol NotAvailable Tgf-Beta Receptor Type I inhibitor Not Availables
[[n-hydroxy-4-(methyl{[5-(2-pyridinyl)-2-thienyl]sulfonyl}amino)benzamide]] C₁₇H₁₅N₃O₄S₂ 389.443 g/mol NotAvailable Copper Amine Oxidase inhibitor Not Availables
n-hydroxy-1-(4-methoxyphenyl)sulfonyl-4-benzyloxycarbonyl-piperazine-2-carboxamide C₂₀H₂₃N₃O₇S₁ 449.478 g/mol NotAvailable Beta-Lactamase Tem inhibitor Not Availables
[[n-(6-{[3-(4-bromophenyl)-1,2-benzisothiazol-6-yl]oxy}hexyl)-n-methylprop-2-en-1-amin]] C₂₃H₂₇N₂O₁Br₁S₁ 459.443 g/mol NotAvailable Dihydroneopterin Aldolase inhibitor Not Availables
n-(5'-phosphopyridoxyl)-l-alanin C₁₁H₁₇N₂O₇P₁ 320.238 g/mol NotAvailable Dihydroneopterin Aldolase inhibitor Not Availables
n-(5-amino-5-carboxypentyl)glutamic säure C₁₁H₂₀N₂O₆ 276.289 g/mol NotAvailable Dihydroneopterin Aldolase inhibitor Not Availables
[[n-[(3z)-5-tert-butyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-ylidene]-n'-(4-chlorophenyl)urea]] C₂₀H₂₂N₄O₁Cl₁ 369.873 g/mol NotAvailable Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh inhibitor Not Availables
000003-[[hydroxymethyl-5-aziridinyl-1methyl-2-[1h-indole-4,7-dione]-propanol]] C₁₅H₁₈N₂O₄ 290.318 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
quisqualate C₅H₆N₃O₅ 188.119 g/mol NotAvailable Tetrameric Beta-Beta-Alpha Mini-Protein inhibitor Not Availables
r-1,2-propanediol C₃H₈O₂ 76.095 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
radicicol C₁₈H₂₆O₆Cl₁ 373.853 g/mol NotAvailable Human Immunodeficiency Virus Type 2 inhibitor Not Availables
[[(4-{2-acetylamino-2-[1-(3-carbamoyl-4-cyclohexylmethoxy-phenyl)-ethylcarbamoyl}-ethyl}-2-phosphono-phenoxy)-acetic säure]] C₂₉H₃₈N₃O₁₀P₁ 619.607 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
n-(5,5,8,8-tetramethyl-5,8-dihydro-naphthalen-2-yl)-terephthalamic säure C₂₂H₂₃N₁O₃ 349.429 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
n-(5-cyclopropyl-1h-pyrazol-3-yl)benzamide C₁₃H₁₃N₃O₁ 227.265 g/mol NotAvailable Cystathionine Gamma-Synthase inhibitor Not Availables
diureido-acetat C₄H₇N₄O₄₁- 767.101 g/mol NotAvailable Glutathione Reductase inhibitor Not Availables
n-(phosphonacetyl)-l-aspartic säure C₆H₁₀N₁O₈P₁ 255.121 g/mol NotAvailable Pepv inhibitor Not Availables
[[[methylseleno]acetat]] C₃H₅O₂Se₁₁- 941.631 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
[[n-[(furan-2-yl)carbonyl]-(s)-leucyl-(r)-[1-amino-2(1h-indol-3-yl)ethyl]-phosphonic säure]] C₂₁H₂₆N₃O₆P₁ 447.427 g/mol NotAvailable RNA Dependent RNA Polymerase inhibitor Not Availables
[[n-[(aminooxy)carbonyl]anilin]] C₇H₈N₂O₂ 152.152 g/mol NotAvailable Kinesin-Like Protein Kif11 inhibitor Not Availables
n-(m-trifluoromethylphenyl) phenoxazine-4,6-dicarboxylic säure C₂₁H₁₂N₁O₅F₃ 415.325 g/mol NotAvailable Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh inhibitor Not Availables
n-(chlorophenyl)-n'-hydroxyguanidin C₇H₈N₃O₁Cl₁ 185.613 g/mol NotAvailable Cruzain inhibitor Not Availables
n-(sulfanylacetyl)tyrosylprolylmethioninamide C₂₁H₃₀N₄O₅S₂ 482.612 g/mol NotAvailable 000003-Phosphoinositide Dependent Protein Kin inhibitor Not Availables
n-(r-carboxy-ethyl)-alpha-(s)-(2-phenylethyl)glycyl-l-arginine-n-phenylamide C₂₅H₃₅N₆O₄₁+ 1075.567 g/mol NotAvailable Glycogen Synthase Kinase-3 Beta inhibitor Not Availables
n-(r-carboxy-ethyl)-alpha-(s)-(2-phenylethyl) C₃₇H₄₄N₄O₃ 592.780 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
n-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide C₁₁H₁₂N₃O₂Cl₁S₁ 285.748 g/mol NotAvailable Rhodopsin inhibitor Not Availables
n-(1-adamantyl)-n'-(4-guanidinobenzyl)urea C₁₉H₂₇N₅O₁ 341.455 g/mol NotAvailable RNA Dependent RNA Polymerase inhibitor Not Availables
n-(4-(2-((3-chlorophenylmethyl)amino)ethyl)phenyl)-2-thiophecarboxamidin C₂₀H₂₀N₃Cl₁S₁ 369.911 g/mol NotAvailable Cruzain inhibitor Not Availables
n-(2-morpholin-4-yl-1-morpholin-4-ylmethyl-ethyl)-3-nitro-5-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-benzamide C₂₄H₃₆N₄O₁₁ 556.569 g/mol NotAvailable Cruzain inhibitor Not Availables
000001-deoxy-nojirimycin C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Thermolysin inhibitor Not Availables
rb106 C₂₂H₂₄N₂O₄S₁ 412.503 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
n-(2-acetamido)iminodiacetic säure C₆H₁₀N₂O₅ 190.155 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
n-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagin C₂₃H₂₇N₃O₆ 441.483 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
xylarohydroxamate C₅H₈N₁O₇₁- 1218.082 g/mol NotAvailable Dihydrodipicolinate Reductase inhibitor Not Availables
cra_10991 C₂₀H₂₀N₃O₂Cl₁ 369.850 g/mol NotAvailable Lactate Dehydrogenase inhibitor Not Availables
n-(2,6-diflouro-benzyl)-4-sulfamoyl-benzamide C₁₄H₁₂N₂O₃F₂S₁ 326.317 g/mol NotAvailable Proline Iminopeptidase inhibitor Not Availables
n-(4-hydroxyphenyl)all-trans retinamide C₂₆H₃₃N₁O₂ 391.552 g/mol NotAvailable Malonamidase E2 inhibitor Not Availables
s-oxy cystein C₃H₇N₁O₃S₁ 137.153 g/mol NotAvailable Cholera Toxin B Subunit inhibitor Not Availables
tazobactam intermediate C₁₀H₁₃N₄O₅S₁ 301.296 g/mol NotAvailable Cathepsin B inhibitor Not Availables
sp-722 C₁₇H₂₀N₂O₉S₁ 428.413 g/mol NotAvailable 000003-Dehydroquinate Dehydratase Arod inhibitor Not Availables
n-(2-thienylmethyl)-2,5-thiophenedisulfonamide C₉H₁₀N₂O₄S₄ 338.429 g/mol NotAvailable Cathepsin V inhibitor Not Availables
[[n-(3-cyclopropyl(5,6,7,8,9,10-hexahydro-2-oxo-2h-cycloocta[b]pyran-3-yl)methyl)phenylbenzensulfonamide]] C₂₇H₂₉N₁O₅S₁ 479.590 g/mol NotAvailable Copper Amine Oxidase inhibitor Not Availables
n-(3-(aminomethyl)benzyl)acetamidin C₁₀H₁₅N₃ Not Available NotAvailable Glycogen Phosphorylase inhibitor Not Availables
r048-8071 C₂₃H₂₇N₁O₂Br₁F₁ 448.374 g/mol NotAvailable Edap : Ace-Ile-Trp-Glu-Ser-Gly-Lys-Leu-Il inhibitor Not Availables
000003-oxiran-2ylalanin C₅H₉N₁O₃ 131.131 g/mol NotAvailable Plasmepsin 2 inhibitor Not Availables
[[n-{3-[(7ar,12as,12bs)-7-oxo-1,3,4,6,7,7a,12a,12b-octahydroindolo[2,3-a]quinolizin-12(2h)-yl]propyl}propane-2-sulfonamide]] C₂₁H₃₁N₃O₃S₁ 405.554 g/mol NotAvailable Homoserine Dehydrogenase inhibitor Not Availables
al-6629, [[[2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide,2-(3-methoxyphenyl)-3-(4-morpholinyl)-]], 1,1-dioxide] C₁₈H₂₁N₃O₆S₃ 471.560 g/mol NotAvailable Chemotaxis Protein Chey inhibitor Not Availables
mesoheme C₃₄H₃₂N₄O₄Fe₁ 616.498 g/mol NotAvailable In process Not Availables
[[n-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide]] C₂₃H₃₇N₅O₉ 527.573 g/mol NotAvailable Isomerase inhibitor Not Availables
[[n-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-nitro-5-(galactopyranosyl)-alpha-benzamide]] C₂₃H₃₇N₅O₉ 527.573 g/mol NotAvailable Nitric-Oxide Synthase, Brain inhibitor Not Availables
[[n-[tosyl-d-prolinyl]amino-ethanethiol]] C₁₄H₂₀N₂O₃S₂ 328.444 g/mol NotAvailable Liver Alcohol Dehydrogenase inhibitor Not Availables
[[n-[3-(dimethylamino)propyl]-2-({[4-({[4-(formylamino)-1-methyl-1h-pyrrol-2-yl]carbonyl}amino)-1-methyl-1h-pyrrol-2-yl]carbonyl}amino)-5-isopropyl-1,3-thiazole-4-carboxamide]] C₂₅H₃₄N₈O₄S₁ 542.655 g/mol NotAvailable Peroxisomal Carnitine O-Octanoyltransfer inhibitor Not Availables
pyridoxyl-alanine-5-phosphat C₁₁H₁₇N₂O₇P₁ 320.238 g/mol NotAvailable Ramoplanin inhibitor Not Availables
pyridoxyl-alanine-5-phosphate; vitamin b6 complexedwith alanin C₁₁H₁₇N₂O₇P₁ 320.238 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
[[n-{(4s)-4-amino-5-[(2-aminoethyl)amino]pentyl}-n'-nitroguanidin]] C₈H₂₁N₇O₂ 247.300 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Deaminase inhibitor Not Availables
fe-mesopone; (8,12-diethyl-3,8,13,17-tetramethyl-7-oxo-porphyrinato-2,18-dipropionic säure)iron(iii) C₃₄H₃₆N₄O₅Fe₁₁+ 1194.999 g/mol NotAvailable Lysozyme inhibitor Not Availables
pyridoxal-5'-phosphate-n-oxide C₈H₁₀N₁O₇P₁ 263.143 g/mol NotAvailable Nonspecific Lipid Transfer Protein inhibitor Not Availables
ru78783 C₇H₉O₆P₂ 251.092 g/mol NotAvailable Inosine-Adenosine-Guanosine Preferring Nucle inhibitor Not Availables
n-acetyl-l-citrullin C₈H₁₅N₃O₄ 217.224 g/mol NotAvailable Cytidine Deaminase inhibitor Not Availables
dibenzofuran-4,6-dicarboxylic säure C₁₄H₈O₅ 256.214 g/mol NotAvailable Glycolate Oxidase inhibitor Not Availables
[[n-{3-[5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-allyl}-2,3-dihydroxy-5-nitro-benzamide]] C₁₉H₁₉N₇O₈ 473.401 g/mol NotAvailable 000003-Dehydroquinate Dehydratase inhibitor Not Availables
pyridoxamine-5'-phosphat C₈H₁₃N₂O₅P₁ 248.175 g/mol NotAvailable 000003-Dehydroquinate Dehydratase inhibitor Not Availables
n-2-thiophen-2-yl-acetamide boronic säure C₇H₁₀N₁O₃B₁S₁ 199.031 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
[[n-1,2,3,4-tetrahydronaphth-1-yl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosin]] C₂₉H₃₂N₆O₆ 560.608 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
n-1-methylheptylformamide C₉H₁₉N₁O₁ 157.255 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
(mu-4-sulfido)-tetra-nuclear copper ion Cu₄S₁₅+ 1445.027 g/mol NotAvailable 000002-Dehydro-3-Deoxyphosphooctonate Aldolase inhibitor Not Availables
[[n-[2-(1-maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide]] C₂₀H₂₁N₃O₅ 383.403 g/mol NotAvailable Lysozyme inhibitor Not Availables
000005-phospho-d-arabinohydroxamic säure C₅H₁₂N₁O₉P₁ 261.125 g/mol NotAvailable Trans-Sialidase inhibitor Not Availables
[[n-[4-(2-{2-[3-(2-bromo-acetylamino)-propionylamino]-3-hydroxy-propionylamino}-ethyl)-phenyl]-oxalamic säure]] C₁₈H₂₃N₄O₇Br₁ 487.306 g/mol NotAvailable Superoxide Dismutase [Mn], Mitochondrial inhibitor Not Availables
000002-[[(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethanol]] C₁₁H₂₄O₆ 252.307 g/mol NotAvailable Hmg-Coa Reductase inhibitor Not Availables
pyruvamide C₃H₅N₁O₂ 87.078 g/mol NotAvailable Beta-1,4-Xylanase inhibitor Not Availables
[[n-[1-hydroxycarboxyethyl-carbonyl]leucylamino-2-methyl-butan]] C₁₅H₂₈N₂O₅ 316.397 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
[[n-[2(s)-cyclopentyl-1(r)-hydroxy-3(r)methyl]-5-[(2(s)-tertiary-butylamino-carbonyl)-4-(n1-(2)-(n-methylpiperazinyl)-3-chloro-pyrazinyl-5-carbonyl)-piperazino]-4(s)-hydroxy-2(r)-phenylmethyl-pentanamide]] C₃₇H₅₅N₈O₅Cl₁ 727.345 g/mol NotAvailable Bioh Protein inhibitor Not Availables
pyrrole-2-carboxylate C₅H₄N₁O₂₁- 414.081 g/mol NotAvailable L-3-Hydroxyacyl-Coa Dehydrogenase inhibitor Not Availables
bromopurin C₅H₃N₄Br₁ 199.010 g/mol NotAvailable 000003-Dehydroquinate Dehydratase inhibitor Not Availables
[[n-[amino(imino)methyl]glycin]] C₃H₇N₃O₂ 117.107 g/mol NotAvailable L-Lactate Dehydrogenase inhibitor Not Availables
n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea C₁₂H₁₂N₄O₄S₁ 308.311 g/mol NotAvailable Nad inhibitor Not Availables
pyridoxyl-n,o-cycloserylamide-5-monophosphat C₁₁H₁₆N₃O₇P₁ 333.237 g/mol NotAvailable Chemotactic Peptide inhibitor Not Availables
000009-(1,3-dihydroxy-propoxymethane)guanin C₉H₁₃N₅O₄ 255.233 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
[[n-[n-[1-hydroxycarboxyethyl-carbonyl]leucylamino-butyl]-guanidin]] C₁₅H₃₀N₅O₅₁+ 1096.405 g/mol NotAvailable Cellobiohydrolase Cel6A inhibitor Not Availables
2,4-dinitrophenyl 2-deoxy-2-fluoro-beta-d-allopyranoside C₁₂H₁₃N₂O₉F₁ 348.241 g/mol NotAvailable Sst1-Selective Somatosatin Analog inhibitor Not Availables
[[n-[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]acetamide]] C₁₄H₁₃N₅O₁ 267.290 g/mol NotAvailable 000003-Isopropylmalate Dehydrogenase inhibitor Not Availables
pyromellitic säure C₁₀H₆O₈ 254.153 g/mol NotAvailable Interleukin-2 inhibitor Not Availables
[[n-[5'-o-phosphono-ribofuranosyl]-2-[2-hydroxy-2-[4-[glutamic säure]-n-carbonylphenyl]-3-[2-amino-4-hydroxy-quinazolin-6-yl]-propanylamino]-acetamide]] C₃₀H₃₇N₆O₁₅P₁ 752.627 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
[[n-[4-methyl-3-*[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-pyridinecarboxamide]] C₂₂H₁₈N₆O₁ 382.424 g/mol NotAvailable Poly inhibitor Not Availables
pentanedial C₅H₈O₂ 100.117 g/mol NotAvailable DNA-3-Methyladenine Glycosylase I inhibitor Not Availables
phenyl boronic säure C₆H₇O₂B₁ 121.930 g/mol NotAvailable Vp39 inhibitor Not Availables
pas219 C₁₄H₁₈O₅P₁ 297.267 g/mol NotAvailable Cathepsin B inhibitor Not Availables
pentaethylene glycol monodecyl ether C₂₀H₄₂O₆ 378.548 g/mol NotAvailable Collagenase 3 inhibitor Not Availables
o-acetylserin C₅H₉N₁O₄ 147.130 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
phenyl-uridine-5'-diphosphat C₁₅H₁₈N₂O₁₂P₂ 480.261 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
alsterpaullon C₁₆H₁₁N₃O₃ 293.281 g/mol NotAvailable Xylose Isomerase inhibitor Not Availables
perchlorate ion O₄Cl₁₁- 453.981 g/mol NotAvailable S-Adenosylmethionine Synthetase inhibitor Not Availables
peridinin C₃₉H₅₀O₇ 630.820 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
000003-(7-hydroxy-8-ribityllumazine-6-yl) propionic säure C₁₄H₁₈N₄O₉ 386.318 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
o-phosphoglycolohydroxamate C₂H₆N₁O₆P₁ 171.046 g/mol NotAvailable Renin Complexed With Polyhydroxymonoamide In inhibitor Not Availables
o-benzylsulfonyl-serin C₁₀H₁₃N₁O₅S₁ 259.276 g/mol NotAvailable Trypsin I inhibitor Not Availables
o-sialic säure (chair conformation) C₁₁H₁₉N₁O₉ 309.272 g/mol NotAvailable L-Lactate Dehydrogenase inhibitor Not Availables
digalactosyl diacyl glycerol (dgdg) C₅₁H₉₆O₁₅ 949.310 g/mol NotAvailable Phosphoglycerate Mutase inhibitor Not Availables
para-xylen C₈H₁₀ 106.167 g/mol NotAvailable Phospho-2-Dehydro-3-Deoxyheptonate Aldolase, inhibitor Not Availables
willardiin C₇H₉N₃O₄ 199.166 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
pentabromophenol C₆H₁O₁Br₅ 488.593 g/mol NotAvailable Acyl-Coa Dehydrogenase, Medium-Chain Specifi inhibitor Not Availables
pd150606 C₉H₉O₂I₁S₁ 308.133 g/mol NotAvailable Fumarase C inhibitor Not Availables
desulfo-coenzyme a C₂₁H₃₆N₇O₁₆P₃ 735.474 g/mol NotAvailable Phosphoenolpyruvate Carboxylase inhibitor Not Availables
Pegvisomant C₉₉₀H₁₅₃₂N₂₆₂O₃₀₀S₇ 22129.0 NotAvailable Transthyretin inhibitor Not Availables
novo nordisk a/s compound C₉H₆N₁O₅I₁ 335.055 g/mol NotAvailable Factor D inhibitor Not Availables
phosphoglycolic säure C₂H₅O₆P₁ 156.032 g/mol NotAvailable D-Amino säure Oxidase inhibitor Not Availables
nz-(dicarboxymethyl)lysin C₉H₁₆N₂O₆ 248.235 g/mol NotAvailable Poly inhibitor Not Availables
000002-[[[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic säure]] C₁₃H₁₈N₂O₁₀P₂ 424.240 g/mol NotAvailable Cytosine Deaminase inhibitor Not Availables
000001-(2-amidinophenyl)-3-(phenoxyphenyl)urea C₂₀H₁₈N₄O₂ 346.388 g/mol NotAvailable Proto-Oncogene Serine/Threonine-Protein Kina inhibitor Not Availables
000003-methylpyridin C₆H₇N₁ 93.128 g/mol NotAvailable Phenylalanine 4-Monooxygenase inhibitor Not Availables
phosphoglycolohydroxamic säure C₂H₆N₁O₆P₁ 171.046 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
1,2,3,4-tetrahydro-isoquinoline-7-sulfonic säure amide C₉H₁₂N₂O₂S₁ 212.266 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
phosphoaspartate C₄H₈N₁O₇P₁ 213.083 g/mol NotAvailable Beta-Amylase inhibitor Not Availables
norleucine phosphonate C₅H₁₄N₁O₃P₁ 167.144 g/mol NotAvailable Queuine tRNA-Ribosyltransferase inhibitor Not Availables
phenylalanylmethan C₁₀H₁₃N₁O₁ 163.219 g/mol NotAvailable Hormone Receptor Alpha 1, Thra1 inhibitor Not Availables
2,3-dihydroxy-valerianic säure C₆H₁₂O₄ 148.158 g/mol NotAvailable Lysozyme inhibitor Not Availables
nz2-tryptophan C₁₀H₁₁N₃O₂ 205.216 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
phenylalanine amide C₉H₁₂N₂O₁ 164.207 g/mol NotAvailable Phenylalanine Ammonia-Lyase inhibitor Not Availables
tu-514 C₂₂H₄₁N₁O₇ 431.568 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
phenylphosphat C₆H₇O₄P₁ 174.093 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
phenylethane boronic säure C₈H₁₁O₂B₁ 149.984 g/mol NotAvailable Estrogen Sulfotransferase inhibitor Not Availables
phenylferricrocin-iron C₃₄H₄₈N₉O₁₂Fe₁ 830.653 g/mol NotAvailable Serum Albumin inhibitor Not Availables
nz-(1-carboxyethyl)-lysin C₉H₁₈N₂O₄ 218.252 g/mol NotAvailable Methionine Aminopeptidase inhibitor Not Availables
octahydroindole-2-carboxylic säure C₉H₁₅N₁O₂ 169.223 g/mol NotAvailable Iota-Carrageenase inhibitor Not Availables
oxiranpseudoglucose C₇H₁₂O₅ 176.169 g/mol NotAvailable Glutathione Reductase inhibitor Not Availables
d-fructose-6-phosphate (open form) C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable Kynureninase inhibitor Not Availables
000003-(3,5-dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonic säure (4-sulfamoyl-phenyl)-amide C₂₃H₁₈N₂O₇Br₂S₂ 658.332 g/mol NotAvailable Tat-Interacting Protein Tip30 inhibitor Not Availables
oxidized coenzyme a C₂₁H₃₆N₇O₁₇P₃S₁ 783.533 g/mol NotAvailable Bacteriorhodopsin inhibitor Not Availables
000005-hydroxyamino-3-methyl-pyrrolidine-2-carboxylic säure C₆H₁₂N₂O₃ 160.172 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
(4s-trans)-4-(ethylamino)-5,6-dihydro-6-methyl-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide C₁₀H₁₆N₂O₄S₃ 324.427 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
pantothenyl-aminoethanol-acetate pivalic säure C₁₈H₃₂N₂O₇ 388.460 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
[[o5'-(4-(3-{2-[2-((r)-3-hydroxy-4-(trimethylammonio)-1-oxo-butyl)sulfanyl-ethylcarbamoyl]-ethylcarbamoyl}-(r)-3-hydroxy-2,2-dimethyl-propyl)-1-hydroxy-3-oxido-1,3-dioxo-2,4-dioxa-1,3-diphosphabut-1-yl) 3'-phospho-adenosin]] C₂₈H₄₉N₈O₁₈P₃S₁ 910.719 g/mol NotAvailable 000003-Methyladenine DNA Glycosylase inhibitor Not Availables
oxonic säure C₄H₅N₃O₄ 159.101 g/mol NotAvailable Udp-N-Acetylglucosamine 1- Carboxyvinylt inhibitor Not Availables
000004-hydroxybenzoyl coenzyme a C₂₈H₄₀N₇O₁₈P₃S₁ 887.641 g/mol NotAvailable Nucleoside Diphosphate Kinase inhibitor Not Availables
000005-hydroxy-2-(hydroxymethyl)-4h-pyran-4-on C₆H₆O₄ 142.111 g/mol NotAvailable Thymidylate Kinase inhibitor Not Availables
oxaloacetate ion C₄H₃O₅₁- 867.037 g/mol NotAvailable Transketolase inhibitor Not Availables
olomoucin C₁₅H₁₈N₆O₁ 298.347 g/mol NotAvailable Nucleoside Diphosphate Kinase inhibitor Not Availables
sp-876 C₂₀H₂₅N₃O₁₀S₁ 499.492 g/mol NotAvailable Dtdp-4-Dehydrorhamnose 3,5-Epimerase inhibitor Not Availables
ono-6818 C₂₃H₃₀N₆O₄ 454.528 g/mol NotAvailable Probable Cysteine Desulfurase inhibitor Not Availables
octanoic säure (caprylic säure) C₈H₁₆O₂ 144.213 g/mol NotAvailable S-Adenosylhomocysteine Hydrolase inhibitor Not Availables
oxidized acetyl dithranol C₁₆H₁₀O₆ 298.251 g/mol NotAvailable Aminoglycoside 2'-N-Acetyltransferase inhibitor Not Availables
ortho-xylen C₈H₁₀ 106.167 g/mol NotAvailable Sulfate Adenylyltransferase inhibitor Not Availables
OspA lipoprotein C₁₁₉₈H₂₀₁₂N₃₂₂O₄₂₂S₂ 27743.1 NotAvailable Ribonuclease Mc inhibitor Not Availables
ovalicin C₁₆H₂₆O₅ 298.378 g/mol NotAvailable Transthyretin inhibitor Not Availables
000001-(5-tert-butyl-2-methyl-2h-pyrazol-3-yl)-3-(4-chloro-phenyl)-urea C₁₅H₁₉N₄O₁Cl₁ 306.794 g/mol NotAvailable Calmodulin inhibitor Not Availables
o-sulfo-l-serin C₃H₇N₁O₆S₁ 185.151 g/mol NotAvailable Granulysin inhibitor Not Availables
tri-chloro-acetaldehyde C₂H₁O₁Cl₃ 147.388 g/mol NotAvailable Beta-Hexosaminidase Beta Chain inhibitor Not Availables
palmitoyl-linoleoyl phosphatidylcholin C₄₂H₈₀N₁O₈P₁ 758.070 g/mol NotAvailable Proteinase K inhibitor Not Availables
compound 16 C₂₈H₃₁N₁O₄S₁ 477.617 g/mol NotAvailable Hypoxanthine-Guanine Phosphoribosyltransfera inhibitor Not Availables
000004-[[[3-carboxymethyl-3-(4-phosphonooxy-benzyl)-ureido]-4-[(3-cyclohexyl-propyl)-methyl-carbamoyl]butyric säure]] C₂₅H₃₈N₃O₁₀P₁ 571.563 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
para-toluene sulfonate C₇H₈O₃S₁ 172.198 g/mol NotAvailable Peroxisomal Hydratase-Dehydrogenase-Epimeras inhibitor Not Availables
para acetamido benzoic säure C₉H₉N₁O₃ 179.175 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
para-coumaric säure C₉H₈O₃ 164.160 g/mol NotAvailable Metabotropic Glutamate Receptor Subtype 1 inhibitor Not Availables
para-iodo-d-phenylalanine hydroxamic säure C₉H₁₁N₂O₂I₁ 306.103 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
dodecyl-coa C₃₃H₅₈N₇O₁₇P₃S₁ 949.839 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
000004-deoxylactose C₁₂H₂₂O₁₀ 326.300 g/mol NotAvailable Trypsin inhibitor Not Availables
p-hydroxybenzoic säure C₇H₆O₃ 138.123 g/mol NotAvailable Actin, Alpha Skeletal Muscle inhibitor Not Availables
s,s'-(1,3-phenylene-bis(1,2-ethanediyl))bis-isothiourea C₁₂H₁₈N₄S₂ 282.421 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
o2-sulfo-glucuronic säure C₆H₁₀O₁₀S₁ 274.199 g/mol NotAvailable Estrogen Receptor Beta inhibitor Not Availables
p1-(adenosine-5'-p5-(uridine-5')pentaphosphat C₁₉H₂₈N₇O₂₄P₅ 893.331 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Synthase inhibitor Not Availables
palmitoyl C₁₆H₃₁O₁ 239.420 g/mol NotAvailable Avidin inhibitor Not Availables
formycin b C₁₀H₁₂N₄O₅ 268.229 g/mol NotAvailable Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh inhibitor Not Availables
o1-methyl-glucose C₇H₁₄O₆ 194.184 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
o1-methyl-4-deoxy-4-thio-beta-d-glucose C₇H₁₄O₅S₁ 210.245 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
2,5-dimethylpyrimidin-4-amin C₆H₁₀N₃ 124.165 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
[[phosphoric säure mono-[3,4-dihydroxy-5-(5-hydroxy-benzoimidazol-1-yl)tetrahydro-furan-2-ylmethyl] ester]] C₁₀H₁₃N₄O₈P₁ 348.208 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
carbenoxolon C₃₄H₅₀O₇ 570.765 g/mol NotAvailable Tgf-Beta Receptor Type I inhibitor Not Availables
[[n2-[(benzyloxy)carbonyl]-n1-[(3s)-1-cyanopyrrolidin-3-yl]-l-leucinamide]] C₁₉H₂₆N₄O₃ 358.439 g/mol NotAvailable Diga16 inhibitor Not Availables
n~2~-succinylarginin C₁₀H₁₈N₄O₅ 274.276 g/mol NotAvailable Diga16 inhibitor Not Availables
[[phosphoric säure mono-[3-fluoro-5-(5-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-yl)-tetrahyro-furan-2-ylmethyl] ester]] C₁₀H₁₄N₂O₇F₁P₁ 324.202 g/mol NotAvailable Cytochrome P450 2B4 inhibitor Not Availables
gamma(amino)-butyric säure C₄H₉N₁O₂ 103.121 g/mol NotAvailable Homoserine Dehydrogenase inhibitor Not Availables
n-pyridoxyl-1-amino-cyclopropanecarboxylic säure-5-monophosphat C₁₂H₁₇N₂O₇P₁ 332.249 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
[[phosphoric säure mono-[5-(2-amino-4-oxo-4,5-dihydro-3h-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-dihydroxy-pyrrolidin-2-ylmethyl] ]] Not Available Not Available NotAvailable Influenza A Subtype N2 Neuraminidase inhibitor Not Availables
[[n'-(pyrrolidino[2,1-b]isoindolin-4-on-8-yl)-n-(pyridin-2-yl)urea]] C₁₇H₁₆N₄O₂ 308.339 g/mol NotAvailable Influenza A Subtype N2 Neuraminidase inhibitor Not Availables
000005-hydroxymethyluridine-2'-deoxy-5'-monophosphat C₁₀H₁₆N₂O₉P₁ 339.218 g/mol NotAvailable Influenza A Subtype N2 Neuraminidase inhibitor Not Availables
n2-(carboxyethyl)-l-arginin C₉H₁₈N₄O₄ 246.266 g/mol NotAvailable Influenza Virus B/Lee/40 Neuraminidase inhibitor Not Availables
000004-amino-2-deoxy-2,3-dehydro-n-neuraminic säure C₁₁H₁₈N₂O₇ 290.272 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
n5-iminoethyl-l-ornithin C₇H₁₅N₃O₂ 173.214 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
s-(n-hydroxy-n-bromophenylcarbamoyl)glutathion C₁₇H₂₃N₄O₈Br₁S₁ 523.355 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
n3, n4-dimethylarginin C₈H₁₈N₄O₂ 202.256 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
n1-(1-dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-n4-(2-pyridin-2-yl-ethyl)-succinamide C₂₂H₂₆N₄O₄ 410.472 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
trifluoroalanin C₃H₄N₁O₂F₃ 143.065 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000003-[[({5-benzyl-6-hydroxy-2,4-bis-(4-hydroxy-benzyl)-3-oxo-[1,2,4]-triazepane-1-sulfonyl)-benzonitrile]] C₃₂N₄O₆S₁ 568.435 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
n1,n14-bis((s-methyl)isothioureido)tetradecan C₁₈H₃₈N₄S₂ 374.645 g/mol NotAvailable Map Kinase P38 inhibitor Not Availables
[[n1-[3-(dimethylsulfonio)-propyl]bleomycinamide]] C₅₅H₈₅N₁₇O₂₁S₃ 1416.558 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
n-propyl-tartramic säure C₇H₁₃N₁O₅ 191.183 g/mol NotAvailable Trypsin inhibitor Not Availables
n-phenylthiourea C₇H₈N₂S₁ 152.214 g/mol NotAvailable Glutamine Aminotransferase inhibitor Not Availables
000001-[[[4-(octahydro-pyrido[1,2-a]pyrazin-2-yl)-phenyl]-2-phenyl-1,2,3,4-tetrahydro-isoquinolin-6-ol]] C₂₉H₃₃N₃O₁ 439.599 g/mol NotAvailable Enoyl-Coa Hydratase inhibitor Not Availables
phosphorylated aspartate C₄H₈N₁O₇P₁ 213.083 g/mol NotAvailable Growth Factor Receptor-Bound Protein 2 inhibitor Not Availables
n-pyridoxyl-2-methylalanine-5-phosphat C₁₂H₁₉N₂O₇P₁ 334.265 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
000006-chloro-2-(2-hydroxy-biphenyl-3-yl)-1h-indole-5-carboxamidin C₂₁H₁₇N₃O₁Cl₁₁+ 717.368 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
n-omega-propyl-l-arginin C₉H₂₁N₄O₂₁+ 521.279 g/mol NotAvailable Sst1-Selective Somatosatin Analog inhibitor Not Availables
phosphorylated dihydropteroate C₁₄H₁₁N₆O₆P₁ 390.251 g/mol NotAvailable Tricorn Protease inhibitor Not Availables
hydroxydimethylarsine oxide C₂H₇O₂As₁ 137.998 g/mol NotAvailable Pp60 V-Src Tyrosine Kinase Transforming Prot inhibitor Not Availables
n-propargyl-1(s)-aminoindan C₁₂H₁₃N₁ 171.241 g/mol NotAvailable Cyclin-Dependent Kinase 2 inhibitor Not Availables
n-trimethyllysin C₉H₂₁N₂O₂₁+ 493.266 g/mol NotAvailable P38 Kinase inhibitor Not Availables
n-succinyl methionin C₉H₁₅N₁O₅S₁ 249.281 g/mol NotAvailable Retinoic säure Receptor Gamma-1 inhibitor Not Availables
n,n'-bis(4-amino-2-methylquinolin-6-yl)urea C₂₁H₂₁N₆O₁ 373.436 g/mol NotAvailable Fibroblast Growth Factor Receptor 2 inhibitor Not Availables
n,n-dimethyl-l-alanin C₅H₁₁N₁O₂ 117.147 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
n,n-bis(4-chlorobenzyl)-1h-1,2,3,4-tetraazol-5-amin C₁₅H₁₃N₅Cl₂ 334.207 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
n-pyridoxyl-threonine-5-monophosphat C₁₂H₁₉N₂O₈P₁ 350.264 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
n-pyridoxyl-glycine-5-monophosphat C₁₀H₁₅N₂O₇P₁ 306.211 g/mol NotAvailable Xanthine Dehydrogenase inhibitor Not Availables
n-tridecanoic säure C₁₃H₂₆O₂ 214.347 g/mol NotAvailable Fumarylacetoacetate Hydrolase inhibitor Not Availables
n-sulfo-flavin mononucleotide C₁₇H₂₁N₄O₁₂P₁S₁ 536.406 g/mol NotAvailable Gfp-Like Chromoprotein Fp595 inhibitor Not Availables
[[phosphoric säure-2'-[2'-deoxy-uridine]ester-5'-guanosine ester]] C₁₉H₂₄N₇O₁₃P₁ 589.411 g/mol NotAvailable Trypsinogen, Cationic inhibitor Not Availables
phosphonoacetaldehyde C₂H₅O₄P₁ 124.033 g/mol NotAvailable Type 2 Rhinovirus 3C Protease inhibitor Not Availables
n-methylnaloxonium C₂₀H₂₄N₁O₄₁+ 934.392 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
nicotinamide adenine dinucleotide acetone adduct C₂₄H₃₁N₇O₁₅P₂ 719.494 g/mol NotAvailable Cell Division Protein Zipa inhibitor Not Availables
phosphomethylphosphonic säure guanosyl ester C₁₁H₁₇N₅O₁₀P₂ 441.230 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
nitromethyldethia coenzyme a C₂₂H₃₇N₈O₁₈P₃ 794.498 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
nitrocefin acyl-serin C₂₄H₂₁N₅O₁₁S₂₄- 1324.897 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
nicotinamide adenine dinucleotide 3-pentanone adduct C₂₆H₃₅N₇O₁₅P₂ 747.548 g/mol NotAvailable Sialidase inhibitor Not Availables
phosphoribosyl atp C₁₅H₁₉N₅O₂₀P₄ 713.232 g/mol NotAvailable Neuraminidase inhibitor Not Availables
nicotinamide-adenine-dinucleotide (säureic form) C₂₁H₂₇N₇O₁₄P₂ 663.430 g/mol NotAvailable ATP Synthase inhibitor Not Availables
nicotinamide mononucleotide C₁₁H₁₆N₂O₈P₁₁+ 644.967 g/mol NotAvailable 000004-Aminobutyrate Aminotransferase inhibitor Not Availables
n-bromoacetyl-aminoethyl phosphat C₄H₉N₁O₅Br₁P₁ 261.997 g/mol NotAvailable In process Not Availables
nonaethylene glycol C₁₈H₃₈O₁₀ 414.492 g/mol NotAvailable Neuraminidase inhibitor Not Availables
7,8-dihydro-l-biopterin C₉H₁₃N₅O₃ 239.233 g/mol NotAvailable Plasmepsin 2 inhibitor Not Availables
indole-3-propanol phosphat C₁₁H₁₄N₁O₄P₁ 255.210 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
norcamphor C₇H₁₀O₁ 110.155 g/mol NotAvailable Lysozyme C inhibitor Not Availables
nitrosoethan C₂H₅N₁O₁ 59.068 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
inhibitor bea409 C₄₀H₅₀N₄O₈S₂ 778.977 g/mol NotAvailable Protoporphyrinogen Oxidase, Mitochondria inhibitor Not Availables
phosphomethylphosphonic säure guanylate ester C₁₁H₁₈N₅O₁₃P₃ 521.210 g/mol NotAvailable Isopentenyl Diphosphate Delta-Isomerase inhibitor Not Availables
nojirimycine tetrazol C₆H₁₀N₄O₄ 202.169 g/mol NotAvailable Inosine-5'-Monophosphate Dehydrogenase inhibitor Not Availables
nogalaviketon C₂₁H₁₄O₇ 378.337 g/mol NotAvailable Protein-Tyrosine-Phosphatase inhibitor Not Availables
000002-[[amino-7-[2-(2-hydroxy-1-hydroxymethyl-ethylamino)-ethyl]-1,7-dihydro-purin-6-on]] C₁₀H₁₆N₆O₃ 268.275 g/mol NotAvailable Glutaminase-Asparaginase inhibitor Not Availables
[[phosphoric säure mono-[2-amino-3-(3h-imidazol-4-yl)-propyl]ester]] C₆H₁₂N₃O₄P₁ 221.152 g/mol NotAvailable Glycolate Oxidase inhibitor Not Availables
colamine phosphoric säure C₂H₈N₁O₄P₁ 141.063 g/mol NotAvailable Phenylalanine Ammonia-Lyase inhibitor Not Availables
2,4,6-trinitrophenol C₆H₃N₃O₇ 229.106 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
namn C₁₁H₁₄N₁O₉P₁ 335.207 g/mol NotAvailable 1,4-Alpha-D-Glucan Glucanohydrolase inhibitor Not Availables
[[n6-(2,5-dimethoxy-benzyl)-n6-methyl-pyrido[2,3-d]pyrimidine-2,4,6-triamin]] C₁₇H₂₀N₆O₂ 340.384 g/mol NotAvailable Cellobiohydrolase II inhibitor Not Availables
n5-methylglutamin C₆H₁₂N₂O₃ 160.172 g/mol NotAvailable Cellobiohydrolase II inhibitor Not Availables
aurodox; 1-methylmocimycin; antibiotic x-5108;goldinodox; goldinomycin C₄₄H₆₂N₂O₁₂ 810.980 g/mol NotAvailable Cyclodextrin-Glycosyltransferase inhibitor Not Availables
[[phosphoric säure mono-[2-(2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-yl)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-3-yl] ]] Not Available Not Available NotAvailable Chondroitinase B inhibitor Not Availables
000001-methyloxy-4-sulfone-benzen C₇H₇O₃S₁ 171.190 g/mol NotAvailable Algq2 inhibitor Not Availables
nd1-phosphonohistidin C₆H₁₁N₃O₅P₁₁+ 545.881 g/mol NotAvailable Glucarate Dehydratase inhibitor Not Availables
phosphonoserin C₃H₈N₁O₆P₁ 185.073 g/mol NotAvailable Galactosyl Transferase Lgtc inhibitor Not Availables
phosphonoacetohydroxamic säure C₂H₆N₁O₅P₁ 155.047 g/mol NotAvailable Histone Deacetylase 8 inhibitor Not Availables
phosphonoformic säure C₁H₃O₅P₁ 126.005 g/mol NotAvailable 000002-C-Methyl-D-Erythritol 2,4-Cyclodiphosphate inhibitor Not Availables
000001-hexadecanosulfonyl-o-l-serin C₁₉H₃₉N₁O₅S₁ 393.581 g/mol NotAvailable 000002-C-Methyl-D-Erythritol 2,4-Cyclodiphosphate inhibitor Not Availables
phosphonothreonin C₄H₁₀N₁O₆P₁ 199.100 g/mol NotAvailable Cell Wall Pentapeptide Ala-[ inhibitor Not Availables
naphthalen-1-yl-acetic säure C₁₂H₁₀O₂ 186.210 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
naphthyridine inhibitor C₁₇H₁₅N₅ 289.339 g/mol NotAvailable Lysozyme inhibitor Not Availables
000005-methyl-5,6,7,8-tetrahydrofolic säure C₂₀H₂₅N₇O₆ 459.461 g/mol NotAvailable Avermectin-Sensitive Chloride Channel Gl inhibitor Not Availables
n-butyl-benzenesulfonamide C₁₀H₁₅N₁O₂S₁ 213.294 g/mol NotAvailable Complement Factor B inhibitor Not Availables
000001-benzyl-(r)-propylamin C₁₀H₁₅N₁ 149.235 g/mol NotAvailable Lipoxygenase-3 inhibitor Not Availables
hydroxyaminovalin C₅H₁₂N₂O₂ 132.162 g/mol NotAvailable Major Nad inhibitor Not Availables
Immune globulin C₆₃₃₂H₉₈₂₆N₁₆₉₂O₁₉₈₀S₄₂ 142682.3 NotAvailable L-Lactate Dehydrogenase B Chain inhibitor Not Availables
000002-aminobenzoic säure C₇H₇N₁O₂ 137.138 g/mol NotAvailable L-Lactate Dehydrogenase inhibitor Not Availables
hypophosphite O₂P₁₁- 372.710 g/mol NotAvailable Fk506-Binding Protein inhibitor Not Availables
hydroxyalanin C₃H₇N₁O₃ 105.093 g/mol NotAvailable Cytochrome P450 2C9 inhibitor Not Availables
fluorotryptophan C₁₁H₁₁N₂O₂F₁ 222.219 g/mol NotAvailable Isopentenyl-Diphosphate Delta-Isomerase inhibitor Not Availables
hydroxyphenyl propionic säure C₉H₁₀O₃ 166.176 g/mol NotAvailable Cytosine Deaminase inhibitor Not Availables
hydroxyethylcystein C₅H₁₁N₁O₃S₁ 165.207 g/mol NotAvailable Aconitase inhibitor Not Availables
s,s-propylthiocystein C₆H₁₃N₁O₁S₂ 179.295 g/mol NotAvailable 000004-Hydroxythreonine-4-Phosphate Dehydrogenase inhibitor Not Availables
immucillin-g C₁₁H₁₅N₅O₄ 281.271 g/mol NotAvailable 000004-Hydroxybenzoyl-Coa Thioesterase inhibitor Not Availables
icrf-187 C₁₁H₁₆N₄O₄ 268.272 g/mol NotAvailable Thioesterase inhibitor Not Availables
Secretin,synthetic C₁₃₀H₂₁₉N₄₃O₄₂ 3056.4 NotAvailable Trypsin inhibitor Not Availables
s,s-(2-hydroxyethyl)thiocystein C₅H₁₁N₁O₃S₂ 197.267 g/mol NotAvailable Ramoplanin inhibitor Not Availables
d-myo-inositol-1,4,5-triphosphat C₆H₁₅O₁₅P₃ 420.097 g/mol NotAvailable Estrogen Receptor Alpha inhibitor Not Availables
i-coeleneterazin C₂₆H₂₂N₃O₄I₁ 567.382 g/mol NotAvailable Blue Fluorescent Protein inhibitor Not Availables
000008-methyl-9-oxoguanin C₆H₆N₄O₂ 166.139 g/mol NotAvailable Thiamin Phosphate Synthase inhibitor Not Availables
imidazole-derived cellobiose C₁₄H₂₂N₂O₉ 362.336 g/mol NotAvailable Thiamin Phosphate Synthase inhibitor Not Availables
idd552 C₁₇H₁₀N₂O₄F₄S₁ 414.331 g/mol NotAvailable Beta-Lactamase Pse-2 inhibitor Not Availables
hexatantalum dodecabromide Br₁₂TA₆₂+ 12177.618 g/mol NotAvailable Trypsin inhibitor Not Availables
hexadecyl octanoate C₂₄H₄₈O₂ 368.642 g/mol NotAvailable Dehaloperoxidase inhibitor Not Availables
hydrolyzed cephalothin C₁₄H₁₄N₂O₄S₂ 338.396 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
salicylic säure C₇H₆O₃ 138.123 g/mol NotAvailable Carminomycin 4-O-Methyltransferase inhibitor Not Availables
hirulog Not Available Not Available NotAvailable Branched-Chain Amino säure Aminotransferase inhibitor Not Availables
heptyl-beta-d-glucopyranoside C₁₃H₂₆O₆ 278.345 g/mol NotAvailable Hydroxyethylthiazole Kinase inhibitor Not Availables
heptyl 1-thiohexopyranoside C₁₃H₂₆O₅S₁ 294.405 g/mol NotAvailable Thiamin Phosphate Synthase inhibitor Not Availables
hexanoyl-coenzyme a C₂₇H₄₆N₇O₁₇P₃S₁ 865.678 g/mol NotAvailable Actin Alpha 1 inhibitor Not Availables
hexane-1,6-diol C₆H₁₄O₂ 118.175 g/mol NotAvailable Monomethylamine Methyltransferase inhibitor Not Availables
000002-[[[4-(4-hydroxy-3-isopropyl-phenoxy)-3,5-dimethyl-phenyl]-2h-[1,2,4]triazine-3,5-dion]] C₂₀H₂₁N₃O₄ 367.404 g/mol NotAvailable Phenylalanine Ammonia-Lyase 1 inhibitor Not Availables
saha C₁₄H₂₀N₂O₃ 264.324 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
huperaine a C₁₅H₂₀N₂O₁ 244.336 g/mol NotAvailable Cathepsin V inhibitor Not Availables
n-acetyl serotonin C₁₂H₁₄N₂O₂ 218.255 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
3,4-dihydro-5-methyl-isoquinolinon C₁₀H₁₁N₁O₁ 161.203 g/mol NotAvailable Lysozyme inhibitor Not Availables
p1-(5'-adenosyl)p5-(5'-(3'azido-3'-deoxythymidyl))pentaphosphat C₂₀H₂₄N₁₀O₂₂P₅₅- 2460.020 g/mol NotAvailable Concanavalin A inhibitor Not Availables
hpp C₉H₈O₄ 180.160 g/mol NotAvailable Cathepsin F inhibitor Not Availables
histidyl-adenosine monophosphat C₁₆H₂₁N₈O₈P₁ 484.364 g/mol NotAvailable Trihydroxynaphthalene Reductase inhibitor Not Availables
hydantocidin-5'-phosphat C₇H₁₁N₂O₉P₁ 298.146 g/mol NotAvailable Alpha-L-Arabinofuranosidase inhibitor Not Availables
methyltrienolone; 17beta-hydroxy-17methyl-19norandrosta-4,9,11-trien-3-one; r1881 C₁₉H₂₄O₂ 284.397 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
hybrid between b and c type hemes (protoporphyrin ixcontaining fe) C₃₄H₃₄N₄O₄Fe₁ 618.514 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
000004-[[(aminosulfonyl)-n-[(2,3,4-trifluorophenyl)methyl]-benzamide]] C₁₄H₁₁N₂O₃F₃S₁ 344.308 g/mol NotAvailable Alpha-D-Glucuronidase inhibitor Not Availables
iodophenyl C₆H₅I₁ 204.010 g/mol NotAvailable Alpha-D-Glucuronidase inhibitor Not Availables
s-methylcystein C₄H₉N₁O₂S₁ 135.181 g/mol NotAvailable Prothrombin inhibitor Not Availables
s-isopropyl-isothiourea C₄H₁₀N₂S₁ 118.196 g/mol NotAvailable Fpra inhibitor Not Availables
iso24 C₉H₁₂N₁O₄P₁ 229.172 g/mol NotAvailable Retinol Dehydratase inhibitor Not Availables
iso-ursodeoxycholic säure C₂₄H₄₀O₄ 392.578 g/mol NotAvailable Porphobilinogen Synthase inhibitor Not Availables
[[phosporic säure mono-[3,4-dihydroxy-5-(5-methoxy-benzoimidazol-1-yl)-tetrahydro-furan-2-ylmethyl] ester]] C₁₃H₁₇N₂O₈P₁ 360.260 g/mol NotAvailable Putative Cytochrome P450 inhibitor Not Availables
inhibitor bea369 C₃₈H₄₀N₂O₈ 652.743 g/mol NotAvailable Trypsinogen inhibitor Not Availables
iodo-willardiin C₇H₈N₃O₄I₁ 325.062 g/mol NotAvailable Carbohydrate-Phosphate Isomerase inhibitor Not Availables
s-methyl thiocysteine group C₄H₉N₁O₂S₂ 167.241 g/mol NotAvailable Carbohydrate-Phosphate Isomerase inhibitor Not Availables
iodo-phenylalanin C₉H₁₀N₁O₂I₁ 291.088 g/mol NotAvailable Liver Carboxylesterase inhibitor Not Availables
s-mercaptocystein C₃H₇N₁O₂S₂ 153.214 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000002-aminopimelic säure C₇H₁₃N₁O₄ 175.184 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
jaspisamide a C₄₄H₆₂N₄O₁₃ 854.993 g/mol NotAvailable Endoglucanase G inhibitor Not Availables
isopropyl alcohol C₃H₈O₁ 60.096 g/mol NotAvailable Cellulase Celf inhibitor Not Availables
isopentyl pyrophosphat C₅H₁₄O₇P₂ 248.109 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
pentane-1,5-diamin C₅H₁₄N₂ 102.179 g/mol NotAvailable Transcriptional Regulator Qacr inhibitor Not Availables
isobutylbenzen C₁₀H₁₄ 134.221 g/mol NotAvailable Chondroitinase Ac inhibitor Not Availables
isoniazid; tubazid; rimitsid; isonicotinylhydrazine;lanizid; nydrazid C₆H₄N₃O₁ 134.117 g/mol NotAvailable Chondroitinase Ac inhibitor Not Availables
isoformononetin C₁₆H₁₂O₄ 268.268 g/mol NotAvailable Chondroitin Ac Lyase inhibitor Not Availables
isocitrate calcium complex C₆H₇O₇Ca₁ 231.197 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
inhibitor bea322 C₃₄H₅₀N₄O₈ 642.791 g/mol NotAvailable Trihydroxynaphthalene Reductase inhibitor Not Availables
indole-3-glycerol phosphat C₁₁H₁₄N₁O₆P₁ 287.208 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
s-octylglutathion C₁₈H₃₃N₃O₆S₁ 419.535 g/mol NotAvailable Alpha-Amylase, Salivary inhibitor Not Availables
dextrofloxacin C₁₈H₂₀N₃O₄F₁ 361.372 g/mol NotAvailable Cyclodextrin Glycosyltransferase inhibitor Not Availables
000004-hydroxy-2-butanon C₄H₈O₂ 88.106 g/mol NotAvailable Cyclomaltodextrin Glucanotransferase inhibitor Not Availables
indole naphthyridinon C₂₂H₂₂N₄O₂ 374.441 g/mol NotAvailable Xanthan Lyase inhibitor Not Availables
indirubin-5-sulphonate C₁₆H₁₀N₂O₅S₁ 342.325 g/mol NotAvailable Azurin inhibitor Not Availables
indolylpropionic säure C₁₁H₁₁N₁O₂ 189.213 g/mol NotAvailable Porphobilinogen Synthase inhibitor Not Availables
s,3-hydroxybutan-2-on C₄H₈O₂ 88.106 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
phosphomethylphosphonic säure adenosyl ester C₁₁H₁₇N₅O₉P₂ 425.231 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
inhibitor idd 384 C₁₉H₂₂N₂O₅S₁ 390.453 g/mol NotAvailable Chalcone--Flavonone Isomerase 1 inhibitor Not Availables
000005-methyluridine 5'-monophosphat C₁₀H₁₅N₂O₉P₁ 338.210 g/mol NotAvailable Beta-D-Glucan Glucohydrolase Isoenzyme Exo1 inhibitor Not Availables
inositol-(1,3,4,5,6)-pentakisphosphat C₆H₁₇O₂₁P₅ 580.056 g/mol NotAvailable Phosphopantetheine Adenylyltransferase inhibitor Not Availables
inositol 1,3,4,5-tetrakisphosphat C₆H₁₆O₁₈P₄ 500.077 g/mol NotAvailable Nitric Oxide Synthase, Inducible inhibitor Not Availables
inositol 1,3-bisphosphat C₆H₁₄O₁₂P₂ 340.117 g/mol NotAvailable Inosine-5'-Monophosphate Dehydrogenase inhibitor Not Availables
inhibitor bea403 C₃₈H₆₂F₂N₂O₈ 712.91 g/mol NotAvailable 000003-Phosphoshikimate 1-Carboxyvinyltransferase inhibitor Not Availables
inhibitor bea403 C₃₈H₃₈N₂O₈F₂ 688.724 g/mol NotAvailable Phenylethylamine Oxidase inhibitor Not Availables
s-oxymethionin C₅H₁₁N₁O₃S₁ 165.207 g/mol NotAvailable Methionine Aminopeptidase inhibitor Not Availables
s-p-nitrobenzyloxycarbonylglutathion C₁₈H₂₄N₄O₁₀S₁ 488.468 g/mol NotAvailable Autoinducer-2 Production Protein Luxs inhibitor Not Availables
s-phosphocystein C₃H₈N₁O₅P₁S₁ 201.134 g/mol NotAvailable Caffeic säure 3-O-Methyltransferase inhibitor Not Availables
[[(s)-2-{methyl-[2-(naphthalene-2-sulfonylamino)-5-(naphthalene-2-sulfonyloxy)-benzoyl]-amino}-succinicsäure]] C₃₂H₂₆N₂O₁₀S₂ 662.685 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
skf 107457 C₂₉H₄₇N₅O₇ 577.720 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
genz-10850 C₂₆H₂₃N₃O₁ 393.487 g/mol NotAvailable 5'-D inhibitor Not Availables
glutathione s-(2,4 dinitrobenzene) C₁₆H₁₉N₅O₁₀S₁ 473.414 g/mol NotAvailable Lumazine Synthase inhibitor Not Availables
glucosamine 1-phosphat C₆H₁₄N₁O₈P₁ 259.152 g/mol NotAvailable Acetolactate Synthase, Mitochondrial inhibitor Not Availables
(1s,3s,4s)-1,3,4-triphospho-myo-inositol C₆H₁₅O₁₅P₃ 420.097 g/mol NotAvailable Monomethylamine Methyltransferase Mtmb1 inhibitor Not Availables
[[furo[2,3d]pyrimidine antifolate]] C₂₀H₂₂N₆O₆ 442.430 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
ghavamiol C₉H₁₈N₁O₉S₁ 316.302 g/mol NotAvailable Troponin C, Slow Skeletal and Cardiac Muscles inhibitor Not Availables
fr221647 C₁₄H₁₇N₃O₂ 259.307 g/mol NotAvailable Neuraminidase inhibitor Not Availables
(s)-n-(3-indol-1-yl-2-methyl-propyl)-4-sulfamoyl-benzamide C₁₉H₂₁N₃O₃S₁ 371.453 g/mol NotAvailable Interleukin-2 inhibitor Not Availables
shikimate-3-phosphat C₇H₁₁O₈P₁ 254.133 g/mol NotAvailable Caspase-3 inhibitor Not Availables
glucosaminyl-(alpha-6)-d-myo-inositol C₁₂H₂₃N₁O₁₀ 341.314 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
tmc114; uic-94017 C₂₇H₃₇N₃O₇S₁ 547.665 g/mol NotAvailable Oxygen-Insensitive Nad inhibitor Not Availables
[[n-butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-7-yl]-n-methylundecanamide]] C₃₄H₅₅N₁O₃ 525.813 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
glutathione sulfonic säure C₁₀H₁₇N₃O₉S₁ 355.319 g/mol NotAvailable Acetolactate Synthase, Mitochondrial inhibitor Not Availables
sinapoyl coenzyme a C₃₂H₄₄N₇O₂₀P₃S₁ 971.716 g/mol NotAvailable Vitamin D3 Receptor inhibitor Not Availables
000002-(beta-d-glucopyranosyl)-5-methyl-1,2,3-benzimidazol C₁₄H₁₅N₂O₅ 291.283 g/mol NotAvailable Carbonic Anhydrase I inhibitor Not Availables
nanaomycin d C₁₆H₁₂O₆ 300.267 g/mol NotAvailable Sex Hormone-Binding Globulin inhibitor Not Availables
glutamine hydroxamate C₅H₁₀N₂O₄ 162.145 g/mol NotAvailable Sex Hormone-Binding Globulin inhibitor Not Availables
glucose-uridine-c1,5'-diphosphat C₁₅H₂₄N₂O₁₇P₂ 566.305 g/mol NotAvailable Trypsin inhibitor Not Availables
n-methyl-n-propargyl-1(r)-aminoindan C₁₃H₁₅N₁ 185.268 g/mol NotAvailable Uricase inhibitor Not Availables
sp-adenosine-3',5'-cyclic-monophosphorothioate C₁₀H₁₂N₅O₅P₁S₁ 345.269 g/mol NotAvailable Ribonuclease inhibitor Not Availables
[[gamma-glutamyl[s-(2-iodobenzyl)cysteinyl]glycin]] C₁₇H₂₂N₃O₆I₁S₁ 523.342 g/mol NotAvailable Aminoglycoside 6'-N-Acetyltransferase inhibitor Not Availables
fusicoccin C₃₆H₅₈O₁₂ 682.847 g/mol NotAvailable Monomethylamine Methyltransferase inhibitor Not Availables
furoyl-leucin C₁₁H₁₅N₁O₄ 225.244 g/mol NotAvailable Cellobiose Dehydrogenase inhibitor Not Availables
000004-(hydroxymethyl)benzamidin C₈H₁₁N₂O₁ 151.188 g/mol NotAvailable Cholera Toxin B Subunit inhibitor Not Availables
fucitol C₆H₁₄O₅ 166.174 g/mol NotAvailable Thymidylate Synthase Thyx inhibitor Not Availables
fructose-6-phosphat C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable Dual Specificity Mitogen-Activated Protein K inhibitor Not Availables
gamma-carboxy-glutamic säure C₆H₉N₁O₆ 191.140 g/mol NotAvailable 5'-D inhibitor Not Availables
gallamin C₃₀H₆₀N₃O₃₃+ 990.804 g/mol NotAvailable T-Cell Ecto-ADP-Ribosyltransferase 2 inhibitor Not Availables
gc-24 C₂₄H₂₄O₄ 376.451 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
2,5-anhydroglucitol-1,6-biphosphat C₆H₁₄O₁₁P₂ 324.118 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
gamma-phenyl-butyric säure C₁₀H₁₂O₂ 164.204 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
g418 C₂₀H₄₀N₄O₁₀ 496.557 g/mol NotAvailable Glycogen Phosphorylase, Liver Form inhibitor Not Availables
[[3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dion]] C₈H₁₂N₂O₈ 264.191 g/mol NotAvailable Thymidine Phosphorylase inhibitor Not Availables
sorbinil C₁₁H₉FN₂O₃ 236.199 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
gallichrome C₂₈H₄₄N₉O₁₃Ga₁ 784.428 g/mol NotAvailable Chalcone--Flavonone Isomerase 1 inhibitor Not Availables
n-(2,3,4,5,6-pentaflouro-benzyl)-4-sulfamoyl-benzamide C₁₄H₉N₂O₃F₅S₁ 380.289 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
heme C₃₄H₃₂N₄O₅Fe₁ 632.498 g/mol NotAvailable Thymidylate Synthase Thyx inhibitor Not Availables
heme C₃₄H₃₂N₄O₄FE₁ 616.498 g/mol NotAvailable Cytosine Deaminase inhibitor Not Availables
tribenuron methyl C₁₅H₁₇N₅O₆S₁ 395.389 g/mol NotAvailable Alpha-Mannosidase II inhibitor Not Availables
heptane-1,2,3-triol C₇H₁₆O₃ 148.202 g/mol NotAvailable Delta-Aminolevulinic säure Dehydratase inhibitor Not Availables
000001-(o-carboxy-phenylamino)-1-deoxy-d-ribulose-5-phosphat C₁₂H₁₈N₁O₉P₁ 351.249 g/mol NotAvailable Uridine Phosphorylase inhibitor Not Availables
000006-hydroxy-flavin-adenine dinucleotide C₂₇H₃₃N₉O₁₆P₂ 801.556 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
guanosine-2',3'-cyclophosphorothioate C₁₀H₁₂N₅O₆P₁S₁ 361.268 g/mol NotAvailable Sst1-Selective Somatosatin Analog inhibitor Not Availables
selenazole-4-carboxyamide-adenine dinucleotide C₁₉H₂₅N₇O₁₄P₂Se₁ 716.353 g/mol NotAvailable Quercetin 2,3-Dioxygenase inhibitor Not Availables
cetyl-trimethyl-ammonium C₁₉H₄₂N₁₁+ 424.615 g/mol NotAvailable Amine Oxidase [Flavin-Containing] B inhibitor Not Availables
guanosine-5'-diphosphate-rhamnose C₁₆H₂₅N₅O₁₅P₂ 589.346 g/mol NotAvailable Monomethylamine Methyltransferase Mtmb1 inhibitor Not Availables
guanosine-3'-monophosphate-5'-diphosphat C₁₀H₁₆N₅O₁₄P₃ 523.183 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
000003-dehydroshikimate C₇H₁₀O₅ 174.153 g/mol NotAvailable 5,10-Methenyltetrahydrofolate Synthetase inhibitor Not Availables
o-succinylbenzoate C₁₁H₁₀O₅ 222.197 g/mol NotAvailable Thymidylate Kinase inhibitor Not Availables
[[benzo[b]thiophene-2-carboxamidin]] C₉H₉N₂S₁₁+ 497.844 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
heptanyl-p-phenol C₁₃H₂₀O₁ 192.300 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
heptanoic säure C₇H₁₄O₂ 130.186 g/mol NotAvailable Dihydropyrimidine Dehydrogenase inhibitor Not Availables
heparin disaccharide i-s C₁₂H₁₅N₁O₁₉S₃ 573.426 g/mol NotAvailable Interleukin-12 Beta Chain inhibitor Not Availables
hemi-babim C₁₆H₁₆N₆₁+ 1062.711 g/mol NotAvailable 2,4-Dienoyl-Coa Reductase inhibitor Not Availables
2'-(4-dimethylaminophenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-benzimidazol C₂₇H₂₉N₇ 451.573 g/mol NotAvailable Nad inhibitor Not Availables
heptaethylene glycol, peg330 C₁₄H₃₀O₈ 326.386 g/mol NotAvailable Nad inhibitor Not Availables
heparin pentasaccharide C₃₆H₆₀O₅₅S₉ 1661.377 g/mol NotAvailable Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
glycerol-2-phosphat C₃H₉O₆P₁ 172.074 g/mol NotAvailable Nucleoside 2-Deoxyribosyltransferase inhibitor Not Availables
sd146 C₄₉H₄₄N₈O₅ 824.937 g/mol NotAvailable Stromelysin-1 inhibitor Not Availables
(2r,4s)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran C₅H₁₀O₅ 150.131 g/mol NotAvailable 000005-Methyltetrahydropteroyltriglutamate-- Homo inhibitor Not Availables
alpha-d-fucose C₆H₁₂O₅ 164.158 g/mol NotAvailable Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
gluthathion C₁₀H₁₇N₃O₆S₁ 307.321 g/mol NotAvailable Lysozyme inhibitor Not Availables
glycochenodeoxycholic säure C₂₆H₄₃N₁O₅ 449.629 g/mol NotAvailable Single Stranded DNA Binding Protein inhibitor Not Availables
000004-[[o-(4,6-dideoxy-4-{[4-[(4-o-hexopyranosylhexopyranosyl)oxy]-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}hexopyranosyl)hexopyranose]] C₃₁H₅₃N₁O₂₃ 807.753 g/mol NotAvailable Neuraminidase inhibitor Not Availables
000009-beta-d-ribofuranosyl-6-methylthiopurin C₁₁H₁₄N₄O₄S₁ 298.316 g/mol NotAvailable Neuraminidase inhibitor Not Availables
glycyl-l-alpha-amino-epsilon-pimelyl-d-alanyl-d-alanin C₁₅H₂₆N₄O₇ 374.393 g/mol NotAvailable Nitric-Oxide Synthase inhibitor Not Availables
guanosine-2'-monophosphat C₁₀H₁₄N₅O₈P₁ 363.223 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
guanosine 5'-diphosphate 2':3'-cyclic monophosphat C₁₀H₁₄N₅O₁₃P₃ 505.168 g/mol NotAvailable Endothelial Nitric-Oxide Synthase inhibitor Not Availables
sc-74020 C₂₉H₄₂N₄O₆S₁ 574.734 g/mol NotAvailable Lumazine Synthase inhibitor Not Availables
se-ethyl-isoselenourea C₃H₈N₂Se₁ 151.070 g/mol NotAvailable Glutamine Phosphoribosylpyrophosphate Amidot inhibitor Not Availables
glycyl-l-alpha-amino-epsilon-pimelyl-d-alanin C₁₂H₂₁N₃O₆ 303.314 g/mol NotAvailable Cytochrome C3 inhibitor Not Availables
gshna C₁₉H₃₃N₃O₈S₁ 463.545 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
camphor C₁₀H₁₆O₁ 152.236 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
gm6001 C₂₀H₂₈N₄O₄ 388.466 g/mol NotAvailable Glucose-6-Phosphate Isomerase inhibitor Not Availables
(s)-blebbistatin, [[(3as)-3a-hydroxy-6-methyl-1-phenyl-3,3a-dihydro-1h-pyrrolo[2,3-b]quinolin-4(2h)-on]] C₁₈H₁₆N₂O₂ 292.337 g/mol NotAvailable Phosphoglucose Isomerase inhibitor Not Availables
lipid fragment C₄₂H₈₆O₃ 639.140 g/mol NotAvailable Quinolinic säure Phosphoribosyltransferase inhibitor Not Availables
mesobiliverdin iv alpha C₃₃H₃₈N₄O₆ 586.686 g/mol NotAvailable Putative Golgi Alpha-Mannosidase II inhibitor Not Availables
methoxyamphetamin C₁₀H₁₅NO 165.232 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
000004-[[{2,6,8-trioxo-9-[(2s,3r,4r)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7h-purin-7-yl}butyl dihydrogen phosphat]] C₁₄H₂₃N₄O₁₁P₁ 454.330 g/mol NotAvailable Formaldehyde-Activating Enzyme Fae inhibitor Not Availables
ru78191 C₉H₇O₄ 179.152 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
meso-erythritol C₄H₁₀O₄ 122.121 g/mol NotAvailable Galactose-Binding Lectin inhibitor Not Availables
tert-butyl(1s)-1-cyclohexyl-2-oxoethylcarbamate C₁₃H₂₃N₁O₃ 241.330 g/mol NotAvailable Chalcone-Flavonone Isomerase 1 inhibitor Not Availables
meta-nitro-tyrosin C₉H₁₀N₂O₅ 226.188 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
meta vanadate O₁₉V₇ 660.578 g/mol NotAvailable Uricase inhibitor Not Availables
[[n-[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]-beta-alanin]] C₉H₁₇N₁O₅ 219.237 g/mol NotAvailable Death-Associated Protein Kinase 1 inhibitor Not Availables
methionine sulfoxide C₅H₁₁N₁O₃S₁ 165.207 g/mol NotAvailable Hypothetical Oxidoreductase Yqhd inhibitor Not Availables
000002-(2-hydroxy-phenyl)-3h-benzoimidazole-5-carboxamidin C₁₄H₁₃N₄O₁₁+ 413.277 g/mol NotAvailable Casein Kinase II, Alpha Chain inhibitor Not Availables
rifamycin cgp 4832 C₄₉H₆₄N₃O₁₅ 935.056 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Synthase inhibitor Not Availables
[[methyl 4,6-o-[(1r)-1-carboxyethylidene]-beta-d-galactopyranoside]] C₁₀H₁₆O₈ 264.232 g/mol NotAvailable Mta/Sah Nucleosidase inhibitor Not Availables
rpr131247 C₁₉H₁₉N₅O₄S₂ 445.510 g/mol NotAvailable 5'-Deoxy-5'-Methylthioadenosine Phosphorylas inhibitor Not Availables
methacrylyl-coenzyme a C₂₅H₄₀N₇O₁₇P₃S₁ 835.609 g/mol NotAvailable 5'-Fluoro-5'-Deoxyadenosine Synthase inhibitor Not Availables
3,9-dimethyladenin C₇H₁₀N₅₁+ 808.498 g/mol NotAvailable Protein-Glutamine Glutamyltransferase E inhibitor Not Availables
roflumilast C₁₇H₁₄N₂O₃Cl₂F₂ 403.212 g/mol NotAvailable Proline-tRNA Synthetase inhibitor Not Availables
methicillin acyl-serin C₂₀H₂₆N₃O₉S₁₂- 837.160 g/mol NotAvailable Proline-tRNA Synthetase inhibitor Not Availables
malonate ion C₃H₂O₄₂- 710.024 g/mol NotAvailable Proline-tRNA Synthetase inhibitor Not Availables
malate ion C₄H₅O₅₁- 869.053 g/mol NotAvailable Threonyl-tRNA Synthetase inhibitor Not Availables
mercury acetate ion C₂H₃O₂Hg₁₁+ 2265.535 g/mol NotAvailable Threonyl-tRNA Synthetase 1 inhibitor Not Availables
000001-[[acetyl-4-(4-{4-[(2-ethoxyphenyl)thio]-3-nitrophenyl}pyridin-2-yl)piperazin]] C₂₅H₂₆N₄O₄S₁ 478.565 g/mol NotAvailable Histidine Triad Nucleotide-Binding Protein 1 inhibitor Not Availables
mannobiose C₁₂H₂₂O₁₁ 342.299 g/mol NotAvailable Methionyl-tRNA Synthetase inhibitor Not Availables
malachite green C₂₃H₂₅N₂₁+ 595.591 g/mol NotAvailable Putative Family 31 Glucosidase Yici inhibitor Not Availables
000002-[[[(dioxidophosphino)oxy]benzoate]] C₇H₄O₅P₁ 199.079 g/mol NotAvailable Estradiol 17 Beta-Dehydrogenase 1 inhibitor Not Availables
ru83876 C₃₀H₃₅N₃O₉P₂ 643.569 g/mol NotAvailable Glyceraldehyde-3-Phosphate Dehydrogenase inhibitor Not Availables
ru84687 C₃₁H₃₄N₃O₈P₁ 607.599 g/mol NotAvailable Inosine-5'-Monophosphate Dehydrogenase 2 inhibitor Not Availables
malate like intermediate C₄H₄O₅₂- 884.044 g/mol NotAvailable Avidin inhibitor Not Availables
mercuribenzoic säure C₇H₅O₂Hg₁ 321.705 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
mdl72527 C₁₂H₂₀N₂ 192.303 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
n-acetyl-l-glutamin C₇H₁₂N₂O₄ 188.183 g/mol NotAvailable 000006-Hydroxymethyl-7,8-Dihydropterin Pyrophosph inhibitor Not Availables
ru79072 C₁₀H₇N₂O₄P₁ 250.150 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
000004-phospho-d-erythronohydroxamic säure C₄H₁₀N₁O₈P₁ 231.099 g/mol NotAvailable H-Protein inhibitor Not Availables
ru82129 C₃₃H₃₃N₃O₆ 567.640 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
mdl 101,146 C₂₉H₃₇N₄O₆F₅ 632.627 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
mercaptomethyl phosphonate C₁H₃O₃P₁S₁₂- 478.727 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
ru79256 C₈H₇O₅S₁ 215.200 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
ru81843 C₃₀H₃₄N₃O₇P₁ 579.588 g/mol NotAvailable Retinoid X Receptor, Beta inhibitor Not Availables
(4e,8e,12z,16z)-n,n,4,8,13,17,21-heptamethyldocosa-4,8,12,16,20-pentaen-1-amin C₂₉H₅₂N₁ 414.736 g/mol NotAvailable Soluble Tumor Necrosis Factor Receptor 1 inhibitor Not Availables
modified ribosylated glutamyl ester C₁₀H₁₈N₁O₈F₁ 299.253 g/mol NotAvailable Avidin inhibitor Not Availables
mmi-175 C₃₈H₆₂N₆O₈ 730.943 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
moxalactam derivative C₁₈H₁₈N₂O₉ 406.348 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
[[mono-[3,4-dihydroxy-5-(5-methyl-benzoimidazol-1-yl)-tetrahydor-furan-2-ylmethyl] ester]] C₁₃H₁₇N₂O₇P₁ 344.260 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
carboxymycobactin s C₃₆H₅₁N₅O₁₂Fe₁ 801.672 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
phosphonopyruvate C₃H₅O₆P₁ 168.043 g/mol NotAvailable Tissue-Type Plasminogen Activator inhibitor Not Availables
riboflavin; vitamin b2 C₁₇H₂₀N₄O₆ 376.368 g/mol NotAvailable Vp39 inhibitor Not Availables
modified acarbose pentasaccharide C₃₁H₅₃N₁O₂₂ 791.753 g/mol NotAvailable Cyclomaltodextrin Glucanotransferase inhibitor Not Availables
udp-d-galactopyranose C₁₅H₂₄N₂O₁₇P₂ 566.305 g/mol NotAvailable D-Amino säure Oxidase inhibitor Not Availables
reduced threonin C₄H₁₁N₁O₂ 105.136 g/mol NotAvailable Beta-1,4-Galactosyltransferase 1 inhibitor Not Availables
[[morpholine-4-carboxylic säure [1s-(2-benzyloxy-1r-cyano-ethylcarbamoyl)-3-methyl-butyl]amide]] C₂₁H₃₀N₄O₄ 402.492 g/mol NotAvailable Orotidine 5'-Phosphate Decarboxylase inhibitor Not Availables
monoisopropylphosphorylserin C₆H₁₄N₁O₆P₁ 227.153 g/mol NotAvailable Dihydropyrimidine Dehydrogenase inhibitor Not Availables
myristoyl-coa C₃₅H₆₂N₇O₁₇P₃S₁ 977.893 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
myo-inositol C₆H₁₂O₆ 180.157 g/mol NotAvailable Glycerol-3-Phosphate Dehydrogenase inhibitor Not Availables
mrna cap analog n7-methyl gpppg C₂₁H₃₀N₁₀O₁₈P₃₁+ 1670.711 g/mol NotAvailable Inosine Monophosphate Dehydrogenase I inhibitor Not Availables
pd173955 C₂₁H₁₆N₄O₁S₁Cl₂ 443.350 g/mol NotAvailable Chondroitinase B inhibitor Not Availables
monoazido-mu-oxo-diiron N₃O₁Fe₂ 169.714 g/mol NotAvailable Aldose 1-Epimerase inhibitor Not Availables
rbt205 inhibitor C₂₅H₂₄N₄O₂ 412.490 g/mol NotAvailable Lectin inhibitor Not Availables
morpholine-4-carboxylic säure (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide C₂₈H₃₇N₃O₅S₁ 527.677 g/mol NotAvailable 000006-Deoxyerythronolide B Hydroxylase inhibitor Not Availables
thiocellobiose C₁₂H₂₂O₁₀S₁ 358.360 g/mol NotAvailable Cyclodextrin Glycosyltransferase inhibitor Not Availables
cra_17312 C₂₅H₂₀N₄O₆₂- 1368.423 g/mol NotAvailable Dihydroorotate Dehydrogenase inhibitor Not Availables
ribulose-5-phosphat C₅H₁₁O₈P₁ 230.111 g/mol NotAvailable 23S Ribosomal RNA inhibitor Not Availables
methylumbelliferyl chitotriose C₃₄H₄₇N₃O₁₈ 785.755 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
n-alpha-l-acetyl-arginin C₈H₁₆N₄O₃ 216.239 g/mol NotAvailable Major Urinary Protein I inhibitor Not Availables
methyl(6s)-1-thio-l-manno-hexodialdo-6,2-pyranoside C₇H₁₂O₅S₁ 208.229 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
methyl nonanoate (ester) C₁₀H₂₀O₂ 172.267 g/mol NotAvailable L-Asparaginase inhibitor Not Availables
methyl methylsulfinylmethyl sulfide C₃H₈O₁S₂ 124.216 g/mol NotAvailable Cellobiose Dehydrogenase inhibitor Not Availables
methyl-beta-galactose C₇H₁₄O₆ 194.184 g/mol NotAvailable L-Asparaginase inhibitor Not Availables
methyl-2-s-(alpha-d-mannopyranosyl)-2-thio-alpha-d-mannopyranoside C₁₃H₂₄O₁₀S₁ 372.387 g/mol NotAvailable 7,8-Dihydroneopterin Aldolase inhibitor Not Availables
[[methyl-[4-(4-piperidine-1-ylmethyl-phenyl)-cyclohexyl]-carbaminic säure-(4-chlorophenyl)-ester]] C₂₆H₃₃N₂O₂Cl₁ 441.012 g/mol NotAvailable 000006-Hydroxymethyl-7,8-Dihydropterin Pyrophosph inhibitor Not Availables
hydantocidin-5'-monophosphat C₇H₁₁N₂O₉P₁ 298.146 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
ribavirin triphosphat C₈H₁₅N₄O₁₄P₃ 484.146 g/mol NotAvailable Orotidine 5'-Phosphate Decarboxylase inhibitor Not Availables
mf268 C₁₅H₃₀N₂O₂ 270.414 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
(3-formyl-but-3-enyl)-phosphonic säure C₅H₉O₄P₁ 164.097 g/mol NotAvailable Dhps, Dihydropteroate Synthase inhibitor Not Availables
methylumbelliferyl sialic säure C₂₁H₂₅N₁O₁₁ 467.429 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
methylmalonyl-coenzyme a C₂₅H₄₀N₇O₁₉P₃S₁ 867.608 g/mol NotAvailable Endothelial Nitric-Oxide Synthase inhibitor Not Availables
xv638 C₄₁H₃₈N₆O₅S₂ 758.908 g/mol NotAvailable Cyclin-Dependent Protein Kinase 2 inhibitor Not Availables
n-dodecyl-n,n-dimethyl-3-ammonio-1-propanesulfonate C₁₇H₃₈N₁O₃S₁ 336.552 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
methylphosphonic säure diisopropyl ester C₇H₁₇O₃P₁ 180.183 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000002-[[[5-methanesulfonylamino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-n-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide]] C₁₉H₂₂N₅O₅F₃S₁ 489.469 g/mol NotAvailable Phospholipase A2, Membrane Associated inhibitor Not Availables
s-2-(boronoethyl)-l-cystein C₅H₁₃N₁O₅B₁S₁₁- 530.631 g/mol NotAvailable Phosphoglucose Isomerase inhibitor Not Availables
nicotinamide 8-bromo-adenine dinucleotide phosphat C₂₁H₂₇N₇O₁₇Br₁P₃ 822.306 g/mol NotAvailable Transthyretin inhibitor Not Availables
000003-[[[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol]] C₁₅H₁₄N₄O₁S₁ 298.362 g/mol NotAvailable Myoglobin inhibitor Not Availables
l-n(omega)-nitroarginine-2,4-l-diaminobutyric amide C₁₀H₂₂N₈O₄ 318.335 g/mol NotAvailable 6,7-Dimethyl-8-Ribityllumazine Synthase inhibitor Not Availables
s-1,2-propanediol C₃H₈O₂ 76.095 g/mol NotAvailable Transketolase inhibitor Not Availables
l-glycero-d-manno-heptopyranose C₇H₁₄O₇ 210.183 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
l-alpha-glycerophospho-d-myo-inositol-4,5-bis-phosphat C₉H₁₈O₁₇P₃ 491.152 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
s-ethyl-n-phenyl-isothiourea C₉H₁₂N₂S₁ 180.267 g/mol NotAvailable Beta-Lactamase Pse-2 inhibitor Not Availables
s-4-nitrobutyryl-coa C₂₅H₄₂N₈O₁₉P₃S₁ 883.630 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
l-alpha-phosphatidyl-beta-oleoyl-gamma-palmitoyl-phosphatidylethanolamin C₃₉H₆₈N₁O₈P₁ 709.942 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
l-alpha-glycerophosphorylserin C₆H₁₄N₁O₈P₁ 259.152 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
000003-bromo-7-nitroindazol C₇H₄N₃O₂Br₁ 242.031 g/mol NotAvailable Dethiobiotin Synthetase inhibitor Not Availables
000002-anhydro-3-fluoro-quinic säure C₇H₉O₅F₁ 192.144 g/mol NotAvailable Histone Deacetylase 8 inhibitor Not Availables
propidium C₂₇H₃₄N₄₂+ 946.847 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
l-phenylalaninol C₉H₁₃N₁O₁ 151.208 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
l-naphthyl-1-acetamido boronic säure alanin C₁₇H₂₂N₂O₆B₁₁- 469.281 g/mol NotAvailable Tetracycline Repressor inhibitor Not Availables
l-histidine beta naphthylamide C₁₆H₁₆N₄O₁ 280.329 g/mol NotAvailable Queuine tRNA-Ribosyltransferase inhibitor Not Availables
malonaldehyde C₃H₄O₂ 72.063 g/mol NotAvailable Queuine tRNA-Ribosyltransferase inhibitor Not Availables
l-myo-inositol-1-phosphat C₆H₁₁O₉P₁₂- 598.833 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
l-leucyl-hydroxylamin C₆H₁₄N₂O₂ 146.189 g/mol NotAvailable Ricin A Chain inhibitor Not Availables
l-iso-aspartate C₄H₆N₁O₄₁- 724.073 g/mol NotAvailable Macrophage Migration Inhibitory Factor inhibitor Not Availables
s-ethylisothiourea C₃H₈N₂S₁ 104.170 g/mol NotAvailable Hypoxanthine Phosphoribosyltransferase inhibitor Not Availables
s-hydroxymethyl glutathion C₁₁H₁₉N₃O₇S₁ 337.347 g/mol NotAvailable 000003-Phosphoinositide Dependent Protein Kin inhibitor Not Availables
s-acetyl-cystein C₅H₉N₁O₃S₁ 163.191 g/mol NotAvailable Phenylethanolamine N-Methyltransferase inhibitor Not Availables
(r)-mesopram C₁₄H₁₇N₁O₄ 263.293 g/mol NotAvailable 7,8-Diaminopelargonic säure Synthase inhibitor Not Availables
000004-[[[hydroxy-[methyl-phosphinoyl]]-3-oxo-butanoic säure]] C₅H₉O₅P₁ 180.097 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
k-252a C₂₇H₂₁N₃O₅ 467.480 g/mol NotAvailable Eukaryotic Translation Initiation Factor 4E inhibitor Not Availables
s-benzyl-glutathion C₁₇H₂₃N₃O₆S₁ 397.445 g/mol NotAvailable Eukaryotic Translation Initiation Factor 4E inhibitor Not Availables
s-hexylglutathion C₁₆H₃₀N₃O₆S₁₁+ 713.090 g/mol NotAvailable Vp39 inhibitor Not Availables
trencam-3,2-hopo C₇H₇N₁O₃ 153.137 g/mol NotAvailable Inducible Nitric Oxide Synthase inhibitor Not Availables
k506 C₄₄H₆₉N₁O₁₂ 804.029 g/mol NotAvailable Nitric-Oxide Synthase inhibitor Not Availables
s-adenosyl-1,8-diamino-3-thiooctan C₁₈H₂₉N₇O₃S₁ 423.532 g/mol NotAvailable Pseudoazurin inhibitor Not Availables
[[l-2-amino-4-[2-aminophenyl]-4-oxobutanoic säure]] C₁₀H₁₂N₂O₃ 208.216 g/mol NotAvailable Dethiobiotin Synthetase inhibitor Not Availables
000002-hydroxyethyl disulfide C₄H₁₀O₂S₂ 154.242 g/mol NotAvailable 7,8-Dihydro-6-Hydroxymethylpterin- Pyrophosp inhibitor Not Availables
l-756,423 C₃₉H₄₈N₄O₅ 652.832 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
000005-deoxyflavanon C₁₅H₁₂O₄ 256.257 g/mol NotAvailable Pteridine Reductase 1 inhibitor Not Availables
s-butyryl-cystein C₇H₁₃N₁O₃S₁ 191.245 g/mol NotAvailable Dihydroneopterin Aldolase inhibitor Not Availables
s-dioxymethionin C₅H₁₁N₁O₄S₁ 181.206 g/mol NotAvailable Beta-Lactamase, Type II inhibitor Not Availables
s-adenosyl-l-homoselenocystein C₁₄H₂₀N₆O₅Se₁ 431.309 g/mol NotAvailable Vp39 inhibitor Not Availables
hydrolyzed cephalothin C₁₄H₁₆N₂O₅S₂ 356.411 g/mol NotAvailable Vp39 inhibitor Not Availables
l-2-amino-4-methoxy-cis-but-3-enoic säure C₅H₉N₁O₃ 131.131 g/mol NotAvailable Translation Initiation Factor Eif4E inhibitor Not Availables
ru78300 C₈H₉O₆P₁ 232.129 g/mol NotAvailable 23S Ribosomal RNA inhibitor Not Availables
lipid fragment C₁₃H₂₈ 184.364 g/mol NotAvailable Vp39 inhibitor Not Availables
levulinic säure C₅H₁₀O₂ 102.133 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
000002-carboxypropyl-coenzyme a C₂₅H₄₂N₇O₁₈P₃S₁ 853.624 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
lpc-ether C₂₆H₅₇N₁O₆P₁₁+ 820.451 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
ru90395 C₃₅H₃₆N₃O₉F₁ 661.683 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
leucine phosphonic säure C₅H₁₄N₁O₃P₁ 167.144 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
l-tryptophanamide C₁₁H₁₃N₃O₁ 203.243 g/mol NotAvailable Dihydroneopterin Aldolase inhibitor Not Availables
lipid fragment C₁₁H₂₄ 156.311 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
lipid fragment C₂₇H₅₆ 380.739 g/mol NotAvailable Uricase inhibitor Not Availables
rwj-51084 C₁₉H₂₅N₅O₂S₁ 387.499 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
lysine nz-carboxylic säure C₇H₁₄N₂O₄ 190.199 g/mol NotAvailable Obelin inhibitor Not Availables
000004-deoxy-4-thio-beta-d-glucopyranose C₆H₁₂O₅S₁ 196.218 g/mol NotAvailable Obelin inhibitor Not Availables
m-aminophenylboronic säure C₆H₈N₁O₂B₁ 136.945 g/mol NotAvailable Histidine Triad Nucleotide-Binding Protein inhibitor Not Availables
m-(n,n,n-trimethylammonio)-2,2,2-trifluoro-1,1-dihydroxyethylbenzen C₁₁H₁₅N₁O₂F₃₁+ 782.195 g/mol NotAvailable S-Adenosylmethionine Synthetase inhibitor Not Availables
lysophosphotidylserin C₂₁H₄₄N₁O₉P₁ 485.554 g/mol NotAvailable P-Hydroxybenzoate Hydroxylase inhibitor Not Availables
ly231514 tetra glu C₃₅H₄₂N₈O₁₅ 814.761 g/mol NotAvailable 000008-Oxoguanine DNA Glycosylase inhibitor Not Availables
ly231514 C₂₀H₂₁N₅O₆ 427.416 g/mol NotAvailable Thiostrepton inhibitor Not Availables
ru85493 C₃₂H₃₆N₃O₉P₁ 637.625 g/mol NotAvailable Pentosyltransferase inhibitor Not Availables
ly341770 C₂₀H₂₁N₉O₄ 451.444 g/mol NotAvailable Mutator Mutt Protein inhibitor Not Availables
alpha-ketoisovaleric säure; ketovalin C₅H₈O₃ 116.116 g/mol NotAvailable Phenylethanolamine N-Methyltransferase inhibitor Not Availables
s-(n-hydroxy-n-iodophenylcarbamoyl)glutathion C₁₇H₂₃N₄O₈I₁S₁ 570.355 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
lambda-bis(2,2'-bipyridine)imidazole ruthenium (ii) C₂₃H₂₀N₆Ru₁₂+ 1593.291 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
l-valinol C₅H₁₃N₁O₁ 103.164 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
l-tyrosinamide C₉H₁₂N₂O₂ 180.206 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
s-(p-nitrobenzyl)glutathion C₁₇H₂₂N₄O₈S₁ 442.443 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
000003-isopropylmalic säure C₇H₁₂O₅ 176.169 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
cra_9785 C₁₅H₁₁N₄O₂F₃ 336.273 g/mol NotAvailable Mitogen-Activated Protein Kinase 10 inhibitor Not Availables
l-thiocitrullin C₆H₁₃N₃O₂S₁ 191.248 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
n5-(1-imino-3-butenyl)-l-ornithin C₉H₂₀N₃O₂ 202.276 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
lambda-bis(2,2'-bipyridine)imidazole osmium (ii) C₂₃H₂₀N₆Os₁₂+ 781.171 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
l-xylulose 5-phosphat C₅H₁₃O₇P₁ 216.127 g/mol NotAvailable Neuraminidase inhibitor Not Availables
leucine - reduced carbonyl C₆H₁₄N₁ 100.183 g/mol NotAvailable 5'-D inhibitor Not Availables
uridine-5'-monophosphate glucopyranosyl-monophosphateester C₁₅H₂₄N₂O₁₇P₂ 566.305 g/mol NotAvailable Cytochrome P450Eryf inhibitor Not Availables
s-(3-iodobenzyl)glutathion C₁₇H₂₂N₃O₆I₁S₁ 523.342 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
s-(dimethylarsenic)cystein C₅H₁₂N₁O₂As₁S₁ 225.137 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
3h-indole-5,6-diol C₈H₇N₁O₂ 149.149 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-c9-adamantane ruthenium (ii) C₅₀H₅₇N₇O₁Ru₁₂+ 1984.887 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
s-(d-carboxybutyl)-l-homocystein C₉H₁₇N₁O₄S₁ 235.298 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
lactose sialic säure; alpha(2,3) sialyl lactose C₂₃H₃₉N₁O₁₉ 633.556 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
000009-butyl-8-(3-methoxybenzyl)-9h-purin-6-amin C₁₇H₂₁N₅O₁ 311.386 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
(4e)-4-aminohex-4-enoic säure C₆H₁₁N₁O₂ 129.158 g/mol NotAvailable Heat Shock Protein Hsp 90-Beta inhibitor Not Availables
reactive red 1 dye C₁₉H₁₆N₈O₁₀S₃ 612.563 g/mol NotAvailable Heat Shock Protein Hsp 90-Alpha inhibitor Not Availables
cb1954 C₉H₈N₄O₅ 252.186 g/mol NotAvailable Adenine Phosphoribosyltransferase inhibitor Not Availables
(4r)-7aza-7,8-dihydrolimonen C₉H₁₇N₁ 139.240 g/mol NotAvailable Ricin A Chain inhibitor Not Availables
000004-phenyl-1h-imidazol C₉H₈N₂ 144.176 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
000002-amino-4-butyl-5-propylselenazol C₁₀H₁₈N₂Se₁ 245.226 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
(3s)-3-amino-1-(cyclopropylamino)heptane-2,2-diol C₁₀H₂₂N₂O₂ 202.296 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
(3s)-2,3,4,5-tetrahydropyridin-3-amin C₅H₁₀N₂ 98.147 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
(3-chloro-4-propoxy-phenyl)-acetic säure C₁₁H₁₃O₃Cl₁ 228.675 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
(4-hydroxymaltosephenyl)glycin C₂₀H₂₉N₁O₁₃ 491.448 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
phenylalanine-n-sulfonamide C₉H₁₂N₂O₄S₁ 244.265 g/mol NotAvailable Uricase inhibitor Not Availables
[[(3s)-tetrahydrofuran-3-yl (1r,2s)-3-[4-((1r)-2-{[(s)-amino(hydroxy)methyl]oxy}-2,3-dihydro-1h-inden-1-yl)-2-benzyl-3-oxopyrrolidin-2-yl]-1-benzyl-2-hydroxypropylcarbamate]] C₃₆H₄₃N₃O₇ 629.752 g/mol NotAvailable Dihydroneopterin Aldolase inhibitor Not Availables
(5r, 6s, 7s, [[8s)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-a]piperidin]] C₆H₁₀N₄O₄ 202.169 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
2(s)-amino-6-boronohexanoic säure C₆H₁₅N₁O₅B₁₁- 300.098 g/mol NotAvailable Androgen Receptor inhibitor Not Availables
[[(5-chloropyrazolo[1,5-a]pyrimidin-7-yl)-(4-methanesulfonylphenyl)amin]] C₁₃H₁₁N₄O₂Cl₁S₁ 322.769 g/mol NotAvailable 12-Oxophytodienoate Reductase 1 inhibitor Not Availables
[[(s)-2-amino-3-(1,3,5,7-pentahydro-2,4-dioxo-cyclopenta[e]pyrimidin-1-yl) proionic säure]] C₁₀H₁₃N₃O₄ 239.230 g/mol NotAvailable Stromelysin-1 Complex inhibitor Not Availables
(5s)-5-iododihydro-2,4(1h,3h)-pyrimidinedion C₄H₅N₂O₂I₁ 240.000 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
(5r)-5-amino-6-hydroxyhexylcarbamic säure C₇H₁₆N₂O₃ 176.215 g/mol NotAvailable Protease inhibitor Not Availables
[[(4s)-2-[(1e)-1-aminoprop-1-enyl]-4,5-dihydro-1,3-thiazole-4-carboxylic säure]] C₇H₁₀N₂O₂S₁ 186.228 g/mol NotAvailable Alpha-Amylase inhibitor Not Availables
(4s,5s)-1,2-dithiane-4,5-diol C₄H₈O₂S₂ 152.226 g/mol NotAvailable Bse634I Restriction Endonuclease inhibitor Not Availables
000003-hydroxy-propanoic säure C₃H₆O₃ 90.079 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
(4s)-7-azabisabolene; s-azabisabolen C₁₄H₂₆N₁₁+ 348.433 g/mol NotAvailable Prostaglandin H2 Synthase inhibitor Not Availables
(4s)-5-fluoro-l-leucin C₆H₁₂N₁O₂F₁ 149.165 g/mol NotAvailable Actva-Orf6 Monooxygenase inhibitor Not Availables
succinamide-coa C₂₅H₄₁N₈O₁₉P₃ 850.562 g/mol NotAvailable Glycine Oxidase inhibitor Not Availables
[[(3-{3-*[[2-chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]propoxy}phenyl)acetic säure]] C₃₃H₃₃N₁O₃Cl₁F₃ 584.077 g/mol NotAvailable Hyaluronate Lyase inhibitor Not Availables
[[(2z)-2-(benzoylamino)-3-[4-(2-bromophenoxy)phenyl]-2-propenoic säure]] C₂₂H₁₆N₁O₄Br₁ 438.277 g/mol NotAvailable GDP-Fucose Synthetase inhibitor Not Availables
(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yl)-phosphoramidic säure dimethyl ester C₈H₁₈N₁O₈P₁ 287.206 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
000004-[[(aminosulfonyl)-n-[(2,5-difluorophenyl)methyl]-benzamide]] C₁₄H₁₂N₂O₃F₂S₁ 326.317 g/mol NotAvailable Aconitate Hydratase 2 inhibitor Not Availables
(2s)-2,8-diaminooctanoic säure C₈H₁₈N₂O₂ 174.242 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
(2s)-2-hydroxypropanal C₃H₆O₂ 74.079 g/mol NotAvailable Cytochrome P450-Cam inhibitor Not Availables
000002-oxalosuccinic säure C₆H₆O₇ 190.109 g/mol NotAvailable Cytochrome P450-Cam inhibitor Not Availables
(2s)-pyrrolidin-2-ylmethylamin C₅H₁₂N₂ 100.163 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
(2s)-hydroxy(4-hydroxyphenyl)ethanenitrile C₈H₇N₁O₂ 149.149 g/mol NotAvailable Thiazole Biosynthetic Enzyme inhibitor Not Availables
(2s)-4-(beta-alanylamino)-2-aminobutanoic säure C₇H₁₅N₃O₃ 189.214 g/mol NotAvailable Gramicidin Synthetase 1 inhibitor Not Availables
(3r)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicsäure-l-phenylalanine ethyl ester C₂₃H₂₈N₂O₅S₂ 476.605 g/mol NotAvailable Fragile Histidine Triad Protein inhibitor Not Availables
(3r)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicsäure-l-leucin C₁₈H₂₆N₂O₅S₂ 414.534 g/mol NotAvailable Nucleoside Diphosphate Kinase, Cytosolic inhibitor Not Availables
000004-(acetylamino)-3-amino benzoic säure C₉H₁₀N₂O₃ 194.190 g/mol NotAvailable Eosinophil-Derived Neurotoxin inhibitor Not Availables
[[(3s,8ar)-3-(4-hydroxybenzyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dion]] C₁₄H₁₆N₂O₃ 260.292 g/mol NotAvailable Eosinophil-Derived Neurotoxin inhibitor Not Availables
2,3-propandiol C₃H₈O₂ 76.095 g/mol NotAvailable Adpr Pyrophosphatase inhibitor Not Availables
[[(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4-hydroxy-3,5,11-trimethyl-8-oxo-1-oxa-7-azaspiro[5.5]undec-2-yl]-8-hydroxy-1,7-dimethylnona-1,3-dienyl}-10,12-dihydroxy-3-(3-hydroxybenzyl)-6-isopropyl-11-methyl-9-(3-oxobutyl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetron]] C₆₀H₉₁N₅O₁₃ 1090.405 g/mol NotAvailable P1 Nuclease inhibitor Not Availables
000002-[[hydroxy-5-[4-(2-hydroxy-ethyl)-piperidin-1-yl]-5-phenyl-1h-pyrimidine-4,6-dion]] C₁₇H₂₁N₃O₄ 331.371 g/mol NotAvailable Folylpolyglutamate Synthase inhibitor Not Availables
(3e)-6'-bromo-2,3'-biindole-2',3(1h,1'h)-dione 3-oxime C₁₆H₁₀N₃O₂Br₁ 356.178 g/mol NotAvailable Inositol 1,3,4-Trisphosphate 5/6-Kinase inhibitor Not Availables
[[(3e)-3-[(4-hydroxyphenyl)imino]-1h-indol-2(3h)-on]] C₁₄H₁₀N₂O₂ 238.245 g/mol NotAvailable Homoserine Kinase inhibitor Not Availables
000004-methylumbelliferyl-alpha-d-glucose C₁₆H₁₈O₈ 338.313 g/mol NotAvailable Adenylylsulfate Kinase inhibitor Not Availables
(3r)-1-acetyl-3-methylpiperidin C₈H₁₅N₁O₁ 141.213 g/mol NotAvailable Protein Kinase C Interacting Protein inhibitor Not Availables
[[(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-dimethyl-8-{[(2r)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic säure]] C₂₄H₃₈O₆ 422.561 g/mol NotAvailable Glucose-1-Phosphate Adenylyltransferase Smal inhibitor Not Availables
gluconic säure C₆H₁₂O₇ 196.157 g/mol NotAvailable Ndx1 inhibitor Not Availables
(s)-2-(phosphonoxy)caproyl-l-leucyl-p-nitroanilide C₁₈H₂₈N₃O₈P₁ 445.408 g/mol NotAvailable ATP Sulfurylase inhibitor Not Availables
formic säure benzyl ester C₈H₈O₂ 136.150 g/mol NotAvailable Acetyl-Coa Synthetase inhibitor Not Availables
[[(s)-2-amino-4-[(2s,3r)-2,3,5-trihydroxy-4-oxo-pentyl]mercapto-butyric säure]] C₉H₁₇N₁O₆S₁ 267.296 g/mol NotAvailable Adenylate Cyclase inhibitor Not Availables
n6-benzyl adenosine-5'-diphosphat C₁₇H₂₁N₅O₁₀P₂ 517.328 g/mol NotAvailable Ermc' Rrna Methyltransferase inhibitor Not Availables
l-2-amino-4-(guanidinooxy)butyric säure C₅H₁₂N₄O₃ 176.175 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
(r)-mandelic säure C₈H₈O₃ 152.149 g/mol NotAvailable Diphtheria Toxin inhibitor Not Availables
[[(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-octahydroindolo[2,3-a]quinolizin-7(6h)-on]] C₁₅H₁₈N₂O₁ 242.320 g/mol NotAvailable Fragile Histidine Triad Protein inhibitor Not Availables
(r)-rolipram C₁₆H₂₁N₁O₃ 275.347 g/mol NotAvailable Phenylalanine Hydroxylase inhibitor Not Availables
000001-(3-o-phosphono-beta-l-arabinofuranosyl)pyrimidine-2,4(1h,3h)-dion C₉H₁₃N₂O₉P₁ 324.183 g/mol NotAvailable Trypsin inhibitor Not Availables
(r)-n-(1-methyl-hexyl)-formamide C₈H₁₇N₁O₁ 143.228 g/mol NotAvailable Alcohol Sulfotransferase inhibitor Not Availables
(south)-methanocarba-thymidin C₁₂H₁₅N₂O₄ 251.262 g/mol NotAvailable Protease Retropepsin inhibitor Not Availables
cra_10972 C₁₈H₁₉N₄O₂Cl₁ 358.827 g/mol NotAvailable Bifunctional Purine Biosynthesis Protein Pur inhibitor Not Availables
geran-8-yl geran C₂₀H₃₄ 274.489 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
[[[(1e)-4-phenylbut-1-enyl]benzen]] C₁₆H₁₆ 208.302 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
[[(z,z)-4-hydroxy-n,n,n-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-3,5,9-trioxa-4-phosphaheptacos-18-en-1-aminium-4-oxide]] C₄₄H₈₅N₁O₈P₁₁+ 1096.869 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
16,17-androstene-3-ol C₁₉H₃₀O₁ 274.445 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
(s)-atpa, (s)-2-amino-3-(3-hydroxy-5-tert-butyl-isoxazol-4-yl)propionic säure C₁₀H₁₅N₂O₄ 227.239 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
(s)-5-(4-benzyloxy-phenyl)-4-(7-phenyl-heptanoylamino)-pentanoic säure C₃₁H₃₇N₁O₄ 487.638 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
diminazine aceturate; 1,3-tris-(4'amidinophenyl)triazin C₁₄H₁₅N₇ 281.319 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
(s)-hmg-coa C₂₇H₃₉N₇O₂₀P₃S₁₅- 1355.461 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
adenosine-5'-propylphosphat C₁₃H₂₀N₅O₇P₁ 389.304 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
000006-hydro-1-methyladenosine-5'-monophosphat C₁₁H₁₆N₅O₇P₁ 361.250 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
000006-aminohexyl-uridine-c1,5'-diphosphat C₁₅H₂₇N₃O₁₂P₂ 503.339 g/mol NotAvailable Antineoplastic Agents For treatment of B-cell chronic lymphocytic leukemias
[[n-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamin]] C₂₉H₂₆N₄O₄Cl₁F₁S₁ 581.060 g/mol NotAvailable Retinol Binding Protein Complexed With Axero inhibitor Not Availables
(9s,10s)-9-(s-glutathionyl)-10-hydroxy-9,10-dihydrophenanthren C₂₄H₂₇N₃O₇S₁ 501.553 g/mol NotAvailable Right-Handed Coiled Coil Tetramer inhibitor Not Availables
000003-[[[3-(2,3-dihydroxy-propylamino)-phenyl]-4-(5-fluoro-1-methyl-1h-indol-3-yl)-pyrrole-2,5-dion]] C₂₂H₂₀N₃O₄F₁ 409.416 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
[[(8ar)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dion]] C₇H₁₀N₂O₂ 154.168 g/mol NotAvailable Chitinase 1 inhibitor Not Availables
000004-o-methyl-alpha-d-glucuronic säure C₇H₁₂O₇ 208.168 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
(5z)-5-(1h-indol-3-ylmethylene)-4h-imidazol-4-on C₁₇H₂₀N₄O₃ 328.370 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
deoxy-bigchap C₄₂H₇₅N₃O₁₅ 862.066 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
(6r,1'r,2's)-5,6,7,8 tetrahydrobiopterin C₉H₁₅N₅O₃ 241.249 g/mol NotAvailable Mol_Id: 1; Molecule: Beta-Lactamase II; Syno inhibitor Not Availables
[[(6e)-6-[(2e,4e,6e)-3,7-dimethylnona-2,4,6,8-tetraenylidene]-1,5,5-trimethylcyclohexen]] C₂₀H₂₈ 268.441 g/mol NotAvailable Pectate Lyase inhibitor Not Availables
[[(6,7-dihydro-5h-cyclopenta[d]imidazo[2,1-b]thiazol-2-yl]-4,7-dihydro[1,4]thiazepine-3,6-dicarboxylic säure]] C₁₅H₁₃N₃O₄S₂ 363.405 g/mol NotAvailable Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
(p-iodophenylacetylamino)methylphosphinic säure C₉H₁₁N₁O₃I₁P₁ 339.069 g/mol NotAvailable B9340 inhibitor Not Availables
(molybdopterin-s,s)-dioxo-thio-molybdenum(v) C₁₀H₁₃N₅O₈Mo₁P₁S₃ 554.335 g/mol NotAvailable Epidermal Growth Factor inhibitor Not Availables
(hydroxyethyloxy)tri(ethyloxy)octan C₁₆H₃₄O₅ 306.442 g/mol NotAvailable Alamethicin - Chain C inhibitor Not Availables
000002-(2-hydroxy-phenyl)-1h-benzoimidazole-5-carboxamidin C₁₄H₁₃N₄O₁₁+ 413.277 g/mol NotAvailable Prostatic säure Phosphatase inhibitor Not Availables
(r)-2-hydroxy-3-sulfopropanoic säure C₃H₆O₆S₁ 170.137 g/mol NotAvailable Cyclodextrin Glycosyltransferase inhibitor Not Availables
(r)-1-para-nitro-phenyl-2-azido-ethanol C₈H₈N₄O₃ 208.176 g/mol NotAvailable L-Arabinose-Binding Protein Complex With D-F inhibitor Not Availables
(carboxyhydroxyamino)ethanoic säure C₃H₅N₁O₅ 135.076 g/mol NotAvailable Beta-Phosphoglucomutase inhibitor Not Availables
(c8-r)-hydantocidin 5'-phosphat C₁₃H₂₂N₃O₁₃P₁ 459.303 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
(aminooxy)acetic säure C₂H₅N₁O₃ 91.066 g/mol NotAvailable Alpha-D-Glucose 1-Phosphate Phosphoglucomuta inhibitor Not Availables
(e)-2-fluoro-p-hydroxycinnamate C₉H₆O₃F₁₁- 371.127 g/mol NotAvailable Mol_Id: 1; Molecule: 6-Phospho-Beta-Glucosid inhibitor Not Availables
(diphosphono)aminophosphonic säure H₆N₁O₉P₃ 256.970 g/mol NotAvailable Cation-Dependent Mannose-6-Phosphate Recepto inhibitor Not Availables
(diaminomethyl-methyl-amino)-acetic säure C₄H₁₁N₃O₂ 133.150 g/mol NotAvailable Ornithine Decarboxylase inhibitor Not Availables
deacetoxycephalosporin-c C₁₄H₁₉N₃O₆S₁ 357.381 g/mol NotAvailable Citrate Synthase inhibitor Not Availables
000002-dehydropantoate C₆H₁₀O₄ 146.143 g/mol NotAvailable Endothiapepsin inhibitor Not Availables
[[n-[2-hydroxy-2-(8-isopropyl-6,9-dioxo-2-oxa-7,10-diaza-bicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-11-yl)-ethyl]-n-(3-methyl-butyl)-benzenesulfonamide,inhibitor 3]] C₃₀H₄₃N₃O₆S₁ 573.746 g/mol NotAvailable 000002-Isopropylmalate Synthase inhibitor Not Availables
2',3'-dideoxyadenosine-5'-triphosphat C₁₀H₁₆N₅O₁₁P₃ 475.185 g/mol NotAvailable Malic Enzyme inhibitor Not Availables
pantothenoylaminoethenethiol C₁₁H₂₀N₂O₄S₁ 276.350 g/mol NotAvailable Mannose-Binding Protein A inhibitor Not Availables
[[(2-[2-ketopropylthio]ethanesulfonate]] C₅H₁₀O₄S₂ 198.252 g/mol NotAvailable Alpha-L-Arabinofuranosidase inhibitor Not Availables
fr239087 C₁₅H₁₇N₃O₂Cl₂ 342.224 g/mol NotAvailable L-Arabinose-Binding Protein inhibitor Not Availables
dodecyl-alpha-d-maltoside C₂₄H₄₆O₁₁ 510.621 g/mol NotAvailable Fucose-Specific Lectin inhibitor Not Availables
[[3,5-dichloro-4-[(4-hydroxy-3-isopropylphenoxy)phenylacetic säure]] C₁₉H₂₂O₄ 314.380 g/mol NotAvailable Chondroitinase Ac inhibitor Not Availables
o3-sulfonylgalactose C₆H₁₂O₉S₁ 260.215 g/mol NotAvailable säureic Lectin inhibitor Not Availables
[[phosphoric säure mono-[5-(4-amino-5-bromo-2-oxo-2h-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ]] Not Available Not Available NotAvailable Cysteine-Rich Domain Of Mannose Receptor inhibitor Not Availables
000004-(2-thienyl)-1-(4-methylbenzyl)-1h-imidazol C₁₅H₁₄N₂S₁ 254.349 g/mol NotAvailable Phosphoribosyl Pyrophosphate Synthetase inhibitor Not Availables
etheno-nadp C₁₇H₂₄N₅O₁₇P₃ 663.321 g/mol NotAvailable Aconitase inhibitor Not Availables
000004-imino-5-methidyl-2-trifluoromethylpyrimidin C₆H₄N₃F₃ 175.113 g/mol NotAvailable Chloramphenicol 3-O Phosphotransferase inhibitor Not Availables
[[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]chroman-6-ol]] C₂₉H₅₀O₂ 430.713 g/mol NotAvailable Hypoxanthine Phosphoribosyltransferase inhibitor Not Availables
l-d-(a-aminoadipoyl)-l-cysteinyl-d-valin C₁₄H₂₅N₃O₆S₁ 363.428 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
000002-iodobenzylthio group C₇H₆I₁S₁ 249.089 g/mol NotAvailable Nicotinate-Nucleotide--Dimethylbenzimidazole inhibitor Not Availables
l-rhamnitol C₆H₁₄O₅ 166.174 g/mol NotAvailable Vanillyl-Alcohol Oxidase inhibitor Not Availables
000006-chloro-2-fluoropurin C₅H₂N₄Cl₁F₁ 172.549 g/mol NotAvailable 000006-Hydroxymethyl-7,8-Dihydropterin Pyrophosph inhibitor Not Availables
adenosine-5'-rp-alpha-thio-triphosphat C₁₀H₁₂N₅O₁₂P₃S₁ 519.212 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
guanidine-3-propanol C₄H₁₂N₃O₁ 118.158 g/mol NotAvailable Glycogen Synthase Kinase-3 Beta inhibitor Not Availables
valpromide C₈H₁₇N₁O₁ 143.228 g/mol NotAvailable Beta-Tryptase inhibitor Not Availables
cp-coeleneterazin C₂₅H₂₇N₃O₅ 449.505 g/mol NotAvailable Odorant-Binding Protein inhibitor Not Availables
[[[(2r,3s,4s,5r)-3,4,5-trihydroxytetrahydrofuran-2-yl]methyl dihydrogen phosphat]] C₅H₁₁O₈P₁ 230.111 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000002-methylleucin C₇H₁₅N₁O₂ 145.201 g/mol NotAvailable Inducible Nitric Oxide Synthase inhibitor Not Availables
000002-deoxy-2-fluoro-alpha-d-mannosyl fluoride C₆H₁₀O₄F₂ 184.139 g/mol NotAvailable Trypsin inhibitor Not Availables
compound 9 C₂₁H₁₆N₁O₇F₁ 413.358 g/mol NotAvailable G25K GTP-Binding Protein inhibitor Not Availables
cpad C₂₁H₂₇N₇O₁₄P₂ 663.430 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
l-n(omega)-nitroarginine-(4r)-amino-l-proline amide C₁₁H₂₂N₈O₄ 330.346 g/mol NotAvailable Adpr Pyrophosphatase inhibitor Not Availables
beta-dadf, msa, multisubstrate adduct inhibitor C₃₂H₃₄N₉O₁₅P₁ 815.646 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
heparin disaccharide iii-s C₁₂H₁₆N₁O₁₆S₂ 494.375 g/mol NotAvailable Antirheumatic Agents; Immunomodulatory Agents For treatment of adult rheumatoid arthritiss
glucosamine 6-phosphat C₆H₁₄N₁O₈P₁ 259.152 g/mol NotAvailable Pol Polyprotein inhibitor Not Availables
n-(2-ferrocenylethyl)maleimide C₁₆H₁₇N₁O₂Fe₁ 311.163 g/mol NotAvailable Coagulants; Thrombotic Agents For the treatment of hemophilia A, von Willebrand diseae and Factor XIII deficiencys
nna C₆H₁₃N₅O₄ 219.200 g/mol NotAvailable Dihydroorotate Dehydrogenase inhibitor Not Availables
000002-[[{[formyl(hydroxy)amino]methyl}-4-methylpentanoic säure]] C₈H₁₅N₁O₄ 189.211 g/mol NotAvailable Immunomodulatory Agents For prevention of renal transplant rejections
000004-thio-d-glucose C₆H₁₂O₅S₁ 196.218 g/mol NotAvailable Xaa-Pro Aminopeptidase inhibitor Not Availables
[[{(1s)-1-benzyl-4-[3-carbamoyl-1-(1-carbamoyl-2-phenyl-ethylcarbamoyl)-(s)-propylcarbamoyl]-2-oxo-5-phenyl-pentyl}-carbamic säure tert-butyl ester]] C₃₈H₄₇N₅O₇ 685.819 g/mol NotAvailable Alpha-L-Arabinofuranosidase inhibitor Not Availables
[[[2-amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-a]pyridin-3-yl]-phenyl-methanon]] C₂₁H₁₃N₃O₂F₂ 377.349 g/mol NotAvailable Kdo-8-Phosphate Synthetase inhibitor Not Availables
histidinol C₆H₁₀N₃O₁₁+ 300.159 g/mol NotAvailable Chitotriosidase 1 inhibitor Not Availables
[[(r)-n-[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester]] C₂₆H₃₀N₄O₃ 446.548 g/mol NotAvailable Chitotriosidase 1 inhibitor Not Availables
trimethyl glycin C₅H₁₂N₁O₂₁+ 422.144 g/mol NotAvailable Potassium Channel Protein Rck4 inhibitor Not Availables
fudp C₉H₁₃N₂O₁₀F₁P₂ 390.155 g/mol NotAvailable Delta 2 Crystallin inhibitor Not Availables
fidarestat(stereoisomer) C₁₂H₁₀N₃O₄F₁ 279.227 g/mol NotAvailable Phosphatase inhibitor Not Availables
5'-o-(n-(l-alanyl)-sulfamoyl)adenosin C₁₃H₁₉N₇O₇S₁ 417.396 g/mol NotAvailable Aspartate-Semialdehyde Dehydrogenase inhibitor Not Availables
000003-[[[aminoethylphosphoryl]-[1,2-di-palmitoyl]-sn-glycerol]] C₃₇H₇₄N₁O₈P₁ 691.967 g/mol NotAvailable L-2-Halosäure Dehalogenase inhibitor Not Availables
[[(s)-2-[4-(aminomethyl)-1h-1,2,3-triazol-1-yl]-4-methylpentanoic säure]] C₉H₁₆N₄O₂ 212.251 g/mol NotAvailable Spo0A inhibitor Not Availables
[[(2r)-2-{[formyl(hydroxy)amino]methyl}hexanoic säure]] C₈H₁₅N₁O₄ 189.211 g/mol NotAvailable Aspartyl-tRNA Synthetase inhibitor Not Availables
(2r)-2-(aminomethyl)-2,4-dihydroxy-5-oxo-3-(2-oxoethyl)-2,5-dihydro-1h-imidazol-3-ium C₆H₁₁N₃O₅ 205.170 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
000004-[[{2-(4-fluoro-benzyl)-6-methyl-5-[(5-methyl-isoxazole-3-carbonyl)-amino]-4-oxo-heptanoylamino}-5-(2-oxo-pyrrolidin-3-yl)-pentanoic säure ethyl ester]] C₃₁H₄₁N₄O₇F₁ 600.686 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
[[(2r)-n-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide]] C₁₈H₁₄N₂O₄F₄S₁ 430.373 g/mol NotAvailable Elongation Factor Tu inhibitor Not Availables
(2r)-amino(4-hydroxyphenyl)acetic säure C₈H₉N₁O₃ 167.164 g/mol NotAvailable Vhh-R2 Anti-Rr6 Antibody inhibitor Not Availables
(2e)-3-(1h-imidazol-4-yl)acrylic säure C₆H₆N₂O₂ 138.126 g/mol NotAvailable Aquaporin Z inhibitor Not Availables
[[(2e,3s)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'h)-on]] C₂₂H₂₃N₃O₅S₁ 441.501 g/mol NotAvailable Aquaporin 1 inhibitor Not Availables
000002-(3,4,5-trihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one; 3,3',4',5,5',7-hexahydroxyflavone;myricetin; cannabiscetin C₁₅H₁₀O₈ 318.239 g/mol NotAvailable Multidrug Resistance Protein inhibitor Not Availables
(2r,3r,4s,5r)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidinium C₈H₁₇N₂O₄₁+ 797.211 g/mol NotAvailable Bacteriochlorophyll A Protein inhibitor Not Availables
[[(2r,3r,4r,5r)-3,4-dihydroxy-n,n'-bis[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide]] C₄₀H₄₄N₂O₆ 648.797 g/mol NotAvailable Camp-Dependent Protein Kinase inhibitor Not Availables
000002-oxy-4-hydroxy-5-(2-hydrazinopyridine)phenylalanin C₁₄H₁₆N₄O₄ 304.305 g/mol NotAvailable Camp-Dependent Protein Kinase, Alpha-Cat inhibitor Not Availables
cyanocinnolin C₂₄H₂₀N₄ 364.449 g/mol NotAvailable Camp-Dependent Protein Kinase, Alpha-Cat inhibitor Not Availables
[[(2s,5r,6r)-6-{[(6r)-6-(glycylamino)-7-oxido-7-oxoheptanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate]] C₁₇H₂₅N₄O₇S₁ 429.467 g/mol NotAvailable Camp-Dependent Protein Kinase, Alpha-Cat inhibitor Not Availables
(2s,4s)-alpha-campholinic säure C₁₀H₁₈O₃ 186.250 g/mol NotAvailable Peptide inhibitor Not Availables
(2s)-2-amino-3-butenoic säure, (2s)-2-aminobut-3-enoicsäure C₄H₇N₁O₂ 101.105 g/mol NotAvailable Matrix Metalloproteinase-8 inhibitor Not Availables
[[(2s)-2-[(5-benzofuran-2-yl-thiophen-2-ylmethyl)-(2,4-dichloro-benzoyl)-amino]-3-phenyl-propionic säure]] C₂₉H₂₁N₁O₄Cl₂S₁ 550.455 g/mol NotAvailable Polypeptide Deformylase inhibitor Not Availables
[[(2s)-2-[(2,4-dichloro-benzoyl)-(3-trifluoromethyl-benzyl)-amino]-3-phenyl-propionic säure]] C₂₄H₁₈N₁O₃Cl₂F₃ 496.312 g/mol NotAvailable Neuraminidase inhibitor Not Availables
(2s,3s)-1,4-dimercaptobutane-2,3-diol C₄H₁₀O₂S₂ 154.242 g/mol NotAvailable Phosphoglycerate Mutase 1 inhibitor Not Availables
(2s,3s,8s,9s)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic säure C₂₀H₂₉N₁O₃ 331.454 g/mol NotAvailable Odorant-Binding Protein inhibitor Not Availables
2'-5'dideoxyuridin C₉H₁₂N₂O₄ 212.205 g/mol NotAvailable Oxysterols Receptor Lxr-Beta inhibitor Not Availables
[[(2s,4r)-1-acetyl-n-[(1s)-4-[(aminoiminomethyl)amino]-1-(2-benzothiazolylcarbonyl)butyl]-4-hydroxy-2-pyrrolidinecarboxamide]] C₂₀H₂₆N₆O₄S₁ 446.523 g/mol NotAvailable Peroxidase inhibitor Not Availables
000002-deazo-6-thiophosphate guanosine-5'-monophosphat C₁₀H₁₅N₄O₁₀P₂S₁₁+ 765.857 g/mol NotAvailable Cephalosporinase inhibitor Not Availables
(2s,3s)-trans-2,3-dihydro-3-hydroxyanthranilic säure C₇H₉N₁O₃ 155.153 g/mol NotAvailable Trypsin inhibitor Not Availables
01.03.335 C₂₀H₂₀N₃O₅F₃ 439.390 g/mol NotAvailable Lysozyme inhibitor Not Availables
n-alpha-(2-naphthylsulfonyl)-n-(3-amidino-l-phenylalaninyl)-d-pipecolinic säure C₂₆H₂₈N₄O₅S₁ 508.591 g/mol NotAvailable Cathepsin K inhibitor Not Availables
(1-tert-butyl-5-hydroxy-1h-pyrazol-4-yl)-(6-methanesulfonyl-4'-methoxy-2-methyl-biphenyl-3-yl)-methanon C₂₃H₂₈N₂O₅S₁ 444.545 g/mol NotAvailable Odorant-Binding Protein inhibitor Not Availables
[[(1-methyl-1h-imidazol-2-yl)-(3-methyl-4-{3-[(pyridin-3-ylmethyl)-amino]-propoxy}-benzofuran-2-yl)-methanon]] C₂₃H₂₄N₄O₃ 404.468 g/mol NotAvailable Cruzain inhibitor Not Availables
000001-o-phosphono-d-glucitol, d-glucitol-6-phosphat C₆H₁₅O₉P₁ 262.153 g/mol NotAvailable Trypsin I inhibitor Not Availables
000005-bromo-2'-deoxyuridine-5'-monophosphat C₉H₁₂N₂O₈Br₁P₁ 387.080 g/mol NotAvailable O6-Alkylguanine-DNA Alkyltransferase inhibitor Not Availables
Alemtuzumab C₆₄₆₈H₁₀₀₆₆N₁₇₃₂O₂₀₀₅S₄₀ 145453.8 NotAvailable Chymotrypsin inhibitor Not Availables
1,6-di-o-phosphono-d-allitol C₆H₁₆O₁₂P₂ 342.133 g/mol NotAvailable Leukotriene A-4 Hydrolase inhibitor Not Availables
000006-deoxy-beta-l-galactose C₆H₁₂O₅ 164.158 g/mol NotAvailable Cyclic Hexapeptide Rr inhibitor Not Availables
000006-(adenosine tetraphosphate-methyl)-7,8-dihydropterin C₁₇H₂₄N₁₀O₁₇P₄ 764.328 g/mol NotAvailable Bradykinin inhibitor Not Availables
dansylamide C₁₂H₁₄N₂O₂S₁ 250.315 g/mol NotAvailable Galactanase inhibitor Not Availables
ge2270a C₅₆H₅₅N₁₅O₁₀S₆ 1290.505 g/mol NotAvailable Galactanase inhibitor Not Availables
(1s,3r,4r,6s)-1,3,4,6-tetrapkisphosphat C₆H₁₆O₁₈P₄ 500.077 g/mol NotAvailable Hcys Beta3-Cys Analogue Of Hiv Gp41 inhibitor Not Availables
(1s,2s)-1-amino-1-(1,3-thiazol-2-yl)propan-2-ol C₆H₁₀N₂O₁S₁ 158.218 g/mol NotAvailable Hiv1 Gp41 Hser Analogue Peptide Ace-Ile-T inhibitor Not Availables
(1s)-1(9-deazahypoxanthin-9yl)1,4-dideoxy-1,4-imino-d-ribitol-5-phosphat C₁₁H₁₅N₄O₇P₁ 346.236 g/mol NotAvailable Beta-Alanine Synthase inhibitor Not Availables
(1s)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-5-methylthio-d-ribitol C₁₂H₁₇N₅O₂S₁ 295.359 g/mol NotAvailable Ribonuclease U2 inhibitor Not Availables
(1s)-1-(0-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-5-methylthio-d-ribitol, mt-immucillin-h, mt-immh C₁₂H₁₇N₄O₃S₁ 297.351 g/mol NotAvailable Zinc Finger Y-Chromosomal Protein inhibitor Not Availables
000001-[[o-[o-nitrophenyl]-beta-d-galactopyranose]] C₁₂H₁₅N₁O₈ 301.252 g/mol NotAvailable Ribose 5-Phosphate Isomerase inhibitor Not Availables
000002-acetamido-2-deoxy-d-glucono-1,5-lacton C₈H₁₃N₁O₆ 219.194 g/mol NotAvailable Hypothetical Protein Lecb inhibitor Not Availables
(1,10 phenanthroline)-(tri-carbon monoxide) rhenium (i) C₁₅H₈N₂O₃Re₁₁+ 2312.440 g/mol NotAvailable Arac inhibitor Not Availables
[[(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-hydroxy-3,7,12,16-tetramethylheptadeca-1,3,5,7,9,11,13,15-octaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol]] C₃₀H₄₂O₂ 434.661 g/mol NotAvailable Glycogen Phosphorylase B inhibitor Not Availables
guanosine-5',3'-tetraphosphat C₁₀H₁₇N₅O₁₇P₄ 603.163 g/mol NotAvailable Glucose 6-Phosphate 1-Dehydrogenase inhibitor Not Availables
(1n)-4-n-butoxyphenylsulfonyl-(2r)-n-hydroxycarboxamido-(4s)-methanesulfonylamino-pyrrolidin C₁₆H₂₅N₃O₇S₂ 435.509 g/mol NotAvailable Lectin inhibitor Not Availables
000008-azaguanin C₄H₄N₆O₁ 152.115 g/mol NotAvailable Bifunctional Purine Biosynthesis Protein Pur inhibitor Not Availables
000001-n-acetyl-beta-d-glucosamin C₈H₁₅N₁O₆ 221.210 g/mol NotAvailable 000006-Phospho-Beta-D-Galactosidase inhibitor Not Availables
000001-monooleoyl-rac-glycerol C₂₁H₄₀O₄ 356.545 g/mol NotAvailable Coagulation Factor X inhibitor Not Availables
000001-o-octyl-2-heptylphosphonyl-sn-glycero-3-phosphoethanolamin C₂₀H₄₅N₁O₈P₂ 489.525 g/mol NotAvailable Mannose-Binding Protein Associated Serin inhibitor Not Availables
tris-hydroxymethyl-methyl-ammonium C₄H₁₂N₁O₃₁+ 570.127 g/mol NotAvailable Tem-1 Beta-Lactamase inhibitor Not Availables
000001-[[o-[p-nitrophenyl]-beta-d-galactopyranose]] C₁₂H₁₅N₁O₈ 301.252 g/mol NotAvailable Seed Lipoxygenase-3 inhibitor Not Availables
000001-methylcytosin C₅H₇N₃O₁ 125.130 g/mol NotAvailable Seed Lipoxygenase-3 inhibitor Not Availables
000001-[[methyl-3-oxo-1,3-dihydro-benzo[c]isothiazole-5-sulfonic säure amide]] C₈H₈N₂O₃S₂ 244.283 g/mol NotAvailable Mannose-Binding Protein A inhibitor Not Availables
000006-[[(2,5-dimethoxy-benzyl)-5-methyl-pyrido[2,3-d]pyrimidine-2,4-diamin]] C₁₇H₁₉N₅O₂ 325.369 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
000001-monohexanoyl-2-hydroxy-sn-glycero-3-phosphat C₉H₁₉O₇P₁ 270.219 g/mol NotAvailable Peptidic Toxin Nodularin inhibitor Not Availables
n7-methyl-formycin a C₁₁H₁₅N₅O₄ 281.271 g/mol NotAvailable Mannose-Binding Protein-A inhibitor Not Availables
000001-methylimidazol C₄H₇N₂₁+ 349.240 g/mol NotAvailable Hemagglutinin-Neuraminidase Glycoprotein inhibitor Not Availables
1,2-dipalmitoyl-phosphatidyl-glycerol C₃₈H₇₅O₁₀P₁ 722.978 g/mol NotAvailable Phenylalanine-4-Hydroxylase inhibitor Not Availables
3,4-dihydro-2h-pyrrolium-5-carboxylate C₅H₇N₁O₂ 113.116 g/mol NotAvailable 36 Kda Soluble Lytic Transglycosylase inhibitor Not Availables
1,2-dichloro-propan C₃H₆Cl₂ 112.986 g/mol NotAvailable Hpv11 Regulatory Protein E2 inhibitor Not Availables
10-cf3c(oh)2-ddacthf, hydrolyzed form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic säure C₂₂H₃₀N₅O₈F₃ 549.503 g/mol NotAvailable Insecticyanin A Form inhibitor Not Availables
norvalin C₅H₁₁N₁O₂ 117.147 g/mol NotAvailable Biliverdin Ix Beta Reductase inhibitor Not Availables
1,2-epoxypropylphosphonic säure C₃H₇O₄P₁ 138.060 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
delta-bis(2,2'-bipyridine)imidazole osmium (ii) C₂₃H₂₀N₆Os₁₂+ 781.171 g/mol NotAvailable Avidin inhibitor Not Availables
000001-phenylsulfonamide-3-trifluoromethyl-5-parabromophenylpyrazol C₁₆H₁₁N₃O₂Br₁F₃S₁ 446.241 g/mol NotAvailable Trypsin inhibitor Not Availables
(-)-galanthamin C₁₇H₂₁N₁O₃ 287.358 g/mol NotAvailable Cathepsin G inhibitor Not Availables
[[[{(5-chloro-2-pyridinyl)amino} methylene]-1,1-bisphosphonate]] C₆H₉N₂O₆Cl₁P₂ 302.547 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
1,2-di-n-pentanoyl-sn-glycero-3-dithiophosphocholin C₁₈H₃₆N₁O₆P₁S₂ 457.579 g/mol NotAvailable Trypsin inhibitor Not Availables
1,2-di-1-(3,7,11,15-tetramethyl-hexadecane)-sn-glycero-3-phosphat C₄₃H₈₉O₆P₁ 733.146 g/mol NotAvailable Trypsin inhibitor Not Availables
000001-deoxynojirimycin C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Trypsin inhibitor Not Availables
000001-deoxymannojirimycin C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Botulinum Neurotoxin Type B inhibitor Not Availables
000002-amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic säure C₁₁H₁₉N₂O₇P₁ 322.254 g/mol NotAvailable Trypsin inhibitor Not Availables
000001-guanidinium-7-aminoheptan C₈H₂₂N₄ 174.289 g/mol NotAvailable Trypsin inhibitor Not Availables
000001-ethyl-pyrrolidine-2,5-dion C₆H₉N₁O₂ 127.143 g/mol NotAvailable Adenylate Kinase inhibitor Not Availables
000001-[[deoxy-6-o-phosphono-1-[(phosphonomethyl)amino]-l-threo-hexitol]] C₇H₁₉N₁O₁₁P₂ 355.175 g/mol NotAvailable Dephospho-Coa Kinase inhibitor Not Availables
000001-deoxy-1-thio-heptaethylene glycol C₁₄H₃₀O₇S₁ 342.447 g/mol NotAvailable Oxygen-Insensitive Nad inhibitor Not Availables
guanosine-3'-monophosphat C₁₀H₁₄N₅O₈P₁ 363.223 g/mol NotAvailable Retinoic säure Receptor Gamma-1 inhibitor Not Availables
000001-deoxy-ribofuranose-5'-phosphat C₅H₁₁O₇P₁ 214.111 g/mol NotAvailable Cholera Toxin B Subunit inhibitor Not Availables
n-(2-flouro-benzyl)-4-sulfamoyl-benzamide C₁₄H₁₃N₂O₃F₁S₁ 308.327 g/mol NotAvailable Pheromone-Binding Protein inhibitor Not Availables
000003-chloro-4-hydroxyphenylglycin C₈H₈N₁O₃Cl₁ 201.609 g/mol NotAvailable Anti-Wrinkle Agents; Antidystonic Agents For treatment of cervical dystonia, axillary hyperhidrosis, strabismus, facial wrinkless
000001-menaphthyl glutathione conjugate C₂₁H₂₅N₃O₆S₁ 447.505 g/mol NotAvailable Anti-Wrinkle Agents; Antidystonic Agents For treatment of cervical dystonia, axillary hyperhidrosis, strabismus, facial wrinkless
000004-[[[(isopropylamino)methyl]phenylalanin]] C₁₃H₂₀N₂O₂ 236.313 g/mol NotAvailable Aequorin 2 inhibitor Not Availables
000001-hydroxy-3-methylbutan C₅H₁₂O₁ 88.149 g/mol NotAvailable Dihydroorotate Dehydrogenase inhibitor Not Availables
[[{3-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-2-methyl-propyl}-phosphonic säure]] C₁₁H₂₀N₂O₉P₂ 386.235 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
000001-[[methoxy-2-[2-(2-methoxy-ethoxy]-ethan]] C₈H₁₈O₄ 178.228 g/mol NotAvailable Analgesics; Anti-Inflammatory Agents, Non-Steroidal For the treatment of postoperative inflammation in patients who have undergone cataract extraction.s
000001-methoxy-2-(2-methoxyethoxy)ethan C₆H₁₄O₃ 134.175 g/mol NotAvailable Chemosensory Protein inhibitor Not Availables
000001-hexyldecanoic säure C₁₆H₃₂O₂ 256.428 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
000001-hexadecylsulfonyl fluoride C₁₆H₃₃O₂F₁S₁ 308.494 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
000001-hydroxy-2-s-glutathionyl-3-para-nitrophenoxy-propan C₁₉H₂₆N₄O₁₀S₁ 502.495 g/mol NotAvailable 70-Kda Soluble Lytic Transglycosylase inhibitor Not Availables
000001-hydroxy-2-amino-3-cyclohexylpropan C₉H₁₉N₁O₁ 157.255 g/mol NotAvailable Odorant Binding Protein Lush inhibitor Not Availables
000001-hydroxy-1-thio-glycerol C₃H₈O₃S₁ 124.154 g/mol NotAvailable Liver Fatty säure Binding Protein inhibitor Not Availables
[[pf-00356231; 3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic säure]] C₂₅H₂₀N₂O₃S₁ 428.505 g/mol NotAvailable Shiga-Like Toxin Iie B Subunit inhibitor Not Availables
10-(4-dimethylamino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-8-ethyl-1,8,11-trihydroxy-7,8,9,10-tetrahydro-naphthacene-5,12-dion C₂₈H₃₃N₁O₈ 511.571 g/mol NotAvailable Aspartic Proteinase inhibitor Not Availables
s-arsonocystein C₃H₈N₁O₅S₁As₁ 245.082 g/mol NotAvailable Triacyl-Glycerol-Hydrolase inhibitor Not Availables
10-propargyl-5,8-dideazafolic säure C₂₄H₂₃N₅O₆ 477.476 g/mol NotAvailable Amic inhibitor Not Availables
10-formyl-5,8,10-trideazafolic säure C₂₃H₂₂N₄O₈ 482.449 g/mol NotAvailable Cholinesterase inhibitor Not Availables
1,8-di-hydroxy-4-nitro-xanthen-9-on C₁₃H₇N₁O₆ 273.201 g/mol NotAvailable Cholera Toxin B Protein inhibitor Not Availables
1,8-di-hydroxy-4-nitro-anthraquinon C₁₄H₇N₁O₆ 285.212 g/mol NotAvailable Cholera Toxin B Protein inhibitor Not Availables
1,3,2-dioxaborolan-2-ol C₂H₅O₃B₁ 87.870 g/mol NotAvailable Cholera Toxin B Protein inhibitor Not Availables
1(r)-1-acetamido-2-(3-carboxyphenyl)ethyl boronic säure C₁₁H₁₄N₁O₅B₁ 251.045 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
1'-deazo-thiamin diphosphat C₁₃H₁₉N₃O₇P₂S₁ 423.317 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
1,8-diaminooctane; octamethylenediamine; 1,8-octanediamin C₈H₂₀N₂ 144.259 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
000002-(1,1'-biphenyl-4-yl)propanoic säure C₁₅H₁₄O₂ 226.274 g/mol NotAvailable C-1027 Apoprotein inhibitor Not Availables
1na C₉H₁₇N₁O₆ 235.236 g/mol NotAvailable Enoyl-Acyl Carrier Protein inhibitor Not Availables
metanitrophenyl-alpha-d-galactoside C₁₂H₁₅N₁O₈ 301.252 g/mol NotAvailable Cathepsin B inhibitor Not Availables
000001-(2-fluorobenzyl)-3-butyl-8-(n-acetyl-4-aminobenzyl)-xanthin C₂₅H₂₆N₅O₃F₁ 463.511 g/mol NotAvailable Integrase inhibitor Not Availables
pyruvoyl group C₃H₃O₂ 71.055 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
000002-[[(11-{2-[benzenesulfonyl-(3-methyl-butyl)-amino]-1-hydroxy-ethyl}-6,9-dioxo-2-oxa-7,10-diaza-bicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-8-yl)-acetamide]], inhibitor 2 C₂₉H₄₀N₄O₇S₁ 588.718 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
(tert-butyloxycarbonyl)-alanyl-alanyl-amin C₁₁H₂₁N₃O₄ 259.305 g/mol NotAvailable Nonspecific Lipid-Transfer Protein inhibitor Not Availables
13-acetylphorbol C₂₂H₃₀O₇ 406.475 g/mol NotAvailable Poly inhibitor Not Availables
12-phenylheme C₄₀H₃₈N₄O₄Fe₁ 694.612 g/mol NotAvailable Acetylcholine-Binding Protein inhibitor Not Availables
000002-fluoro-2'-deoxyadenosin C₁₀H₁₂N₅O₃F₁ 269.235 g/mol NotAvailable 000003-Dehydroquinate Synthase inhibitor Not Availables
17-dmag C₃₂H₄₈N₄O₈ 616.753 g/mol NotAvailable Fatty säure-Binding Protein, Adipocyte inhibitor Not Availables
16g C₈H₁₆N₁O₉P₁ 301.189 g/mol NotAvailable Corticosteroid 11-Beta-Dehydrogenase Isozyme inhibitor Not Availables
1,3-thiazole-4-carboxylic säure C₄H₃N₁O₂S₁ 129.133 g/mol NotAvailable Astacin inhibitor Not Availables
1,3-propandiol C₃H₈O₂ 76.095 g/mol NotAvailable ADP, ATP Carrier Protein Heart Isoform T1 inhibitor Not Availables
1,4-butanediol C₄H₁₀O₂ 90.122 g/mol NotAvailable Riboflavin Synthase inhibitor Not Availables
1,3,5-trichloro-benzen C₆H₃Cl₃ 181.449 g/mol NotAvailable Nicotinate Phosphoribosyltransferase From Th inhibitor Not Availables
l-glucuronic säure C₆H₁₀O₇ 194.141 g/mol NotAvailable D-Glyceraldehyde-3-Phosphate-Dehydrogena inhibitor Not Availables
1,2,5,6-tetrahydro-4h-pyrrolo(3,2,1-ij)quinolin-4-on C₁₁H₁₁N₁O₁ 173.214 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
1,2,4-triazole-carboxamidin C₃H₆N₅₁+ 756.422 g/mol NotAvailable Cystathionine Gamma-Synthase inhibitor Not Availables
1,2,4-triazol C₂H₃N₃ 69.066 g/mol NotAvailable Neutrophil Gelatinase-Associated Lipocalin inhibitor Not Availables
1,3-di(n-propyloxy-a-mannopyranosyl)-carbomyl 5-methyazido-benzen C₂₇H₄₁N₅O₁₄ 659.646 g/mol NotAvailable Neutrophil Gelatinase-Associated Lipocalin inhibitor Not Availables
1,3-dedimethyl-1,3-divinyl heme C₃₆H₃₂N₄O₄Fe₁ 640.520 g/mol NotAvailable ADP, ATP Carrier Protein Heart Isoform T1 inhibitor Not Availables
1,3-butanediol C₄H₁₀O₂ 90.122 g/mol NotAvailable Scytalone Dehydratase inhibitor Not Availables
oxalate ion C₂O₄₂- 695.997 g/mol NotAvailable Minor Fmn-Dependent Nitroreductase inhibitor Not Availables
1,5-bis(n-benzyloxycarbonyl-l-leucinyl)carbohydrazide C₂₉H₄₀N₆O₇ 584.671 g/mol NotAvailable Retinoic säure Receptor Gamma-1 inhibitor Not Availables
1,4-dithiothreitol C₄H₁₀O₂S₂ 154.242 g/mol NotAvailable Toho-1 Beta-Lactamase inhibitor Not Availables
000008-(pyrimidin-2-ylamino)naphthalene-2-carboximidamide C₁₅H₁₃N₅ 263.301 g/mol NotAvailable Endoglucanase V Cellobiose Complex inhibitor Not Availables
1,6-fructose diphosphate (linear form) C₆H₁₄O₁₂P₂ 340.117 g/mol NotAvailable Cellobiohydrolase II inhibitor Not Availables
1,6-diaminohexan C₆H₁₆N₂ 116.206 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
1,4-dideoxy-5-dehydro-o2-sulfo-glucuronic säure C₆H₈O₈S₁ 240.184 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase Precurso inhibitor Not Availables
1,4-dideoxy-4-aza-1-(s)-(9-deazahypoxanthin-9-yl)-d-ribitol C₁₁H₁₄N₄O₄ 266.256 g/mol NotAvailable Toho-1 Beta-Lactamase inhibitor Not Availables
000002-allylphenol C₉H₁₀O₁ 134.177 g/mol NotAvailable Methoxy Mycolic säure Synthase 2 inhibitor Not Availables
1,4-dithio-alpha-d-mannose C₆H₁₂O₄S₂ 212.278 g/mol NotAvailable Lysozyme inhibitor Not Availables
000002-deoxy-d-glucitol 6-(e)-vinylhomophosphonate C₇H₁₅O₇P₁ 242.165 g/mol NotAvailable Myohemerythrin inhibitor Not Availables
1,4-dideoxy-o2-sulfo-glucuronic säure C₆H₁₀O₈S₁ 242.200 g/mol NotAvailable Hydroxynitrile Lyase inhibitor Not Availables
[[[pterin-6-yl methanyl]-phosphonophosphat]] C₇H₉N₅O₈P₂ 353.124 g/mol NotAvailable Nuclear Receptor Ror-Alpha inhibitor Not Availables
[[[methylthio]acetat]] C₃H₅O₂S₁₁- 425.731 g/mol NotAvailable Cholesterol Esterase inhibitor Not Availables
[[{[2-(1h-1,2,3-benzotriazol-1-yl)-2-(3,4-difluorophenyl)propane-1,3-diyl]bis[4,1-phenylene(difluoromethylene)]}bis(phosphonic säure)]] C₂₉H₂₃N₃O₆F₆P₂ 685.455 g/mol NotAvailable Green Fluorescent Protein inhibitor Not Availables
[[{[(2,2-dihydroxy-ethyl)-(2,3,4,5-tetrahydroxy-6-phosphonooxy-hexyl)-amino]-methyl}-phosphonic säure]] C₉H₂₃N₁O₁₃P₂ 415.227 g/mol NotAvailable Kindling Fluorescent Protein inhibitor Not Availables
[[{[-(bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetic säure]] C₁₀H₁₆N₂O₈ 292.245 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
[[[4-(6-chloro-naphthalene-2-sulfonyl)-piperazin-1-yl]-(3,4,5,6-tetrahydro-2h-[1,4']bipyridinyl-4-yl)-methanon]] C₂₅H₂₇N₄O₃Cl₁S₁ 499.026 g/mol NotAvailable Renal Dipeptidase inhibitor Not Availables
000001-aminocyclopropylphosphonate C₃H₇N₁O₃P₁₁- 445.805 g/mol NotAvailable Ubiquitin-Protein Ligase E3 Mdm2 inhibitor Not Availables
000004-hydroxy-3-methyl butyl diphosphat C₅H₁₄O₈P₂ 264.108 g/mol NotAvailable Ubiquitin-Protein Ligase E3 Mdm2 inhibitor Not Availables
[[[methyltelluro]acetat]] C₃H₅O₂Te₁₁- 1476.671 g/mol NotAvailable Yeast Cytochrome C Peroxidase inhibitor Not Availables
mant-adp C₁₈H₂₂N₆O₁₀P₂ 544.354 g/mol NotAvailable 000003-Deoxy-Manno-Octulosonate Cytidylyltran inhibitor Not Availables
[[[cyclohexylethyl]-*[[*[[4-[2-methyl-1-imidazolyl-butyl]phenyl]acetyl]-seryl]-lysinyl]-amin]] C₃₃H₅₂N₆O₄ 596.812 g/mol NotAvailable Vitamin B12 Receptor inhibitor Not Availables
000001-(2-chlorophenyl)-3,5-dimethyl-1h-pyrazole-4-carboxylic säure ethyl ester C₁₄H₁₅N₂O₂Cl₁ 278.738 g/mol NotAvailable Methionine Synthase inhibitor Not Availables
phosphoaminophosphonic säure guanylate ester C₁₀H₁₇N₆O₁₃P₃ 522.198 g/mol NotAvailable Mimochrome IV, Miniaturized Metalloprotei inhibitor Not Availables
[[{4-[3-(6,7-diethoxy-quinazolin-4-ylamino)-phenyl]-thiazol-2-yl}-methanol]] C₂₂H₂₂N₄O₃S₁ 422.501 g/mol NotAvailable Serotonin N-Acetyltransferase inhibitor Not Availables
000006-(hydroxyethyldithio)-8-(aminomethylthio)octanoic säure C₁₁H₂₃N₁O₃S₃ 313.488 g/mol NotAvailable Serotonin N-Acetyltransferase inhibitor Not Availables
000001-(2-ethanone)-2-hydroxy-2-(1-amino-2-methyl-2-ethanol)-4-(2-dimethyl)ethane-imidazoline-5-one;chromophore (thr-leu-gly) C₁₂H₂₁N₃O₄ 271.316 g/mol NotAvailable Serotonin N-Acetyltransferase inhibitor Not Availables
000001-(2-deoxy-2-fluoro-3-o-phosphono-beta-l-ribofuranosyl)pyrimidine-2,4(1h,3h)-dion C₉H₁₂N₂O₈F₁P₁ 326.175 g/mol NotAvailable Methionine Synthase inhibitor Not Availables
000001-methyl-2-oxy-5,5-dimethyl pyrrolidin C₇H₁₃N₁O₁ 127.186 g/mol NotAvailable Chorismate Synthase inhibitor Not Availables
[[{1-[(3-hydroxy-methyl-5-phosphonooxy-methyl-pyridin-4-ylmethyl)-amino]-ethyl}-phosphonic säure]] C₁₀H₁₈N₂O₈P₂ 356.208 g/mol NotAvailable Obelin inhibitor Not Availables
[[{[7-(difluoro-phosphono-methyl)-naphthalen-2-yl]-difluoro-methyl}-phosphonic säure]] C₁₂H₁₀O₆F₄P₂ 388.149 g/mol NotAvailable Isovaleryl-Coa Dehydrogenase inhibitor Not Availables
[[{4-[2-acetylamino-2-(3-carbamoyl-2-cyclohexylmethoxy-6,7,8,9-tetrahydro-5h-benzocyclohepten-5ylcarbamoyl)-ethyl]-2-phosphono-phenyl}-phosphonic säure]] C₃₀H₄₁N₃O₁₀P₂ 665.616 g/mol NotAvailable Phosphatidylethanolamine-Binding Protein inhibitor Not Availables
[[{4-[(2s,4e)-2-(1,3-benzothiazol-2-yl)-2-(1h-1,2,3-benzotriazol-1-yl)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic säure]] C₃₁H₂₅N₄O₃F₂P₁S₁ 602.594 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
ado-p-ch2-p-ps-ado C₂₁H₂₉N₁₀O₁₄P₃S₁ 770.500 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
[[[1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic säure pyridin-4-ylmethyl ester]] C₂₇H₂₉N₃O₅ 475.543 g/mol NotAvailable Estrogen Receptor inhibitor Not Availables
[[[1-(1-methyl-4,5-dioxo-pent-2-enylcarbamoyl)-2-phenyl-ethyl]-carbamic säure benzyl ester]] C₂₃H₂₄N₂O₅ 408.453 g/mol NotAvailable Estrogen Receptor inhibitor Not Availables
acarbose derived hexasaccharide C₃₆H₆₃N₁O₂₉ 973.883 g/mol NotAvailable Estrogen Receptor inhibitor Not Availables
[[[2-(1-amino-2-hydroxy-propyl)-4-(4-fluoro-1h-indol-3-ylmethyl)-5-hydroxy-imidazol-1-yl]-acetic säure]] C₁₇H₁₉N₄O₄F₁ 362.360 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
000002-aminoprop-2-enamide C₃H₆N₂O₁ 86.093 g/mol NotAvailable Estrogen Receptor inhibitor Not Availables
[[*[[4-(aminomethyl)phenyl]amino]oxo-acetic säure,]] C₉H₁₀N₂O₃ 194.190 g/mol NotAvailable Estrogen Receptor inhibitor Not Availables
[[[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl sulfamate]] C₁₀H₁₄N₆O₆S₁ 346.317 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
[[[(2-ethoxy-1-naphthoyl)amino]methylboronic säure]] C₁₄H₁₆N₁O₄B₁ 273.095 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
[[[1-(1-benzyl-3-hydroxy-2-oxo-propylcarbamoyl)-2-phenyl-ethyl]-carbamic säure benzyl ester]] C₂₇H₂₈N₂O₅ 460.529 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
2'-deoxyuridine 5'-alpha,beta-imido-triphosphat C₉H₁₆N₃O₁₃P₃ 467.159 g/mol NotAvailable Ferrichrome-Binding Periplasmic Protein inhibitor Not Availables
000007-deaza-7-cyano-guanin C₇H₅N₅O₁ 175.149 g/mol NotAvailable Uroporphyrinogen Decarboxylase inhibitor Not Availables
[[[3-(dodecanoylamino)propyl](hydroxy)dimethylammonium]] C₁₇H₃₇N₂O₂ 301.491 g/mol NotAvailable De Novo Designed Cyclic Peptide inhibitor Not Availables
[[[3-(4-bromo-2-fluoro-benzyl)-7-chloro-2,4-dioxo-3,4-dihydro-2h-quinazolin-1-yl]-acetic säure]] C₁₇H₁₁N₂O₄Br₁Cl₁F₁ 441.640 g/mol NotAvailable Uroporphyrinogen Decarboxylase inhibitor Not Availables
[[[3-(1,3,2-dioxaborolan-2-yloxy)propyl]guanidin]] C₆H₁₅N₃O₃B₁ 188.013 g/mol NotAvailable Poly inhibitor Not Availables
[[[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]-acetic säure]] C₁₄H₉O₄I₃ 621.936 g/mol NotAvailable Sorbitol Dehydrogenase inhibitor Not Availables
[[[4-(1,3,2-dioxaborolan-2-yloxy)methyl]benzamidin]] C₁₀H₁₄N₂O₃B₁ 221.042 g/mol NotAvailable Macrophage Metalloelastase inhibitor Not Availables
[[[3,5-dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl]-acetic säure]] C₂₃H₂₃N₁O₅Br₂ 553.246 g/mol NotAvailable Liver Glycogen Phosphorylase inhibitor Not Availables
[[[2-cytidylate-o'-phosphonyloxyl]-ethyl-trimethyl-ammonium]] C₁₄H₂₆N₄O₁₁P₂ 488.327 g/mol NotAvailable Aequorin 2 inhibitor Not Availables
[[[2-aminomethyl-5-oxo-4-(4-oxo-cyclohexa-2,5-dienylmethyl)-4,5-dihydro-imidazol-1-yl] -acetaldehyde]] C₁₃H₁₅N₃O₃ 261.280 g/mol NotAvailable Liver Glycogen Phosphorylase inhibitor Not Availables
n-omega-hydroxy-l-arginin C₆H₁₄N₄O₃ 190.202 g/mol NotAvailable Horse Liver Alcohol Dehydrogenase inhibitor Not Availables
[[[3-(1-benzyl-3-carbamoylmethyl-2-methyl-1h-indol-5-yloxy)-propyl-]-phosphonic säure]] C₂₁H₂₅N₂O₅P₁ 416.413 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
[[[2(r,s)-2-sulfanylheptanoyl]-phe-ala]] C₁₉H₂₈N₂O₄S₁ 380.501 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
vinylsulphonic säure C₂H₄O₃S₁ 108.112 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-amino-1-carbonyl pentan C₆H₁₂N₁O₁ 114.167 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000005-(4-methoxyphenoxy)-2,4-quinazolinediamin C₁₅H₁₄N₄O₂ 282.301 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-[[azepan-1-yl-2-phenyl-2-(4-thioxo-1,4-dihydro-pyrazolo[3,4-d]pyrimidin-5-yl)ethanone adduct]] C₄₀H₄₄N₁₂O₁₅P₂S₁ 1026.867 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-anilino-8-naphthalene sulfonate C₁₆H₁₃N₁O₃S₁ 299.344 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000002-[[(oxalyl-amino)-4,7-dihydro-5h-thieno[2,3-c]pyran-3-carboxylic säure]] C₁₀H₉N₁O₆S₁ 271.244 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000003-(p-tolyl)propionic säure C₁₀H₁₂O₂ 164.204 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-[[[n[(phenylmethoxy)carbonyl]-l-leucyl-4-*[[n/n-[(phenylmethoxy)carbonyl]-/nl-leucyl]amino]-3-pyrrolidinone/n]] C₃₂H₄₂N₄O₇ 594.706 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-(4-tert-butylcarbamoyl-piperazine-1-carbonyl)-3-(3-guanidino-propyl)-4-oxo-azetidine-2-carboxylic säure C₁₈H₃₃N₇O₅ 427.503 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
ru82197 C₃₂H₃₃N₃O₆ 555.629 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
cra_9076 C₁₆H₁₄N₃O₁Br₁ 344.210 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-[[{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-4-(1,1,3,3-tetramethylbutyl)benzen]] C₂₁H₃₆O₄ 352.513 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
beta-1,4-galactobioside C₁₂H₂₂O₁₁ 342.299 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-carboxyethylaminomethyl-4-aminomethylbenzen C₁₁H₁₇N₂O₂₁+ 513.256 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-butane boronic säure C₄H₁₁O₂B₁ 101.940 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-deoxy-1-methoxycarbamido-beta-d-gluco-2-heptulopyranosonamide C₉H₁₆N₂O₈ 280.234 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-deoxy-1-acetylamino-beta-d-gluco-2-heptulopyranosonamide C₉H₁₆N₂O₇ 264.235 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-deaza-adenosin C₁₁H₁₄N₄O₄ 266.256 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-benzyl-5-methoxy-2-methyl-1h-indol-3-yl)-acetic säure C₁₉H₁₉N₁O₃ 309.364 g/mol NotAvailable Beta-Trypsin inhibitor Not Availables
000001-benzyl-3-(4-methoxy-benzenesulfonyl)-6-oxo-hexahydro-pyrimidine-4-carboxylic säure hydroxyamide C₁₉H₂₁N₃O₆S₁ 419.451 g/mol NotAvailable Trypsin inhibitor Not Availables
n-cyclohexyl-n'-decylurea C₁₇H₃₄N₂O₁ 282.468 g/mol NotAvailable Aldehyde Dehydrogenase inhibitor Not Availables
000001-bromopropane-2-ol C₃H₇O₁Br₁ 138.992 g/mol NotAvailable Lysozyme C inhibitor Not Availables
000003-[[(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-benzoic säure]] C₁₁H₈N₆O₃ 272.223 g/mol NotAvailable Lysozyme C inhibitor Not Availables
((2r,3s,5r)-3-hydroxy-5-(4-hydroxy-2-oxo-3,4-dihydropyrimidin-1(2h)-yl)-tetrahydrofuran-2-yl)methyldihydrogen phosphat C₉H₁₅N₂O₈P₁ 310.200 g/mol NotAvailable Scytalone Dehydratase inhibitor Not Availables
000001-(4-aminophenyl)-3,5-dimethyl-1h-pyrazole-4-carboxylic säure ethyl ester C₁₄H₁₇N₃O₂ 259.307 g/mol NotAvailable Camp-Dependent Protein Kinase Type I-Alpha R inhibitor Not Availables
pantoyl adenylate C₁₆H₂₄N₅O₁₀P₁ 477.367 g/mol NotAvailable Alpha-Amylase II inhibitor Not Availables
000001-(5-chloroindol-3-yl)-3-hydroxy-3-(2h-tetrazol-5-yl)-propenon C₁₂H₈N₅O₂Cl₁ 289.680 g/mol NotAvailable Mono-ADP-Ribosyltransferase C3 inhibitor Not Availables
000001-[[(5-carboxypentyl)-5-[(2,6-dichlorobenzyl)oxy]-1 h-indole-2-carboxylic säure]] C₂₂H₂₁N₁O₅Cl₂ 450.318 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
methylhydrazin C₁H₄N₂ 44.056 g/mol NotAvailable Mitogen-Activated Protein Kinase 10 inhibitor Not Availables
000001-(2,6-dichlorophenyl)-5-(2,4-difluorophenyl)-7-piperazin-1-yl-3,4-dihydroquinazolin-2(1h)-on C₂₄H₂₀N₄O₁Cl₂F₂ 489.351 g/mol NotAvailable Beta-Lactamase Shv-2 inhibitor Not Availables
000001-[[(2-methoxy-ethoxy)-2-{2-[2-(2-methoxy-ethoxy]-ethoxy}-ethan]] C₁₂H₂₆O₆ 266.334 g/mol NotAvailable Udp-N-Acetylglucosamine Enolpyruvyltrans inhibitor Not Availables
000001-(4-amidinophenyl)-3-(4-chlorophenyl)urea C₁₄H₁₃N₄O₁Cl₁ 288.736 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
(r)-n-(3-indol-1-yl-2-methyl-propyl)-4-sulfamoyl-benzamide C₁₉H₂₁N₃O₃S₁ 371.453 g/mol NotAvailable Mitogen-Activated Protein Kinase 10 inhibitor Not Availables
debromohymenialdisin C₁₁H₁₁N₅O₂ 245.240 g/mol NotAvailable Beta Trypsin Complexed With Cyclotheonamide inhibitor Not Availables
000001-[[[2-(3-biphenyl)-4-methylvaleryl)]amino-3-(2-pyridylsulfonyl)amino-2-propanon]] C₂₆H₃₁N₃O₄S₁ 481.609 g/mol NotAvailable Nephropathic cystinosis therapy Used to prevent damage that may be caused by the buildup of cystine crystals in organs such as the kidneys.s
000001-[[[(2-amino-6,9-dihydro-1h-purin-6-yl)oxy]-3-methyl-2-butanol]] C₁₀H₁₃N₅O₂ 235.245 g/mol NotAvailable Cog4826: Serine Protease Inhibitor inhibitor Not Availables
methionine phosphinate C₄H₁₂N₁O₂P₁S₁ 169.178 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
000001-[[[glycerolylphosphonyl]-2-[8-(2-hexyl-cyclopropyl)-octanal-1-yl]-3-[hexadecanal-1-yl]-glycerol]] C₃₉H₇₅O₁₀P₁ 734.989 g/mol NotAvailable Adipocyte Lipid Binding Protein inhibitor Not Availables
000001-[[[4-carboxy-2-(3-pentylamino)phenyl]-5,5'-di(hydroxymethyl)pyrrolidin-2-on]] C₁₈H₂₆N₂O₅ 350.414 g/mol NotAvailable 2'-5'-Oligoadenylate Synthetase 1 inhibitor Not Availables
000001-[[[3,3-dimethyl-2-(2-methylamino-propionylamino)-butyryl]-pyrrolidine-2-carboxylic säure(1,2,3,4-tetrahydro-naphthalen-1-yl)-amide]] C₂₅H₃₈N₄O₃ 442.600 g/mol NotAvailable Calcitonin Analogue inhibitor Not Availables
000001-(isopropylamino)-3-(1-naphthyloxy)-2-propanol C₁₆H₂₁N₁O₂ 259.347 g/mol NotAvailable Peroxiredoxin inhibitor Not Availables
000001-(5'-phospho-beta-d-ribofuranosyl)barbituric säure C₉H₁₃N₂O₁₀P₁ 340.183 g/mol NotAvailable Uridine-Cytidine Kinase 2 inhibitor Not Availables
000001-[[(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea]] C₃₁H₃₇N₅O₃ 527.665 g/mol NotAvailable Glycerol-3-Phosphate Cytidylyltransferase inhibitor Not Availables
sb220025 C₁₈H₁₉N₆F₁ 338.387 g/mol NotAvailable Ribonuclease A inhibitor Not Availables
000001-(n-imidazolyl)-2-hydroxy-2-(2,3-dichlorophenyl)octan C₁₇H₂₂N₂O₁Cl₂ 341.280 g/mol NotAvailable Cdp-Glucose 4,6-Dehydratase inhibitor Not Availables
s-(methylmercury)-l-cystein C₄H₆N₁O₂Hg₁S₁ 332.747 g/mol NotAvailable Cytidine Monophospho-N-Acetylneuraminic säure inhibitor Not Availables
d-gluco-2,5-anhydro-1-deoxy-1-phosphonohexitol-6-phosphat C₆H₁₄O₁₀P₂ 308.118 g/mol NotAvailable Rc-Rnase6 Ribonuclease inhibitor Not Availables
p-(2'-iodo-5'-thenoyl)hydrotropic säure C₁₄H₁₁O₃I₁S₁ 386.204 g/mol NotAvailable Cytidylate Kinase inhibitor Not Availables
zinc trihydroxide H₃O₃Zn₁₁- 770.202 g/mol NotAvailable Isopenicillin N Synthetase inhibitor Not Availables
000003-methoxybenzamide C₈H₉N₁O₂ 151.165 g/mol NotAvailable Carboxypeptidase A inhibitor Not Availables
[[adenosine-5'-[beta]], [[gamma-methylene]triphosphat]] C₁₁H₁₈N₅O₁₂P₃ 505.211 g/mol NotAvailable Carboxypeptidase A inhibitor Not Availables
glutathionylspermidine disulfide C₃₄H₆₆N₁₂O₁₀S₂ 867.090 g/mol NotAvailable L-3-Phosphoserine Phosphatase inhibitor Not Availables
000004-piperidino-piperidin C₁₀H₂₀N₂ 168.281 g/mol NotAvailable 000002-Keto-3-Deoxy Gluconate Aldolase inhibitor Not Availables
[[d-[(n-hydroxyamino)carbonyl]phenylalanin]] C₁₀H₁₂N₂O₄ 224.216 g/mol NotAvailable 000002-Keto-3-Deoxy Gluconate Aldolase inhibitor Not Availables
coproporphyrin i C₃₆H₄₄N₄O₈ 660.766 g/mol NotAvailable D-Ribose-5-Phosphate Isomerase inhibitor Not Availables
2,4-difluorobenzyl alcohol 2,4-difluoro-1-(hydroxymethyl)benzen C₇H₆O₁F₂ 144.121 g/mol NotAvailable Precursor Of Periplasmic Sugar Receptor inhibitor Not Availables
bcx-1812 C₁₅H₂₈N₄O₄ 328.411 g/mol NotAvailable Biotin Synthase inhibitor Not Availables
d-isovalin C₅H₁₁N₁O₂ 117.147 g/mol NotAvailable S-Adenosyl-L-Homocysteine Hydrolase inhibitor Not Availables
000004-[[{[1-methyl-5-(2-methyl-benzoimidazol-1-ylmethyl)-1h-benzoimidazol-2-ylmethyl]-amino}-benzamidin]] C₂₅H₂₅N₇ 423.519 g/mol NotAvailable Glucose-6-Phosphate Isomerase inhibitor Not Availables
cra_8696 C₂₁H₁₇N₃O₁ 327.385 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
alpha-hydroxy-beta-phenyl-propionic säure C₉H₁₀O₃ 166.176 g/mol NotAvailable Iota-Carrageenase inhibitor Not Availables
bb-3497 C₁₆H₃₁N₃O₄ 329.439 g/mol NotAvailable Beta-Galactosidase inhibitor Not Availables
[[r-2-{[4'-methoxy-(1,1'-biphenyl)-4-yl]-sulfonyl}-amino-6-methoxy-hex-4-ynoic säure]] C₂₀H₂₁N₁O₆S₁ 403.449 g/mol NotAvailable Fructose-2,6-Bisphosphatase inhibitor Not Availables
vitamin b6 complexed with 2-amino-pentanoic säure C₁₃H₂₁N₂O₇P₁ 348.292 g/mol NotAvailable Myrosinase inhibitor Not Availables
[[ca-074; [n-(l-3-trans-propylcarbamoyl-oxirane-2-carbonyl)-l-isoleucyl-l-prolin]]] C₁₈H₃₁N₃O₆ 385.459 g/mol NotAvailable Endo-1,4-Beta-Glucanase F inhibitor Not Availables
000003-iodo-tyrosin C₉H₁₀N₁O₃I₁ 307.087 g/mol NotAvailable Phosphoheptose Isomerase inhibitor Not Availables
free cystein C₃H₇N₁O₂S₁ 121.154 g/mol NotAvailable Antiamoebin I inhibitor Not Availables
bombykol C₁₆H₃₀O₁ 238.412 g/mol NotAvailable Alpha-2U-Globulin inhibitor Not Availables
ethyl isocyanide C₃H₆N₁ 56.087 g/mol NotAvailable Phosphomannomutase inhibitor Not Availables
bis-benzamidin C₂₃H₂₈N₄O₁ 376.500 g/mol NotAvailable Fructose 1,6-Bisphosphatase/Inositol Monopho inhibitor Not Availables
tartronate C₃H₂O₅₂- 870.018 g/mol NotAvailable Phosphoinositide-Specific Phospholipase C, I inhibitor Not Availables
n-carboxymethionin C₆H₁₁N₁O₄S₁ 193.217 g/mol NotAvailable Phosphoinositide-Specific Phospholipase C, I inhibitor Not Availables
3,5,3',5'-tetraiodo-l-thyronin C₁₅H₁₁N₁O₄I₄ 776.874 g/mol NotAvailable Myo-Inositol Hexaphosphate Phosphohydrolase inhibitor Not Availables
2,3-dideoxyfucose C₆H₁₂O₃ 132.159 g/mol NotAvailable Subtilisin Carlsberg, Type Viii inhibitor Not Availables
000005-methoxybenzimidazol C₈H₈N₂O₁ 148.164 g/mol NotAvailable Subtilisin Carlsberg, Type Viii inhibitor Not Availables
acetylphosphat C₂H₅O₅P₁ 140.032 g/mol NotAvailable Subtilisin Carlsberg, Type Viii inhibitor Not Availables
000004-hydroxy-1,2,5-oxadiazole-3-carboxylic säure C₃H₂N₂O₄ 130.060 g/mol NotAvailable 2,2-Dialkylglycine Decarboxylase inhibitor Not Availables
000007-[[hydroxy-pyrazolo[4,3-d]pyrimidin]] C₅H₄N₄O₁ 136.113 g/mol NotAvailable Formate Acetyltransferase 1 inhibitor Not Availables
fructose-1,6-diphosphat C₆H₁₄O₁₂P₂ 340.117 g/mol NotAvailable F1-Gramicidin C inhibitor Not Availables
000002-[[[5-hydroxy-3-methyl-1-(2-methyl-4-sulfo-phenyl)-1h-pyrazol-4-ylazo]-4-sulfo-benzoic säure]] C₁₈H₁₆N₄O₉S₂ 496.466 g/mol NotAvailable 32.1 Kda Protein In Adh3-Rca1 Intergenic inhibitor Not Availables
000007-alpha-d-ribofuranosyl-2-aminopurine-5'-phosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol NotAvailable D-3-Phosphoglycerate Dehydrogenase inhibitor Not Availables
flavin-n7 protonated-adenine dinucleotide C₂₇H₃₄N₉O₁₅P₂₁+ 1375.066 g/mol NotAvailable Streptogramin A Acetyltransferase inhibitor Not Availables
tetraphenyl-arsonium C₂₄H₂₀As₁₁+ 1132.560 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
molybdenum cofactor; moco C₁₉H₂₆N₈O₁₆Mo₁P₂S₂ 844.466 g/mol NotAvailable Antithrombotic Agents; Fibrinolytic Agents; Anticoagulants Prevention of venous thrombosis after suspected myocardial infarctions
alpha d-galacturonic säure C₆H₁₀O₇ 194.141 g/mol NotAvailable N-Methyl-D-Aspartate Receptor Subunit 1 inhibitor Not Availables
(10r)-10-formyl-5,8,10-trideazafolic säure C₂₃H₂₂N₄O₈ 482.449 g/mol NotAvailable Deacetoxycephalosporin C Synthase inhibitor Not Availables
000009-butyl-8-(2,5-dimethoxy-benzyl)-9h-purin-6-ylamin C₁₈H₂₃N₅O₂ 341.412 g/mol NotAvailable Nh inhibitor Not Availables
alpha-n-dichloroacetyl-p-aminophenylserinol C₁₁H₁₄N₂O₃Cl₂ 293.149 g/mol NotAvailable Dual Specificity Protein Kinase Clk1 inhibitor Not Availables
r-styrene oxide C₈H₈O₁ 120.151 g/mol NotAvailable Der F II inhibitor Not Availables
methyl phosphinic säure C₁H₅O₂P₁ 80.023 g/mol NotAvailable Bacteriorhodopsin inhibitor Not Availables
000004-[[(aminosulfonyl)-n-[(4-fluorophenyl)methyl]-benzamide]] C₁₄H₁₃N₂O₃F₁S₁ 308.327 g/mol NotAvailable Ferrichrome-Iron Receptor inhibitor Not Availables
1,2-di-1-(3,7,11,15-tetramethyl-hexadecane)-sn-glycerol C₄₃H₈₈O₃ 653.166 g/mol NotAvailable Ribosome Recycling Factor inhibitor Not Availables
l-xylose (cyclic form) C₅H₁₀O₅ 150.131 g/mol NotAvailable Cell Wall Peptide In Complex With Deglucobalhi inhibitor Not Availables
[[(4s)-4-{[(2s)-2-amino-3-oxopropyl]sulfanyl}-l-homoserinate]] C₇H₁₄N₂O₄S₁ 222.259 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
000004-methyl-pyrroline-5-carboxylic säure C₆H₉N₁O₂ 127.143 g/mol NotAvailable Isopenicillin N Synthetase inhibitor Not Availables
glutamyl group C₅H₉N₁O₃₁+ 579.114 g/mol NotAvailable Ferric Hydroxamate Receptor inhibitor Not Availables
ru78262 C₇H₇O₅P₁ 202.103 g/mol NotAvailable L-Arginine: Glycine Amidinotransferase inhibitor Not Availables
bestatin C₁₆H₂₄N₂O₄ 308.377 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
[[n-[1-(4-bromophenyl)ethyl]-5-fluoro salicylamide]] C₁₅H₁₃N₁O₂Br₁F₁ 338.176 g/mol NotAvailable Cytochrome P450 inhibitor Not Availables
000003-thiaoctanoyl-coenzyme a C₂₈H₄₈N₇O₁₇P₃S₂ 911.765 g/mol NotAvailable Azurin inhibitor Not Availables
n-pyridoxyl-7-keto-8-aminopelargonic säure-5'-monophosphat C₁₇H₂₇N₂O₈P₁ 418.383 g/mol NotAvailable Azurin inhibitor Not Availables
000003-phosphoglycerol C₃H₉O₆P₁ 172.074 g/mol NotAvailable Endoglucanase 5A inhibitor Not Availables
uridylyl-2'-5'-phospho-adenosin C₁₉H₂₄N₇O₁₂P₁ 573.412 g/mol NotAvailable Insulin-Like Growth Factor 1A inhibitor Not Availables
000006-hydroxyuridine-5'-phosphat C₉H₁₃N₂O₁₀P₁ 340.183 g/mol NotAvailable Beta-Lactam Synthetase inhibitor Not Availables
cra_1802 C₁₄H₁₁N₄O₁F₁ 270.266 g/mol NotAvailable Deoxyuridine Triphosphatase inhibitor Not Availables
000004-[[(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-trifluoromethyl-phenyl)-amin]] C₁₆H₁₃N₄F₃S₁ 350.361 g/mol NotAvailable Protein Maf inhibitor Not Availables
(2r)-amino(3,5-dihydroxyphenyl)acetic säure C₈H₉N₁O₄ 183.163 g/mol NotAvailable Phosphopantetheine Adenylyltransferase inhibitor Not Availables
[[[(1-{2[(4-carbamimidoyl-phenylamino)-methyl]-1-methyl-1h-benzoimidazol-5-yl}-cyclopropyl)-pyridin-2-yl-methyleneaminooxy]-acetic säure ethyl ester]] C₂₉H₃₁N₇O₃ 525.609 g/mol NotAvailable Acriflavine Resistance Protein B inhibitor Not Availables
cu-bicyclam C₂₈H₅₄N₈Cu₂ 990.857 g/mol NotAvailable Ferrichrome-Binding Periplasmic Protein inhibitor Not Availables
000002-[[hydroxy-5-({1-[(2-naphthyloxy)methyl]-3-oxoprop-1-enyl}amino)tyrosin]] C₂₃H₂₂N₂O₆ 422.437 g/mol NotAvailable Xenobiotic Acetyltransferase inhibitor Not Availables
(c8-s)-hydantocidin 5'-phosphat C₁₃H₂₂N₃O₁₃P₁ 459.303 g/mol NotAvailable Glycosyltransferase Gtfd inhibitor Not Availables
000004-[[oxo-2-phenylmethanesulfonyl-octahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic säure [1-(n-hydroxycarbamimidoyl)-piperidin-4-ylmethyl]-amide]] C₂₂H₃₂N₆O₅S₁ 492.592 g/mol NotAvailable Autolysin inhibitor Not Availables
balanol analog 2 C₂₇H₂₆N₂O₆ 474.512 g/mol NotAvailable Phosphatidylcholine Transfer Protein inhibitor Not Availables
inhibitor bea425 C₃₈H₄₀N₂O₇ 636.743 g/mol NotAvailable ADP, ATP Carrier Protein Heart Isoform T1 inhibitor Not Availables
3'-o-n-octanoyl-a-d-glucopyranosyl-b-d-fructofuranoside C₂₀H₃₆O₁₂ 468.497 g/mol NotAvailable Saposin B inhibitor Not Availables
000008-oxo-2'-deoxy-guanosine-5'-monophosphat C₁₀H₁₄N₅O₈P₁ 363.223 g/mol NotAvailable Lysozyme C inhibitor Not Availables
n-(phosphonoacetyl)-l-ornithin C₇H₁₅N₂O₆P₁ 254.179 g/mol NotAvailable Cytochrome C Peroxidase inhibitor Not Availables
beta-3-cystein C₄H₉N₁O₂S₁ 135.181 g/mol NotAvailable Transthyretin inhibitor Not Availables
4'-nitrophenyl-3i-thiolaminaritrioside C₂₄H₃₅N₁O₁₇S₁ 641.597 g/mol NotAvailable Caspase-7 inhibitor Not Availables
antiproliferative agent a771726 C₁₂H₁₁N₂O₂F₃ 272.226 g/mol NotAvailable Enoyl-Acp Reductase inhibitor Not Availables
3pp; 3-phenylpropionic säure C₉H₁₀O₂ 150.177 g/mol NotAvailable Cyclopropane-Fatty-Acyl-Phospholipid Synthas inhibitor Not Availables
(4r,5s, 6s, 7r)-1,3-dibenzyl-4,7-bis(phenoxymethyl)-5,6-dihydroxy-1,3 diazepan-2-on C₃₃H₃₄N₂O₅ 538.642 g/mol NotAvailable Phosphotriesterase inhibitor Not Availables
000003-(prop-2-ene-1-sulfinyl)-propene-1-thiol C₆H₁₀O₁S₂ 162.264 g/mol NotAvailable Quercetin 2,3-Dioxygenase inhibitor Not Availables
4,5-dehydro-l-iduronic säure C₆H₈O₇ 192.125 g/mol NotAvailable Butyrylcholinesterase inhibitor Not Availables
000007-keto-8-aminopelargonic säure C₉H₁₇N₁O₃ 187.238 g/mol NotAvailable Methionyl-tRNA Synthetase inhibitor Not Availables
br-coeleneterazin C₂₆H₂₂N₃O₄Br₁ 520.381 g/mol NotAvailable Chlorophyll A-B Binding Protein, Chloroplast inhibitor Not Availables
2,3-dihydroxy-benzoic säure C₇H₆O₄ 154.122 g/mol NotAvailable Digoxin Antidote For the treatment of digitoxin overdose or digitalis glycoside toxicitys
acetylamino-acetic säure C₄H₇N₁O₃ 117.104 g/mol NotAvailable Digoxin Antidote For treatment of digitoxin overdose or digitalis glycoside toxicitys
forskolin C₂₂H₃₄O₇ 410.506 g/mol NotAvailable Mrna Capping Enzyme inhibitor Not Availables
capric säure C₁₀H₂₀O₂ 172.267 g/mol NotAvailable Glucoamylase-471 inhibitor Not Availables
3,3-dichloro-2-phosphonomethyl-acrylic säure C₄H₅O₅Cl₂P₁ 234.960 g/mol NotAvailable Phosphate-Binding Protein inhibitor Not Availables
[[[(4-{4-[4-(difluoro-phosphono-methyl)-phenyl]-butyl}-phenyl)-difluoro-methyl]-phosphonic säure]] C₁₈H₂₀O₆F₄P₂ 470.294 g/mol NotAvailable Dihydroorotase inhibitor Not Availables
gamma-arsono-beta, gamma-methyleneadenosine-5'-diphosphat C₁₁H₁₉N₅O₁₂As₁P₂ 550.167 g/mol NotAvailable Sex Hormone-Binding Globulin inhibitor Not Availables
alpha-d-glucose-6-phosphat C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable Complement Factor B inhibitor Not Availables
000002-[[[2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethyl]-4-(4'-ethoxy-1,1'-biphenyl-4-yl)-4-oxobutanoic säure]] C₂₈H₂₅N₁O₆ 471.509 g/mol NotAvailable Cytochrome B5 inhibitor Not Availables
s-hydroxycystein C₃H₇N₁O₃S₁ 137.153 g/mol NotAvailable Geranyltranstransferase inhibitor Not Availables
b-octylglucoside C₁₄H₂₈O₆ 292.372 g/mol NotAvailable Elastase inhibitor Not Availables
000002-[[amino-3-(3-hydroxy-7,8-dihydro-6h-cyclohepta[d]-4-isoxazolyl)propionic säure]] C₁₁H₁₄N₂O₄ 238.243 g/mol NotAvailable Peroxiredoxin 5 Residues 54-214 inhibitor Not Availables
[[[4-(4-hydroxy-benzyl)-2-(2-hydroxy-1-methyl-ethyl)-5-oxo-imidazolidin-1-yl]-acetic säure]] C₁₄H₁₉N₃O₅ 309.321 g/mol NotAvailable Mannan Endo-1,4-Beta-Mannosidase inhibitor Not Availables
(s)-wiskostatin C₁₇H₁₈N₂O₁Br₂ 426.150 g/mol NotAvailable Arginase 1 inhibitor Not Availables
000002-[[[(2-oxo-2-piperidin-1-ylethyl)thio]-6-(trifluoromethyl)pyrimidin-4(1h)-on]] C₁₂H₁₄N₃O₂F₃S₁ 321.317 g/mol NotAvailable Xanthine Dehydrogenase inhibitor Not Availables
4r-fluoro-n6-ethanimidoyl-l-lysin C₈H₁₆N₃O₂F₁ 205.232 g/mol NotAvailable Selenosubtilisin Bpn inhibitor Not Availables
n-hydroxy-n-isopropyloxamic säure C₅H₉N₁O₄ 147.130 g/mol NotAvailable Cathepsin B inhibitor Not Availables
orotidine-5'-monophosphat C₁₀H₁₃N₂O₁₁P₁ 368.193 g/mol NotAvailable Elongation Factor 2 inhibitor Not Availables
000003-methylphenylalanin C₁₀H₁₃N₁O₂ 179.218 g/mol NotAvailable Dihydrodipicolinate Reductase inhibitor Not Availables
n-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide C₁₆H₂₁N₂O₂Cl₁S₁ 340.867 g/mol NotAvailable Porphobilinogen Deaminase inhibitor Not Availables
[[n-[isoleucinyl]-n'-[adenosyl]-diaminosufon]] C₁₆H₂₆N₈O₆S₁ 458.491 g/mol NotAvailable Alpha-1-Purothionin inhibitor Not Availables
[[[4-(2-amino-4-methyl-thiazol-5-yl)-pyrimidin-2-yl]-(3-nitro-phenyl)-amin]] C₁₄H₁₂N₆O₂S₁ 328.348 g/mol NotAvailable Penicillin V Acylase inhibitor Not Availables
5,10-dideazatetrahydrofolic säure C₂₁H₂₅N₅O₆ 443.458 g/mol NotAvailable Lipase inhibitor Not Availables
000002-oxo-3-pentenoic säure C₅H₆O₃ 114.101 g/mol NotAvailable Allantoate Amidohydrolase inhibitor Not Availables
000006-[[[n-(1-isopropyl-1,2,3,4-tetrahydro-7-isoquinolinyl)carbamyl]-2-naphthalenecarboxamidin]] C₂₄H₂₆N₄O₁ 386.496 g/mol NotAvailable Protease inhibitor Not Availables
pteric säure C₁₄H₁₃N₆O₃₁+ 761.278 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
[[3,8-diamino-6-phenyl-5-[6-[1-[2-[(1,2,3,4-tetrahydro-9-acridinyl)amino]ethyl]-1h-1,2,3-triazol-5-yl]hexyl]-phenanthridinium]] C₄₂H₄₅N₈₁+ 1684.360 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
000002-cyclopropylmethylenepropanal C₇H₁₂O₁ 112.171 g/mol NotAvailable Fatty säure-Binding Protein, Brain inhibitor Not Availables
delta-2-albomycin a1 C₃₇H₅₇N₁₂O₁₈Fe₁S₁ 1045.834 g/mol NotAvailable Shp-2 inhibitor Not Availables
c-(1-hydrogyl-beta-d-glucopyranosyl) formamide C₇H₁₃N₁O₇ 223.182 g/mol NotAvailable Cardiotoxin-3 inhibitor Not Availables
[[[4-({[5-benzyloxy-1-(3-carbamimidoyl-benzyl)-1h-indole-2-carbonyl]-amino}-methyl)-phenyl]-trimethyl-ammonium]] C₃₄H₃₆N₅O₂ 546.691 g/mol NotAvailable Retinoic säure Receptor Gamma-2 inhibitor Not Availables
6s-5,6,7,8-tetrahydrobiopterin C₉H₁₅N₅O₃ 241.249 g/mol NotAvailable Transcriptional Regulator inhibitor Not Availables
z-pro-prolinal C₁₈H₂₂N₂O₄ 330.383 g/mol NotAvailable Glutamate Receptor, Ionotropic Kainate 2 inhibitor Not Availables
alpha chlorophyll a C₅₅H₇₂N₄O₅Mg₁ 893.503 g/mol NotAvailable Peptide Deformylase Pdf1 inhibitor Not Availables
1,3-bis(4-amidinophenoxy)pentan C₁₉H₂₄N₄O₂ 340.424 g/mol NotAvailable 5 inhibitor Not Availables
prostaglandin b2 C₂₀H₃₀O₄ 334.455 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase S inhibitor Not Availables
tribromomethan C₁H₁Br₃ 252.731 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
000004-[[benzoylamino-4-{1-{1-carbamoyl-2-[4-(difluoro-phosphono-methyl)-phenyl]-ethylcarbamoyl}-2-[4-(difluoro-phosphono-methyl)-phenyl]-ethylcarbamoyl}-butyric säure]] C₃₂H₃₄N₄O₁₂F₄P₂ 804.581 g/mol NotAvailable Quinone-Reductase inhibitor Not Availables
2s,4r-4-methylglutamate C₆H₁₀N₁O₄₁- 752.127 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
sulfoquinovose-uridine-c1,5'-diphosphat C₁₅H₂₄N₂O₁₉P₂S₁ 630.364 g/mol NotAvailable Type 1 17 Beta-Hydroxysteroid Dehydrogenase inhibitor Not Availables
heme d C₃₄H₃₂N₄O₁₀Fe₁ 712.495 g/mol NotAvailable Protein Kinase Ck2, Alpha Subunit inhibitor Not Availables
isochorismic säure C₁₀H₁₀O₆ 226.185 g/mol NotAvailable Antineoplastic Agents Increases the effectiveness of fluorouracil in cancer treatments
methyl mercury ion C₁H₃HG₁₁+ 2221.525 g/mol NotAvailable Antiviral Agents; ATC:J05AF10 For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.s
[[3[n-morpholino]propane sulfonic säure]] C₇H₁₅N₁O₄S₁ 209.260 g/mol NotAvailable Lipoxygenase-3 inhibitor Not Availables
l-threonohydroxamate 4-phosphat C₄H₁₂N₁O₈P₁ 233.114 g/mol NotAvailable P450 Epoxidase inhibitor Not Availables
ribose-1-phosphat C₅H₁₁O₈P₁ 230.111 g/mol NotAvailable Steroid Delta-Isomerase inhibitor Not Availables
l-guluronic säure 6-phosphat C₆H₁₃O₁₀P₁ 276.136 g/mol NotAvailable Estradiol 17 Beta-Dehydrogenase 1 inhibitor Not Availables
6((s)-3-benzylpiperazin-1-yl)-3-(naphthalen-2-yl)-4-(pyridin-4-yl)pyrazin C₃₀H₂₇N₅ 457.577 g/mol NotAvailable Epidermal Growth Factor Receptor inhibitor Not Availables
mixed carbamic phosphoric säure anhydride of 7,8-diaminononanic säure C₁₀H₂₁N₂O₇P₁ 312.259 g/mol NotAvailable 000002-Dehydro-3-Deoxyphosphooctonate Aldolase inhibitor Not Availables
000005-oxo-l-norleucin C₆H₁₁N₁O₃ 145.158 g/mol NotAvailable Connective Tissue Activating Peptide-III inhibitor Not Availables
9alpha-fluorocortisol C₂₁H₂₉O₅F₁ 380.456 g/mol NotAvailable Bone Marrow Stromal Cell Antigen 1 inhibitor Not Availables
n'-pyridoxyl-lysine-5'-monophosphat C₁₄H₂₄N₃O₇P₁ 377.333 g/mol NotAvailable Bone Marrow Stromal Cell Antigen 1 inhibitor Not Availables
11-deoxy-beta-rhodomycin C₄₀H₅₁N₁O₁₄ 769.841 g/mol NotAvailable Acetolactate Synthase, Mitochondrial inhibitor Not Availables
dipyrromethane cofactor C₂₀H₂₄N₂O₈ 420.418 g/mol NotAvailable Parathion Hydrolase inhibitor Not Availables
000003-[[{[(1r)-1-benzyl-2-sulfanylethyl]amino}-3-oxopropanoic säure]] C₁₂H₁₅N₁O₃S₁ 253.315 g/mol NotAvailable Cryptochrome 1 Apoprotein inhibitor Not Availables
trifluoromethionin C₅H₈N₁O₂F₃S₁ 203.179 g/mol NotAvailable Myoglobin inhibitor Not Availables
bis(5-amidino-benzimidazolyl)methan C₁₇H₁₉N₈₂+ 1371.887 g/mol NotAvailable Peptidyl-Prolyl Cis-Trans Isomerase A inhibitor Not Availables
tetrafluoroaluminate ion Al₁F₄₁- 805.916 g/mol NotAvailable Shiga-Like Toxin I B Subunit inhibitor Not Availables
beta-hydroxyleucin C₆H₁₃N₁O₃ 147.174 g/mol NotAvailable Tetanus Toxin Heavy Chain inhibitor Not Availables
000005-n-acetyl-alpha-d-neuraminic säure C₁₁H₁₉N₁O₉ 309.272 g/mol NotAvailable Aspartic Proteinase inhibitor Not Availables
000003-amino-1-chloro-4-phenyl-butanol-2-yl C₁₀H₁₃N₁O₁Cl₁ 198.672 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
undecyl-beta-d-maltopyranoside C₂₃H₄₄O₁₁ 496.594 g/mol NotAvailable Methylaspartate Mutase S Chain inhibitor Not Availables
diisopropylphosphono group C₆H₁₄O₃P₁ 165.149 g/mol NotAvailable Predicted Cobalamin Binding Protein inhibitor Not Availables
n-(4-aminobutanoyl)-s-(4-methoxybenzyl)-l-cysteinylglycin C₁₇H₂₅N₃O₅S₁ 383.462 g/mol NotAvailable Cytochrome C Peroxidase inhibitor Not Availables
000005-acetamido-1,3,4-thiadiazole-2-sulfonamide C₄H₆N₄O₃S₂ 222.236 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
trans-o-hydroxy-alpha-methyl cinnamate C₁₀H₁₂O₃ 180.203 g/mol NotAvailable Caffeoyl-Coa O-Methyltransferase inhibitor Not Availables
beta-cyclohexyl-alanin C₉H₁₇N₁O₂ 171.239 g/mol NotAvailable Bile säure Receptor inhibitor Not Availables
methyl-carbamic säure ethyl ester C₄H₉N₁O₂ 103.121 g/mol NotAvailable Caspase-7 inhibitor Not Availables
[[l-[(n-hydroxyamino)carbonyl]phenylalanin]] C₁₀H₁₂N₂O₄ 224.216 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
000003-(4-carbamoyl-1-carboxy-2-methylsulfonyl-buta-1,3-dienylamino)-indolizine-2-carboxylic säure C₁₆H₁₅N₃O₆S₁ 377.371 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
crc200 (chiron-behring) C₂₉H₃₉N₅O₇S₁ 601.716 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
5,10-dimethylene tetrahydromethanopterin C₃₁H₄₅N₆O₁₆P₁ 788.701 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodieste inhibitor Not Availables
2,6-diamino-hexanoic säure amide C₆H₁₆N₃O₁₁+ 306.206 g/mol NotAvailable Fk506-Binding Protein inhibitor Not Availables
inhibitor of p38 kinase C₁₅H₁₄N₂ 222.289 g/mol NotAvailable D-Amino säure Oxidase inhibitor Not Availables
(r)-4-amino-isoxazolidin-3-on C₃H₆N₂O₂ 102.093 g/mol NotAvailable Cholesterol Oxidase inhibitor Not Availables
l-2-amino-6-methylene-pimelic säure C₈H₁₃N₁O₄ 187.195 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
000002-amino-6-aminomethyl-8-phenylsulfanylmethyl-3h-quinazolin-4-on C₁₆H₁₆N₄O₁S₁ 312.389 g/mol NotAvailable Transthyretin inhibitor Not Availables
tatp C₂₁H₂₈N₇O₁₆P₃S₁ 759.471 g/mol NotAvailable Bilin-Binding Protein inhibitor Not Availables
glycyl-l-a-aminopimelyl-e-(d-2-aminoethyl)phosphonate C₁₁H₂₀N₃O₆P₁₁- 631.007 g/mol NotAvailable Cellobiohydrolase II inhibitor Not Availables
[[(2z)-3-{[oxido(oxo)phosphino]oxy}-2-phenylacrylate]] C₉H₆O₅P₁ 225.117 g/mol NotAvailable Pyridoxal Phosphorylase B inhibitor Not Availables
delta-(l-alpha-aminoadipoyl)-l-cysteinyl-d-vinylglycin C₁₃H₂₁N₃O₆S₁ 347.385 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
000002-[[[2-(2-hydroxy-ethoxy)-ethoxy]-ethanol]] C₆H₁₄O₄ 150.174 g/mol NotAvailable Tetra- inhibitor Not Availables
000003-[[(1h-indol-3-yl)-2-[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-propionic säure]] C₂₈H₂₉N₃O₄S₁ 503.615 g/mol NotAvailable Prostaglandin H2 Synthase-1 inhibitor Not Availables
laevulinic säure C₅H₈O₃ 116.116 g/mol NotAvailable Thermolysin inhibitor Not Availables
5'-o-(n-(l-threonyl)-sulfamoyl)adenosin C₁₄H₂₁N₇O₈S₁ 447.422 g/mol NotAvailable Alpha-Trichosanthin Complexed With Formycin inhibitor Not Availables
3'-phosphate-adenosine-5'-phosphate sulfat C₁₀H₁₅N₅O₁₃P₂S₁ 507.262 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
meropenem; merrem; meronem C₁₇H₂₇N₃O₆S₁ 401.477 g/mol NotAvailable Amp Nucleosidase inhibitor Not Availables
4,6-o-(1-carboxyethylidene)-beta-d-glucose C₉H₁₄O₈ 250.205 g/mol NotAvailable Adenylyl Cyclase inhibitor Not Availables
nalpha-(2-naphthylsulfonylglycyl)-3-amidino-d,l-phenylalanine-isopropylester C₂₀H₂₄N₄O₅S₁ 432.493 g/mol NotAvailable 000001-Deoxy-D-Xylulose 5-Phosphate Reductois inhibitor Not Availables
000004-[[[4-(1-amino-1-methylethyl)phenyl]-5-chloro-n-[4-(2-morpholin-4-ylethyl)phenyl]pyrimidin-2-amin]] C₂₅H₃₀N₅O₁Cl₁ 451.998 g/mol NotAvailable Antineoplastic Agents Disseminated malignant melanomas
1,2-hydro-1-oxy-3,4-hydro-3-(1-methoxy-2-oxy-3,4-dihydroxypentyl)-8,9-dihydroxy-7-(sec-butyl)-anthracene Not Available Not Available NotAvailable Adenosine Deaminase inhibitor Not Availables
000002-amino-n,3,3-trimethylbutanamide C₇H₁₆N₂O₁ 144.216 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
000003-[[amino-n-{4-[2-(2,6-dimethyl-phenoxy)-acetylamino]-3-hydroxy-1-isobutyl-5-phenyl-pentyl}-benzamide]] C₃₂H₄₁N₃O₄ 531.694 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
meta-tyrosin C₉H₁₁N₁O₃ 181.191 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
000004-iodopyrazol C₃H₃N₂I₁ 193.975 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
[[(5r)-6-(4-{[2-(3-iodobenzyl)-3-oxocyclohex-1-en-1-yl]amino}phenyl)-5-methyl-4,5-dihydropyridazin-3(2h)-on]] C₂₄H₂₄N₃O₂I₁ 513.377 g/mol NotAvailable Adenosine Deaminase inhibitor Not Availables
[[n-{1-[5-(1-carbamoyl-2-mercapto-ethylcarbamoyl)-pentylcarbamoyl]-2-[4-(difluoro-phosphono-methyl)-phenyl]-ethyl}-3-{2-[4-(difluoro-phosphono-methyl)-phenyl]-acetylamino}-succinamic säure]] C₃₂H₄₁N₅O₁₃F₄P₂S₁ 873.703 g/mol NotAvailable Uricase inhibitor Not Availables
000002-(2-hydroxy-1,1-dihydroxymethyl-ethylamino)-ethanesulfonic säure C₆H₁₅N₁O₆S₁ 229.248 g/mol NotAvailable Fragile Histidine Protein inhibitor Not Availables
brodimoprim-4,6-dicarboxylate C₂₀H₂₄N₄O₆Br₁₁- 1295.377 g/mol NotAvailable Glucosamine-6-Phosphate Deaminase inhibitor Not Availables
3,6,9,12,15-pentaoxaheptadecan C₁₂H₂₆O₅ 250.334 g/mol NotAvailable Glycerol Kinase inhibitor Not Availables
3'-azido-3'-deoxythymidine-5'-diphosphat C₁₀H₁₅N₅O₁₀P₂ 427.204 g/mol NotAvailable 000006-Phosphofructo-2-Kinase/Fructose-2,6- Bisph inhibitor Not Availables
glucosamine 4-phosphat C₆H₁₄N₁O₈P₁ 259.152 g/mol NotAvailable L-Fucose Isomerase inhibitor Not Availables
3'-o-acetylthymidine-5'-diphosphat C₁₂H₁₈N₂O₁₂P₂ 444.228 g/mol NotAvailable Duck Ovotransferrin inhibitor Not Availables
aha047 C₃₄H₃₇N₃O₇S₁ 631.742 g/mol NotAvailable Nucleoside Diphosphate Kinase inhibitor Not Availables
000002-(trimethylammonium)ethyl thiol C₅H₁₅N₁S₁ 121.240 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
000004-fluorotryptophan C₁₁H₁₁N₂O₂F₁ 222.219 g/mol NotAvailable Adamalysin II inhibitor Not Availables
coelenteramide C₂₅H₂₁N₃O₃ 411.459 g/mol NotAvailable 14-3-3-Like Protein C inhibitor Not Availables
deamido-nad+ C₂₁H₂₇N₆O₁₅P₂₁+ 1253.924 g/mol NotAvailable Chloramphenicol Acetyltransferase inhibitor Not Availables
(2s)-amino(4-hydroxyphenyl)acetic säure C₈H₉N₁O₃ 167.164 g/mol NotAvailable Ornithine Decarboxylase inhibitor Not Availables
n,4-dihydroxy-n-oxo-3-(sulfooxy)benzenaminium C₆H₆N₁O₇S₁₁+ 556.776 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
000004-phenylbutylamin C₁₀H₁₅N₁ 149.235 g/mol NotAvailable Ferrichrome-Binding Periplasmic Protein inhibitor Not Availables
quinonoid 7,8-tetrahydrobiopterin C₉H₁₃N₅O₃ 239.233 g/mol NotAvailable Nh inhibitor Not Availables
000002-bromoacetyl group C₂H₂O₂Br₁ 137.941 g/mol NotAvailable Coagulation Factor X inhibitor Not Availables
000002-(biphenyl-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic säure C₂₂H₁₉N₁O₄S₁ 393.456 g/mol NotAvailable Cgmp Phosphodiesterase A2 inhibitor Not Availables
aminomethylcyclohexan C₇H₁₆N₁₁+ 254.277 g/mol NotAvailable Aromatic Amino säure Aminotransferase inhibitor Not Availables
(e)-(2r,3r,4s,5r)-3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-6-enoic säure ((3s,6r)-6-hydroxy-2-oxo-azepan-3-yl)-amide C₁₈H₃₂N₂O₇ 388.460 g/mol NotAvailable L-Arginine: Glycine Amidinotransferase inhibitor Not Availables
propionamide C₃H₇N₁O₁ 73.094 g/mol NotAvailable Thyroid Hormone Receptor Beta-1 inhibitor Not Availables
000003-amino-3-oxopropanoic säure C₃H₅N₁O₃ 103.077 g/mol NotAvailable Elongation Factor Tu inhibitor Not Availables
selenomethionine selenoxide C₅H₁₁N₁O₃Se₁ 212.107 g/mol NotAvailable Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh inhibitor Not Availables
methylphosphinic säure C₁H₅O₂P₁ 80.023 g/mol NotAvailable Rab GDP Disossociation Inhibitor Alpha inhibitor Not Availables
Muromonab C₆₄₆₀H₉₉₄₆N₁₇₂₀O₂₀₄₃S₅₆ 146189.7 NotAvailable Ispd/Ispf Bifunctional Enzyme inhibitor Not Availables
000005-bromothienyldeoxyuridin C₁₃H₁₃N₂O₅Br₁S₁ 389.220 g/mol NotAvailable Alpha-Mannosidase II inhibitor Not Availables
[[n-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside]] C₁₃H₂₃N₁O₈ 321.327 g/mol NotAvailable Beta-D-Glucan Glucohydrolase Isoenzyme Exo1 inhibitor Not Availables
000001-[[ter-butyl-3-p-tolyl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamin]] C₁₆H₁₉N₅ 281.360 g/mol NotAvailable Beta-Glucosidase A inhibitor Not Availables
uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-d-galactose C₁₅H₂₃N₂O₁₆F₁P₂ 568.296 g/mol NotAvailable Myrosinase inhibitor Not Availables
000001-[[[(1s)-carboxy-2-(methylsulfinyl)ethyl]-(3r)-[(5s)-5-amino-5-carboxypentanamido]-(4r)-sulfanylazetidin-2-on]] C₁₃H₂₁N₃O₇S₂ 395.445 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
biotinyl p-nitroanilin C₁₆H₂₀N₄O₄S₁ 364.418 g/mol NotAvailable Ferric Hydroxamate Uptake Receptor inhibitor Not Availables
000004-guanidinobenzoic säure C₈H₉N₃O₂ 179.178 g/mol NotAvailable Glucosamine 6-Phosphate Synthase inhibitor Not Availables
[[[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino] -2-(3-{4-[3-(3-nitro-5-[galactopyranosyloxy]-benzoylamino)-propyl]-piperazin-1-yl} ]] Not Available Not Available NotAvailable Phosphatidylinositol-Specific Phospholipase inhibitor Not Availables
cytidyl-2'-5'-phospho-guanosin C₁₉H₂₅N₈O₁₂P₁ 588.427 g/mol NotAvailable Galactose-1-Phosphate Uridylyltransferase inhibitor Not Availables
000002-amino-3-methyl-1-pyrrolidin-1-yl-butan-1-on C₉H₁₈N₂O₁ 170.254 g/mol NotAvailable Glucosamine--Fructose-6-Phosphate Aminotrans inhibitor Not Availables
beta-d-fructopyranose C₆H₁₂O₆ 180.157 g/mol NotAvailable Cell Wall Pentapeptide Ala-[ inhibitor Not Availables
(3s)-3,4-di-n-hexanoyloxybutyl-1-phosphocholin C₂₁H₄₂N₁O₇P₁ 451.539 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
(2s)-2-amino-4-(methylsulfanyl)-1-pyridin-2-ylbutane-1,1-diol C₁₀H₁₆N₂O₂S₁ 228.309 g/mol NotAvailable Glutathione S-Transferase Yfyf inhibitor Not Availables
000004-[[(3,14-dihydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl)-5h-furan-2-on]] C₂₃H₃₄O₄ 374.519 g/mol NotAvailable Tryparedoxin II inhibitor Not Availables
[[(s)-2-amino-3-(4h-selenolo[3,2-b]-pyrrol-6-yl)-propionic säure]] C₉H₁₀N₂O₂Se₁ 257.150 g/mol NotAvailable Glutathione Reductase inhibitor Not Availables
[[{[5-(6-amino-purin-7-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]-hydroxy-phosphorylmethyl}-phosphonic säure ]] Not Available Not Available NotAvailable Hematopoietic Prostagladin D Synthase inhibitor Not Availables
7,8-dihydro-7,7-dimethyl-6-hydroxypterin C₈H₁₁N₅O₂ 209.207 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
guanosine 5'-(trihydrogen diphosphate), p'-d-mannopyranosyl ester C₁₆H₂₃N₅O₁₇P₂ 619.329 g/mol NotAvailable Triosephosphate Isomerase inhibitor Not Availables
rpr128515 C₂₇H₃₀N₄O₃ 458.559 g/mol NotAvailable Matrix Metallo Proteinase-8 inhibitor Not Availables
nonan-1-ol C₉H₂₀O₁ 144.256 g/mol NotAvailable Glycinamide Ribonucleotide Transformylase inhibitor Not Availables
7,8-diamino-nonanoic säure C₉H₂₀N₂O₂ 188.269 g/mol NotAvailable 7 Alpha-Hydroxysteroid Dehydrogenase inhibitor Not Availables
000001-deoxy-1-methoxycarbamido-beta-d-glucopyranose C₈H₁₅N₁O₇ 237.209 g/mol NotAvailable Streptavidin inhibitor Not Availables
000002-deoxy-2fluoro-glucose C₆H₁₁O₅F₁ 182.148 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
je-2147, ag1776, kni-764 C₃₂H₃₇N₃O₅S₁ 575.721 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
pyridoxyl-glutamic säure-5'-monophosphat C₁₃H₁₉N₂O₉P₁ 378.275 g/mol NotAvailable D-Alanyl-D-Alanine Carboxypeptidase inhibitor Not Availables
hydrogenobyrinic säure C₄₅H₆₀N₄O₁₄ 880.987 g/mol NotAvailable Lethal Factor inhibitor Not Availables
carbazole butanoic säure C₁₆H₁₅N₁O₂ 253.300 g/mol NotAvailable Fk506 Binding Protein inhibitor Not Availables
para-bromobenzyl alcohol C₇H₇O₁Br₁ 187.036 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
000001-(4-methoxyphenyl)-3,5-dimethyl-1h-pyrazole-4-carboxylic säure ethyl ester C₁₅H₁₈N₂O₃ 274.319 g/mol NotAvailable Ribonuclease A inhibitor Not Availables
benzylamin C₇H₉N₁ 107.155 g/mol NotAvailable Trypsin inhibitor Not Availables
000002-deoxy-beta-d-galactose C₆H₁₂O₅ 164.158 g/mol NotAvailable GDP-Mannose 6-Dehydrogenase inhibitor Not Availables
[[[formylmethyl]trimethyl-ammonium]], n,n,n-trimethylammonium acetaldehyde C₅H₁₂N₁O₁₁+ 262.150 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
n-carbamoyl-alanin C₄H₈N₂O₃ 132.119 g/mol NotAvailable Guanyl-Specific Ribonuclease T1 inhibitor Not Availables
000005-fluorouridin C₉H₁₁N₂O₆F₁ 262.194 g/mol NotAvailable Ribonuclease Sa inhibitor Not Availables
[[{3-[3-(3,4-dimethoxy-phenyl)-1-(1-{1-[2-(3,4,5-trimethoxy-phenyl)-butyryl]-piperidin-2yl}-vinyloxy)-propyl]-phenoxy}-acetic säure]] C₃₈H₄₇N₁O₁₁ 693.789 g/mol NotAvailable Guanyl-Specific Ribonuclease T1 inhibitor Not Availables
000002-[[{3-[4-(4-fluorophenyl)-3,6-dihydro-1(2h)-pyridinyl]propyl}-8-methyl-4(3h)-quinazolinon]] C₂₃H₂₄N₃O₁F₁ 377.461 g/mol NotAvailable ADP-Ribosylation Factor 2 inhibitor Not Availables
cordycepin triphosphat C₁₀H₁₆N₅O₁₂P₃ 491.184 g/mol NotAvailable Nucleoside Diphosphate Transferase inhibitor Not Availables
000006-methylamino-5-nitroisocytosin C₅H₇N₅O₃ 185.142 g/mol NotAvailable GDP-D-Mannose-4,6-Dehydratase inhibitor Not Availables
d-valinexvigaxaxvxwxwxwxwx Not Available Not Available NotAvailable Spo0B-Associated GTP-Binding Protein inhibitor Not Availables
000003-amino-5-phenylpentan C₁₁H₁₇N₁ 163.262 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
000004-hydroxy-l-threonine-5-monophosphat C₄H₁₀N₁O₇P₁ 215.099 g/mol NotAvailable Catalase Hpii inhibitor Not Availables
amido phenyl pyruvic säure C₁₀H₁₀N₂O₃ 206.201 g/mol NotAvailable Catalase Hpii inhibitor Not Availables
(4s-trans)-4-(methylamino)-5,6-dihydro-6-methyl-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide C₉H₁₄N₂O₄S₃ 310.401 g/mol NotAvailable Nitrite Reductase inhibitor Not Availables
000002-[[{1-[2-(2-amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-2-oxo-ethyl}-5,5-dimethyl-thiazolidine-4-carboxylic säure]] C₁₄H₁₉N₅O₅S₂ 401.455 g/mol NotAvailable Nitrite Reductase inhibitor Not Availables
000006-[[[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoic säure]] C₁₆H₂₇N₃O₄S₁ 357.467 g/mol NotAvailable Trypsin inhibitor Not Availables
000006-hydroxy-d-norleucin C₆H₁₃N₁O₃ 147.174 g/mol NotAvailable Small Inducible Cytokine A5 inhibitor Not Availables
n-hydroxy-4-phosphono-butanamide C₄H₈N₁O₅P₁₂- 521.796 g/mol NotAvailable Small Inducible Cytokine A5 inhibitor Not Availables
n7-methyl-guanosine-5'-monophosphat C₁₁H₁₇N₅O₈P₁₁+ 687.995 g/mol NotAvailable Antithrombin-III inhibitor Not Availables
l-pyridoxyl-n,o-cycloserylamide-5-monophosphat C₁₁H₁₆N₃O₇P₁ 333.237 g/mol NotAvailable Carbonyl Reductase [Nadph] 1 inhibitor Not Availables
000002-phosphoglyceric säure C₃H₇O₇P₁ 186.058 g/mol NotAvailable Sensor Kinase Cita inhibitor Not Availables
aspartyl phosphat C₄H₈N₁O₇P₁ 213.083 g/mol NotAvailable Limonene-1,2-Epoxide Hydrolase inhibitor Not Availables
inhibitor bea428 C₄₂H₅₂N₆O₈ 768.908 g/mol NotAvailable Type 4 Pilin inhibitor Not Availables
000001-hydroxy-2-(3-pyridinyl)ethylidene bis-phosphonic säure C₇H₁₀N₁O₇P₂ 282.106 g/mol NotAvailable Phospholipase A2 inhibitor Not Availables
000002-(beta-d-glucopyranosyl)-5-methyl-1,3,4-benzothiazol C₁₄H₁₇N₁O₅S₁ 311.352 g/mol NotAvailable Vanillyl-Alcohol Oxidase inhibitor Not Availables
000005-n-allyl-arginin C₉H₁₉N₄O₂ 215.275 g/mol NotAvailable Glycogen Phosphorylase b inhibitor Not Availables
000004-(4-chlorophenyl)imidazol C₉H₇N₂Cl₁ 178.621 g/mol NotAvailable Rhodopsin inhibitor Not Availables
(5-methyl-6-oxo-1,6-dihydro-pyridin-3-yl)-1,2-dideoxy-ribofuranose-5-monophosphat C₁₁H₁₆N₁O₇P₁ 305.224 g/mol NotAvailable Peroxisome Proliferator Activated Receptor D inhibitor Not Availables
tropinon C₈H₁₃N₁O₁ 139.197 g/mol NotAvailable Transcriptional Repressor Ethr inhibitor Not Availables
000002-bromo-6-hydroxy-purin C₅H₃N₄O₁Br₁ 215.009 g/mol NotAvailable Hydroxynitrile Lyase inhibitor Not Availables
2,4-diamino-5-(3,4,5-trimethoxy-benzyl)-pyrimidin-1-ium C₁₄H₁₉N₄O₃₁+ 739.312 g/mol NotAvailable Cryptochrome 1 Apoprotein inhibitor Not Availables
beta-methyl-aspartic säure C₅H₉N₁O₄ 147.130 g/mol NotAvailable Chalcone Synthase inhibitor Not Availables
di-stearoyl-3-sn-phosphatidylcholin C₄₄H₈₉N₁O₈P₁₁+ 1100.900 g/mol NotAvailable Ubiquitin-Activating Enzyme E1 1 inhibitor Not Availables
pasbn C₁₄H₁₃O₅P₁ 292.227 g/mol NotAvailable Cgmp-Inhibited 3',5'-Cyclic Phosphodiesteras inhibitor Not Availables
2s,3r-2-amino-3-methylpentanedioic säure C₆H₁₀N₁O₄ 160.149 g/mol NotAvailable Anticoagulants; Antithrombotics Unstable anginas
2,4-dihydroxy-7-(methyloxy)-2h-1,4-benzoxazin-3(4h)-on C₉H₉N₁O₅ 211.174 g/mol NotAvailable Histidyl-tRNA Synthetase inhibitor Not Availables
1,4-deoxy-4-((5-hydroxymethyl-2,3,4-trihydroxycyclohex-5-enyl)amino)fructose C₁₃H₂₃N₁O₇ 305.327 g/mol NotAvailable Histidyl-tRNA Synthetase inhibitor Not Availables
trifluoroethanol C₂H₃O₁F₃ 100.040 g/mol NotAvailable Sodium/Hydrogen Exchanger 1 inhibitor Not Availables
phosphonotyrosin C₉H₁₂N₁O₆P₁ 261.171 g/mol NotAvailable Macrophage Migration Inhibitory Factor inhibitor Not Availables
000004-[[(acetylamino)-3-[(hydroxyacetyl)amino]benzoic säure]] C₁₁H₁₂N₂O₅ 252.226 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
thymidine-3',5'-diphosphat C₁₀H₁₆N₂O₁₁P₂ 402.191 g/mol NotAvailable Cytochrome B562 inhibitor Not Availables
thio-maltohexaose C₃₆H₆₂O₂₈S₃ 1039.049 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
000008-[[benzyl-2-hydroxy-2-(4-hydroxy-benzyl)-6-(4-hydroxy-phenyl)-2h-imidazo[1,2-a]pyrazin-3-on]] C₂₆H₂₁N₃O₄ 439.470 g/mol NotAvailable Adenylosuccinate Synthetase inhibitor Not Availables
000007-deaza-7-aminomethyl-guanin C₇H₉N₅O₁ 179.181 g/mol NotAvailable Precorrin-8X Methylmutase inhibitor Not Availables
siroheme C₄₂H₄₂N₄O₁₆Fe₁ 914.658 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
4'-deaza-1'-aza-2'-deoxy-1'-(9-methylene)-immucillin-h, [[(3r,4r)-n-[9-deazahypoxanthin-9-yl)methyl]-4-hydroxymethyl-pyrrolidin-3-ol]] C₁₂H₁₉N₄O₃₁+ 715.290 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
000009-hyroxyethoxymethylguanin C₈H₁₁N₅O₃ 225.207 g/mol NotAvailable Liver Carboxylesterase I inhibitor Not Availables
brequinar analog C₂₃H₁₆N₁O₂F₁ 357.383 g/mol NotAvailable S-Adenosylmethionine Decarboxylase Proen inhibitor Not Availables
fluoro-phosphite ion O₃F₁P₁₂- 438.682 g/mol NotAvailable Stromelysin-1 inhibitor Not Availables
5'-deoxy-5'-(methylthio)-tubercidin C₁₂H₁₆N₄O₃S₁ 296.343 g/mol NotAvailable Transducin-Alpha inhibitor Not Availables
methylphosphonic säure ester group C₁H₃O₂P₁₁- 387.745 g/mol NotAvailable Integrase inhibitor Not Availables
heptulose-2-phosphat C₇H₁₅O₉P₁ 274.164 g/mol NotAvailable Tyrosine Phenol-Lyase inhibitor Not Availables
000008-(2,5-dimethoxy-benzyl)-2-fluoro-9-pent-9h-purin-6-ylamin C₁₉H₂₀N₅O₂F₁ 369.398 g/mol NotAvailable Cyclin-Dependent Kinase 2 inhibitor Not Availables
000001-octadecyl-2-acetamido-2-deoxy-sn-glycerol-3-phosphoethylmethyl sulfide C₂₆H₅₄N₁O₆P₁S₁ 539.749 g/mol NotAvailable Orphan Nuclear Receptor Pxr inhibitor Not Availables
violaxanthin C₄₀H₅₆O₄ 600.880 g/mol NotAvailable Sulfurtransferase inhibitor Not Availables
zinc substituted heme c C₃₄H₃₄N₄O₄Zn₁ 628.047 g/mol NotAvailable Glycogen Synthase Kinase-3 Beta inhibitor Not Availables
n-propyl isocyanide C₄H₇N₁ 69.106 g/mol NotAvailable Aequorin 2 inhibitor Not Availables
[[1,3,4,9-tetrahydro-2-(hydroxybenzoyl)-9-[(4-hydroxyphenyl)methyl]-6-methoxy-2h-pyrido[3,4-b]indol]] C₂₅H₂₂N₂O₃ 398.460 g/mol NotAvailable Casein Kinase-1 inhibitor Not Availables
mafp C₂₁H₃₆F₁O₂P₁ 370.486 g/mol NotAvailable DNA Topoisomerase II inhibitor Not Availables
s-acetonylcystein C₆H₁₁N₁O₃S₁ 177.218 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
000004-(1,3-benzodioxol-5-yl)-5-(5-ethyl-2,4-dihydroxyphenyl)-2h-pyrazole-3-carboxylic säure C₁₉H₁₆N₂O₆ 368.345 g/mol NotAvailable Cellulase inhibitor Not Availables
2,3-di-o-phytanly-3-sn-glycero-1-phosphoryl-3'-sn-glycerol-1'-phosphat C₄₆H₉₄O₁₁P₂₂- 1504.665 g/mol NotAvailable D-Amino säure Oxidase inhibitor Not Availables
000004-[[[2-(3-benzyloxycarbonylamino-4-cyclohexyl-1-hydroxy-2-oxo-butylamino)-5-guanidino-pentanoylamino]-4-(1-carboxy-2-cyclohexyl-ethylcarbamoyl)-butyric säure]] C₃₈H₅₇N₇O₁₀ 771.909 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
kaempherol C₁₅H₁₀O₆ 286.240 g/mol NotAvailable Anti-infectives; Immunomodulatory Agents For treatment of immunodeficiencies, thrombocytopenic purpura, Kawasaki disease, gammablobulinemia, leukemia, bone transplants
000002-[[(carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-carboxypropanoyl)amino] -3-phenylpropanoyl}amino)-3-oxo-3-(pentylamino)propyl]benzoic säure]] C₃₀H₃₇N₃O₁₀ 599.636 g/mol NotAvailable Lysozyme inhibitor Not Availables
000003-[[{2,6,8-trioxo-9-[(2s,3s,4r)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7h-purin-7-yl}propyl dihydrogen phosphat]] C₁₃H₂₁N₄O₁₁P₁ 440.303 g/mol NotAvailable Glycogen Synthase Kinase-3 Beta inhibitor Not Availables
[[n-{(1s)-4-[bis(2-chloroethyl)amino]-1-methylbutyl}-n-(6-chloro-2-methoxy-9-acridinyl)amin]] C₂₃H₂₉N₃O₁Cl₃ 469.861 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
Digoxin Immune Fab C₂₀₈₅H₃₂₂₃N₅₅₃O₆₇₂S₁₆ 47301.7 NotAvailable Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh inhibitor Not Availables
000004-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-ylamin C₈H₅N₃Cl₂S₁ 246.114 g/mol NotAvailable Indole-3-Glycerolphosphate Synthase inhibitor Not Availables
2'-deoxy-thymidine-beta-l-rhamnose C₁₆H₂₆N₂O₁₅P₂ 548.333 g/mol NotAvailable Tryptophan Synthase Alpha Chain inhibitor Not Availables
1,n6-ethenoadenin C₇H₅N₅ 159.150 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
000001-o-methyl-alpha-d-mannose C₇H₁₄O₆ 194.184 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
n-(3-phenyl-2-sulfanylpropanoyl)phenylalanylalanin C₂₁H₂₄N₂O₄S₁ 400.492 g/mol NotAvailable Pol Protein inhibitor Not Availables
acetylsalicylic säure, aspirin C₉H₈O₄ 180.160 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
000001-(s-glutathionyl)-2,4-dinitrobenzen C₁₆H₁₉N₅O₁₀S₁ 473.414 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
delta-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-c9-adamantane ruthenium (ii) C₅₀H₅₇N₇O₁Ru₁₂+ 1984.887 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
Ribavirin and Alfa Interferon (Intron A) C₈₆₀H₁₃₅₃N₂₂₉O₂₅₅S₉ 19269.1 NotAvailable Hiv-1 Protease inhibitor Not Availables
000003-dehydroquinic säure C₇H₁₀O₆ 190.152 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
000007-nitroindazol C₇H₅N₃O₂ 163.135 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
r,3-hydroxybutan-2-on C₄H₈O₂ 88.106 g/mol NotAvailable Aldose Reductase inhibitor Not Availables
n-succinyl phenylglycin C₁₂H₁₃N₁O₅ 251.238 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
prostaglandin g2 C₂₀H₃₂O₆ 368.469 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
2'-deoxyguanosine-5'-diphosphat C₁₀H₁₅N₅O₁₀P₂ 427.204 g/mol NotAvailable Endosome-Associated Protein inhibitor Not Availables
000005-aminoimidazole ribonucleoside C₈H₁₃N₃O₄ 215.208 g/mol NotAvailable Rac-Alpha Serine/Threonine Kinase inhibitor Not Availables
(1'r,2's)-9-(2-hydroxy-3'-keto-cyclopenten-1-yl)adenin C₁₀H₁₁N₅O₂ 233.229 g/mol NotAvailable Guanine Nucleotide Exchange Factor and Integ inhibitor Not Availables
acetyl dithranol C₁₆H₁₂O₅ 284.268 g/mol NotAvailable Grp1 inhibitor Not Availables
000009-beta-d-arabinofuranosyl-adenin C₁₀H₁₃N₅O₄ 267.244 g/mol NotAvailable Lysozyme inhibitor Not Availables
3,6-anhydro-d-galactose-2-sulfat C₆H₁₀O₈S₁ 242.200 g/mol NotAvailable General Control Protein Gcn4 inhibitor Not Availables
000004-(1h-imidazol-4-yl)-3-(5-ethyl-2,4-dihydroxy-phenyl)-1h-pyrazol C₁₄H₁₄N₄O₂ 270.290 g/mol NotAvailable Complement Factor D inhibitor Not Availables
000004-carboxyphenylboronic säure C₇H₇O₄B₁ 165.940 g/mol NotAvailable 000003-Alpha-Hydroxysteroid Dehydrogenase inhibitor Not Availables
5,6-dihydroxy-nadp C₂₁H₃₂N₇O₁₉P₃ 779.441 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
inhibitor msa367 C₄₂H₅₂N₆O₈ 768.908 g/mol NotAvailable Lysozyme inhibitor Not Availables
5'-fluoro-5'-deoxyadenosin C₁₀H₉N₅O₃F₁ 266.211 g/mol NotAvailable Phenazine Biosynthesis Protein Phzd inhibitor Not Availables
d-glucose in linear form C₆H₁₂O₆ 180.157 g/mol NotAvailable Isocitrate Dehydrogenase inhibitor Not Availables
alpha-difluoromethylornithin C₆H₁₂N₂O₂F₂ 182.170 g/mol NotAvailable Isoflavone O-Methytransferase inhibitor Not Availables
000006-[[[(z)-amino(imino)methyl]-n-[4-(aminomethyl)phenyl]-4-(pyrimidin-2-ylamino)-2-naphthamide]] C₂₃H₂₁N₇O₁ 411.465 g/mol NotAvailable Arylamine N-Acetyltransferase inhibitor Not Availables
000005-mercapto-2-nitro-benzoic säure C₇H₅N₁O₄S₁ 199.181 g/mol NotAvailable Isopenicillin N Synthase inhibitor Not Availables
mdl-29951 C₁₂H₉N₁O₄Cl₂ 302.113 g/mol NotAvailable Geranyltranstransferase inhibitor Not Availables
flavin-adenine dinucleotide-n5-isobutyl keton C₃₁H₃₉N₉O₁₆P₂ 855.647 g/mol NotAvailable Pectate Lyase inhibitor Not Availables
000002-(sec-butyl)thiazol C₇H₁₁N₁S₁ 141.231 g/mol NotAvailable Actin, Alpha Skeletal Muscle inhibitor Not Availables
coprogen C₃₅H₅₃N₆O₁₃Fe₁ 821.683 g/mol NotAvailable Protease inhibitor Not Availables
[[n-[2-(1-formyl-2-methyl-propyl)-1-(4-piperidin-1-yl-but-2-enoyl)-pyrrolidin-3-yl]-methanesulfonamide]] C₁₉H₃₃N₃O₄S₁ 399.547 g/mol NotAvailable Hepatocyte Growth Factor Receptor inhibitor Not Availables
maltosyl-alpha (1,4)-d-gluconhydroximo-1,5-lactam C₁₈H₃₂N₂O₁₅ 516.455 g/mol NotAvailable Annexin V inhibitor Not Availables
000003-cyclohexyl-1-propylsulfonic säure C₉H₁₉N₁O₃S₁ 221.314 g/mol NotAvailable Fkbp-Type Peptidyl-Prolyl Cis-Trans Isom inhibitor Not Availables
mo(vi)(=o)(oh)2 cluster H₂O₃Mo₁₃ 1297.234 g/mol NotAvailable Actin, Alpha Skeletal Muscle inhibitor Not Availables
000004-[[[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1h-imidazol-2-yl]-piperidin]] C₂₈H₂₉N₆F₃ 506.573 g/mol NotAvailable Quercetin 2,3-Dioxygenase inhibitor Not Availables
pyrophosphate 2- H₂O₇P₂₂- 795.434 g/mol NotAvailable Alpha-Mannosidase II inhibitor Not Availables
000006-amino-1-methylpurin C₆H₈N₅₁+ 794.471 g/mol NotAvailable Carboxypeptidase A inhibitor Not Availables
(2-sulfanyl-3-phenylpropanoyl)-phe-tyr C₂₇H₂₈N₂O₅S₁ 492.589 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
000002-(thiomethylene)-4-methylpentanoic säure C₇H₁₄O₂S₁ 162.246 g/mol NotAvailable Daptomycin inhibitor Not Availables
dihydro-acarbose C₂₅H₄₅N₁O₁₈ 647.626 g/mol NotAvailable S-Adenosylmethionine Synthetase inhibitor Not Availables
[[(4'-{[allyl(methyl)amino]methyl}-1,1'-biphenyl-4-yl)(4-bromophenyl)methanon]] C₂₄H₂₂N₁O₁Br₁ 420.348 g/mol NotAvailable Meso-Diaminopimelate D-Dehydrogenase inhibitor Not Availables
000001-hydroxyamine-2-isobutylmalonic säure C₇H₁₃N₁O₄ 175.184 g/mol NotAvailable Fk506-Binding Protein inhibitor Not Availables
indirubin-3'-monoxime C₁₆H₁₁N₃O₂ 277.282 g/mol NotAvailable Nonspecific Lipid-Transfer Protein 1 inhibitor Not Availables
phenylmercury C₆H₅Hg₁ 277.696 g/mol NotAvailable Tubby Protein inhibitor Not Availables
dephospho coenzyme a C₂₁H₃₅N₇O₁₃P₂S₁ 687.554 g/mol NotAvailable Annexin V inhibitor Not Availables
ndelta-(n'-sulphodiaminophosphinyl)-l-ornithin C₅H₁₅N₄O₆P₁S₁ 290.230 g/mol NotAvailable Annexin V inhibitor Not Availables
1,5-dideoxy-1,5-imino-d-mannitol C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Ultraspiracle Protein inhibitor Not Availables
000003-o-methylfructose in linear form C₇H₁₄O₆ 194.184 g/mol NotAvailable Isopenicillin N Synthase inhibitor Not Availables
000004-methyl valeric säure C₆H₁₂O₂ 116.160 g/mol NotAvailable Algq2 inhibitor Not Availables
000003-[[[(1s)-1-(dimethylamino)ethyl]phenol]] C₁₀H₁₅N₁O₁ 165.235 g/mol NotAvailable Ferrichrome-Iron Receptor inhibitor Not Availables
beta-aspartyl residue; isoaspartyl group C₄H₆N₁O₃ 116.096 g/mol NotAvailable 000003-Keto-L-Gulonate 6-Phosphate Decarboxylase inhibitor Not Availables
000005-amino 6-nitro uracil C₄H₄N₄O₄ 172.100 g/mol NotAvailable Hut Operon Positive Regulatory Protein inhibitor Not Availables
000006-o-phosphoryl inosine monophosphat C₁₀H₁₄N₄O₁₁P₂ 428.188 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
n'-l-seryl-3'-amino-(3'-deoxy)-adenosin C₁₃H₁₉N₇O₅ 353.337 g/mol NotAvailable Udp-N-Acetylglucosamine Enolpyruvyltrans inhibitor Not Availables
3,5-dimethyl-1-(3-nitrophenyl)-1h-pyrazole-4-carboxylic säure ethyl ester C₁₄H₁₅N₃O₄ 289.290 g/mol NotAvailable Thermolysin inhibitor Not Availables
pentyl trihydrogen diphosphat C₅H₁₄O₇P₂ 248.109 g/mol NotAvailable Inositol Monophosphatase inhibitor Not Availables
2,6-diamino-8-propylsulfanylmethyl-3h-quinazoline-4-on C₁₂H₁₆N₄O₁S₁ 264.345 g/mol NotAvailable Nitric-Oxide Synthase, Endothelial inhibitor Not Availables
peldesin C₁₂H₁₁N₅O 241.249 g/mol NotAvailable Nitric-Oxide Synthase, Endothelial inhibitor Not Availables
000005-(4-morpholin-4-yl-phenylsulfanyl)-2,4-quinazolinediamin C₁₈H₁₉N₅O₁S₁ 353.441 g/mol NotAvailable Subtilisin Carlsberg, Type Viii inhibitor Not Availables
(2r,3s)-1,4-dimercaptobutane-2,3-diol C₄H₁₀O₂S₂ 154.242 g/mol NotAvailable Antiamoebin I inhibitor Not Availables
methyl isocyanide C₂H₃N₁ 41.052 g/mol NotAvailable Pyruvate Kinase inhibitor Not Availables
beta-galactose-6-phosphat C₆H₁₃O₉P₁ 260.137 g/mol NotAvailable 2,2-Dialkylglycine Decarboxylase inhibitor Not Availables
su4984 C₂₀H₂₁N₃O₂ 335.405 g/mol NotAvailable L-Rhamnose Isomerase inhibitor Not Availables
porphyrin fe(iii) C₂₀H₁₂N₄Fe₁₃+ 1034.353 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
methyl-o3-(alpha-d-mannose)-alpha-d-mannose C₁₃H₂₄O₁₁ 356.326 g/mol NotAvailable 000003-Keto-L-Gulonate 6-Phosphate Decarboxylase inhibitor Not Availables
butyrylthiocholin C₉H₂₀N₁O₁S₁₁+ 510.923 g/mol NotAvailable Tryptophan-tRNA Ligase inhibitor Not Availables
000004-methylpiperazin-1-yl carbonyl group C₆H₁₁N₂O₁ 127.166 g/mol NotAvailable Pancreatic Hormone inhibitor Not Availables
000003-deoxyguanosin C₁₀H₁₃N₅O₄ 267.244 g/mol NotAvailable Trichotoxin_A50E inhibitor Not Availables
000004-nitro-inden-1-on C₉H₅N₁O₃ 175.143 g/mol NotAvailable 000003-Keto-L-Gulonate 6-Phosphate Decarboxylase inhibitor Not Availables
000004-[[morpholin-4-yl-piperidine-1-carboxylic säure [1-(3-benzenesulfonyl-1-propyl-allylcarbamoyl)-2-phenylethyl]-amide]] C₃₁H₄₂N₄O₅S₁ 582.757 g/mol NotAvailable Xylose Isomerase inhibitor Not Availables
000004-methylumbelliferyl chitobiose C₂₆H₃₄N₂O₁₃ 582.560 g/mol NotAvailable 000003-Keto-L-Gulonate 6-Phosphate Decarboxylase inhibitor Not Availables
000004-methyl-5-hydroxyethylthiazol C₆H₉N₁O₁S₁ 143.203 g/mol NotAvailable Trans-Sialidase inhibitor Not Availables
000004-methoxy-e-rhodomycin t C₃₁H₃₇N₁O₁₁ 599.633 g/mol NotAvailable 000005-Aminolaevulinic säure Dehydratase inhibitor Not Availables
000004-[[hydroxy-3-[(1s)-3-oxo-1-phenylbutyl]-2h-chromen-2-on]] C₁₉H₁₆O₄ 308.333 g/mol NotAvailable Cytochrome P450 inhibitor Not Availables
000004-methylidene-5-on C₈H₁₃N₃O₃ 199.209 g/mol NotAvailable Azurin inhibitor Not Availables
000004-methyl-histidin C₇H₁₁N₃O₂ 169.183 g/mol NotAvailable Azurin inhibitor Not Availables
000002-phenethyl-2,3-dihydro-phthalazine-1,4-dion C₁₆H₁₄N₂O₂ 266.299 g/mol NotAvailable Actin Depolymerizing Factor inhibitor Not Availables
(4r)-7-azabisabolene; r-azabisabolen C₁₄H₂₆N₁₁+ 348.433 g/mol NotAvailable Ovomucoid inhibitor Not Availables
000004-oxosebacic säure C₁₀H₁₇O₅ 217.241 g/mol NotAvailable Molecule: Leucine Aminopeptidase; Chain: A, inhibitor Not Availables
000004-oxoretinol C₂₀H₂₈O₂ 300.440 g/mol NotAvailable Delta-Aminolevulinic säure Dehydratase inhibitor Not Availables
000005-(hydroxy-methyl-amino)-3-methyl-pyrrolidine-2-carboxylic säure C₇H₁₄N₂O₃ 174.199 g/mol NotAvailable Integrin Alpha-L inhibitor Not Availables
mercury diiodide Hg₁I₂ 454.399 g/mol NotAvailable Bacteriorhodopsin inhibitor Not Availables
000004-phospho-d-erythronate C₄H₉O₈P₁ 216.084 g/mol NotAvailable Lipoprotein Mxim inhibitor Not Availables
000004-[[o-(4,6-dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-beta-d-lyxo-hexopyranosyl)-alpha-d-erythro-hexopyranose]] C₁₉H₃₃N₁O₁₃ 483.469 g/mol NotAvailable Bacteriorhodopsin inhibitor Not Availables
selenoinosin C₁₀H₁₂N₄O₄Se₁ 331.189 g/mol NotAvailable Bacteriorhodopsin inhibitor Not Availables
000004-nitrophenyl-ara C₁₁H₁₃N₁O₇ 271.226 g/mol NotAvailable Phospholipase A2, Major Isoenzyme inhibitor Not Availables
000004-oxo-nicotinamide-adenine dinucleotide phosphat H₂₈C₂₁N₇O₁₈P₃ 759.410 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
000004-o-methyl-beta-d-glucuronic säure C₇H₁₂O₇ 208.168 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
(6,7-difluoro-quinazolin-4-yl)-(1-methyl-2,2-diphenyl-ethyl)-amin C₂₃H₁₉N₃F₂ 375.420 g/mol NotAvailable Methylenetetrahydrofolate Dehydrogenase/Cycl inhibitor Not Availables
inhibitor bea388 C₃₅H₄₃N₃O₈ 633.740 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
000004-hydroxy-1,2,5-thiadiazole-3-carboxylic säure C₃H₂N₂O₃S₁ 146.120 g/mol NotAvailable Methylenetetrahydrofolate Dehydrogenase / Cy inhibitor Not Availables
000004-hydroxy-aconitate ion C₆H₃O₇₃- 1243.046 g/mol NotAvailable 000003-Methyladenine DNA Glycosylase inhibitor Not Availables
000004-hydroxy-3,4-dihydro-1h-pyrimidin-2-on C₄H₆N₂O₂ 114.104 g/mol NotAvailable Lipid Transfer Protein inhibitor Not Availables
n-acetylalanin C₅H₉N₁O₃ 131.131 g/mol NotAvailable Prothrombin inhibitor Not Availables
000004-fluorobenzylamin C₇H₉N₁F₁₁+ 316.137 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
000004-flourobenzenesulfonamide C₆H₆N₁O₂F₁S₁ 175.177 g/mol NotAvailable Ampc Beta-Lactamase inhibitor Not Availables
000004-(3-pyridin-2-yl-1h-pyrazol-4-yl)quinolin C₁₇H₁₂N₄ 272.309 g/mol NotAvailable Fatty-säure Amide Hydrolase inhibitor Not Availables
000004-hydroperoxy-2-methoxy-phenol C₇H₈O₄ 156.138 g/mol NotAvailable Nad-Dependent Malic Enzyme, Mitochondria inhibitor Not Availables
000004-fluorophenethyl alcohol C₈H₉O₁F₁ 140.157 g/mol NotAvailable Flavocytochrome C3 inhibitor Not Availables
000004-iodo-acetamido phenylboronic säure C₈H₉N₁O₃B₁I₁ 304.879 g/mol NotAvailable Beta-Lactamase Shv-1 inhibitor Not Availables
000007-[[methoxy-8-[1-(methylsulfonyl)-1h-pyrazol-4-yl]naphthalene-2-carboximidamide]] C₁₆H₁₆N₄O₃S₁ 344.387 g/mol NotAvailable Protein 1D10 inhibitor Not Availables
000004-imino-5-methidyl-2-methylpyrimidin C₆H₇N₃ 121.141 g/mol NotAvailable Alpha-Amylase, Pancreatic inhibitor Not Availables
uridine-5'-diphosphate-n-acetylmuramoyl-l-alanin C₂₃H₃₆N₄O₂₀P₂ 750.500 g/mol NotAvailable Endo-1,4-B-D-Mannanase inhibitor Not Availables
000004-iodophenol C₆H₅O₁I₁ 220.009 g/mol NotAvailable Myosin inhibitor Not Availables
000004-[[iodobenzo[b]thiophene-2-carboxamidin]] C₉H₈N₂I₁S₁₁+ 623.740 g/mol NotAvailable Elastase inhibitor Not Availables
000004-hydroxybutan-1-aminium C₄H₁₂N₁O₁ 90.145 g/mol NotAvailable Fructose-1,6-Bisphosphatase inhibitor Not Availables
000004-hydroxybenzyl coenzyme a C₂₈H₄₂N₇O₁₇P₃S₁ 873.658 g/mol NotAvailable Polyamine Oxidase inhibitor Not Availables
oxyphenbutazon C₁₉H₂₀N₂O₃ 324.379 g/mol NotAvailable Imp-1 Metallo Beta-Lactamase inhibitor Not Availables
000004-imidazolmethylene-5-imidazolone chromophore C₁₁H₁₇N₅O₃ 267.287 g/mol NotAvailable Alkaline Phosphatase inhibitor Not Availables
000004-hydroxytamoxifen C₂₆H₂₉N₁O₂ 387.521 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000004-hydroxyphenacyl coenzyme a C₂₉H₄₂N₇O₁₈P₃S₁ 901.668 g/mol NotAvailable Cutinase inhibitor Not Availables
000005-(aminomethyl)-2-methylpyrimidin-4-amin C₆H₁₀N₄ 138.172 g/mol NotAvailable Alcohol Sulfotransferase inhibitor Not Availables
000005-(6-d-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic säure C₁₄H₂₆N₃O₉P₁ 411.348 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
d-4-phosphoerythronic säure C₄H₉O₈P₁ 216.084 g/mol NotAvailable 000005-Methyltetrahydropteroyltriglutamate-- Homo inhibitor Not Availables
000005-[[[1-(3,4-dimethoxy-benzoyl)-1,2,3,4-tetrahydro-quinolin-6-yl]-6-methyl-3,6-dihydro-[1,3,4]thiadiazin-2-on]] C₂₂H₂₃N₃O₄S₁ 425.501 g/mol NotAvailable Biliverdin Ix Beta Reductase inhibitor Not Availables
000005-[[[(4-methylphenyl)sulfanyl]-2,4-quinazolinediamin]] C₁₅H₁₄N₄S₁ 282.362 g/mol NotAvailable Yeast Cytochrome C Peroxidase inhibitor Not Availables
000005-(3,3-dihydroxypropeny)-3-methoxy-benzene-1,2-diol C₁₀H₁₂O₅ 212.202 g/mol NotAvailable Uridine Phosphorylase inhibitor Not Availables
000005-(3-amino-4,4-dihyroxy-butylsulfanylmethyl)-tetrahydro-furan-2,3,4-triol C₉H₁₇N₁O₆S₁ 267.296 g/mol NotAvailable Glutathione Reductase inhibitor Not Availables
000002-[[[4-(4-chlorophenyl)cyclohexylidene]-3,4-dihydroxy-1(2h)-naphthalenon]] C₂₂H₁₉O₃Cl₁ 366.843 g/mol NotAvailable Tyrosine 3-Monooxygenase inhibitor Not Availables
000005-(6-amino-9h-purin-9-yl)-4-hydroxytetrahydrofuran-3-yl dihydrogen phosphat C₉H₁₂N₅O₆P₁ 317.197 g/mol NotAvailable Cholera Toxin B inhibitor Not Availables
glycinamid C₂H₆N₂O₁ 74.082 g/mol NotAvailable Acyl-Coa Dehydrogenase Family Member 8, Mito inhibitor Not Availables
000001-allyl-3-butyl-8-(n-acetyl-4-aminobenzyl)-xanthin C₂₁H₂₅N₅O₃ 395.460 g/mol NotAvailable Penicillin-Binding Protein 2A inhibitor Not Availables
000005-alpha-androstane-3-beta,17beta-diol C₁₉H₃₂O₂ 292.461 g/mol NotAvailable Methionine Aminopeptidase inhibitor Not Availables
000005-alpha-androstane-3-beta,17-alpha-diol C₁₉H₃₂O₂ 292.461 g/mol NotAvailable Methionine Aminopeptidase inhibitor Not Availables
o4-sulfonylgalactose C₆H₁₂O₉S₁ 260.215 g/mol NotAvailable Catalase inhibitor Not Availables
000005-amino-1h-pyrimidine-2,4-dion C₄H₅N₃O₂ 127.102 g/mol NotAvailable Hallucinogens Not Availables
sp7343-sp7964 C₁₉H₂₇N₅O₅S₂ 469.573 g/mol NotAvailable Serum Amyloid P-Component inhibitor Not Availables
000002-amino-5-hydroxy-benzimidazol C₇H₇N₃O₁ 149.152 g/mol NotAvailable Myoglobin inhibitor Not Availables
000005-[[[4-tert-butylphenylsulfanyl]-2,4-quinazolinediamin]] C₁₈H₂₀N₄S₁ 324.443 g/mol NotAvailable Alpha-1,3-Mannosyl-Glycoprotein Beta-1,2-N- inhibitor Not Availables
000005-[[[4-(1-carboxymethyl-2-oxo-propylcarbamoyl)-benzylsulfamoyl]-2-hydroxy-benzoic säure]] C₂₀H₂₀N₂O₉S₁ 464.446 g/mol NotAvailable Fk506-Binding Protein inhibitor Not Availables
000005-[[[2,3-dichloro-4-(5-{1-[2-(2-guanidino-4-methyl-pentanoylamino)-acetyl]-piperidin-4-yl}-1-methyl-1h-pyrazol-3-yl)-phenoxymethyl]-furan-2-carboxylic säure]] C₃₀H₃₇N₇O₆Cl₂ 662.572 g/mol NotAvailable Neutrophil Gelatinase inhibitor Not Availables
000005-[[{2-[1-(6-ethyl-6-hydroxy-1-methyl-octa-2,4-dienyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol; 22-24-diene-24a,26a,27a,trihomo-1alpha,25-dihydroxyvitamin d3]] C₃₀H₄₆O₃ 454.692 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
000005-[[{[ethyl(methyl)amino]methyl}-2-methyl-5,6-dihydropyrimidin-4-amin]] C₉H₁₆N₄ 180.252 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
n-hexadecanoylglycin C₁₈H₃₅N₁O₃ 313.479 g/mol NotAvailable Endoplasmic Reticulum Mannosyl-Oligosacchari inhibitor Not Availables
4,5-dihydroxy-tetrahydro-pyran-2-carboxylic säure C₆H₁₀O₅ 162.142 g/mol NotAvailable Lectin inhibitor Not Availables
ru82209 C₃₁H₃₄N₃O₆F₂P₁ 613.597 g/mol NotAvailable Shiga-Like Toxin I B Subunit inhibitor Not Availables
4,6-dideoxy-4-amino-alpha-d-glucose C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Agglutinin inhibitor Not Availables
cp403700, [[(s)-1-{2-[(5-chloro-1h-indole-2-carbonyl)-amino]-3-phenyl-propionyl}-azetidine-3-carboxylate]] C₂₂H₂₀N₃O₄Cl₁ 425.871 g/mol NotAvailable Hemagglutinin-Neuraminidase Glycoprotein inhibitor Not Availables
4,5,6,7-tetrachloro-3h-isobenzofuran-1-on C₈H₂O₂Cl₄ 271.915 g/mol NotAvailable Myoglobin inhibitor Not Availables
000004-[[sulfonamide-[4-(thiomethylaminobutane)]benzamide]] C₁₂H₁₉N₃O₃S₂ 317.420 g/mol NotAvailable Soluble Quinoprotein Glucose Dehydrogenase inhibitor Not Availables
000004-[[sulfonamide-[1-(4-aminobutane)]benzamide]] C₁₁H₁₇N₃O₃S₁ 271.334 g/mol NotAvailable Methylmalonyl-Coa Carboxyltransferase 12S Su inhibitor Not Availables
adenosyl-ornithin C₁₅H₂₃N₇O₅ 381.391 g/mol NotAvailable Esterase inhibitor Not Availables
[[4,4'[1,6-hexanediylbis(oxy)]bisbenzenecarboximidamide]] C₂₀H₂₆N₄O₂ 354.451 g/mol NotAvailable Parathion Hydrolase inhibitor Not Availables
4,4'-biphenyldiboronic säure C₁₂H₁₂O₄B₂ 241.844 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
000004-thio-beta-d-glucopyranose C₆H₁₂O₅S₁ 196.218 g/mol NotAvailable Androgen Receptor inhibitor Not Availables
000005--monophosphate-9-beta-d-ribofuranosyl xanthin C₁₀H₁₄N₄O₉P₁₁+ 674.953 g/mol NotAvailable Lysozyme inhibitor Not Availables
000001-amino-2,3-dihydroxy-5-hydroxymethyl cyclohex-5-en C₇H₁₃N₁O₃ 159.185 g/mol NotAvailable Trans-Sialidase inhibitor Not Availables
4'-phosphopantethein C₁₁H₂₃N₂O₇P₁S₁ 358.346 g/mol NotAvailable Hmg-Coa Reductase inhibitor Not Availables
adr adrenalin C₉H₁₃N₁O₃ 183.207 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
000005-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone;2,4,5-trihydroxyphenylalanine quinone; topa quinon C₉H₉N₁O₅ 211.174 g/mol NotAvailable Dethiobiotin Synthetase inhibitor Not Availables
000005-(1-carboxy-1-phosphonooxy-ethoxyl)-shikimate-3-phosphat C₁₀H₁₆O₁₄P₂ 422.176 g/mol NotAvailable Beta-Secretase 1 inhibitor Not Availables
homoserine lacton C₄H₇N₁O₂ 101.105 g/mol NotAvailable Sensor Kinase Cita inhibitor Not Availables
4,6-dideoxyglucose C₆H₁₂O₄ 148.158 g/mol NotAvailable Taka Amylase inhibitor Not Availables
4,6-dideoxy-4-amino-beta-d-glucopyranoside C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable 000004-Alpha-Glucanotransferase inhibitor Not Availables
imino-tryptophan C₁₁H₁₀N₂O₂ 202.212 g/mol NotAvailable Purine Trans Deoxyribosylase inhibitor Not Availables
docosa-4,7,10,13,16,19-hexaenoic säure C₂₂H₃₂O₂ 328.494 g/mol NotAvailable Aldehyde Oxidoreductase inhibitor Not Availables
[[4,7-dimethyl-[1,10]phenanthrolin]] C₁₄H₁₂N₂ 208.262 g/mol NotAvailable Kinesin-Like Protein Kif11 inhibitor Not Availables
000004-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamin C₉H₁₀N₄S₁ 206.265 g/mol NotAvailable Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
000004-(2-thienyl)butyric säure C₈H₁₀O₂S₁ 170.226 g/mol NotAvailable Hemerythrin inhibitor Not Availables
000004-(5-bromo-2-oxo-2h-indol-3-ylazo)-benzenesulfonamide C₁₄H₉N₄O₃Br₁S₁ 393.214 g/mol NotAvailable Capsid Protein P40 inhibitor Not Availables
[[(2e)-n-allyl-4-{[3-(4-bromophenyl)-5-fluoro-1-methyl-1h-indazol-6-yl]oxy}-n-methyl-2-buten-1-amin]] C₂₂H₂₃N₃O₁Br₁F₁ 444.346 g/mol NotAvailable Beta Trypsin inhibitor Not Availables
000004-[[(3,12,14-trihydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl)-5h-furan-2-on]] C₂₃H₃₄O₅ 390.519 g/mol NotAvailable Prolyl Oligopeptidase inhibitor Not Availables
000004-[[(2-{[4-{[3-(4-chlorophenyl)propyl]sulfanyl}-6-(1-piperazinyl)-1,3,5-triazin-2-yl]amino}ethyl)phenol]] C₂₄H₂₉N₆O₁Cl₁S₁ 485.046 g/mol NotAvailable Cathepsin S inhibitor Not Availables
000004-[[(17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl)-2-thiazolidinon]] C₂₂H₃₁N₁O₅S₁ 421.551 g/mol NotAvailable Cathepsin S inhibitor Not Availables
3'-azido-3'-deoxythymidine-5'-monophosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol NotAvailable Cathepsin S inhibitor Not Availables
adenosine monophosphat C₁₀H₁₄N₅O₇P₁ 347.224 g/mol NotAvailable Beta-Lactamase inhibitor Not Availables
000004-[[(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-butyricsäure]] C₉H₁₄N₂O₃S₁ 230.281 g/mol NotAvailable Mrna Decapping Enzyme inhibitor Not Availables
000004-[[(2-amino-ethoxy)-2-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-but-3-enoic säure]] C₁₄H₂₂N₃O₈P₁ 391.317 g/mol NotAvailable Immunomodulatory Agents; Immunosuppressants; ATC:L04AA02 For treatment of organ transplant recipients, prevention of organ rejections
000002-[[(2-{2-[2-(2-{2-[2-(2-ethoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethanol]], polyethyleneglycol peg400 C₁₈H₃₈O₉ 398.493 g/mol NotAvailable Phosphatidylinositol-Specific Phospholipase inhibitor Not Availables
000004-[[(aminosulfonyl)-n-[(3,4,5-trifluorophenyl)methyl]-benzamide]] C₁₄H₁₁N₂O₃F₃S₁ 344.308 g/mol NotAvailable Peptide N-Myristoyltransferase inhibitor Not Availables
9r,13r-opda C₁₈H₂₈O₃ 292.417 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
000004-carbamoyl-1-beta-d-ribofuranosyl-imidazolium-5-olate-5'-phosphat C₉H₁₂N₃O₉P₁₂- 677.894 g/mol NotAvailable Plasmepsin 2 inhibitor Not Availables
000004-(fluorophenyl)-1-cyclopropylmethyl-5-(2-amino-4-pyrimidinyl)imidazol C₁₇H₁₆N₅F₁ 309.345 g/mol NotAvailable Elastase inhibitor Not Availables
000004-(carboxyvin-2-yl)phenylboronic säure C₉H₉O₄B₁ 191.978 g/mol NotAvailable Peptide Deformylase inhibitor Not Availables
000004-(acetylamino)-3-guanidinobenzoic säure C₁₀H₁₄N₄O₃ 238.246 g/mol NotAvailable Casein Kinase-1 inhibitor Not Availables
(3r)-3-methyl-l-glutamic säure C₆H₁₁N₁O₄ 161.157 g/mol NotAvailable Cytochrome P450-Cam inhibitor Not Availables
000004-[[(acetylamino)-3-[(aminoacetyl)amino]benzoic säure]] C₁₁H₁₄N₃O₄₁+ 844.227 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000004-[[(aminosulfonyl)-n-[(2,4,6-trifluorophenyl)methyl]-benzamide]] C₁₄H₁₁N₂O₃F₃S₁ 344.308 g/mol NotAvailable Heat-Labile Enterotoxin B Subunit inhibitor Not Availables
pentanal C₅H₁₀O₁ 86.133 g/mol NotAvailable Carbonic Anhydrase inhibitor Not Availables
isatoic anhydride C₇H₉N₁O₁ 123.154 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
3'-1-carboxy-1-phosphonooxy-ethoxy-uridine-diphosphate-n-acetylglucosamin C₂₀H₃₂N₃O₂₃P₃ 775.400 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
methionine phosphonate C₄H₁₂N₁O₃P₁S₁ 185.177 g/mol NotAvailable Nitric Oxide Synthase, Inducible inhibitor Not Availables
cytidine 5'-diphosphoglycerol C₁₂H₂₁N₃O₁₃P₂ 477.258 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
3'-deoxy 3'-amino adenosine-5'-diphosphat C₁₀H₁₆N₆O₉P₂ 426.219 g/mol NotAvailable Neprilysin inhibitor Not Availables
3'-deazo-thiamin diphosphat C₁₃H₁₉N₃O₇P₂S₁ 423.317 g/mol NotAvailable Nitric-Oxide Synthase, Brain inhibitor Not Availables
3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol C₁₆H₃₄O₉ 370.439 g/mol NotAvailable Glutathione S-Transferase A1 inhibitor Not Availables
fica C₁₁H₁₁N₂O₁F₁S₁ 238.279 g/mol NotAvailable Retinol Binding Protein Complexed With Fenre inhibitor Not Availables
3,6-dihydroxy-xanthene-9-propionic säure C₁₆H₁₄O₅ 286.284 g/mol NotAvailable Glycogen Synthase Kinase-3 Beta inhibitor Not Availables
fusidic säure C₃₁H₄₈O₆ 516.717 g/mol NotAvailable Saccharopine Reductase inhibitor Not Availables
[[3,8-diamino-6-phenyl-5-[6-[1-[2-[(1,2,3,4-tetrahydro-9-acridinyl)amino]ethyl]-1h-1,2,3-triazol-4-yl]hexyl]-phenanthridinium]] C₄₂H₄₅N₈ 661.871 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
3,7,11,15-tetramethyl-hexadecan-1-ol C₂₀H₄₂O₁ 298.551 g/mol NotAvailable Crabp-I inhibitor Not Availables
3r-hydroxydecanoyl-coa C₃₁H₅₄N₇O₁₈P₃S₁ 937.785 g/mol NotAvailable Alanine Racemase inhibitor Not Availables
argininosuccinate C₁₀H₁₈N₄O₆ 290.275 g/mol NotAvailable Alanine Racemase inhibitor Not Availables
[[3h-pyrazolo[4,3-d]pyrimidin-7-ol]] C₅H₄N₄O₁ 136.113 g/mol NotAvailable Squalene--Hopene Cyclase inhibitor Not Availables
000004-(1,3,2-dioxaborolan-2-yloxy)butan-1-aminium C₆H₁₅N₁O₃B₁ 159.999 g/mol NotAvailable Calmodulin inhibitor Not Availables
000004-(1-amino-1-carboxy-ethyl)-benzoic säure C₁₀H₁₁N₁O₄ 209.201 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
000004-[[((3r,4s,5r)-4-amino-3,5-dihydroxy-hex-1-ynyl)-5-fluoro-3-[1-(3-methoxy-1h-pyrrol-2-yl)-meth-(z)-ylidene]-1,3-dihydro-indol-2-on]] C₂₀H₂₀N₃O₄F₁ 385.394 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
3'-uridinemonophosphat C₉H₁₃N₂O₉P₁ 324.183 g/mol NotAvailable Transthyretin inhibitor Not Availables
3'-phosphate-adenosine-5'-diphosphat C₁₀H₁₆N₅O₁₃P₃ 507.183 g/mol NotAvailable Aspartate Transcarbamoylase inhibitor Not Availables
3'-oxo-adenosin C₁₀H₁₁N₅O₄ 265.228 g/mol NotAvailable Ornithine Transcarbamoylase inhibitor Not Availables
[[3ar,5r,6s,7r,7ar-5-hydroxymethyl-2-methyl-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d]thiazole-6,7-diol]] C₈H₁₃N₁O₄S₁ 219.255 g/mol NotAvailable Plasmepsin II inhibitor Not Availables
3"-(beta-chloroethyl)-2",4"-dioxo-3, 5"-spiro-oxazolidino-4-deacetoxy-vinblastin C₄₆H₅₆N₅O₇Cl₁ 826.431 g/mol NotAvailable Endoglucanase I inhibitor Not Availables
3',5'-dinitro-n-acetyl-l-thyronin C₁₇H₁₅N₃O₉ 405.320 g/mol NotAvailable Lethal Factor inhibitor Not Availables
000004-bromo-3-hydroxy-3-methyl butyl diphosphat C₅H₁₃O₈P₂Br₁ 343.004 g/mol NotAvailable Pantothenate Kinase inhibitor Not Availables
000004-bromo-3-(5'-carboxy-4'-chloro-2'-fluorophenyl)-1-methyl-5-trifluoromethyl-pyrazol C₁₂H₆N₂O₂Br₁Cl₁F₄ 401.542 g/mol NotAvailable Mitogen-Activated Protein Kinase 14 inhibitor Not Availables
000004-carboxy-5-(1-pentyl)hexylsulfanyl-1,2,3-triazol C₁₄H₂₅N₃O₂S₁ 299.430 g/mol NotAvailable Chitinase B inhibitor Not Availables
000004-carboxy-4-aminobutanal C₅H₉N₁O₃ 131.131 g/mol NotAvailable Adamalysin II inhibitor Not Availables
[[n-[o-phosphono-pyridoxyl]-isoleucin]] C₁₄H₂₃N₂O₇P₁ 362.319 g/mol NotAvailable Scytalone Dehydratase inhibitor Not Availables
[[phosphoric säure mono-[3-amino-5-(5-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester]] C₁₀H₁₆N₃O₇P₁ 321.226 g/mol NotAvailable Cathepsin B inhibitor Not Availables
000004-[[amino-1-[(1s,3r,4r,7s)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]hept-3-yl]-5-methylpyrimidin-2(1h)-one ]] Not Available Not Available NotAvailable Elastase 1 inhibitor Not Availables
000004-[[[3-methylsulfanylanilino]-6,7-dimethoxyquinazolin]] C₁₇H₁₇N₃O₂S₁ 327.400 g/mol NotAvailable Phosphate-Binding Protein inhibitor Not Availables
000004-aminophthalhydrazide C₈H₇N₃O₂ 177.162 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
000004-aminophenylarsonic säure C₆H₈N₁O₃As₁ 217.056 g/mol NotAvailable Pol Polyprotein inhibitor Not Availables
000004-aminohydrocinnamic säure C₉H₁₁N₁O₂ 165.191 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
000004-dimethylamino-n-(6-hydroxycarbamoyethyl)benzamide-n-hydroxy-7-(4-dimethyla minobenzoyl)aminoheptanamide C₁₆H₂₅N₃O₃ 307.392 g/mol NotAvailable 5'-D inhibitor Not Availables
o1-methyl-4-deoxy-4-thio-alpha-d-glucose C₇H₁₄O₅S₁ 210.245 g/mol NotAvailable Neprilysin inhibitor Not Availables
000004-deoxyglucarate C₆H₈O₇₂- 1232.086 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
000003-[[(3,5-dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonic säure [4-(thiazol-2-ylsulfamoyl)-phenyl]-amide]] C₂₆H₁₉N₃O₇Br₂S₃ 741.440 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
000004-amido-4-carbamoyl-butyric säure C₅H₁₀N₂O₃ 146.146 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
2'-o-acetyl adenosine-5-diphosphoribose C₁₇H₂₅N₅O₁₅P₂ 601.357 g/mol NotAvailable Alpha Amylase inhibitor Not Availables
000004-deoxy-4-amino-beta-d-glucose C₆H₁₃N₁O₅ 179.172 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Abl inhibitor Not Availables
000004-deoxy-4-((5-hydroxymethyl-2,3,4-trihydroxycyclohex-5,6-enyl)amino)fructose C₁₃H₂₃N₁O₈ 321.327 g/mol NotAvailable Phosphoribosylglycinamide Formyltransferase inhibitor Not Availables
benzenesulfonyl C₆H₅O₂S₁ 141.164 g/mol NotAvailable Guanidinoacetate N-Methyltransferase inhibitor Not Availables
000004-deoxy-d-mannuronic säure C₆H₈O₆ 176.126 g/mol NotAvailable Isoleucyl-tRNA Synthetase inhibitor Not Availables
000004-deoxy-d-glucuronic säure C₆H₁₀O₆ 178.141 g/mol NotAvailable Npqtn Specific Sortase B inhibitor Not Availables
ly249543 C₂₁H₂₅N₅O₆ 443.458 g/mol NotAvailable Branched-Chain Amino säure Aminotransferase, inhibitor Not Availables
000004-[[[3-hydroxyanilino]-6,7-dimethoxyquinazolin]] C₁₆H₁₅N₃O₃ 297.313 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
para-isopropylanilin C₉H₁₃N₁ 135.208 g/mol NotAvailable Trypanothione Reductase inhibitor Not Availables
000004-[[[5-(trans-4-aminocyclohexylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-7-ylamino]-n,n-dimethylbenzenesulfonamide]] C₂₃H₃₃N₇O₂S₁ 471.619 g/mol NotAvailable Nitric-Oxide Synthase, Endothelial inhibitor Not Availables
000004-[[[4-(4-methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol]] C₁₅H₁₅N₅O₁S₁ 313.376 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
000004-[[[3-oxo-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-propenyl]-benzoic säure]] C₂₄H₂₆O₃ 362.468 g/mol NotAvailable Cell Division Protein Zipa inhibitor Not Availables
000004-(methylsulfanyl)-2-oxobutanoic säure C₅H₈O₃S₁ 148.176 g/mol NotAvailable Cholera Toxin B Subunit inhibitor Not Availables
fructose -6-phosphat C₆H₁₁O₉P₁ 258.121 g/mol NotAvailable Cholera Toxin B Subunit inhibitor Not Availables
000004-(hydroxymercury)benzoic säure C₇H₆O₃Hg₁ 338.713 g/mol NotAvailable Cholera Toxin B Subunit inhibitor Not Availables
[[2,4-diamino-6-[n-(3',5'-dimethoxybenzyl)-n-methylamino]pyrido[2,3-d]pyrimidin]] C₁₇H₂₀N₆O₂ 340.384 g/mol NotAvailable Catechol O-Methyltransferase, Soluble Form inhibitor Not Availables
000004-[[[(10s,14s,18s)-18-(2-amino-2-oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-triazaspiro[5.14]icos-11-en-10-yl]benzylphosphonic säure]] C₃₇H₄₅N₄O₇P₁ 688.759 g/mol NotAvailable Epidermal Growth Factor Receptor inhibitor Not Availables
000004-(n,n-dimethylamino)cinnamoyl-coa C₃₂H₄₇N₈O₁₇P₃S₁ 940.748 g/mol NotAvailable Alcohol Dehydrogenase Gamma Chain inhibitor Not Availables
000004-acetamido-2,4-didexoy-d-glycero-beta-d-galacto-octopyranosylphosphonic säure (an axial phosphonate) C₁₀H₂₀N₁O₉P₁ 329.243 g/mol NotAvailable Glyceraldehyde 3-Phosphate Dehydrogenase inhibitor Not Availables
sri-9439 C₁₈H₁₇N₇ 331.379 g/mol NotAvailable Cephalosporinase inhibitor Not Availables
000004-[[{2,4-bis[(3-nitrobenzoyl)amino]phenoxy}phthalic säure]] C₂₈H₁₈N₄O₁₁ 586.470 g/mol NotAvailable Sepiapterin Reductase inhibitor Not Availables
000004-amino hexanoic säure C₆H₁₃N₁O₂ 131.174 g/mol NotAvailable Leukosialin inhibitor Not Availables
000004-diphosphocytidyl-2-c-methyl-d-erythritol 2-phosphat C₁₄H₂₆N₃O₁₇P₃ 601.291 g/mol NotAvailable Hevamine inhibitor Not Availables
000004-acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2h-pyran-2-carboxylic säure C₁₄H₂₃N₅O₅ 341.366 g/mol NotAvailable N-Acetyl-L-Ornithine Carbamoyltransferase inhibitor Not Availables
000004-[[{(z)-[2-[3-(methylsulfanyl)propanoyl]-5-oxo-1-(2-oxoethyl)-1,5-dihydro-4h-imidazol-4-ylidene]methyl}benzenolate]] C₁₆H₁₅N₂O₄S₁ 331.365 g/mol NotAvailable N-Acylamino säure Racemase inhibitor Not Availables
[[s-ethyl-n-[4-(trifluoromethyl)phenyl]isothiourea]] C₁₀H₁₁N₂F₃S₁ 248.266 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
cra_9678 C₁₇H₁₃N₃O₃Br₁₁- 1186.252 g/mol NotAvailable Chloramphenicol 3-O Phosphotransferase inhibitor Not Availables
000004-[[{2-[4-(2-aminoethyl)piperazin-1-yl]pyridin-4-yl}-n-(3-chloro-4-methylphenyl)pyrimidin-2-amin]] C₂₂H₂₆N₇Cl₁ 423.947 g/mol NotAvailable Uricase inhibitor Not Availables
000004-[[{2-[(3-nitrobenzoyl)amino]phenoxy}phthalic säure]] C₂₁H₁₄N₂O₈ 422.350 g/mol NotAvailable C-Terminal Analogue Of Neuropeptide Y, A inhibitor Not Availables
(2s,3r)-1-amino-2-methylbutane-2,3-diol C₅H₁₃N₁O₂ 119.163 g/mol NotAvailable Polysialic säure Capsule Biosynthesis Protein inhibitor Not Availables
000002-[[acetyl-3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-(4,6,6-trihydroxy-3,5-dioxa-4,6-diphosphahex-1-yl)thiazolium inner salt p,p'-dioxide]] C₁₄H₂₀N₄O₈P₂S₁ 466.342 g/mol NotAvailable Carbapenem Synthase inhibitor Not Availables
phosphomethylphosphonic säure adenosyl ester C₁₁H₁₇N₅O₉P₂ 425.231 g/mol NotAvailable Lysozyme inhibitor Not Availables
000007-[[((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-(3-((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic säure]] C₂₀H₂₀N₆O₉S₁ 520.473 g/mol NotAvailable Trypsin inhibitor Not Availables
000007-[[[4-(dimethylamino)phenyl]-n-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide]] C₁₇H₂₂N₂O₃ 302.372 g/mol NotAvailable Trypsin inhibitor Not Availables
000007-(carboxyamino)-8-amino-nonanoic säure C₁₀H₂₀N₂O₄ 232.279 g/mol NotAvailable Trypsin inhibitor Not Availables
000007-[[(2-amino-2-phenyl-acetylamino)-3-chloro-8-oxo-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic säure]] C₁₆H₁₆N₃O₄Cl₁ 349.773 g/mol NotAvailable Peptidylglycine Alpha-Hydroxylating Monooxyg inhibitor Not Availables
000001-(2,6-dichlorophenyl)-5-(2,4-difluorophenyl)-7-piperidin-4-yl-3,4-dihydroquinolin-2(1h)-on C₂₆H₂₂N₂O₁Cl₂F₂ 487.375 g/mol NotAvailable Beta-Agarase A inhibitor Not Availables
000006-phosphogluconic säure C₆H₁₃O₁₀P₁ 276.136 g/mol NotAvailable Saccharopepsin inhibitor Not Availables
000006-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methylquinoline-4-carboxylic säure C₂₃H₁₅N₁O₂F₂ 375.374 g/mol NotAvailable Glycogen Phosphorylase inhibitor Not Availables
6'-methyl-thiamin diphosphat C₁₃H₂₀N₄O₇P₂S₁ 438.331 g/mol NotAvailable Heat-Labile Enterotoxin B Chain inhibitor Not Availables
6,7-dioxo-5h-8-ribitylaminolumazin C₁₁H₁₄N₄O₈ 330.254 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
6,7-dicarboxyl-1,2,3,4,5,8-hexamethylhemin C₂₈H₂₄N₄O₄Fe₁ 536.369 g/mol NotAvailable Alcohol Dehydrogenase Beta Chain inhibitor Not Availables
000007-iodo-1,2,3,4-tetrahydro-isoquinolin C₉H₁₀N₁I₁ 259.089 g/mol NotAvailable Phosphoglucose Isomerase inhibitor Not Availables
000007-hydroxystaurosporin C₂₈H₂₆N₄O₄ 482.538 g/mol NotAvailable Hemoglobin-Like Protein Hbn inhibitor Not Availables
beta-d-glucopyranose spirohydantoin C₈H₁₂N₂O₇ 248.192 g/mol NotAvailable Oestrogen Receptor Beta inhibitor Not Availables
[[8,9,10-trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-on]] C₈H₁₂N₂O₆S₁ 264.253 g/mol NotAvailable Pheromone-Binding Protein Asp1 inhibitor Not Availables
000007-methyl-gpppa C₂₁H₃₀N₁₀O₁₇P₃₁+ 1654.711 g/mol NotAvailable Nitric-Oxide Synthase inhibitor Not Availables
gluco-phenylimidazol C₁₄H₁₆N₂O₄ 276.291 g/mol NotAvailable Lysozyme inhibitor Not Availables
000007-chlorotetracyclin C₂₂H₂₃N₂O₈Cl₁ 478.885 g/mol NotAvailable Human Thioredoxin Peroxidase-B inhibitor Not Availables
000007-alpha-d-ribofuranosyl-purine-5'-phosphat C₁₀H₁₃N₄O₇P₁ 332.209 g/mol NotAvailable Dihydroorotase inhibitor Not Availables
[[(3r)-3-{[(benzyloxy)carbonyl]amino}-2-oxo-4-phenylbutane-1-diazonium]] C₁₈H₁₈N₃O₃ 324.358 g/mol NotAvailable N-Carbamyl-D-Amino säure Amidohydrolase inhibitor Not Availables
000007-deazaguanin C₆H₆N₄O₁ 150.140 g/mol NotAvailable N-Carbamyl-D-Amino säure Amidohydrolase inhibitor Not Availables
000007-deazaadenosin C₁₁H₁₄N₄O₄ 266.256 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
[[*[[n-(benzyloxycarbonyl)amino]methyl]phosphat]] C₉H₁₂N₁O₅P₁ 245.171 g/mol NotAvailable Aequorin 2 inhibitor Not Availables
000006-deoxyglucose C₆H₁₂O₅ 164.158 g/mol NotAvailable Epoxide Hydrolase 2, Cytoplasmic inhibitor Not Availables
000006-deoxyerythronolide b C₂₁H₃₈O₆ 386.528 g/mol NotAvailable Epoxide Hydrolase inhibitor Not Availables
000006-hydroxy-6-methyl-heptan-3-on C₈H₁₆O₂ 144.213 g/mol NotAvailable Epoxide Hydrolase inhibitor Not Availables
000006-hydroxy-1,6-dihydro purine nucleoside C₁₀H₁₅N₄O₅₁+ 1007.225 g/mol NotAvailable Cyanovirin-N inhibitor Not Availables
ru78299 C₉H₉O₆P₁ 244.140 g/mol NotAvailable Alcohol Dehydrogenase Alpha Chain inhibitor Not Availables
lysophosphatidylglycerol C₂₂H₄₄O₉P₁₁- 793.296 g/mol NotAvailable Conserved Hypothetical Protein inhibitor Not Availables
2',4'-dinitrophenyl-2deoxy-2-fluro-b-d-cellobioside C₁₈H₂₃N₂O₁₄F₁ 510.383 g/mol NotAvailable Penton Protein inhibitor Not Availables
000005-methyl-2-(1-methylethyl)phenol C₁₀H₁₄O₁ 150.220 g/mol NotAvailable Retinol Binding Protein Complex With N-Ethyl inhibitor Not Availables
000006-deoxy-alpha-d-glucose C₆H₁₂O₅ 164.158 g/mol NotAvailable Endoplasmin inhibitor Not Availables
000006-deoxy-2-o-methyl-alpha-l-galactopyranose C₇H₁₄O₅ 178.185 g/mol NotAvailable Hypothetical Protein Af1521 inhibitor Not Availables
000006-chloropurine riboside, 5'-monophosphat C₁₀H₁₃N₄O₇Cl₁P₁₁+ 677.400 g/mol NotAvailable Liver Alcohol Dehydrogenase inhibitor Not Availables
000006-nitroindazol C₇H₅N₃O₂ 163.135 g/mol NotAvailable Alcohol Dehydrogenase Beta Chain inhibitor Not Availables
000006-methylpurin C₆H₆N₄ 134.140 g/mol NotAvailable Bifunctional P-450: Nadph-P450 Reductase inhibitor Not Availables
000006-methyl-formycin a C₁₁H₁₆N₅O₄₁+ 874.256 g/mol NotAvailable Lipase B inhibitor Not Availables
000006-phenyl-4(r)-(7-phenyl-heptanoylamino)-hexanoic säure C₂₅H₃₃N₁O₃ 395.541 g/mol NotAvailable Stromelysin-1 Precursor inhibitor Not Availables
000006-[[oxo-8,9,10,11-tetrahydro-7h-cyclohepta[c][1]benzopyran-3-o-sulfamate]] C₁₄H₁₅N₁O₅S₁ 309.336 g/mol NotAvailable Stromelysin-1 Precursor inhibitor Not Availables
000006-o-cyclohexylmethyl guanin C₁₂H₁₇N₅O₁ 247.299 g/mol NotAvailable Histone Deacetylase 8 inhibitor Not Availables
000006-hydroxy-l-norleucin C₆H₁₃N₁O₃ 147.174 g/mol NotAvailable Stromelysin-1 inhibitor Not Availables
heme c C₃₄H₃₄N₄O₄FE₁ 618.514 g/mol NotAvailable Triosephosphate Isomerase inhibitor Not Availables
000006-hydroxy-7,8-dihydro purine nucleoside C₁₀H₁₄N₄O₅ 270.244 g/mol NotAvailable Acetohydroxy säure Isomeroreductase inhibitor Not Availables
000004-[[[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]benzenesulfonamide]] C₁₇H₁₄N₆O₂S₁ 366.397 g/mol NotAvailable Cytochrome C Peroxidase inhibitor Not Availables
000006-hydroxypropylthymin C₈H₁₂N₂O₃ 184.194 g/mol NotAvailable Nitric-Oxide Synthase inhibitor Not Availables
000006-hydroxymethyl-7,8-dihydropterin C₇H₉N₅O₂ 195.180 g/mol NotAvailable Microcystin-Lr inhibitor Not Availables
[[8,9-dichloro-2,3,4,5-tetrahydro-1h-benzo[c]azepin]] C₁₀H₁₁N₁Cl₂ 216.110 g/mol NotAvailable Maltooligosyl Trehalose Synthase inhibitor Not Availables
alpha-methyl-d-galactoside C₇H₁₄O₆ 194.184 g/mol NotAvailable Signal Peptidase I inhibitor Not Availables
000009-(2-deoxy-beta-d-ribofuranosyl)-6-methylpurin C₁₁H₁₄N₄O₃ 250.257 g/mol NotAvailable Renin inhibitor Not Availables
000004-[[carbamoyl-4-{[6-(difluoro-phosphono-methyl)-naphthalene-2-carbonyl]-amino}-butyric säure]] C₁₇H₁₇N₂O₇F₂P₁ 430.301 g/mol NotAvailable Cell Division Protein Zipa inhibitor Not Availables
[[8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dion]] C₉H₁₄N₂O₇ 262.219 g/mol NotAvailable Amine Oxidase [Flavin-Containing] B inhibitor Not Availables
000008-demethyl-8-dimethylamino-flavin-adenine-dinucleotide C₂₈H₃₆N₁₀O₁₅P₂ 814.598 g/mol NotAvailable Amine Oxidase [Flavin-Containing] A inhibitor Not Availables
000008-bromoadenosine-5'-diphosphat C₁₀H₁₄N₅O₁₀Br₁P₂ 506.100 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
bis(5-amidino-2-benzimidazolyl)methanon C₁₇H₁₄N₈O₁ 346.351 g/mol NotAvailable Peptidic Toxin Nodularin inhibitor Not Availables
000008-iodo-guanin C₅H₄N₅O₁I₁ 277.024 g/mol NotAvailable Cyclosporin A As Bound To Cyclophilin inhibitor Not Availables
000008-hydroxy-4-(1-hydroxyethyl)quinoline-2-carboxylic säure C₁₂H₁₃N₁O₄ 235.239 g/mol NotAvailable Ferrochelatase inhibitor Not Availables
benzoic säure phenylmethylester C₁₄H₁₂O₂ 212.248 g/mol NotAvailable Protoheme Ferrolyase inhibitor Not Availables
mercaptocarboxylate inhibitor C₁₉H₁₉N₅O₃S₂ 429.511 g/mol NotAvailable Liver Carboxylesterase I inhibitor Not Availables
000009-aminophenanthren C₁₄H₁₁N₁ 193.248 g/mol NotAvailable Glyceraldehyde 3-Phosphate Dehydrogenase inhibitor Not Availables
000009-[[amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide]] C₁₉H₂₂N₄O₁ 322.409 g/mol NotAvailable Penicillin-Binding Protein 2X inhibitor Not Availables
000009-butyl-8-(2,5-dimethoxy-benzyl)-2-fluoro-9h-purin-6-ylamin C₁₈H₂₂N₅O₂F₁ 359.403 g/mol NotAvailable Ferrichrome-Iron Receptor Precursor inhibitor Not Availables
000009-butyl-8-(2-chloro-3,4,5-trimethoxy-benzyl)-9h-purin-6-ylamin C₁₉H₂₄N₅O₃Cl₁ 405.883 g/mol NotAvailable Endothelial Nitric-Oxide Synthase inhibitor Not Availables
000009-beta-d-xylofuranosyl-adenin C₁₀H₁₃N₅O₄ 267.244 g/mol NotAvailable Nitric Oxide Synthase, Inducible inhibitor Not Availables
000002-methyl-2,4-pentanediol C₆H₁₄O₂ 118.175 g/mol NotAvailable Catechol Oxidase inhibitor Not Availables
000009-(4-hydroxybutyl)-n2-phenylguanin C₁₅H₁₇N₅O₂ 299.332 g/mol NotAvailable Amine Oxidase [Flavin-Containing] B inhibitor Not Availables
000009-(4-hydroxy-3-(hydroxymethyl)but-1-yl)guanin C₁₀H₁₅N₅O₃ 253.260 g/mol NotAvailable Myoglobin inhibitor Not Availables
feruloyl coenzyme a C₃₁H₄₄N₇O₂₀P₃S₁ 959.705 g/mol NotAvailable säure Phosphatase inhibitor Not Availables
000009-(6-deoxy-beta-d-allofuranosyl)-6-methylpurin C₁₂H₁₆N₄O₄ 280.283 g/mol NotAvailable 000001-Aminocyclopropane-1-Carboxylate Deaminase inhibitor Not Availables
000009-(6-deoxy-alpha-l-talofuranosyl)-6-methylpurin C₁₂H₁₆N₄O₄ 280.283 g/mol NotAvailable 2,2-Dialkylglycine Decarboxylase inhibitor Not Availables
7,8-dihydroneopterin C₉H₁₃N₅O₄ 255.233 g/mol NotAvailable 000008-Amino-7-Oxononanoate Synthase inhibitor Not Availables
7,8-dihydrobiopterin C₉H₁₃N₅O₃ 239.233 g/mol NotAvailable Serine Hydroxymethyltransferase, Cytosolic inhibitor Not Availables
7n-methyl-8-hydroguanosine-5'-diphosphat C₁₁H₁₉N₅O₁₁P₂ 459.246 g/mol NotAvailable L-Allo-Threonine Aldolase inhibitor Not Availables
7n-methyl-8-hydroguanosine-5'-diphosphat C₁₁H₁₉N₅O₁₁P₂ 459.246 g/mol NotAvailable N-Acylamino säure Racemase inhibitor Not Availables
7,9-dimethylguanin C₇H₁₁N₅O₁₁+ 341.191 g/mol NotAvailable N-Acylamino säure Racemase inhibitor Not Availables
000007-nitroindazole-2-carboxamidin C₈H₇N₅O₂ 205.176 g/mol NotAvailable Cytochrome B2, Mitochondrial inhibitor Not Availables
pentasulfide-sulfur S₅₂- 1667.120 g/mol NotAvailable Phospholipase A2 Vrv-Pl-Viiia inhibitor Not Availables
000007-methylguanosin C₁₁H₁₆N₅O₅₁+ 1034.250 g/mol NotAvailable Calmodulin inhibitor Not Availables
o-trifluoromethylphenyl anthranilic säure C₁₄H₁₀N₁O₂F₃ 281.234 g/mol NotAvailable Protein-Tyrosine Phosphatase Yoph inhibitor Not Availables
purvalanol C₂₀H₂₅N₆O₃Cl₁ 432.909 g/mol NotAvailable Beta-Lactamase Tem inhibitor Not Availables
bis(adenosine)-5'-triphosphat C₂₀H₂₇N₁₀O₁₆P₃ 756.412 g/mol NotAvailable Neurotoxin Bmk37 inhibitor Not Availables
000008-azaxanthin C₄H₃N₅O₂ 153.100 g/mol NotAvailable Lethal Factor inhibitor Not Availables
carba-nicotinamide-adenine-dinucleotide C₂₂H₂₉N₇O₁₃P₂ 661.458 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
000008-amino-1,3-dimethyl-3,7-dihydropurine-2,6-dion C₇H₉N₅O₂ 195.180 g/mol NotAvailable Annexin V inhibitor Not Availables
000008-bromo-adenosine-5'-monophosphat C₁₀H₁₃N₅O₇Br₁P₁ 426.120 g/mol NotAvailable Methionine Aminopeptidase 2 inhibitor Not Availables
000008-[[benzyl-2-hydroperoxy-2-(4-hydroxy-benzyl)-6-(4-hydroxy-phenyl)-2h-imidazo[1,2-a]pyrazin-3-on]] C₂₆H₂₁N₃O₅ 455.469 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
000008-[[benzo[1,3]dioxol-,5-ylmethyl-9-butyl-2-fluoro-9h-purin-6-ylamin]] C₁₇H₁₈N₅O₂F₁ 343.360 g/mol NotAvailable Threonyl-tRNA Synthetase inhibitor Not Availables
000008-(2-chloro-3,4,5-trimethoxy-benzyl)-9-pent-4-ylnyl-9h-purin-6-ylamin C₂₀H₂₂N₅O₃Cl₁ 415.878 g/mol NotAvailable Glycogen Phosphorylase, Muscle Form inhibitor Not Availables
000008-(2-chloro-3,4,5-trimethoxy-benzyl)-2-fluoro-9-pent-4-ylnyl-9h-purin-6-ylamin C₂₀H₂₁N₅O₃Cl₁F₁ 433.869 g/mol NotAvailable Chitinase B inhibitor Not Availables
7n-methyl-8-hydroguanosine-5'-triphosphat C₁₁H₂₀N₅O₁₄P₃ 539.225 g/mol NotAvailable Succinylarginine Dihydrolase inhibitor Not Availables
1,8-cineol C₁₀H₁₈O₁ 154.252 g/mol NotAvailable Succinylarginine Dihydrolase inhibitor Not Availables
000008-(2,5-dimethoxy-benzyl)-2-fluoro-9h-purin-6-ylamin C₁₄H₁₄N₅O₂F₁ 303.295 g/mol NotAvailable Papain inhibitor Not Availables
arabinose-5-phosphat C₅H₁₃O₈P₁ 232.127 g/mol NotAvailable Bleomycin-Binding Protein inhibitor Not Availables
000005-methoxy-1,2-dimethyl-3-(phenoxymethyl)indole-4,7-dion C₁₈H₁₇N₁O₄ 311.337 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
000005-mercaptoethanol-2-decenoyl-coenzyme a C₃₃H₅₅N₇O₁₈P₃S₂ 994.875 g/mol NotAvailable Cathepsin K inhibitor Not Availables
guanosine-3',5'-monophosphat C₁₀H₁₂N₅O₇P₁ 345.208 g/mol NotAvailable Beta-Lactam Synthetase inhibitor Not Availables
000005-methyl-5-(4-phenoxy-phenyl)-pyrimidine-2,4,6-trion C₁₇H₁₄N₂O₄ 310.309 g/mol NotAvailable Cathepsin K inhibitor Not Availables
000005-methyl-2'-deoxypseudouridin C₁₀H₁₄N₂O₅ 242.231 g/mol NotAvailable 1,3,4,6-Tetrachloro-1,4-Cyclohexadiene H inhibitor Not Availables
000005-iodo-2'-deoxyuridine-5'-monophosphat C₉H₁₂N₂O₈I₁P₁ 434.081 g/mol NotAvailable Nitric-Oxide Synthase, Brain inhibitor Not Availables
n-methyldehydrobutyrin C₅H₉N₁O₂ 115.132 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
000005-[[chloro-1h-indole-2-carboxylic säure{[cyclopentyl-(2-hydroxy-ethyl)-carbamoyl]-methyl}-amide]] C₁₈H₂₂N₃O₃Cl₁ 363.843 g/mol NotAvailable Hemk Protein inhibitor Not Availables
glycinamide ribonucleotide C₇H₁₃N₂O₈P₁₂- 624.873 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
000005-iodouracil C₄H₃N₂O₂I₁ 237.984 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase S inhibitor Not Availables
000005-iododeoxyuridin C₉H₁₁N₂O₅I₁ 354.101 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
2,3,4,5,6-pentafluorobenzyl alcohol C₇H₃O₁F₅ 198.092 g/mol NotAvailable Heat Shock-Like Protein 1 inhibitor Not Availables
000005-nitro-6-ribityl-amino-2,4(1h,3h)-pyrimidinedion C₉H₁₄N₄O₈ 306.232 g/mol NotAvailable Pteridine Reductase inhibitor Not Availables
000002-[[amino-3-[5-(amino-carboxy-methyl)-2,3-dihydro-isoxazol-3-ylsulfanyl]-propionic säure]] C₈H₁₃N₃O₅S₁ 263.268 g/mol NotAvailable Trypsin inhibitor Not Availables
000006-(dihydroxy-isobutyl)-thymin C₉H₁₄N₂O₄ 214.221 g/mol NotAvailable Quinolinate Phosphoribosyl Transferase inhibitor Not Availables
000005-oxo-pyrrolidine-2-carbaldehyde C₅H₇N₁O₂ 113.116 g/mol NotAvailable Actva-Orf6 Monooxygenase inhibitor Not Availables
000005-nitroso-6-ribityl-amino-2,4(1h,3h)-pyrimidinedion C₉H₁₄N₄O₇ 290.232 g/mol NotAvailable Auxin-Binding Protein 1 inhibitor Not Availables
000005-methylpyrrol C₅H₇N₁ 81.117 g/mol NotAvailable säureic Fibroblast Growth Factor inhibitor Not Availables
000005-methylcytidine-5'-monophosphat C₁₀H₁₆N₃O₈P₁ 337.225 g/mol NotAvailable Tgf-Beta Receptor Type I inhibitor Not Availables
000005-methylbenzimidazol C₈H₈N₂ 132.165 g/mol NotAvailable Immunomodulatory Agents; ATC:L04AA23 For treatment of multiple sclerosiss
000005-n-acetyl-4-amino-6-diethylcarboxamide-4,5-dihydro-2h-pyran-2-carboxylic säure C₁₃H₂₃N₃O₅ 301.342 g/mol NotAvailable Histidine Containing Protein inhibitor Not Availables
000005-n-acetyl-3-(1-ethylpropyl)-1-cyclohexene-1-carboxylic säure C₁₄H₂₄N₂O₄ 284.355 g/mol NotAvailable Ornithine Transcarbamoylase inhibitor Not Availables
phosphomethylphosphonic säure-guanylate ester C₁₁H₁₈N₅O₁₃P₃ 521.210 g/mol NotAvailable 000006-Phosphogluconate Dehydrogenase inhibitor Not Availables
2,6-dihydroanthra/1,9-cd/pyrazol-6-on C₁₄H₈N₂O₁ 220.230 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
000005-bromovinyldeoxyuridin C₁₁H₁₃N₂O₅Br₁ 333.138 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
co(iii)-(deuteroporphyrin ix) C₃₀H₂₈N₄O₄Co₁₁+ 696.580 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
000002-thioethenamin C₂H₅N₁S₁ 75.128 g/mol NotAvailable Fksg76 inhibitor Not Availables
emodin C₁₅H₁₀O₅ 270.241 g/mol NotAvailable Alcohol Dehydrogenase E Chain inhibitor Not Availables
000005-beta-d-ribofuranosylnicotinamide adenine dinucleotide C₂₁H₂₇N₇O₁₄P₂ 663.430 g/mol NotAvailable Homoserine Dehydrogenase inhibitor Not Availables
trans-2-hydroxycinnamic säure; o-coumaric säure C₉H₈O₃ 164.160 g/mol NotAvailable Ovotransferrin inhibitor Not Availables
000005-[[amino-2-aminomethyl-6-[4,6-diamino-2-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yloxy)-3-hydroxy-cyclohexyloxy]-tetrahydro-pyran-3,4-diol]] C₁₇H₃₄N₄O₁₀ 454.476 g/mol NotAvailable Penicillin-Binding Protein 2A inhibitor Not Availables
000005-bromonicotinamide C₆H₅N₂O₁Br₁ 201.022 g/mol NotAvailable Citrate Synthase inhibitor Not Availables
000005-[[bromo-n[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide]] C₁₈H₂₁N₄O₁Br₁₂+ 1268.238 g/mol NotAvailable Myoglobin inhibitor Not Availables
000005-[[bromo-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide]] C₁₆H₁₃N₂O₄Br₁F₃I₁ 561.093 g/mol NotAvailable Nitric-Oxide Synthase inhibitor Not Availables
n~2~-succinylornithin C₉H₁₆N₂O₅ 232.236 g/mol NotAvailable Nogalonic säure Methyl Ester Cyclase inhibitor Not Availables
000005-hydroxy norvalin C₅H₁₁N₁O₃ 133.147 g/mol NotAvailable Beta-Glucosidase inhibitor Not Availables
000005-formyl-6-hydrofolic säure C₂₀H₂₁N₇O₇ 471.429 g/mol NotAvailable Virb11 Homolog inhibitor Not Availables
000005-hydroxymethylene-6-hydrofolic säure C₂₀H₂₃N₇O₇ 473.444 g/mol NotAvailable Subunit C inhibitor Not Availables
000005-hydroxymethyl-chonduritol C₇H₁₂O₅ 176.169 g/mol NotAvailable Arginase 1 inhibitor Not Availables
oxidized glutathione disulfide C₂₀H₃₂N₆O₁₂S₂ 612.626 g/mol NotAvailable Phenylalanine Hydroxylase inhibitor Not Availables
000005-fluoro-4-(s)-hydroxy-3,4-dihydropyrimidin C₄H₅N₂O₂F₁ 132.094 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
beta-1,2,3,4,6-penta-o-galloyl-d-glucopyranose C₄₁H₃₂O₂₆ 940.688 g/mol NotAvailable Phenylalanine-4-Hydroxylase inhibitor Not Availables
000005-exo-hydroxycamphor C₁₀H₁₆O₂ 168.235 g/mol NotAvailable Methionine Aminopeptidase inhibitor Not Availables
thioprolin C₄H₇N₁O₂S₁ 133.165 g/mol NotAvailable Leucyl-tRNA Synthetase inhibitor Not Availables
000005-fluorolevulinic säure C₅H₇O₃F₁ 134.107 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
000005-fluoro-beta-l-gulosyl fluoride C₆H₁₀O₅F₂ 200.139 g/mol NotAvailable Poly inhibitor Not Availables
000006-(4-difluoromethoxy-3-methoxy-phenyl)-2h-pyridazin-3-on C₁₂H₁₀N₂O₃F₂ 268.219 g/mol NotAvailable Dihydrodipicolinate Synthase inhibitor Not Availables
adenosine-5'-pentaphosphat C₁₀H₁₈N₅O₁₉P₅ 667.143 g/mol NotAvailable Transaldolase inhibitor Not Availables
000006-(octahydro-1h-indol-1-ylmethyl)decahydroquinazoline-2,4-diamin C₁₇H₃₃N₅ 307.481 g/mol NotAvailable Lysozyme inhibitor Not Availables
000006-(n-phenylcarbamyl)-2-naphthalenecarboxamidin C₁₈H₁₅N₃O₁ 289.336 g/mol NotAvailable Isolectin B4 inhibitor Not Availables
cysteine-s-acetamide C₅H₁₀N₂O₃S₁ 178.206 g/mol NotAvailable Prostaglandin H2 Synthase inhibitor Not Availables
chromophore (met-tyr-gly) C₁₆H₁₉N₃O₃S₁ 333.404 g/mol NotAvailable Serine Protease inhibitor Not Availables
5(r)-5-fluoro-beta-d-xylopyranosyl-enzyme intermediate C₅H₈O₅F₁ 167.114 g/mol NotAvailable Tagatose-Bisphosphate Aldolase Agay inhibitor Not Availables
000004-[[{2,6,8-trioxo-9-[(2r,3s,4r)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7h-purin-7-yl}butyl dihydrogen phosphat]] C₁₄H₂₃N₄O₁₁P₁ 454.330 g/mol NotAvailable Fiber Protein inhibitor Not Availables
000006-[[(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-hexanoic säure]] C₁₁H₁₈N₂O₃S₁ 258.335 g/mol NotAvailable 000003-Deoxy-Manno-Octulosonate Cytidylyltransfer inhibitor Not Availables
000006-(1,3-dihydro-7-hydroxy-5-methoxy-4-methyl-1-oxoisobenzofuran-6-yl)-4-methyl-4-hexanoic säure C₁₇H₂₀O₆ 320.341 g/mol NotAvailable O-Succinylbenzoate Synthase inhibitor Not Availables
000006-[[(1,1-dimethylallyl)-2-(1-hydroxy-1-methylethyl)-2,3-dihydro-7h-furo[3,2-g]chromen-7-on]] C₁₉H₂₂O₄ 314.380 g/mol NotAvailable Hypothetical Protein Vca0042 inhibitor Not Availables
000006-aminobenzoic säure C₇H₇N₁O₂ 137.138 g/mol NotAvailable Transthyretin inhibitor Not Availables
000006-amino-4-hydroxymethyl-cyclohex-4-ene-1,2,3-triol C₇H₁₃N₁O₄ 175.184 g/mol NotAvailable Cellobiohydrolase II inhibitor Not Availables
n-methyl-alpha-beta-dehydroalanin C₄H₇N₁O₂ 101.105 g/mol NotAvailable Cellobiohydrolase II inhibitor Not Availables
000006-carboxymethyluracil C₆H₆N₂O₄ 170.124 g/mol NotAvailable Cellobiohydrolase II inhibitor Not Availables
000006-aza-ump C₈H₁₂N₃O₉P₁ 325.171 g/mol NotAvailable Fv Fragment inhibitor Not Availables
(6s)-5,6,7,8-tetrahydrofolate C₁₉H₂₃N₇O₆ 445.434 g/mol NotAvailable Cyanovirin-N inhibitor Not Availables
000006-[[[3-(4-morpholinyl)propyl]-2-(3-nitrophenyl)-5-thioxo-5,6,-dihydro-7h-thienol[2',3':4,5]pyrrolo[1,2-c]imidazol-7-on]] C₂₁H₂₀N₄O₄S₂ 456.533 g/mol NotAvailable Heparan Sulfate D-Glucosaminyl 3-O- Sulfotra inhibitor Not Availables
000006-[[[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-3-carboxylic säure]] C₂₄H₂₉N₁O₂ 363.499 g/mol NotAvailable Mannose-Binding Protein-A inhibitor Not Availables
000006-(oxalyl-amino)-1h-indole-5-carboxylic säure C₁₁H₈N₂O₅ 248.195 g/mol NotAvailable Mannose-Binding Protein-A inhibitor Not Availables
000006-[[[n-(4-ethyl-1,2,3,4-tetrahydro-6-isoquinolinyl)carbamyl]-2-naphthalenecarboxamidin]] C₂₃H₂₄N₄O₁ 372.469 g/mol NotAvailable Crotonobetainyl-Coa: Carnitine Coa-Transfera inhibitor Not Availables
000006-[[[n-(4-(aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidin]] C₁₉H₁₈N₄O₁ 318.377 g/mol NotAvailable B9340 inhibitor Not Availables
[[[1-(4-fluorobenzyl)cyclobutyl]methyl (1s)-1-[oxo(1h-pyrazol-5-ylamino)acetyl]pentylcarbamate]] C₂₃H₂₉N₄O₄F₁ 444.505 g/mol NotAvailable Acyl-Coa Thioesterase I inhibitor Not Availables
000009-methyl uric säure C₆H₆N₄O₃ 182.138 g/mol NotAvailable 3,2-Trans-Enoyl-Coa Isomerase, Mitochondrial inhibitor Not Availables
5,10-methylene-6-hydrofolic säure C₂₀H₂₁N₇O₆ 455.429 g/mol NotAvailable Extracellular Regulated Kinase 2 inhibitor Not Availables
[[5,6-dihydro-benzo[h]cinnolin-3-ylamin]] C₁₂H₁₁N₃ 197.239 g/mol NotAvailable Elastase 1 inhibitor Not Availables
5,6-diaminouracil C₄H₆N₄O₂ 142.117 g/mol NotAvailable Aldolase Protein inhibitor Not Availables
5,6-cyclic-tetrahydropteridin C₈H₉N₅O₃ 223.191 g/mol NotAvailable Orotidine 5'-Phosphate Decarboxylase inhibitor Not Availables
000005-phosphoarabinonic säure C₅H₁₁O₉P₁ 246.110 g/mol NotAvailable Lysozyme inhibitor Not Availables
000005-phenylvaleric säure C₁₁H₁₄O₂ 178.230 g/mol NotAvailable Vaccine For prophylactic treatment of Lyme Diseases
000005-phenylsulfanyl-2,4-quinazolinediamin C₁₄H₁₂N₄S₁ 268.336 g/mol NotAvailable Methionine Aminopeptidase inhibitor Not Availables
n-formylpiperidin C₆H₁₁N₁O₁ 113.159 g/mol NotAvailable Lactoferrin inhibitor Not Availables
000005-thio-a/b-d-mannopyranosylamin C₆H₁₃N₁O₄S₁ 195.233 g/mol NotAvailable Sepiapterin Reductase inhibitor Not Availables
000005-phosphoribosyl-1-(beta-methylene) pyrophosphat C₆H₁₅O₁₃P₃ 388.098 g/mol NotAvailable Actva-Orf6 Monooxygenase inhibitor Not Availables
5'-o-(n-(l-seryl)-sulfamoyl)adenosin C₁₃H₁₉N₇O₈S₁ 433.395 g/mol NotAvailable Formyl-Coenzyme A Transferase inhibitor Not Availables
5'-o-(n-(l-prolyl)-sulfamoyl)adenosin C₁₅H₂₁N₇O₇S₁ 443.434 g/mol NotAvailable Glutathione S-Transferase Mu 2 inhibitor Not Availables
5'-o-(n-(l-cysteinyl)-sulfamoyl)adenosin C₁₃H₁₉N₇O₇S₂ 449.456 g/mol NotAvailable Cyclodextrin Glycosyltransferase inhibitor Not Availables
[[5'-o-[(l-methionyl)-sulphamoyl]adenosin]] C₁₅H₂₃N₇O₇S₂ 477.509 g/mol NotAvailable Uricase inhibitor Not Availables
5'-o-(n-ethyl-sulfamoyl)adenosin C₁₂H₁₈N₆O₆S₁ 374.371 g/mol NotAvailable Phospholipase A2 Vrv-Pl-Viiia inhibitor Not Availables
000009-deazaadenin C₆H₆N₄ 134.140 g/mol NotAvailable Prostaglandin H2 Synthase-1 inhibitor Not Availables
[[5'-*[[2-(aminooxy)ethyl]methylsulfonio]-5'-deoxy-adenosine; [2-(amino-oxy)ethyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonium]] C₁₃H₂₁N₆O₄S₁₁+ 678.007 g/mol NotAvailable Heat-Labile Enterotoxin B Chain inhibitor Not Availables
5,8-di-amino-1,4-dihydroxy-anthraquinon C₁₄H₁₀N₂O₄ 270.244 g/mol NotAvailable Chorismate Lyase inhibitor Not Availables
1,3-dihydroxyacetonephosphat C₃H₇O₆P₁ 170.058 g/mol NotAvailable Thymidylate Kinase inhibitor Not Availables
5'-guanosine-diphosphate-monothiophosphat C₁₀H₁₆N₅O₁₃P₃S₁ 539.243 g/mol NotAvailable Thymidine Kinase inhibitor Not Availables
5'-deoxy-5'-methylthioadenosin C₁₁H₁₅N₅O₃S₁ 297.331 g/mol NotAvailable Uridylmonophosphate/Cytidylmonophosphate Kin inhibitor Not Availables
[[5'-[n-[(3s)-3-amino-3-carboxypropyl]-n-methylamino]-5'-deoxyadenosin]] C₁₅H₂₃N₇O₅ 381.391 g/mol NotAvailable Rhodopsin inhibitor Not Availables
2,3-di-o-sulfo-alpha-d-glucopyranose C₆H₁₂O₁₂S₂ 340.274 g/mol NotAvailable Phosphatidylcholine Transfer Protein inhibitor Not Availables
000002-guanidinoethylthio)succinic säure; guanidinoethylmercaptosuccinic säure; gemsa C₇H₁₃N₃O₄S₁ 235.257 g/mol NotAvailable Ppc Decarboxylase Athal3A inhibitor Not Availables
000002-propenyl-n-acetyl-neuramic säure C₁₄H₂₃N₁O₈ 333.338 g/mol NotAvailable Acetyl-Coa Acetyltransferase inhibitor Not Availables
000002-hydroxy-4-aminobenzoic säure C₇H₇N₁O₃ 153.137 g/mol NotAvailable Pantothenate Synthetase inhibitor Not Availables
000002-hydroxy-3-amino-4-phenyl butan C₁₀H₁₅N₁O₁ 165.235 g/mol NotAvailable General Control Protein Gcn4 inhibitor Not Availables
000002-hexyloxy-6-hydroxymethyl-tetrahydro-pyran-3,5-diol C₁₂H₂₄O₅ 248.319 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
000002-fluoro-2-deoxy-beta-d-galactopyranose C₆H₁₁O₅F₁ 182.148 g/mol NotAvailable Photoactive Yellow Protein inhibitor Not Availables
000002-ethoxyethanol C₄H₁₀O₂ 90.122 g/mol NotAvailable Aminopeptidase inhibitor Not Availables
000005-(aminomethyl)-6-(2,4-dichlorophenyl)-2-(3,5-dimethoxyphenyl)pyrimidin-4-amin C₁₉H₁₈N₄O₂Cl₂ 405.283 g/mol NotAvailable Elastase inhibitor Not Availables
000002-fluoroadenosin C₁₀H₁₂N₅O₄F₁ 285.234 g/mol NotAvailable Glucose-1-Phosphate Adenylyltransferase Smal inhibitor Not Availables
1alpha,25-dihydroxyl-20-epi-22-oxa-24,26,27-trihomovitamin d3 C₂₉H₄₈O₄ 460.696 g/mol NotAvailable Papain inhibitor Not Availables
000002-fluoro-2-deoxy-beta-d-galactopyranosyl-beta-d-glucopyranose C₁₂H₂₁O₁₀F₁ 344.290 g/mol NotAvailable T4 Lysozyme inhibitor Not Availables
[[n-(8,9,10-trihydroxy-7-hydroxymethyl-2,4-dioxo-6-oxa-1,3-diaza-spiro[4.5]dec-3-yl-acetamide]] C₁₀H₁₅N₃O₈ 305.244 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-isobutyl-3-methoxypyrazin C₉H₁₄N₂O₁ 166.222 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-iminobiotin C₁₀H₁₇N₃O₂S₁ 243.323 g/mol NotAvailable Calcium-Dependent Protease, Small Subunit inhibitor Not Availables
[[2,2':6',2-terpyridine platinum(ii)]] C₁₅H₁₁N₃Pt₁ 428.362 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Abl1 inhibitor Not Availables
000002-methoxyestradiol C₁₉H₂₆O₃ 302.413 g/mol NotAvailable Anabolic Agents; Hormone replacement For treatment of acromegalys
000002-methoxy-3-isopropylpyrazin C₈H₁₂N₂O₁ 152.196 g/mol NotAvailable Antineoplastic Agents Cutaneous T-cell lymphomas;Psoriasiss
000002-hydroxy-tryptophan C₁₁H₁₂N₂O₃ 220.227 g/mol NotAvailable Regulatory Protein Blar1 inhibitor Not Availables
000003-beta-hydroxy-5-androsten-17-on C₁₉H₂₈O₂ 288.429 g/mol NotAvailable Transthyretin inhibitor Not Availables
cra_16847 C₁₈H₁₃N₄O₅Br₁₂- 1324.173 g/mol NotAvailable Nalp inhibitor Not Availables
000002-iminiopropanoate C₃H₅N₁O₂ 87.078 g/mol NotAvailable Camp-Dependent Protein Kinase, Alpha-Cat inhibitor Not Availables
(2s,5s)-5-carboxymethylprolin C₇H₁₁N₁O₄ 173.168 g/mol NotAvailable Protein: Igfbp-1 Antagonist inhibitor Not Availables
l-alfa-lysophosphatidylcholine, lauroyl C₂₀H₄₃N₁O₇P₁₁+ 750.274 g/mol NotAvailable 000002-C-Methyl-D-Erythritol 4-Phosphate Cytidyly inhibitor Not Availables
000002-chlorophenol C₆H₅O₁Cl₁ 128.558 g/mol NotAvailable Alpha-Momorcharin inhibitor Not Availables
000002-chlorodideoxyadenosin C₁₀H₁₂N₅O₂Cl₁ 269.690 g/mol NotAvailable Sulfide Dehydrogenase inhibitor Not Availables
000002-decenoyl n-acetyl cysteamin C₁₄H₂₅N₁O₂S₁ 271.417 g/mol NotAvailable Acetolactate Synthase, Mitochondrial inhibitor Not Availables
000009-[[hydroxy-8-methoxy-6-nitro-phenanthrol[3,4-d][1,3]dioxole-5-carboxylic säure]] C₁₇H₁₁N₁O₈ 357.276 g/mol NotAvailable Arsenate Reductase inhibitor Not Availables
000002-deamino-6-deoxy-6thiophosphite-5'-phosphate guanosin C₁₀H₁₅N₄O₁₀P₂S₁₁+ 765.857 g/mol NotAvailable Peridinin-Chlorophyll Protein inhibitor Not Availables
cholesterol-sulfat C₂₇H₄₆O₄S₁ 466.718 g/mol NotAvailable Macrophage Metalloelastase inhibitor Not Availables
isopenicillin n C₁₄H₂₁N₃O₆S₁ 359.396 g/mol NotAvailable Cocaine Esterase inhibitor Not Availables
000002-[[[3-(2-hydroxy-1,1-dihydroxymethyl-ethylamino)-propylamino]-2-hydroxymethyl-propane-1,3-diol]] C₁₁H₂₆N₂O₆ 282.336 g/mol NotAvailable Udp-Galactose 4-Epimerase inhibitor Not Availables
000002-chloro-6-methyl-anilin C₈H₈N₁ 118.158 g/mol NotAvailable Fluorescent Protein Fp538 inhibitor Not Availables
000002-carboxyethylphosphonic säure C₃H₇O₅P₁ 154.059 g/mol NotAvailable Carboxypeptidase A inhibitor Not Availables
bv3 C₆₃H₉₁N₁₅O₂₆ 1474.497 g/mol NotAvailable Human Immunodeficiency Virus Type 2 inhibitor Not Availables
1,4-diethylene dioxide C₄H₈O₂ 88.106 g/mol NotAvailable Alpha Chymotrypsin A inhibitor Not Availables
000001-aminocyclopropanecarboxylic säure C₄H₇N₁O₂ 101.105 g/mol NotAvailable Ferric Hydroxamate Receptor inhibitor Not Availables
000002-deoxy-2,3-dehydro-n-acetyl-neuraminic säure C₁₁H₁₇N₁O₈ 291.257 g/mol NotAvailable Coagulation Factor V inhibitor Not Availables
d-para-chlorophenyl-1-acetamidoboronic säure alanin C₁₃H₁₉N₂O₆B₁Cl₁₁- 700.096 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-deoxy-glucose-6-phosphat C₆H₁₃O₈P₁ 244.138 g/mol NotAvailable Anabaena Sensory Rhodopsin inhibitor Not Availables
000002-deoxy-glucitol-6-phosphat C₆H₁₅O₈P₁ 246.153 g/mol NotAvailable Ras-Related Protein Sec4 inhibitor Not Availables
cyclohexylammonium ion C₆H₁₄N₁₁+ 240.250 g/mol NotAvailable Udp-N-Acetylmuramate--Alanine Ligase inhibitor Not Availables
000002-deoxy-2-amino glucitol-6-phosphat C₆H₁₆N₁O₈P₁ 261.168 g/mol NotAvailable Beta-Phosphoglucomutase inhibitor Not Availables
000002-[[(pyrido[1,2-e]purin-4-yl)amino-ethanol]] C₁₁H₁₁N₅O₁ 229.241 g/mol NotAvailable Putative Phosphatase inhibitor Not Availables
tetrabromo-2-benzotriazol C₆H₁N₃Br₄ 434.710 g/mol NotAvailable L-Fuculose-1-Phosphate Aldolase inhibitor Not Availables
000006-hydroxymethylpterin C₇H₇N₅O₂ 193.165 g/mol NotAvailable 5'-Nucleotidase inhibitor Not Availables
000002-deoxy-2-fluoro-alpha-d-mannose C₆H₁₁O₅F₁ 182.148 g/mol NotAvailable 5'-Nucleotidase inhibitor Not Availables
7n-methyl-8-hydroguanosine-5'-monophosphat C₁₁H₁₈N₅O₈P₁ 379.266 g/mol NotAvailable Apyrase inhibitor Not Availables
[[2,2-dichloro-1-methanesulfinyl-3-methyl-cyclopropanecarboxylic säure [1-(4-bromo-phenyl)-ethyl]-amide]] C₁₄H₁₆N₁O₂Br₁Cl₂S₁ 413.156 g/mol NotAvailable Cell Division Protein Ftsz Homolog 1 inhibitor Not Availables
000001-octen-3-ol C₈H₁₆O₁ 128.214 g/mol NotAvailable Phosphoenolpyruvate Carboxykinase, Cytosolic inhibitor Not Availables
[[2,3-bis-benzo[1,3]dioxol-5-ylmethyl-succinic säure]] C₂₀H₁₈O₈ 386.357 g/mol NotAvailable 000002-Aminoethylphosphonate-Pyruvate Aminotr inhibitor Not Availables
2,3 -anhydro-quinic säure C₇H₁₀O₅ 174.153 g/mol NotAvailable Enolase 1 inhibitor Not Availables
000002-[[ribofuranosyl-3-iodo-2,3-dihydro-1h-pyrazolo[3,4-d]pyrimidin-4-ylamin]] C₁₀H₁₄N₅O₄I₁ 395.156 g/mol NotAvailable Probable Fosfomycin Resistance Protein inhibitor Not Availables
000002-pyridinethiol C₅H₅N₁S₁ 111.161 g/mol NotAvailable Pyruvate Phosphate Dikinase inhibitor Not Availables
000002-o-methyl fucose C₇H₁₄O₅ 178.185 g/mol NotAvailable Probable Glutaminase Ybgj inhibitor Not Availables
000002-tridecanoyloxy-pentadecanoic säure C₂₈H₅₄O₄ 454.732 g/mol NotAvailable Camp-Dependent Protein Kinase, Alpha-Cat inhibitor Not Availables
butylphosphonate C₄H₁₁O₃P₁ 138.103 g/mol NotAvailable Stat Protein inhibitor Not Availables
000005-chloryl-2,4,6-quinazolinetriamin C₈H₈N₅O₂Cl₁ 241.636 g/mol NotAvailable Neutral Endopeptidase inhibitor Not Availables
[[(3s,8ar)-3-(1h-imidazol-5-ylmethyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dion]] C₁₁H₁₄N₄O₂ 234.257 g/mol NotAvailable ATP Phosphoribosyltransferase inhibitor Not Availables
2,3-dimethylimidazolium ion C₅H₉N₂₁+ 363.267 g/mol NotAvailable Rnase Ngr3 inhibitor Not Availables
alpha-l-arabinofuranose C₅H₁₀O₅ 150.131 g/mol NotAvailable Histidinol-Phosphate Aminotransferase inhibitor Not Availables
2,3,5,6-tetrafluoro-4-methoxy-benzamide C₈H₅N₁O₂F₄ 223.127 g/mol NotAvailable Similar To Thymidylate Kinase inhibitor Not Availables
000005-nitroindazol C₇H₅N₃O₂ 163.135 g/mol NotAvailable Similar To Thymidylate Kinase inhibitor Not Availables
2,3,-dihydroxybenzoylserin C₁₀H₁₁N₁O₆ 241.200 g/mol NotAvailable Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
2,3-didehydroalanin C₃H₅N₁O₂ 87.078 g/mol NotAvailable Guanine Phosphoribosyltransferase inhibitor Not Availables
2,3-dicarboxy-4-(2-chloro-phenyl)-1-ethyl-5-isopropoxycarbonyl-6-methyl-pyridinium C₂₀H₂₁N₁O₆Cl₁₁+ 761.372 g/mol NotAvailable 5'-D inhibitor Not Availables
000002-hexyloxy-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol C₁₂H₂₄O₆ 264.318 g/mol NotAvailable Ribonuclease Pancreatic inhibitor Not Availables
2,3-dihydroxy-5-oxo-hexanedioate C₆H₆O₇₂- 1230.070 g/mol NotAvailable Transcriptional Regulatory Protein Fixj inhibitor Not Availables
2,3-difluorobenzyl alcohol C₇H₆O₁F₂ 144.121 g/mol NotAvailable Folc Bifunctional Protein inhibitor Not Availables
al6528 C₁₃H₁₂N₂O₅S₃ 372.428 g/mol NotAvailable Trypsin inhibitor Not Availables
000002-nitro-p-cresol C₇H₇N₁O₃ 153.137 g/mol NotAvailable Pms1 Protein Homolog 2 inhibitor Not Availables
000002-methylpentane-1,2,4-triol C₆H₁₄O₃ 134.175 g/mol NotAvailable Nicotinate Mononucleotide:5,6- Dimethylbenzi inhibitor Not Availables
000005-[[[1-(acetylamino)-3-methylbutyl]-2,5-anhydro-3,4-dideoxy-4-(methoxycarbonyl)pentonic säure]] C₁₄H₂₃N₁O₆ 301.339 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
000002-oxo-glutaric säure C₅H₆O₅ 146.099 g/mol NotAvailable Beta-Lactamase Ctx-M-14 inhibitor Not Availables
000002-oxo-4-methylpentanoic säure C₆H₁₀O₃ 130.143 g/mol NotAvailable Ganglioside Gm2 Activator inhibitor Not Availables
000009-(5,5-difluoro-5-phosphonopentyl)guanin C₁₀H₁₄N₅O₄F₂P₁ 337.222 g/mol NotAvailable Alanine Racemase inhibitor Not Availables
000002-methyl-2-propanol C₄H₁₀O₁ 74.122 g/mol NotAvailable Protein-Tyrosine Phosphatase 1B inhibitor Not Availables
000002-methoxyethanol C₃H₈O₂ 76.095 g/mol NotAvailable Myoglobin inhibitor Not Availables
000002-methylbutanoic säure C₅H₁₀O₂ 102.133 g/mol NotAvailable Sulfotransferase Family, Cytosolic, 2B, Memb inhibitor Not Availables
000002-methyl-propionic säure C₄H₈O₂ 88.106 g/mol NotAvailable Osmoprotection Protein inhibitor Not Availables
000002-methyl-3-(2-aminothiazolo)propanal C₇H₁₀N₂O₁S₁ 170.229 g/mol NotAvailable Acetylcholinesterase inhibitor Not Availables
000002-[[prolyl-5-tert-butyl-[1,3,4]oxadiazol]] C₁₁H₁₇N₃O₂ 223.274 g/mol NotAvailable Anti-Platelet Protein inhibitor Not Availables
000002-phosphoglycolic säure C₂H₅O₆P₁ 156.032 g/mol NotAvailable Carboxylesterase Precursor inhibitor Not Availables
000002-phospho-d-glyceric säure C₃H₇O₇P₁ 186.058 g/mol NotAvailable Acetolactate Synthase, Mitochondrial inhibitor Not Availables
000002-propyl-anilin C₉H₁₃N₁ 135.208 g/mol NotAvailable Nonspecific Lipid Transfer Protein inhibitor Not Availables
000002-formyl-protoporphryn ix C₃₃H₃₀N₄O₅Fe₁ 618.471 g/mol NotAvailable Prostaglandin H2 Synthase-2 inhibitor Not Availables
000002-propanol, isopropanol C₃H₈O₁ 60.096 g/mol NotAvailable Cytochrome C inhibitor Not Availables
000002-[[phenyl-1-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-ol]] C₂₈H₃₂N₂O₂ 428.573 g/mol NotAvailable Cytochrome C inhibitor Not Availables
000004-methyl-5-hydroxyethylthiazole phosphat C₆H₁₀N₁O₄P₁S₁ 223.183 g/mol NotAvailable 23S Ribosomal RNA inhibitor Not Availables
000002-oxyglutaric säure C₅H₆O₅ 146.099 g/mol NotAvailable Pokeweed Antiviral Protein inhibitor Not Availables
000002-phenylheme C₄₀H₃₆N₄O₄Fe₁ 692.596 g/mol NotAvailable Aldehyde Oxidoreductase inhibitor Not Availables
000002-phenylamino-ethanesulfonic säure C₈H₁₁N₁O₃S₁ 201.240 g/mol NotAvailable Dhps, Dihydropteroate Synthase inhibitor Not Availables
[[n-[3-[(1-aminoethyl)(hydroxy)phosphoryl]-2-(1,1'-biphenyl-4-ylmethyl)propanoyl]alanin]] C₂₁H₂₇N₂O₅P₁ 418.428 g/mol NotAvailable Ribonuclease A inhibitor Not Availables
000003-fluorotyrosin C₉H₁₀N₁O₃F₁ 199.181 g/mol NotAvailable Cell Division Control Protein 2 Homolog inhibitor Not Availables
000002-[[[2-(2-cyclohexyl-2-guanidino-acetylamino)-acetylamino]-n-(3-mercapto-propyl)-propionamide]] C₁₇H₃₂N₆O₃S₁ 400.538 g/mol NotAvailable Ferripyoverdine Receptor inhibitor Not Availables
4,5-dimethyl-1,2-phenylenediamin C₈H₁₂N₂ 136.196 g/mol NotAvailable ADP-Ribosyl Cyclase inhibitor Not Availables
000002-[[[4-(2,4-dichlorophenoxy)phenoxy]propanoic säure]] C₁₅H₁₂O₄Cl₂ 327.163 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
000002-[[[3,4-dihydroxy-2-hydroxymethyl-5-(2-hydroxy-nonyl)-tetrahydro-furan-2-yloxy]-6-hydroxymethyl-tetra hydro-pyran-3,4,5-triol]] C₂₀H₃₈O₁₁ 454.514 g/mol NotAvailable Pyridoxal Kinase inhibitor Not Availables
stearic säure C₁₈H₃₆O₂ 284.481 g/mol NotAvailable Alanine Racemase inhibitor Not Availables
000002-(phosphonooxy)butanoic säure C₄H₉O₆P₁ 184.085 g/mol NotAvailable L-Cysteine/L-Cystine C-S Lyase inhibitor Not Availables
16923 C₁₃H₁₄N₂O₃S₃ 342.445 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
000002-[[[(3-trifluoromethyl)phenyl]amino-3-pyridine-carboxylic säure]] C₁₃H₉N₂O₂F₃ 282.222 g/mol NotAvailable Histidinol-Phosphate Aminotransferase inhibitor Not Availables
nu1025 C₉H₈N₂O₂ 176.174 g/mol NotAvailable Branched-Chain Amino säure Aminotransferase inhibitor Not Availables
000002-[[[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaenyl]phenol]] C₄₆H₇₀O₁ 639.058 g/mol NotAvailable Arnb Aminotransferase inhibitor Not Availables
000002-[[{1-[2-amino-2-(4-hydroxy-phenyl)-acetylamino]-2-oxo-ethyl}-5,5-dimethyl-thiazolidine-4-carboxylic säure]] C₁₆H₂₁N₃O₅S₁ 367.419 g/mol NotAvailable Fumarase C inhibitor Not Availables
000004-deoxy-alpha-d-glucose C₆H₁₂O₅ 164.158 g/mol NotAvailable Regulatory Protein Blar1 inhibitor Not Availables
000002-[[{(9as)-9a-[(1s)-1-hydroxyethyl]-2,7-dimethyl-9a,10-dihydro-5h-pyrimido[4,5-d][1,3]thiazolo[3,2-a]pyrimidin-8-yl}ethyl trihydrogen diphosphat]] C₁₄H₂₂N₄O₈P₂S₁ 468.357 g/mol NotAvailable Sarcosine Oxidase inhibitor Not Availables
000002-amino-vinyl-phosphat C₂H₆N₁O₄P₁ 139.047 g/mol NotAvailable Pyruvate Decarboxylase inhibitor Not Availables
000002-[[{4-[(2s)-2-[({[(1s)-1-carboxy-2-phenylethyl]amino}carbonyl)amino]-3-oxo-3-(pentylamino)propyl]phenoxy}malonic säure]] C₂₇H₃₃N₃O₉ 543.572 g/mol NotAvailable Phospholipase A=2= inhibitor Not Availables
000002-[[{2-[2-2-(methoxy-ethoxy)-ethoxy]-ethoxy}-ethanol]] C₉H₂₀O₅ 208.254 g/mol NotAvailable Phenylalanine-4-Hydroxylase inhibitor Not Availables
000002-[[[4-*[[(s)-1-*[[(s)-2-*[[(rs)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]aminocarbonyl]pyrrolidin-1-yl-]carbonyl]-2-methylpropyl]aminocarbonyl]benzoylamino]acetic säure]] C₂₆H₃₃N₄O₇F₃ 570.565 g/mol NotAvailable Glutamate Receptor, Ionotropic Kainate 2 inhibitor Not Availables
000002-[[[4-(hydroxy-methoxy-methyl)-benzyl]-7-(4-hydroxymethyl-benzyl)-1,1-dioxo-3,6-bis-phenoxymethyl-1lambda6-[1,2,7]thiadiazepane-4,5-diol]] C₃₅H₄₀N₂O₉S₁ 664.769 g/mol NotAvailable Isocitrate Dehydrogenase inhibitor Not Availables
hexafluoroacetone hydrate C₃H₂O₂F₆ 184.038 g/mol NotAvailable Stromelysin-1 inhibitor Not Availables
000002-[[[trans-(4-aminocyclohexyl)amino]-6-(benzyl-amino)-9-cyclopentylpurin]] C₂₃H₃₁N₇ 405.545 g/mol NotAvailable Halohydrin Dehalogenase inhibitor Not Availables
ribavirin monophosphat C₈H₁₃N₄O₈P₁ 324.186 g/mol NotAvailable Pheromone Binding Protein inhibitor Not Availables
(1r,4s)-2-azabornan C₉H₁₇N₁ 139.240 g/mol NotAvailable Lanosterol Synthase inhibitor Not Availables
000002-(3,4-dihydroxyphenyl)acetic säure C₈H₈O₄ 168.149 g/mol NotAvailable Endoplasmin inhibitor Not Availables
000002-[[(3,4-dihydro-3-oxo-2h-benzo[b][1,4]thiazin-2-yl)-n-hydroxyacetamide]] C₁₀H₁₀N₂O₃S₁ 238.261 g/mol NotAvailable Fkbp25 inhibitor Not Availables
000002-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-on C₁₉H₁₇N₁O₃ 307.348 g/mol NotAvailable Amine Oxidase [Flavin-Containing] B inhibitor Not Availables
000002-(4-chlorophenyl)-5-quinoxalinecarboxamide C₁₅H₁₀N₃O₁Cl₁ 283.716 g/mol NotAvailable Thermolysin inhibitor Not Availables
000002-(3'-methoxyphenyl) benzimidazole-4-carboxamide C₁₅H₁₃N₃O₂ 267.287 g/mol NotAvailable Proto-Oncogene Serine/Threonine-Protein Kina inhibitor Not Availables
bicin C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Antibody Vhh Lama Domain inhibitor Not Availables
000002-(2-hydroxy-5-methoxy-phenyl)-1h-benzoimidazole-5-carboxamidin C₁₅H₁₅N₄O₂₁+ 587.298 g/mol NotAvailable Sandostatin inhibitor Not Availables
000002-phenyl-ethanol C₈H₁₀O₁ 122.166 g/mol NotAvailable Chondroitinase B inhibitor Not Availables
000002-(3-cyano-4-isobutoxy-phenyl)-4-methyl-5-thiazole-carboxylic säure C₁₆H₁₆N₂O₃S₁ 316.374 g/mol NotAvailable Coagulants; Thrombotic Agents For treatment of Hepatitis Cs
000002-(2-oxo-1,2-dihydro-pyridin-3-yl)-1h-benzoimidazole-5-carboxamidin C₁₃H₁₂N₅O₁₁+ 414.265 g/mol NotAvailable Inosine-5'-Monophosphate Dehydrogenase 2 inhibitor Not Availables
000002-(2-hydroxy-phenyl)-1h-indole-5-carboxamidin C₁₅H₁₄N₃O₁₁+ 412.289 g/mol NotAvailable Ndp Kinase inhibitor Not Availables
000002-[[(oxalyl-amino)-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine-3-carboxylic säure]] C₁₀H₁₀N₂O₅S₁ 270.259 g/mol NotAvailable Riboflavin Synthase Alpha Chain inhibitor Not Availables
000002-(n-morpholino)-ethanesulfonic säure C₆H₁₃N₁O₄S₁ 195.233 g/mol NotAvailable Purine Nucleoside Phosphorylase inhibitor Not Availables
000002-(ethylmercuri-thio)-benzoic säure C₉H₁₀O₂Hg₁S₁ 382.827 g/mol NotAvailable High Affinity Ribose Transport Protein Rbsd inhibitor Not Availables
000002-(oxalyl-amino)-benzoic säure C₉H₇N₁O₅ 209.158 g/mol NotAvailable 000003-Keto-L-Gulonate 6-Phosphate Decarboxylase inhibitor Not Availables
000002-[[(oxalyl-amino)-4,7-dihydro-5h-thieno[2,3-c]thiopyran-3-carboxylic säure]] C₁₀H₉N₁O₅S₂ 287.305 g/mol NotAvailable Ferrichrome-Iron Receptor inhibitor Not Availables
000001-amino-6-cyclohex-3-enylmethyloxypurin C₁₃H₁₈N₄O₁ 246.311 g/mol NotAvailable Camp-Specific 3',5'-Cyclic Phosphodiesterase inhibitor Not Availables
000002-(acetylamino)-2-deoxy-6-o-methyl-alpha-d-allopyranose C₉H₁₇N₁O₆ 235.236 g/mol NotAvailable Trypsin inhibitor Not Availables
000002-(acetylamino)-2-deoxy-4-o-sulfo-alpha-d-galactopyranose C₈H₁₅N₁O₉S₁ 301.268 g/mol NotAvailable Trypsin inhibitor Not Availables
dcka, 5,7-dichlorokynurenic säure C₁₀H₅N₁O₃Cl₂ 258.060 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000005-amino-3-methyl-pyrrolidine-2-carboxylic säure C₆H₁₂N₂O₂ 144.173 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-(beta-d-glucopyranosyl)-5-methyl-1,3,4-oxadiazol C₉H₁₄N₂O₆ 246.219 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-(acetylamino)-2-deoxy-a-d-glucopyranose C₈H₁₅N₁O₆ 221.210 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-amino-pentanoic säure C₅H₁₁N₁O₂ 117.147 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-amino-p-cresol C₇H₉N₁O₁ 123.154 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-aminomethylpyrrol-3-acetic säure 4-propionic säure;porphobilinogen; 5-(aminomethyl)-4-(carboxymethyl)-1h-pyrrole-3-propanoic säure C₁₀H₁₄N₂O₄ 226.232 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase S inhibitor Not Availables
thymidine-5'-monophosphat C₁₀H₁₅N₂O₈P₁ 322.211 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
i-5 C₁₇H₁₀N₂O₄Cl₂ 377.183 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000001-thio-beta-d-glucopyranose C₆H₁₂O₅S₁ 196.218 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-amino-6-oxo-hexanoic säure C₆H₁₁N₁O₃ 145.158 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
bromo-willardiin C₇H₈N₃O₄Br₁ 278.062 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-amino-but-3-ynoic säure C₄H₅N₁O₂ 99.089 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-amino-adenosin C₁₀H₁₄N₆O₃ 266.259 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-amino-8-methylquinazolin-4(3h)-on C₉H₉N₃O₁ 175.190 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-benzyl-3-iodopropanoic säure C₁₀H₁₁O₂I₁ 290.100 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
000002-[[benzo[1,3]dioxol-5-ylmethyl-3-benzyl-succinic säure]] C₁₉H₁₈O₆ 342.348 g/mol NotAvailable Proto-Oncogene Tyrosine-Protein Kinase Src inhibitor Not Availables
l-homoarginin C₇H₁₆N₄O₂₁+ 492.218 g/mol NotAvailable Beta-Trypsin Protein inhibitor Not Availables
000002-bromo-6-chloro-purin C₅H₂N₄Br₁Cl₁ 233.455 g/mol NotAvailable Myristoyl-Coa\: Protein N-Myristoyltransfera inhibitor Not Availables
000002-bromo-2-propene-1-ol C₃H₅O₁Br₁ 136.976 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
pyridin-3-ylmethanol C₆H₇N₁O₁ 109.127 g/mol NotAvailable Betaine-Homocysteine Methyltransferase inhibitor Not Availables
000002-aminopropanedioic säure C₃H₅N₁O₄ 119.077 g/mol NotAvailable RNA-Directed RNA Polymerase inhibitor Not Availables
[[[2-(1-amino-2-hydroxy-propyl)-4-(1h-indol-3-ylmethylene)-5-oxo-4,5-dihydro-imidazol-1-yl]-acetaldehyde]] C₁₇H₁₈N₄O₃ 326.354 g/mol NotAvailable Translation Elongation Factor Selb inhibitor Not Availables
s-methyl phosphocystein C₄H₁₀N₁O₅P₁S₁ 215.160 g/mol NotAvailable Hydroxyacylglutathione Hydrolase inhibitor Not Availables
fr117016 C₁₆H₁₅N₇S₂ 369.461 g/mol NotAvailable Lactoylglutathione Lyase inhibitor Not Availables
n-benzyl-4-sulfamoyl-benzamide C₁₄H₁₄N₂O₃S₁ 290.336 g/mol NotAvailable Ure2 Protein inhibitor Not Availables
000002-aminoquinazolin-4(3h)-on C₈H₇N₃O₁ 161.163 g/mol NotAvailable Arginase 1 inhibitor Not Availables
000002-amino-3-(4-amino-1h-indol-3-yl)propanoic säure C₁₁H₁₃N₃O₂ 219.243 g/mol NotAvailable Sigma Factor Sigb Regulation Protein Rsbq inhibitor Not Availables
000002-amino-3-(1h-indol-3-yl)-propan-1-ol C₁₁H₁₄N₂O₁ 190.244 g/mol NotAvailable Arginase II, Mitochondrial Precursor inhibitor Not Availables
000002-[[amino-3-[4-hydroxy-6-oxo-3-(2-phenyl-cyclopropylimino)-cyclohexa-1,4-dienyl]-propionic säure]] C₁₈H₂₀N₂O₄ 328.367 g/mol NotAvailable Glutaryl-Coa Dehydrogenase inhibitor Not Availables
000002-amino-3-(diethoxy-phosphoryloxy)-propionic säure C₇H₁₆N₁O₆P₁ 241.180 g/mol NotAvailable Hydroxynitrile Lyase inhibitor Not Availables
000002-amino-3-(cystein-s-yl)-isoxazolidin-5-yl-acetic säure C₈H₁₅N₃O₅S₁ 265.284 g/mol NotAvailable Acetyl-Coa Acetyltransferase inhibitor Not Availables
000005-amino-5-deoxy-cellobiono-1,5-lactam C₁₂H₂₃N₁O₁₀ 341.314 g/mol NotAvailable Spermidine Synthase inhibitor Not Availables
000002-[[{n'-[2-(5-amino-1-phenylcarbamoyl-pentylcarbamoyl)-hexyl]-hydrazinomethyl}-hexanoic säure(5-amino-1-phenylcarbamoyl-pentyl)-amide]] C₃₈H₆₂N₈O₄ 694.959 g/mol NotAvailable Lmaj004091Aaa inhibitor Not Availables
000002-[[{4-[4-(4-chloro-phenoxy)-benzenesulfonyl]-tetrahydro-pyran-4-yl}-n-hydroxy-acetamide]] C₁₉H₂₀N₁O₆Cl₁S₁ 425.883 g/mol NotAvailable Possible 3-Mercaptopyruvate Sulfurtransf inhibitor Not Availables
000002-allyl-6-methyl-phenol C₁₀H₁₂O₁ 148.204 g/mol NotAvailable Lactoylglutathione Lyase inhibitor Not Availables
000002-acetyl-protoporphyrin ix C₃₄H₃₁N₄O₅Fe₁ 631.490 g/mol NotAvailable Acetyl-Coa Acetyltransferase inhibitor Not Availables
000007-[[(1,1-dioxo-1h-benzo[d]isothiazol-3-yloxymethyl)-2-(oxalyl-amino)-4,7-dihydro-5h-thieno[2,3-c]pyran-3-carboxylic säure]] C₁₈H₁₄N₂O₉S₂ 466.437 g/mol NotAvailable Catalase inhibitor Not Availables
000002-amino-4h-1,3-benzoxathiin-4-ol C₈H₉N₁O₂S₁ 183.225 g/mol NotAvailable Nitric-Oxide Synthase inhibitor Not Availables
000002-amino-4-mercapto-butyric säure C₄H₉N₁O₂S₁ 135.181 g/mol NotAvailable Nitric-Oxide Synthase inhibitor Not Availables
000002-amino-4-(4-amino-cyclohexa-2,5-dienyl)-butyric säure C₁₀H₁₆N₂O₂ 196.249 g/mol NotAvailable Inducible Nitric Oxide Synthase inhibitor Not Availables
000002-amino-6-chloropyrazin C₄H₄N₃Cl₁ 129.549 g/mol NotAvailable Glutathione S-Transferase inhibitor Not Availables
000005-amidino-benzimidazol C₈H₉N₄₁+ 679.434 g/mol NotAvailable Subtilisin Bpn' inhibitor Not Availables
000002-amino-5-bromo-6-phenylpyrimidin-4-ol C₁₀H₈N₃O₁Br₁ 266.097 g/mol NotAvailable Alcohol Dehydrogenase Class III Chi Chain inhibitor Not Availables
000002-amino-3-ketobutyric säure C₄H₇N₁O₃ 117.104 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
000002-amino-3-hydroxy-3-phosphonooxy-propionic säure C₃H₈N₁O₇P₁ 201.072 g/mol NotAvailable Hydroxylamine Reductase inhibitor Not Availables
000004-methylimidazol C₄H₆N₂ 82.105 g/mol NotAvailable Chemotaxis Protein Chey inhibitor Not Availables
000002-amino-4-(2-amino-ethoxy)-butyric säure C₆H₁₄N₂O₃ 162.188 g/mol NotAvailable Endoglucanase 9G inhibitor Not Availables
000002-amino-3-oxo-4-sulfo-butyric säure C₃H₅N₁O₇S₁ 199.135 g/mol NotAvailable Saccharopepsin inhibitor Not Availables
000002-amino-3-mercapto-propionamide C₃H₈N₂O₁S₁ 120.169 g/mol NotAvailable Glutathione S-Transferase 26 Kda inhibitor Not Availables
000003-chlorophenol C₆H₅O₁Cl₁ 128.558 g/mol NotAvailable Prolyl Oligopeptidase inhibitor Not Availables
000003-chloroalaninate C₃H₆N₁O₂Cl₁ 123.539 g/mol NotAvailable Endo-1,4-Beta-Glucanase inhibitor Not Availables
000003-[[chloro-9-ethyl-6,7,8,9,10,11-hexahydro-7,11-methanocycloocta[b]quinolin-12-amin]] C₁₈H₁₉N₂Cl₁ 298.815 g/mol NotAvailable Lactoylglutathione Lyase inhibitor Not Availables
000003-decyl-2,5-dioxo-4-hydroxy-3-pyrrolin C₁₄H₂₃N₁O₃ 253.341 g/mol NotAvailable Yjgf Protein inhibitor Not Availables
000003-deazacytidin C₁₀H₁₄N₂O₅ 242.231 g/mol NotAvailable Selenocysteine Lyase inhibitor Not Availables
000003-deaza-adenosin C₁₁H₁₄N₄O₄ 266.256 g/mol NotAvailable Pheromone Binding Protein inhibitor Not Availables
(3r,4r,5r)-5-(hydroxymethyl)piperidine-3,4-diol C₆H₁₃N₁O₃ 147.174 g/mol NotAvailable Proto-Oncogene Serine/Threonine-Protein inhibitor Not Availables
000003-aza-2,3-dihydrogeranyl diphosphat C₉H₁₈N₁O₇P₂₃- 964.640 g/mol NotAvailable Prfa inhibitor Not Availables
000003-[[[n-[benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonylmethylbenzen]] C₃₅H₃₈N₂O₅S₁ 598.756 g/mol NotAvailable Bovine Endothelial Nitric Oxide Synthase Hem inhibitor Not Availables
000001-deoxy-d-xylulose-5-phosphat C₅H₁₁O₇P₁ 214.111 g/mol NotAvailable Bovine Endothelial Nitric Oxide Synthase Hem inhibitor Not Availables
000003-carboxy-n,n,n-trimethyl-2-(octanoyloxy)propan-1-aminium C₁₅H₃₀N₁O₄ 288.406 g/mol NotAvailable Histone Deacetylase 8 inhibitor Not Availables
amylamin C₅H₁₃N₁ 87.164 g/mol NotAvailable S-Adenosyl-L-Methionnine: Salicylic säure Car inhibitor Not Availables
000003-hydroxy-3-methyl-glutaric säure C₆H₁₀O₅ 162.142 g/mol NotAvailable Map Kinase P38 inhibitor Not Availables
ribose(pyranose form) C₅H₁₀O₅ 150.131 g/mol NotAvailable Matrix Metalloproteinase-2 inhibitor Not Availables
000003-fluorosialic säure C₁₁H₁₈N₁O₈F₁ 311.264 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
000001-[[tert-butyl-3-(4-chloro-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-ylamin]] C₁₅H₁₇N₅Cl₁₁+ 657.316 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
000003-hydroxy-myristic säure C₁₄H₂₈O₃ 244.373 g/mol NotAvailable Diagnostic Agents For diagnosis of pancreatic exocrine dysfunction and gastrinomas
000003-hydroxy-4-(3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-piperidin-2-on C₁₀H₁₇N₁O₇ 263.247 g/mol NotAvailable Inosine Monophosphate Dehydrogenase 2 inhibitor Not Availables
000003-deoxy-d-glucosamin C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Nucleoside Diphosphate Kinase, Cytosolic inhibitor Not Availables
heptanamide C₇H₁₅N₁O₁ 129.202 g/mol NotAvailable Purine Trans Deoxyribosylase inhibitor Not Availables
cibacron blue C₂₉H₂₀N₇O₁₁Cl₁S₃ 774.150 g/mol NotAvailable Tetrameric Beta-Beta-Alpha Mini-Protein inhibitor Not Availables
000003-fluoro-2-methyl-anilin C₇H₈N₁F₁ 125.145 g/mol NotAvailable Alkaline Phosphatase inhibitor Not Availables
000009-(4-hydroxyphenyl)-2,7-phenanthrolin C₁₈H₁₂N₂O₁ 272.306 g/mol NotAvailable 000005-Enolpyruvylshikimate-3-Phosphate Synthase inhibitor Not Availables
sr11254 C₂₆H₂₇N₁O₃ 401.504 g/mol NotAvailable Caffeoyl-Coa O-Methyltransferase inhibitor Not Availables
000003-[[[n-[benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonic säure 4-nitro-phenyl ester]] C₃₄H₃₅N₃O₈S₁ 645.726 g/mol NotAvailable Sulfite Reductase Hemoprotein inhibitor Not Availables
000003-[[[isopropyl(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic säure]] C₂₂H₂₁N₁O₃S₁ 379.473 g/mol NotAvailable Simian Immunodeficiency Virus inhibitor Not Availables
000003-[[{2,6,8-trioxo-9-[(2r,3s,4r)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7h-purin-7-yl}propyl dihydrogen phosphat]] C₁₃H₂₁N₄O₁₁P₁ 440.303 g/mol NotAvailable Antioxidants; Anti-Angiogenesis Agents Diabetic retinopathy and neuropathys
000003-[[{2,6,8-trioxo-9-[(2r,3r,4r)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7h-purin-7-yl}propyl dihydrogen phosphat]] C₁₃H₂₁N₄O₁₁P₁ 440.303 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
k201 C₂₅H₃₂N₂O₂S₁ 424.600 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
protoporphyrin ix containing co C₃₄H₃₂N₄O₄Co₁ 588.662 g/mol NotAvailable Camp-Dependent Protein Kinase Type I-Alpha R inhibitor Not Availables
000003-[[[(acetyl-methyl-amino)-methyl]-4-amino-n-methyl-n-(1-methyl-1h-indol-2-ylmethyl)-benzamide]] C₂₂H₂₆N₄O₂ 378.473 g/mol NotAvailable Interleukin-2 inhibitor Not Availables
2,6-diisopropylphenol; propofol C₁₂H₁₈O₁ 178.274 g/mol NotAvailable Interleukin-2 inhibitor Not Availables
l-alpha-glycerophosphorylethanolamin C₅H₁₄N₁O₆P₁ 215.142 g/mol NotAvailable Protein-Tyrosine Phosphatase, Non-Receptor T inhibitor Not Availables
(9r,10r)-9-(s-glutathionyl)-10-hydroxy-9,10-dihydrophenanthren C₂₄H₂₇N₃O₇S₁ 501.553 g/mol NotAvailable 23S Ribosomal inhibitor Not Availables
000003-[[[1-(3-aminopropyl)-1h-indol-3-yl]-4-(1-methyl-1h-indol-3-yl)-1h-pyrrole-2,5-dion]] C₂₄H₂₂N₄O₂ 398.463 g/mol NotAvailable Putative Cytochrome P450 inhibitor Not Availables
000003-[[amino-8,9,10-trihydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dion]] C₈H₁₃N₃O₇ 263.207 g/mol NotAvailable Chemotaxis Protein Chea inhibitor Not Availables
000003-amino-6-hydroxy-tyrosin C₉H₁₂N₂O₄ 212.205 g/mol NotAvailable Retinoic säure Receptor Gamma-1 inhibitor Not Availables
000003-amino-4,5-dihydroxy-cyclohex-1-enecarboxylate C₇H₁₀N₁O₄₁- 764.138 g/mol NotAvailable Orphan Nuclear Receptor Pxr inhibitor Not Availables
000003-aminosuccinimide C₄H₆N₂O₂ 114.104 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
000003-aminomethyl-pyridinium-adenine-dinucleotide C₂₁H₂₉N₇O₁₃P₂ 649.447 g/mol NotAvailable Dihydrofolate Reductase inhibitor Not Availables
000003-amino-alanin C₃H₉N₂O₂₁+ 409.105 g/mol NotAvailable Fatty säure Binding Protein inhibitor Not Availables
000003-acetyl pyridine adenine dinucleotide C₂₂H₂₈N₆O₁₄P₂ 662.443 g/mol NotAvailable Tyrosine-Protein Kinase Syk inhibitor Not Availables
nitrilotriacetic säure C₆H₉N₁O₆ 191.140 g/mol NotAvailable Fgf Receptor 1 inhibitor Not Availables
000003-[[{2,6,8-trioxo-9-[(2s,3r,4r)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7h-purin-7-yl}propyl dihydrogen phosphat]] C₁₃H₂₁N₄O₁₁P₁ 440.303 g/mol NotAvailable Cell Division Protein Kinase 2 inhibitor Not Availables
000003-amino-4-oxybenzyl-2-butanon C₁₁H₁₅N₁O₂ 193.245 g/mol NotAvailable 2,3,4,5-Tetrahydropyridine-2-Carboxylate N- inhibitor Not Availables
000003-[[amino-4-{3-[2-(2-propoxy-ethoxy)-ethoxy]-propylamino}-cyclobut-3-ene-1,2-dion]] C₁₄H₂₄N₂O₅ 300.354 g/mol NotAvailable säureic Fibroblast Growth Factor inhibitor Not Availables
000003-acetylpyridine adenine dinucleotide C₂₁H₂₈N₇O₁₄P₂ 664.438 g/mol NotAvailable Carbonic Anhydrase II inhibitor Not Availables
1,2-dimethoxyethan C₄H₁₀O₂ 90.122 g/mol NotAvailable Phosphoenolpyruvate Phosphomutase inhibitor Not Availables
3,4-dichloroisocoumarin C₉H₄O₂Cl₂ 215.035 g/mol NotAvailable Sulfolipid Biosynthesis Protein Sqd1 inhibitor Not Availables
3,4-dihydroxyphenylalanin C₉H₁₁N₁O₄ 197.190 g/mol NotAvailable Alpha-Mannosidase II inhibitor Not Availables
3,4-dihydroxy-1-methylquinolin-2(1h)-on C₁₀H₉N₁O₃ 191.186 g/mol NotAvailable Nad-Dependent Malic Enzyme inhibitor Not Availables
3,4-dihydrouracil C₄H₆N₂O₂ 114.104 g/mol NotAvailable Nad inhibitor Not Availables
000003-phosphoglyceric säure C₃H₇O₇P₁ 186.058 g/mol NotAvailable Beta-Lactamase Shv-1 inhibitor Not Availables
000003-phenylpyruvic säure C₉H₈O₃ 164.160 g/mol NotAvailable Beta-Lactamase Shv-1 inhibitor Not Availables
[[s-{2-[amino(dihydroxy)-lambda~4~-sulfanyl]ethyl}-d-cystein]] C₅H₁₄N₂O₄S₂ 230.297 g/mol NotAvailable Vasoconstrictor Agents; Antihypertensive Agents Oesophageal varices with bleedings
3,3',5,5'-tetraiodothyroacetic säure C₁₄H₈O₄I₄ 747.833 g/mol NotAvailable Lysozyme inhibitor Not Availables
000003-[[pyridin-4-yl-2,4-dihydro-indeno[1,2-.c.]pyrazol]] C₁₅H₁₁N₃ 233.272 g/mol NotAvailable Cathepsin K inhibitor Not Availables
000004-[[(aminosulfonyl)-n-[(2,4-difluorophenyl)methyl]-benzamide]] C₁₄H₁₂N₂O₃F₂S₁ 326.317 g/mol NotAvailable Protease Retropepsin inhibitor Not Availables
3,5-dinitrocatechol C₆H₄N₂O₆ 200.107 g/mol NotAvailable Azurin inhibitor Not Availables
3,5-dimethyl-1h-pyrazole-4-carboxylic säure ethyl ester C₈H₁₂N₂O₂ 168.195 g/mol NotAvailable Azurin inhibitor Not Availables
3,5-dihydro-5-methylidene-4h-imidazol-4-on C₈H₁₆N₄O₃ 216.239 g/mol NotAvailable Casein Kinase II, Alpha Chain inhibitor Not Availables
3,5,6,8-tetramethyl-n-methyl phenanthrolinium C₁₇H₁₉N₂₁+ 517.478 g/mol NotAvailable Voltage-Gated Potassium Channel inhibitor Not Availables
nor-n-omega-hydroxy-l-arginin C₅H₁₂N₄O₃ 176.175 g/mol NotAvailable Bacteriorhodopsin inhibitor Not Availables
3,5,3',5'-tetrachloro-biphenyl-4,4'-diol C₁₂H₆O₂Cl₄ 323.990 g/mol NotAvailable Parvalbumin Alpha inhibitor Not Availables
3,4-epoxybutyl-alpha-d-glucopyranoside C₁₀H₁₈O₇ 250.248 g/mol NotAvailable Myosin inhibitor Not Availables
3,4-dimethylphenol C₈H₁₀O₁ 122.166 g/mol NotAvailable Cytidine Deaminase inhibitor Not Availables
(s)-des-me-ampa C₆H₈N₂O₄ 172.140 g/mol NotAvailable Bifunctional Puta Protein inhibitor Not Availables
3,5-difluorobenzenesulfonamide C₆H₅N₁O₂F₂S₁ 193.168 g/mol NotAvailable Endoglucanase 5A inhibitor Not Availables
3,5-difluoroanilin C₆H₅N₁F₂ 129.109 g/mol NotAvailable Laccase inhibitor Not Availables
3,5-diaminophthalhydrazide C₈H₈N₄O₂ 192.177 g/mol NotAvailable Osmoprotection Protein inhibitor Not Availables
alpha,alpha,alpha-trifluoro-p-cresol C₇H₅O₁F₃ 162.111 g/mol NotAvailable Integrase inhibitor Not Availables
000003-indolebutyric säure C₁₂H₁₃N₁O₂ 203.240 g/mol NotAvailable Myoglobin inhibitor Not Availables
000003-methyl-5-sulfo-pyrrolidine-2-carboxylic säure C₆H₁₁N₁O₅S₁ 209.217 g/mol NotAvailable Ykof inhibitor Not Availables
000003-mercuri-4-aminobenzenesulfonamide C₆H₇N₂O₂Hg₁S₁ 371.784 g/mol NotAvailable Arsenate Reductase inhibitor Not Availables
000003-mercapto-1-(1,3,4,9-tetrahydro-b-carbolin-2-yl)-propan-1-on C₁₄H₁₆N₂O₁S₁ 260.353 g/mol NotAvailable Arsenate Reductase inhibitor Not Availables
000003-hydroxyimino quinic säure C₇H₁₁N₁O₆ 205.167 g/mol NotAvailable Trypsin inhibitor Not Availables
000003-hydroxybutyryl-coenzyme a C₂₅H₄₂N₇O₁₈P₃S₁ 853.624 g/mol NotAvailable Cyclodextrin-Glycosyltransferase inhibitor Not Availables
p-aminophenyl-alpha-d-galactopyranoside C₁₂H₁₇N₁O₆ 271.269 g/mol NotAvailable Cyclodextrin-Glycosyltransferase inhibitor Not Availables
000003-hydroxyphenylalanin C₉H₁₁N₁O₃ 181.191 g/mol NotAvailable Acyl Carrier Protein inhibitor Not Availables
000002-keto-3-deoxygluconate C₆H₁₀O₆ 178.141 g/mol NotAvailable Cytochrome P450Cam inhibitor Not Availables
000003-hydroxyisoxazole-4-carboxylic säure C₄H₃N₁O₄ 129.072 g/mol NotAvailable Beta-D-Glucan Glucohydrolase Isoenzyme Exo1 inhibitor Not Availables
000003-oxo-butyric säure C₄H₆O₃ 102.090 g/mol NotAvailable Nitric Oxide Synthase inhibitor Not Availables
beta-(2-naphthyl)-alanin C₁₃H₁₃N₁O₂ 215.251 g/mol NotAvailable Galactose-Specific Lectin inhibitor Not Availables
4,5-dehydro-d-glucuronic säure C₆H₈O₇ 192.125 g/mol NotAvailable Glyceraldehyde 3-Phosphate Dehydrogenase inhibitor Not Availables
000003-phenylpropylamin C₉H₁₄N₁₁+ 276.283 g/mol NotAvailable Annexin V inhibitor Not Availables
[[benzofuran-2-carboxylic säure {(s)-3-methyl-1-[3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylcarbamoyl]butyl}amide]] C₂₆H₃₀N₄O₆S₁ 526.606 g/mol NotAvailable Acetate Kinase inhibitor Not Availables
000003-oxo-pentadecanoic säure C₁₅H₂₈O₃ 256.384 g/mol NotAvailable Peptidyl-Glycine Alpha-Amidating Monooxygena inhibitor Not Availables
trihydroxyantimonite(iii) H₃O₃Sb₁ 93.892 g/mol NotAvailable L-Asparagine Amidohydrolase inhibitor Not Availables
000003-methylcytosin C₅H₈N₃O₁₁+ 286.132 g/mol NotAvailable Staphylococcal Nuclease inhibitor; Thermonuclease inhibitor Not Availables
000003-methyladenin C₆H₇N₅ 149.155 g/mol NotAvailable Nucleoside Diphosphate Kinase inhibitor Not Availables
000003-nitrophenylboronic säure C₆H₆N₁O₄B₁ 166.928 g/mol NotAvailable P1 Nuclease inhibitor Not Availables
000003-nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide C₁₀H₁₁N₃O₅S₁ 285.274 g/mol NotAvailable Dtdp-6-Deoxy-D-Xylo-4-Hexulose 3,5-Epimerase inhibitor Not Availables
norleucin C₆H₁₃N₁O₂ 131.174 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
triethyl phosphat C₆H₁₅O₄P₁ 182.156 g/mol NotAvailable Thymidine Kinase, Cytosolic inhibitor Not Availables
2,6-difluorobenzenesulfonamide C₆H₅N₁O₂F₂S₁ 193.168 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
heptamolybdate O₂₄₆- 3935.852 g/mol NotAvailable Retropepsin inhibitor Not Availables
2,6,8-trimethyl-3-amino-9-benzyl-9-methoxynonanoic säure C₂₀H₃₃N₁O₃ 335.486 g/mol NotAvailable Protease Retropepsin inhibitor Not Availables
2,6-dimethyl-7-octen-2-ol C₁₀H₂₀O₁ 156.267 g/mol NotAvailable Actin Alpha 1 inhibitor Not Availables
2,6-diamino-8-(2-dimethylaminoethylsulfanylmethyl)-3h-quinazolin-4-on C₁₃H₁₉N₅O₁S₁ 293.386 g/mol NotAvailable Pentaerythritol Tetranitrate Reductase inhibitor Not Availables
2,6-diamino-8-(1h-imidazol-2-ylsulfanylmethyl)-3h-quinazoline-4-on C₁₂H₁₂N₆O₁S₁ 288.326 g/mol NotAvailable Thymidylate Synthase inhibitor Not Availables
2,4-diaminobutyric säure C₄H₁₀N₂O₂ 118.135 g/mol NotAvailable Major Nad inhibitor Not Availables
2,6-diaminoquinazolin-4(3h)-on C₈H₈N₄O₁ 176.177 g/mol NotAvailable Trypsin inhibitor Not Availables
2,6-diaminopimelic säure C₇H₁₄N₂O₄ 190.199 g/mol NotAvailable Plasminogen inhibitor Not Availables
000002-(2f-benzothiazolyl)-5-styryl-3-(4f-phthalhydrazidyl)tetrazolium chloride C₂₄H₁₆N₇O₂S₁₁+ 787.096 g/mol NotAvailable Urokinase-Type Plasminogen Activator inhibitor Not Availables
2'-deoxymaltose C₁₂H₂₂O₁₀ 326.300 g/mol NotAvailable Gamma Chymotrypsin inhibitor Not Availables
2'-deoxyinosin C₁₀H₁₂N₄O₄ 252.229 g/mol NotAvailable Neutrophil Gelatinase-Associated Lipocalin inhibitor Not Availables
000004-hydroxyphenylglycin C₈H₉N₁O₃ 167.164 g/mol NotAvailable Hydroxynitrile Lyase inhibitor Not Availables
000003-(4-hydroxy-3-imino-6-oxo-cyclohexa-1,4-dienyl)-alanin C₉H₁₀N₂O₄ 210.189 g/mol NotAvailable Acetolactate Synthase, Mitochondrial inhibitor Not Availables
1,2-diacyl-sn-glycero-3-phosphoinositol C₄₃H₈₀O₁₃P₁₁- 1145.809 g/mol NotAvailable Luciferase inhibitor Not Availables
2'-deoxyuridine 3'-monophosphat C₉H₁₃N₂O₈P₁ 308.184 g/mol NotAvailable Aconitase inhibitor Not Availables
2'-deoxy-adenosine 3'-monophosphat C₁₀H₁₄N₅O₆P₁ 331.224 g/mol NotAvailable Lipase 3 inhibitor Not Availables
2'-chloro-biphenyl-2,3-diol C₁₂H₉Cl₁O₂ 220.655 g/mol NotAvailable Trihydroxynaphthalene Reductase inhibitor Not Availables
(2s,3r)-3-amino-2-hydroxy-5-(ethylsulfanyl)pentanoyl-((s)-(-)-(1-naphthyl)ethyl)amide C₁₉H₂₆N₂O₂S₁ 346.487 g/mol NotAvailable Phosphotriesterase inhibitor Not Availables
2'-deoxycytidine-2'-deoxyguanosine-3',5'-monophosphat C₁₉H₂₅N₈O₁₀P₁ 556.428 g/mol NotAvailable Thiamin Phosphate Synthase inhibitor Not Availables
2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphat C₁₉H₂₅N₈O₉P₁ 540.428 g/mol NotAvailable Citrate Synthase inhibitor Not Availables
2'-deoxyadenosin C₁₀H₁₃N₅O₃ 251.244 g/mol NotAvailable D-Amino säure Oxidase inhibitor Not Availables
2,4-diamino-6-phenyl-5,6,7,8,-tetrahydropteridin C₁₂H₁₄N₆ 242.283 g/mol NotAvailable Alcohol Dehydrogenase inhibitor Not Availables
000004-[[[(6-amino-4-pyrimidinyl)amino]benzenesulfonamide]] C₁₀H₁₁N₅O₂S₁ 265.289 g/mol NotAvailable 000005-Epi-Aristolochene Synthase inhibitor Not Availables
[[2,4-dinitro,5-[bis(2-bromoethyl)amino]-n-(2',3'-dioxopropyl)benzamide]] C₁₄H₁₄N₄O₇Br₂ 510.095 g/mol NotAvailable Methionine Aminopeptidase inhibitor Not Availables
2,4-dihydroxybenzoic säure C₇H₆O₄ 154.122 g/mol NotAvailable Serine Hydroxymethyltransferase inhibitor Not Availables
2,4-dihydroxy-trans cinnamic säure C₉H₈O₄ 180.160 g/mol NotAvailable Arsenite-Translocating Atpase inhibitor Not Availables
(s)-4-bromo-3-hydroxy-3-methylbutyl diphosphat C₅H₁₃O₈Br₁P₂ 343.004 g/mol NotAvailable Arsenate Reductase inhibitor Not Availables
2,4-diamino-4,6-dihydroxypyrimidin C₄H₆N₄O₂ 142.117 g/mol NotAvailable Osmoprotection Protein inhibitor Not Availables
2,4-deoxy-4-guanidino-5-n-acetyl-neuraminic säure C₁₂H₂₂N₄O₇ 334.328 g/mol NotAvailable Poly inhibitor Not Availables
[[2,4-diamino-6-[n-(3',4',5'-trimethoxybenzyl)-n-methylamino]pyrido[2,3-d]pyrimidin]] C₁₈H₂₂N₆O₃ 370.410 g/mol NotAvailable Hypothetical Protein Af2198 inhibitor Not Availables
[[2,4-diamino-6-[n-(2',5'-dimethoxybenzyl)-n-methylamino]quinazolin]] C₁₈H₂₁N₅O₂ 339.396 g/mol NotAvailable Alpha-Lytic Protease inhibitor Not Availables
[[2,4-diamino-5-methyl-6-[(3,4,5-trimethoxy-n-methylanilino)methyl]pyrido[2,3-d]pyrimidin]] C₁₉H₂₄N₆O₃ 384.437 g/mol NotAvailable Autolysin inhibitor Not Availables
[[n-{3-[(3s,8ar)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]propyl}guanidin]] C₁₁H₁₉N₅O₂ 253.303 g/mol NotAvailable Phosphatase inhibitor Not Availables
2,5-dideoxy-2,5-imino-d-glucitol C₆H₁₃N₁O₄ 163.173 g/mol NotAvailable Short-Chain Dehydrogenase/Reductase Family M inhibitor Not Availables
2,5-diaziridin-1-yl-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dion C₁₂H₁₄N₂O₃ 234.254 g/mol NotAvailable Trypanothione Reductase inhibitor Not Availables
2,6-anhydro-3-deoxy-d-erythro-hex-2-enonic säure C₆H₈O₅ 160.126 g/mol NotAvailable Tryptophanyl-tRNA Synthetase inhibitor Not Availables
2,5,7-trihydroxynaphthoquinon C₁₀H₆O₅ 206.154 g/mol NotAvailable Retinoic säure Receptor Beta inhibitor Not Availables
2,5-xylidin C₈H₁₁N₁ 121.182 g/mol NotAvailable Udp-3-O-[3-Hydroxymyristoyl] N-Acetylglucosa inhibitor Not Availables
2,4,6-tribromophenol C₆H₃O₁Br₃ 330.801 g/mol NotAvailable Formaldehyde Ferredoxin Oxidoreductase inhibitor Not Availables
2,4,6-triaminoquinazolin C₈H₉N₅ 175.193 g/mol NotAvailable Formaldehyde Ferredoxin Oxidoreductase inhibitor Not Availables
[[pinacol*[[2-amino-alpha-(1-carboxy-1-methylethoxyimino)-4-thiazoleacetyl]amino]methaneboronate]] H₁₅C₁₀N₄O₆B₁S₁ 330.122 g/mol NotAvailable Sedolisin inhibitor Not Availables
n,o-didansyl-l-tyrosin C₃₃H₃₃N₃O₇S₂ 647.760 g/mol NotAvailable Tyrosyl-tRNA Synthetase inhibitor Not Availables
o1-methyl-mannose C₇H₁₄O₆ 194.184 g/mol NotAvailable Tailspike Protein inhibitor Not Availables
phosphoramidon C₂₃H₃₄N₃O₁₀P₁ 543.509 g/mol NotAvailable Ribonuclease A inhibitor Not Availables
cra_1801 C₁₃H₁₁N₅O₁ 253.263 g/mol NotAvailable Udp-Glucose Dehydrogenase inhibitor Not Availables
000003-[[(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1h-pyrrolo[3,2-b]pyridin]] C₁₈H₁₂N₃O₁F₁ 305.311 g/mol NotAvailable Udp-Glucose 4-Epimerase inhibitor Not Availables
n-allyl-anilin C₉H₁₁N₁ 133.193 g/mol NotAvailable Beta-1,3-Glucuronyltransferase 3 inhibitor Not Availables
000001-beta-ribofuranosyl-1,3-diazepinon C₁₀H₁₄N₂O₅ 242.231 g/mol NotAvailable Actin inhibitor Not Availables
em-1745 C₃₇H₅₁N₅O₇ 677.839 g/mol NotAvailable Odorant-Binding Protein inhibitor Not Availables
000003-(3,5-dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonic säure dimethylamide C₁₉H₁₇N₁O₅Br₂S₁ 531.215 g/mol NotAvailable V-Type Sodium ATP Synthase Subunit K inhibitor Not Availables
000004-epi-vancosaminyl derivative of vancomycin C₇₃H₉₁N₁₀O₂₆Cl₂₃+ 2339.992 g/mol NotAvailable Triacylglycerol Lipase, Gastric inhibitor Not Availables
2',3'-dideoxythymidine-5'-monophosphat C₁₀H₁₅N₂O₇P₁ 306.211 g/mol NotAvailable Ribonuclease A inhibitor Not Availables
000003-(4-benzenesulfonyl-thiophene-2-sulfonylamino)-phenylboronic säure C₁₆H₁₄N₁O₆B₁S₃ 423.280 g/mol NotAvailable Alpha, Alpha-Trehalose-Phosphate Synthase inhibitor Not Availables
d-dethiobiotin C₁₀H₁₈N₂O₃ 214.264 g/mol NotAvailable Udp-Galactose-4-Epimerase inhibitor Not Availables
000003-[[(4-amino-1-tert-butyl-1h-pyrazolo[3,4-d]pyrimidin-3-yl)phenol]] C₁₅H₁₇N₅O₁ 283.332 g/mol NotAvailable Udp-Galactose-4-Epimerase inhibitor Not Availables
000003-(phosphonomethyl)pyridine-2-carboxylic säure C₇H₈N₁O₅P₁ 217.118 g/mol NotAvailable Udp-N-Acetylmuramoyl-L-Alanine/: D-Gluta inhibitor Not Availables
uridine-diphosphate-n-acetylglucosamin C₁₇H₂₇N₃O₁₇P₂ 607.358 g/mol NotAvailable Udp-N-Acetylmuramoyl-L-Alanine: D-Glutam inhibitor Not Availables
000003-(oxalyl-amino)-naphthalene-2-carboxylic säure C₁₃H₉N₁O₅ 259.218 g/mol NotAvailable Alpha-1,4-Galactosyl Transferase inhibitor Not Availables
000003-[[[(5s)-1-acetyl-3-(2-chlorophenyl)-4,5-dihydro-1h-pyrazol-5-yl]phenol]] C₁₇H₁₅N₂O₂Cl₁ 314.771 g/mol NotAvailable Udp-Glucose 4-Epimerase inhibitor Not Availables
000003-[[[(2,4-dichlorobenzoyl)(isopropyl)amino]-5-phenylthiophene-2-carboxylic säure]] C₂₁H₁₇N₁O₃Cl₂S₁ 434.336 g/mol NotAvailable Glcnac1P Uridyltransferase inhibitor Not Availables
000003-[[[(1-amino-2-carboxy-ethyl)-hydroxy-phosphinoyl]-2-methyl-propionic säure]] C₇H₁₄N₁O₆P₁ 239.164 g/mol NotAvailable Glcnac1P Uridyltransferase Isoform 1: Agx1 inhibitor Not Availables
[[10-{4-dimethylamino-5-[4-hydroxy-6-methyl-5-(6-methyl-5-oxo-tetrahydro-pyran-2-yloxy)-tetrahydro-pyrane-2-yloxy]-6-methyl-tetrahydro-pyran-2-yloxy}-8-ethyl-1,8,11-trihydroxy-7,8,9,10-tetrahydro-naphthacene-5,12-dion]] C₄₀H₅₁N₁O₁₃ 753.842 g/mol NotAvailable Ribonuclease, Seminal inhibitor Not Availables
000003-[[(6-aminopyridin-3-yl)-n-methyl-n-[(1-methyl-1h-indol-2-yl)methyl]acrylamide]] C₁₉H₂₀N₄O₁ 320.393 g/mol NotAvailable Limonene-1,2-Epoxide Hydrolase inhibitor Not Availables
000003-[[(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-n-[2-(2-(hydroxymethyl-phenylsulfanyl)-benzyl]-benzamide]] C₂₅H₂₁N₇O₃S₁ 499.546 g/mol NotAvailable Anti-craving Agents; Cocaine Antagonists Not Availables
000003-(mercaptomethylene)pyridin C₆H₇N₁S₁ 125.188 g/mol NotAvailable Phosphonoacetaldehyde Hydrolase inhibitor Not Availables
000003-(benzyloxy)pyridin-2-amin C₁₂H₁₂N₂O₁ 200.240 g/mol NotAvailable Chlorophyll A-B Binding Protein, Chloroplast inhibitor Not Availables
ulapualide a C₄₆H₆₆N₄O₁₃ 883.046 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
2',3'-dideoxycytidine-5'-monophosphat C₉H₁₄N₃O₆P₁ 291.200 g/mol NotAvailable Aspartate Aminotransferase inhibitor Not Availables
2',3'-dehydro-2',3'-deoxy-thymidine 5'-triphosphat C₁₀H₁₄N₂O₁₃P₃ 463.147 g/mol NotAvailable Collagenase-3 inhibitor Not Availables
2',6'-dichloro-biphenyl-2,6-diol C₁₂H₈Cl₂O₂ 255.100 g/mol NotAvailable Glutamate Receptor 2 inhibitor Not Availables
phosphorylisopropan C₃H₉O₄P₁ 140.075 g/mol NotAvailable Cruzain inhibitor Not Availables
2',4,4'-trihydroxychalcon C₁₅H₁₂O₄ 256.257 g/mol NotAvailable Cruzain inhibitor Not Availables
2'-monophosphoadenosine-5'-diphosphoribose C₁₅H₂₇N₅O₁₇P₃₁+ 1509.588 g/mol NotAvailable Cruzain inhibitor Not Availables
2'-monophosphoadenosine-5'-diphosphat C₁₀H₁₆N₅O₁₃P₃ 507.183 g/mol NotAvailable Hiv-1 Protease inhibitor Not Availables
adenosine-5'-monophosphate glucopyranosyl-monophosphate ester C₁₆H₂₅N₅O₁₅P₂ 589.346 g/mol NotAvailable Glucarate Dehydratase inhibitor Not Availables
2',3'-dehydro-2',3'-deoxy-thymidine 5'-diphosphat C₁₀H₁₃N₂O₁₀P₂ 383.168 g/mol NotAvailable Chondroitinase B inhibitor Not Availables
2'-o-methyl-3'-methyl-3'-deoxy-arabinofuranosyl-thymine-5'-phosphat C₁₂H₁₉N₂O₈P₁ 350.264 g/mol NotAvailable Beta-1,4-Xylanase inhibitor Not Availables
000004-diphosphocytidyl-2-c-methyl-d-erythritol C₁₄H₂₅N₃O₁₄P₂ 521.311 g/mol NotAvailable Beta-1,4-Xylanase inhibitor Not Availables
000003-(2-aminoethyl)-4-(aminomethyl)heptanedioic säure C₁₀H₂₀N₂O₄ 232.279 g/mol NotAvailable Xanthine Dehydrogenase/Oxidase inhibitor Not Availables
000003-(1,10-phenanthrol-2-yl)-l-alanin C₁₅H₁₃N₃O₂ 267.287 g/mol NotAvailable Prolyl Endopeptidase inhibitor Not Availables
000003-(1-aminoethyl)nonanedioic säure C₁₁H₂₁N₁O₄ 231.291 g/mol NotAvailable Epilancin 15X inhibitor Not Availables
cacodylate ion C₂H₆O₂As₁₁- 886.206 g/mol NotAvailable Prolyl Oligopeptidase inhibitor Not Availables
000003-(3,4-dimethoxyphenyl)propionic säure C₁₁H₁₄O₄ 210.229 g/mol NotAvailable Cytidine Deaminase inhibitor Not Availables
000003-(2-benzothiazolylthio)-1-propanesulfonic säure C₁₀H₁₁N₁O₃S₃ 289.382 g/mol NotAvailable Zinc-Substituted Cytochrome C inhibitor Not Availables
[[(5-oxo-5,6-dihydro-indolo[1,2-a]quinazolin-7-yl)-acetic säure]] C₁₇H₁₂N₂O₃ 292.293 g/mol NotAvailable Glutathione S-Transferase Mu 1 inhibitor Not Availables
2'deoxy-thymidine-5'-diphospho-alpha-d-glucose C₁₆H₂₆N₂O₁₆P₂ 564.333 g/mol NotAvailable Trypsin inhibitor Not Availables
2'3'-dideoxyinosin C₁₀H₁₂N₄O₃ 236.230 g/mol NotAvailable Trypsin inhibitor Not Availables
[[n2-({[(4-bromophenyl)methyl]oxy}carbonyl)-n1-[(1s)-1-formylpentyl]-l-leucinamide]] C₂₀H₂₉N₂O₄Br₁ 441.364 g/mol NotAvailable Trypsin inhibitor Not Availables
2s,3s-3-methylaspartic säure C₅H₉N₁O₄ 147.130 g/mol NotAvailable Trypsin inhibitor Not Availables
2c-methyl-d-erythritol 2,4-cyclodiphosphat C₅H₁₂O₉P₂ 278.092 g/mol NotAvailable Cytochrome C Peroxidase inhibitor Not Availables

We provide Linux to the World